









ANTIGENIC MIMICRY AND AUTOANTIBODIES IN 
RHEUMATIC FEVER 
Thesis presented by 
QUENTIN GAVIN EICHBAUM 
in fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
in 




FACULTY OF MEDICINE 
UNIVERSITY OF CAPE TOWN 











The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 











Certificate of Supervisors / ii 
CERTIFICATE OF SUPERVISORS 
In terms of paragraph eight of the "General regulations for the degree of Ph. 
D. ", we as supervisors of the candidate Q. G. EICH BAUM, certify that we 
approve of the incorporation into this thesis of material that has already been 
published or submitted for publication. 
Professor D W Beatty 
Associate Professor and Senior Specialist 
Department of Paediatrics and Child Health 
Dr M I Parker 
Senior Lecturer 
Department of Medical Biochemistry 
Acknowledgements / iii 
ACKNOWLEDGEMENTS 
I wish to acknowledge and express my sincere appreciation to the following: 
• My supervisor Professor David Beatty for his patience, enthusiasm and 
guidance; for his untiring efforts to obtain funding for the project; and for 
the keen and supportive interest he has taken in my career. 
• My co-supervisor Dr Iqbal Parker for his encouragement and support and 
for skilfully and enthusiastically introducing me to molecular biology. 
• Professor Wieland Gevers for providing the facilities to do aspects of this 
work, and for his keen support and the interest he has shown in my 
career. 
• Margaret Cooper and Renee Allin who (at different stages of the project) 
persisted in casting gels and setting up ELISA plates. 
• Miss Jane Hughes for assistance in screening and characterizing the 
monoclonal antibodies, and for her superb vigilance in seeing to the 
material needs of the Immunology Laboratory. 
• Professor Pat Commerford (Head of the Department of Cardiology, 
Groote Schuur Hospital) for obtaining the sera from ischaemic heart 
disease and chronic rheumatic heart disease patients, and Professor 
Heinz Rode (Department of Paediatric Surgery) for obtaining child 
surgical control sera. 
• The staff of the Rheumatic Fever Clinic at Red Cross Children's Hospital 
for their meticulous examination of patients and for always being so 
wonderfully obliging in "feeding" this project with serum. 
• The technologists in the Department of Histopathology at Red Cross 
Children's Hospital, for always somehow managing to squeeze-in the 
cutting of a few more sections of heart tissue. 
• The many doctors, medical technologists and secretarial staff members 
of Red Cross Children's Hospital who have been my friends, who have 
created a pleasant working environment and have done me innumerable 
favours. 
• The hospital and laboratory workers of Red Cross Children's Hospital and 
the Department of Medical Biochemistry, for ensuring the smooth 
running of facilities. 
Acknowledgements / iv 
• Ms Jane Hall of the Institute of Biostatistics (South African Medical 
Research Council) for performing the statistical analyses on the ELISA 
data. 
• Ms Rose Cooper for measuring antibodies to cardiolipin in the rheumatic 
fever patients. 
• Dr James Dale of the University of Tennessee, Memphis (USA) for 
measuring antibodies to the streptococcal M proteins, and for the gifts of 
the rabbit antisera against these M proteins. 
• Dr John Zabriskie of the Rockefeller University (New York) for the gift of 
the purified streptoccocal cell membranes and cell walls. 
• My colleagues, in the Department of Medical Biochemistry, Paul 
Goldberg, Rachel Judd, Johann te Water Naude, Arlene Smith, Juli 
Roussouw and Malcolm Collins for their assistance, many kindnesses and 
for the fun we· shared. 
• Brenda Cowley for her unstinting support and for putting up with being a 
"thesis widow" for so long! 
• Ms Vicky Melly for her superb word-processing skills in typing the tables 
and references, and her patient assistance in printing the text. 
• I am also deeply indebted to the generous support of the following 
funding bodies: the South African Arthritis Foundation; the South African 
Heart Foundation; the Medical Research Council; the Institute of Child 
Health, Red Cross Children's Hospital; and the University of Cape Town 
for various scholarships and bursaries. 













RHEUMATIC FEVER: OVERVIEW AND IMMUNOPATHOLOGY 
1 .A.1 Introduction 
1.A.2 Incidence, Clinical Manifestations and Diagnosis 
1 .A .3 Pathogenic Concepts 
ANTIGENIC MIMICRY, AUTOANTIBODIES AND AUTOIMMUNE DISEASE 
1 . B. 1 Introduction 
1.B.2 Antigenicity, Cross-reactivity & Antigenic Mimicry 
1. B.3 Structural Properties of Cross-reactive Antigens 







Origin of Autoantibodies 
Pathogenic Autoantibodies 
Polyclonal B cell Activation 
1.B.6 Antigenic Mimicry and Autoimmune disease 
1 . B. 7 Cross-reactivity: Serum and Monoclonal Antibodies 























2. ANTIBODIES TO CARDIAC, NUCLEAR AND STREPTOCOCCAL 
ANTIGENS 
2.1 INTRODUCTION 
2.1 .1 Myosin ELISA 
2.1.2 Actin ELISA 
2.1.3 Collagen Type II ELISA 
2 .1.4 Heart Extract ELISA 
2.1.5 Group A Streptococcus ELISA 
2.1.6 Streptococcal M Protein ELISA 
2.1.7 ASO and anti-DNAse antibodies 
2.2 RES UL TS AND DISCUSSIONS 
2.2.1 Study Design and Statistical Analyses. 




















Rabbit Hyperimmune and Nonimmune Control Sera 
Patient Sera : lmmunoglobulin Concentrations 
Cardiac Autoantigens 
2.2.2 .1 Heart Extract ELISA 






Phosphorylase b ELISA 
Anticardiolipin Antibodies (ACA) 
Collagen ELISA 
Group A streptococcal Antigens 
2.2 .3 .1 ASO and anti-DNAse 8 Titres 
2.2.3.2 
2.2.3 .3 
Group A Streptococcus ELISA 
M Protein ELISAs 
Nuclear Autoantigens 
2.2 .4 .1 Antinuclear Antibodies (ANA) 
























Biotin-Streptavidin-Peroxidase and lmmunofluorescence 53 
CONCLUSIONS 60 
3. IMMUNOBLOTIING: CARDIAC AND STREPTOCOCCAL ANTIGENS 
AGAINST RHEUMATIC FEVER AND CONTROL SERA 
3. 1. INTRODUCTION 64 
3 .1.1 lmmunoblotting of cardiac antigens: Crude Extracts, 
Sarcolemmal membrane and Purified Proteins 64 
3.1 .1 .1 Extracts of Heart Tissue: Procedures 64 
3 .1. 1.1 .1 Crude Extracts 64 
3 .1.1.1.2 Sarcolemmal Membrane Extracts 65 
3.1 . 1.2 lmmunoblotting of Heart Antigen Against Human Sera and 
Monoclonal Antibodies 65 
3 . 1. 1 .2 .1 Crude Extracts of Heart 65 
3 .1.1 .2.2 Sarcolemmal Membrane Preparations 67 
3. 1 .1 .2 .3 Purified Cardiac Antigens 67 
3 .1 .1 .2.3.1 Myosin 67 
3 .1.1 .2.3 .1 .1 Rabbit Antiserum 67 
3.1 .1 .2 .3 .1 .2 Monoclonal Antibodies 68 
3 . 1 .1 .2.3.2 Tropomyosin 
3 .1.2 lmmunoblotting of Streptococcal Antigens 
3 .1 .2 . 1 Crude Extracts and Purified M Proteins 
3.1 .3 Special Applications of lmmunoblotting 













Antigens Recognized by T Lymphocytes 
Cross-reactivity and lmmunoblotting: Some Pitfalls 
RESULTS 
3 .2.1 Human Heart Detergent Extracts 
3.2 .1.1 Non-rheumatic Heart Extract 
3.2.1 .2 
3 .2.1.1.1 Preliminary Investigations 
3.2.1.1 .2 Main Investigation 
3.2.1.1.2.1 Identification and Descriptions 
of Antigen Bands 
3.2.1 .1.2.2 lgG Binding 
3.2.1.1.2 .3 
3.2.1 .1 .2.4 
ARF Heart Extract 
lgA Binding 
lgM Binding 





3.2.2.1 Eluted Antibody: Reactivity with lmmunoblotted 
S.pyogenes Antigens 




Reactivity of Anti-Streptococcal Sera with Heart Extract 
Additional Experiments 
3.2 .6.1 Reactivity to Human Collagen Types II, Ill and VI 
3.2 .6.2- Ca2 + ATPase Binding 
DISCUSSION 
3.3 . 1 Human Heart Detergent Extracts 
3.3 . 1 .1 lsotype Binding Patterns of Groups of Sera 
3.3.1 .2 Hypothesis: Raised lgM Anti-heart Antibodies 
3.3.1 .3 Individual Protein Bands Recognised 
3.3 .1.4 Specificity and Pathological Relevance of Antigens 





























3.3 .2 Cross-reactivity: Heart and S.pyogenes M Proteins 113 
3.3.2.1 Reactivity of HRA with lmmunoblotted Streptococcal Antigens 113 
3.3 .2.2 lmmunofluorescence Staining of Eluted Antibody Against Heart 114 
3 .3.3 Sarcolemmal Membranes 114 
3.3.4 Nuclear Antigens 
3.3.5 Rabbit Anti-S.Pyogenes Serum Reactivity with Heart Antigens 
3.3.6 Additional Experiments 







Contents / viii 
4. HUMAN MONOCLONAL ANTIBODIES DERIVED FROM LYMPHOCYTES 
OF ACUTE RHEUMATIC FEVER PATIENTS 
4.1 INTRODUCTION 121 
4 .1 .1 Rheumatic Fever: Use Of Murine And Human Monoclonal Antibodies 121 
4. 1 .1 .1 Mouse Monoclonal Antibodies 121 
4 . 1 . 1 . 1 . 1 Heart and S.pyogenes 121 
4 . 1 .1 .1 .2 Myosin and Tropomyosin 121 
4 . 1 .1 .1 .3 Multispecificity of Anti-streptococcal mAbs 122 
4 .1 .1.1.4 Reactivity with DNA 123 
4 . 1 .1 .1 .5 Human Sarcolemma 123 
4 .1.1 .1 .6 Other Streptococcal Serotypes (and Myosin) 123 
4.1 .1.1.7 Shortcomings of Murine mAbs 124 
4 .1.1 .2 Human Monoclonal Antibodies in Rheumatic Fever 124 
4.1.2 Problems in Development of Human Monoclonal Antibodies 125 
4.1.2.1 Range of lmmunogens and Poor Source of Lymphocytes 125 
4 .1.2.2 Instability of Human Hybridomas 126 
4.1 .2.3 lmmortalization of Human B Cells 126 
4 .1.2.4 Expansion of Human Monoclonal Antibody Cell Lines 127 
4.2 RESULTS 128 
4 .2.1 Screening and Characterization of Monoclonal Antibodies 128 
4.2 .1.1 ARF Patients 128 
4 .2.1 .2 Hybrid Screening and Selection 128 
4.2.1.3 Stability of Hybridomas in Culture 129 
4.2 .1.4 Karyotyping of Selected Hybrids 129 
4.2 .1 .5 Characteristics of lmmunoglobulin Produced 129 
4.2.1.6 Propagation of Hybridomas in Nude Mice 132 
4.2.1.7 Stability of Antibody Production 132 
4.2 .1.8 CD5 + Cell Surface Marker 132 
4.2.1 .9 Anti-Streptococcal Antigen Reactivity 132 
4.2.1 .10 Selection of mAbs against Group A Streptococci 132 
4.2 .1 .11 Cross-reactivity with other Streptococcal Groups (B,C,D,G) 133 
4.2 .1.12 Cross-Reactivity with Non-streptococcal Bacteria 134 
4.2 .2 Anti-Human Heart Antigen Reactivity 134 
4.2 .2.1 Binding to Heart Sections: lmmunoperoxidase Sandwich Assay 134 
4.2.2.2 lmmunoblotting of Heart Extract and Sarcolemma 135 
4 .2.2 .3 Organ Non-Specificity of mAb Binding 135 
4.2 .2.4 Nonspecific Binding to Mammalian Tissue Antigens 135 
4 .2.3 Cross-reactive Binding of Human mAbs to Heart and Streptococcal Ags 135 
4.2.3.1 lmmunoblotting 135 
4.2 .3 .2 ELISA Inhibition Assay 139 
4.2.4 Binding to Nuclear Antigens 139 
4.3 DISCUSSION 141 






Contents I ix 




5.2. 1 cDNA Synthesis and Construction of Agt11 Libraries 
5.2 .1.1 RNA Extraction 
5.2 .1.2 cDNA Synthesis 
5.2.1 .3 
5.2.1.4 
Cloning of cDNA into Bacteriophage Agt11 
Analysis of cDNA Inserts 
5.2.2 Screening of Agt11 cDNA Expression Libraries with Antibodies 
5 .2.2.1 Expression of Recombinant Fusion Proteins 
5.2.2.2 Detection of Clones Reactive with ARF Patient Serum 
5.2 .2.3 Analysis of Positive Clones 
5.2.2.3.1 Size Analysis cDNA Inserts 














5.2.3 Reactivity of Fusion Proteins with Sera 166 
5.2.3.1 Purified Plaque Assay: Specificity for ARF Sera 166 
5.2.3 .2 Fusion Proteins: lmmunoblots against ARF and Normal Sera 170 
5 .2.3.2.1 lmmunoblots of Bacterial Lysogen Lysates 170 
5 .2.3 .2.1 Affinity Purification of Fusion Proteins 
5 .2.3.3 Plaque Selected Antibodies: Cross-reactivity 
with Streptococcal Antigens 
5 .2.4 DNA Sequence Analysis of Positive Clones 
DISCUSSION 
5.3. 1 cDNA Synthesis and Construction of Agt11 Libraries 
5.3.2 Screening of Libraries and Detection of Positive Clones 
5.3 .3 Characterization of Positive Clones 
5 .3 .3.1 Specificity of Positive Fusion Proteins 
5.3.3. 1 .1 Specificity of Purified Plaques for ARF Sera 
5 .3.3 .1.2 lmmunoblots of Bacterial Lysogen Lysates 
5 .3 .3 .1 .3 Cross-reactivity of Plaque-Selected 
Antibodies with Streptococcal Antigens 
















6.1 STUDY OBJECTIVES 185 
6.2 NOVEL TY OF THE APPROACH 185 
Contents I x 
6.3 SALIENT FINDINGS 185 
6.4 DIFFICULTIES IN THE STUDY OF ANTIGENIC MIMICRY 189 
6.5 RHEUMATIC FEVER AS A MODEL OF AUTOIMMUNITY AND IMMUNE FUNCTION 189 
7. MATERIALS AND METHODS 
7.A AUTOANTIBODIES AND IMMUNOBLOTIING (Chapters 2, 3) 192 
7.A.1 Raising Rabbit Hyperimmune Sera 192 
7.A.2 ASO and DNAse B Antibody Titres 192 
7.A.2.1 Anti-streptolysin O antibodies (ASO) 192 
7.A.2.2 Anti-DNAse B antibodies (DNAseB) 192 
7.A.3 Group A Streptococcus ELISA 192 
7.A.4 Actin ELISA 193 
7 .A .5 Collagen Type II ELl~A 193 
7.A .6 ELISAs to Cardiac Autoantigens 194 
7.A.6.1 Myosin 194 
7.A.6.2 Heart Extract 194 
7.A.6.3 Phosphorylase b 195 
7.A .7 Antinuclear Antibodies 195 
7.A.8 Bacterial Cell Cultures 195 
7.A.9 lmmunoblotting 195 
7.A .10 SOS Polyacrylamide Gel Electrophoresis 196 
7 .A.11 Heart Antigen Extract 197 
7.A.12 Sarcolemmal Membrane Purification 197 
7.A.13 Affinity Purification of Antibody on lmmunoblots 198 
7 .A.14 Nuclear Extracts from Cultured Heart Cells 198 
7.A.15 Primary Culture of Human Heart Cells 199 
7 .A.16 Processing of Tissue for lmmunocytochemistry 199 
7.A.16.1 Paraffin Wax Sections 199 
7.A.16.2 Frozen Sections 199 
7.A.17 lmmunofluorescence on Tissue Sections 200 
7 .A.18 lmmunocytochemistry: Biotin-streptavidin-peroxidase 200 
MONOCLONAL ANTIBODIES (Chapter 4) 201 
7 .A.19 Cell Culture 201 
7 .A.20 EAC Rosettes: B Cell Purification 201 
7.A.21 Monoclonal Antibody Cell Fusions 202 
7.A.22 Hybridoma Screening against Heart and S.pyogenes 202 
7.A.23 lmmunoperoxidase Sandwich Assay 202 
7.A.24 Production of Ascites 203 
. 7.A.25 Cryopreservation of Hybridoma Cells 203 
7.A.26 Karyotyping of Hybridomas 203 
7.A.27 lmmunoprecipitation of Hybridoma lmmunoglobulin 203 
7 .A.28 Indirect lmmunofluorescence: Cell Surface Antigens 
7.A.28.1 Cell surface immunoglobulin 
7.A.28.2 CDS+ Antigen 
7 .A.29 Tissue Absorptions 
7 .A.30 Bacterial Antigen Sonicates 
7 .A.31 Bacterial Detergent Extracts: S.pyogenes and E.coli 







7.8 AGT11 CDNA LIBRARIES: CONSTRUCTION AND IMMUNOSCREENING (Chap. 5) 206 
7. B. 1 Preparation of RNA and Synthesis of cDNA 
7. B. 1 . 1 RNA Extraction 
7.8.1.2 Poly (A)+ RNA Isolation 
7.B.1.3Synthesis of cDNA 
7.8.1.3.1 S1 Nuclease Method 
7.8.1.3.2 RNAse H Method 
7.8.1.3.3 Random Hexanucleotide Priming Method 
7.8.1.3.4 Calculation of cDNA Reaction Yields 
7.8.2 Cloning of cDNA into .Agt11 Expression Vector 










Methylation of Internal EcoR I Sites 
Ligation of EcoR I Phosphorylated Linkers to cDNA 
EcoR I Digestion of Linkered cDNA 
Separation of Excess Linker Molecules 
Ligation of EcoR I-Ended cDNA into Agt11 
Packaging of Agt11 Recombinants 
Plating and Titration of Agt11 Libraries 
Evaluation of Libraries 
Lambda DNA Extraction 
7.8.2.10.1 DNA Extraction from Liquid Lysates 
7.B.2.10.1.1 Liquid Lysate 
7.8.2.10.1.2 DNA Extraction 
7 .B.2.10.2 Plate Lysates 
7. 8.3 lmmunoscreening of .Agt11 Libraries 





Primary Antibody Dilution and Treatment 
Removal of £. coli Cross-reactivity 
Affinity Purification of Antibody on Western Blots 






























7. 8. 4 Analysis of positive clones 21 7 
7 . 8.4. 1 Analysis of Fusion Proteins 217 
7.B.4 .1.1 Isolation of Recombinant Lysogens 217 
7.8.4.1.2 Fusion Proteins 217 
7. 8.4.2 Analysis of DNA Positive Inserts 218 
7.8.4.2.1 Subcloning of Agt11 Inserts into pUC19 218 




Plasmid DNA Isolation 
Small Scale (Rapid) Preparation 








Contents / xii 
Preparation of Competent £. coli Cells 21 9 
Plasmid DNA Transfection of £. Coli Cells 220 
Sequencing of DNA 220 
7 .8.5 General Nucleic Acid Techniques 220 
220 
221 
7.8.5.1 Formaldehyde Agarose Gel Electrophoresis of RNA 
7.8.5 .2 Agarose Gel Electrophoresis of DNA 
BUFFERS AND SOLUTIONS 222 
APPENDIX A: STATISTICAL TESTS AND UNIVARIATE DESCRIPTIVE STATISTICS 230 
APPENDIX B: CLINICAL AND DEMOGRAPHIC PARTICULARS OF ARF PATIENTS 242 

























































absorbance at 260nm 
adenine or adenosine 
anti-actin antibodies 
antibody 
Abbreviations / xiii 
2.2 azinodi-3-ethylbenzthiazoline sulphonic acid diammonium salt 
anti-cardiolipin antibodies 
aminoethylcarbizole 




anti-phosphorylase b antibodies 
acute rheumatic fever 
anti-streptolysin 0 
adenosine 5 '-triphosphate 
Bacillus Calmette-Gul§rin 
5-bromo-4-chloro-3-indolyl phosphate 
dry-milk powder immunobf ot blocking reagent 
base pair 
bovine serum albumin 
cytosine or cytidine 
degree Celsius 
complementary deoxyribonucleic acid 




counts per minute 











enzyme-linked immunosorbent assay 
antigen-binding fragment 
Freund's complete adjuvant 
fetal calf serum 
Freund's incomplete adjuvant 
fluorescein isothiocyanate 
unit of gravity 
guanine or guanosine 
group A Streptococcus 
Dulbecco's PBS with added 2g/L glucose, 0.01 g/L phenol red 
heavy chain of immunoglobulin 
hypoxanthine, aminopterin, thymidine 
hypoxanthine guanosine phosphoribosyl transferase 
heart-reactive antibodies 
horseradish peroxidase 
Abbreviations / xiv 
HSP heat shock protein 
HT RPMI containing hypoxanthine 1 x1 o-4 M, thymidine 1.6x1 o-5M, 











































minimum essential medium 
multiplicity of infection 
molecular weight 
number in study or group 
nitroblue tetrazolium 
not determined 
optical density at 260nm 
oligonucleotide 
polyacrylamide gel electrophoresis 
peripheral blood lymphocyte 
phosphate-buffered saline 
polyethylene glycol 






positive clone No. 5 
positive clone No. 6 








SOS sodium dodecyl sulfate 
SRBC sheep red blood cells 
Strep A group A streptococci 
Strep A-ELISA streptococcal group A ELISA 
T thymine or thymidine 
Tris tris(hydroxymethyl)aminomethane 
Tris-HCI tris hydrochloride 
UV ultraviolet 
Xgal 5-bromo-4-chloro-3-indolyl-B-D-galactoside 
Dedication / xv 
FOR 
MY FATHER AND MY MOTHER 
FOR THEIR SUPPORT AND FRIENDSHIP 
Abstract / xvi 
ABSTRACT 
Antigenic m1m1cry or cross-reactivity between antigens of the group A 
streptococcus and human heart antigens may initiate an autoimmune response 
in certain individuals leading to cardiovascular damage and the production of 
heart reactive antibodies in rheumatic fever. 
The objective of this study was to identify cross-reactive cardiac antigens, and 
to examine and compare the autoantibody profiles in seven groups of subjects. 
These groups, each of twenty individuals, were: children with acute rheumatic 
fever, rheumatic heart disease, acute glomerulonephritis and normal children; 
and adults with rheumatic heart disease, ischaemic heart disease and normal 
adults. 
Enzyme-linked immunosorbent assays (ELISA) and immunocytochemistry were 
used to measure antibody levels to the following cardiac, nuclear and 
streptococcal antigens: crude extracts of human heart, myosin, actin, 
phosphorylase b, cardiolipin, type II collagen, nuclear antigens, DNA, heart 
muscle sections, whole group A streptococci and streptococcal M proteins . 
It was shown that acute and chronic rheumatic fever patients have elevated 
titres of antibody to crude extracts of heart (as well as heart sections in 
immunocytochemistry), and to myosin, actin, phosphorylase b and nuclear 
antigens. Antibody levels to cardiolipin, collagen and DNA were not 
significantly raised. Antibodies to group A streptococcal antigens, particularly 
the M proteins, were also elevated in the groups of rheumatic fever patients. 
The finding that adult chronic rheumatic fever patients showed the highest 
levels of antibodies to several of these antigens suggested an underlying 
autoimmune polyclonal B ceU activation response, or repeated exposure to 
streptococcal infection which may have contributed to the chronicity of the 
disease in these patients. It was noted that normal and related-disease control 
subjects also had antibodies to some of the tested antigens, although usually at 
much lower titres, indicating that these antibodies may form part of the 
natural/physiologic autoantibody repertoire. It is therefore uncertain whether 
these autoantibodies have a role in the pathogenesis of rheumatic fever. 
lmmunoblotting was used to determine whether rheumatic fever sera reacted 
with specific constituents in extracts of human heart, which were not 
recognised by control sera. Crude extracts of human heart as well as purified 
cardiac sarcolemmal membranes, nuclear extracts of cultured heart cells and 
cardiac myosin were examined. 
The pattern of binding of lgM antibody (but not lgG and lgA) to constituents in 
crude extracts of human heart prepared using the detergent CHAPS, differed 
markedly in acute rheumatic fever sera (ARF) compared to chronic rheumatic 
Abstract I xvii 
fever {CRF) and control groups of sera. CRF sera showed only lgG and lgA 
{but no lgM) binding to these extracts, which may be a consequence of a 
natural shift in antibody isotype production during chronic infection, or may 
represent a shift from natural lgM to pathological lgG autoantibody production. 
More specifically, lgM binding to a 33 kD doublet constituent in these extracts 
was virtually unique to ARF sera. Other cardiac antigens which appeared to be 
uniquely recognised by ARF sera were a 200 kD constituent in purified 
sarcolemmal membranes and a 140 kD nuclear antigen in extracts of cultured 
heart cells. Elution experiments showed some evidence of antibodies in ARF 
sera that were cross-reactive between a 38-40 kD antigen in crude heart 
extracts and streptococcal M5 protein. 
The constituents recognised by these rheumatic fever patient sera, were also 
compared {in molecular weight) to constituents in similar heart extracts 
reported to be reactive with monoclonal antibodies and rabbit immune sera 
evoked by group A streptococcal antigens. The innovation of this 
immunoblotting study lay in the use of patient sera as opposed to such 
monoclonal antibodies and rabbit sera to identify cardiac antigens . 
Human monoclonal antibodies were isolated from hybridomas developed by the 
fusion of lymphocytes from patients with acute rheumatic fever with mouse 
myeloma SP2 cells. These {lgM) monoclonal antibodies were selected for 
cross-reactivity between group A streptococcal antigens (by ELISA) and human 
heart tissue {by immunocytochemistry). However, they appeared to lack 
specificity, reacting with a wide range of cardiac, nuclear and bacterial 
antigens, and were possibly low affinity natural autoantibodies . One of the 
monoclonals showed strong binding to 43 kD constituents in both crude heart 
extracts and in purified sarcolemmal membranes. This constituent corresponds 
in molecular weight to a region in SDS and Triton X-100 extracts of heart 
reported to be reactive with murine monoclonal antibodies and rabbit immune 
sera evoked by group A streptococcal antigens, and may therefore be of 
relevance to rheumatic fever. 
Two cDNA expression libraries in Agt11 were constructed and screened with 
rheumatic fever patient sera, using an alkaline phosphatase-conjugated 
antibody detection system. Three positive clones were detected using serum 
from an ARF (acute-on-chronic) patient with severe carditis and high titres of 
anti-streptococcal antibodies. The DNA from . one of these clones was 
sequenced and showed 100 % homology with human cytokeratin 8 , an a-
helical coiled-coil protein, and 40-50% homology with human cardiac heavy 
chain myosin, tropomyosin and streptococcal M5 protein, which all have similar 
coiled -coil protein structures. Since keratin {antigenically related to cytokeratin) 
has been identified in other investigations as a member of one of two groups of 
autoantigens cross-reactive with streptococcal M5 and M6 proteins {as defined 
by human and murine monoclonal antibodies), this cardiac autoantigen may be 
of significance to rheumatic fever. Autoantibodies directed at such cytoskeletal 
Abstract I xviii 
proteins are known to occur also in normal human sera, but this does not 
preclude their potential pathogenicity. 
This study has therefore introduced a number of innovations into the 
investigation of antigenic mimicry in rheumatic fever by relying on patient sera 
and lymphocytes rather than on rabbit and murine products to identify cross-
reactive cardiac antigens. It showed that rheumatic fever patients have 
autoantibodies to cardiac and nuclear antigens that differ from those of normal 
and related-disease control subjects. Specific cardiac antigens were identified 
both by immunoblotting and by immunoscreening of Agt11 cDNA expression 
libraries comprised of human heart cell genes. Antibody reactivity against 
these autoantigens may be unique to rheumatic fever sera and of significance 
to the pathogenesis or aetiology of the disease. In addition, this study 
highlighted a number of conceptual and practical difficulties in the study of 
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Chapter 1 Introduction / 2 
A. RHEUMATIC FEVER: OVERVIEW AND IMMUNOPATHOLOGY· 
1 .A. 1 Introduction 
After more than 50 years of intensive investigation, the pathogenesis of 
rheumatic fever is still not understood. It is well-recognised that the group A 
streptococcus is the aetiologic agent, but the mechanism by which it induces 
pathology has not been elucidated. 
Acute rheumatic fever has been described as, "a post-streptococcal disease 
characterised by nonsuppurative inflammation of various organs, most 
characteristically the heart" (Schaller and Szer, 1989). There are many 
excellent reviews on rheumatic fever and no point would be served in trying to 
emulate these (Zabriskie et al., 1971; Bisno, 1979, 1980; DiSciascio and 
Taranta, 1980; Zabriskie, 1982, 1985; Rotta, 1983; Senitzer and Freimer, 
1984; Ayoub, 1984; Williams, 1985; Zabriskie and Gibofsky, 1986; Stollerman, 
1988; Gibofsky and Zabriskie, 1988; Schaller and Szer, 1989). 
This chapter presents a brief overview of the incidence, clinical manifestations 
and pathogenic concepts in rheumatic fever (section A), and then reviews some 
current concepts in autoimmunity - with particular reference to autoantibodies 
and antigenic m1m1cry, the hypothetical framework within which the 
investigations described in this thesis were performed (section B). 
1.A.2 Incidence, Clinical Manifestations and Diagnosis 
Although the incidence of rheumatic fever in most industrialised countries has 
declined markedly since 1950, the disease remains a major health problem in 
many third world countries, with an estimated 15-20 million new cases 
appearing each year. 
The disease is certainly more common in impoverished living conditions, as 
reflected by reports of ongoing rheumatic fever in Soweto, South Africa 
(McLaren et al., 1975), in New Zealand (Stanhope, 1975), and in Egypt (Husby 
et al., 1976). Among Black South .African school children the overall 
prevalence rate was. shown to be 7 per 1000 (McLaren et al., 1975). 
However, recent resurgences of rheumatic fever in affluent communities in the 
USA (Hosier et al., 1987), indicate that improved socioeconomic and medical 
conditions alone, cannot account for the decline of the disease in industrialised 
countries. Neither can the use of antibiotics solely account for this decline, 
since 'it was already apparent before the introduction of penicillin. 
There is considerable variation in the clinical manifestations of the disease -
carditis, arthritis, chorea, erythema marginatum and subcutaneous nodules -
which occur with varying degrees of severity. The first attack usually occurs in 
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children between the ages of 5 and 15 years of age, after repeated group A 
streptococcal pharyngeal infections. 
The most serious consequence and characteristic feature, as well as the only 
permanently damaging manifestation, is carditis which may involve 
endocardium, myocardium and pericardium. About one third of first-attack 
patients have carditis, but the incidence of cardiac involvement increases with 
recurrent attacks (to about 50%). Arthritis is the most common manifestation, 
occurring in about three fourths of patients during the initial attack, whereas 
chorea (a neurologic manifestation involving caudate nucleii in the brain) occurs 
in about 8-23% of patients and has a longer latent period (one to six months) 
than the other manifestations (Feinstein and Spagnuolo, 1962; Massei! et al., 
1958). Manifestations affecting the skin are subcutaneous nodules and 
erythema marginatum, both usually only seen in patients with carditis (Feinstein 
and Spagnuolo, 1962; Massell et al., 1964). 
The modified Jones Criteria (Table 1.1) are widely accepted as valuable 
guidelines in the diagnosis of rheumatic fever. There is no single diagnostic or 
laboratory test for the disease, and the various manifestations can be 
ambiguous and sometimes difficult to distinguish from those of other diseases. 
TABLE 1.1 (American Heart Association: Committee Report 1984) 









Previous rheumatic fever 





Acute phase reactions: elevated 
erythrocyte sedimentation rate, C-
reactive protein , leukocytosis 
Prolonged P-R interval 
Supporting evidence of preceding streptococcal infection (increased ASO or other 
streptococcal antibodies; positive throat culture for Group A streptococcus; recent scarlet 
fever). 
The presence of two major criteria, or of one major and two minor criteria, indicates a high 
probability of the presence of rheumatic fever if supported by evidence of a preceding 
streptococcal infection. The absence of the latter should make the diagnosis doubtful, except 
in situations in which rheumatic fever is first discovered after a long latent period from the 
antecedent infection (e.g . Sydenham's chorea or low-grade carditis). 
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Two major criteria, or one major and one minor criterion, are highly suggestive, 
but not diagnostic, of rheumatic fever. In addition, it is important to establish 
the presence of an antecedent group A streptococcal infection (usually by 
demonstration of increased titres of streptococcal antibodies). (Chorea, as the 
sole manifestation, can usually be accepted as diagnostic). 
1.A.3 Pathogenic Concepts 
Gibofsky and Zabriskie ( 1988) list the following reasons for the slow progress 
in elucidating the pathogenesis of rheumatic fever: ( 1) the lack of a suitable 
animal or other experimental model; (2) the difficulty in deciphering which of 
the group A streptococcal products capable of causing tissue injury, are 
actua.lly implicated in pathogenesis; (3) the long latency period between the 
initial streptococcal infection and the appearance of clinical and pathologic 
signs and symptoms, which restricts prospective studies. 
The initial group A streptococcal infection of the throat is essential to 
pathogenesis-. Although streptococci may be isolated from the skin or 
pyodermal lesions of patients with acute rheumatic fever, these are not 
associated with pathogenesis, nor have other groups of streptococci or other 
organisms been implicated in the disease. Furthermore, it appears that several 
group A streptococcal pharyngeal infections are needed before complications 
develop, since attacks of rheumatic fever rarely occur in children under 3 years 
of age (Rosenthal -et al., 1968). Group A streptococcal infection of the upper 
respiratory tract appears therefore to hold important clues to the pathogenesis 
of rheumatic fever. 
Hypotheses explaining this link of S.pyogenes to pathogenesis are listed by 
Schaller and Szer ( 1988): ( 1) rheumatic fever is caused by the persistence of 
S.pyogenes bacteria in the patient; (2) rheumatic fever is caused by the toxic 
intra-or extracellular products or components of S.pyogenes; (3) rheumatic 
fever is caused by a hypersensitivity or autoimmune reaction sparked off by 
group A streptococci; (4) rheumatic fever is a consequence of antigenic 
mimicry and partial tolerance between streptococcal and cardiac antigens . 
There is no evidence to suggest that persistent group A streptococcal 
infections cause rheumatic fever; nor have the toxic products of the organism 
been directly implicated in pathogenesis; and hypersensitivity reactions exhibit 
progressively shorter latency periods than those seen in rheumatic fever. For 
such reasons (and others) theories of autoimmunity and antigenic mimicry 
between streptococcal and human antigens have appeared more credible. 
The demonstration, in 60-80% of patients with acute rheumatic fever, of 
autoantibodies against cardiac tissue that cross-react with group A 
streptococcal antigens (Kaplan et al., 1961; Hess et al., 1964), as well as the 
deposition of lgG antibodies and complement in myocardial and valvular tissue 
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(evident by immunofluorescence) in some rheumatic fever patients (Kaplan and 
Svec, 1964), has been propounded as evidence of an autoimmune pathogenic 
mechanism. Difficulties with this theory are, (1) that the reactions are not 
entirely specific for heart tissue nor unique to rheumatic fever; (2) that it has 
not been established whether the cross-reactive antibodies and the depositions 
in the heart are the cause or result of pathology; (3) that the cross-reactive 
antigens, particularly the cardiac antigens, are still poorly defined and some of 
the findings have been contested. 
The cross-reactivity between a human heart valve glycoprotein and S.pyogenes 
polysaccharides (Goldstein et al., 1967) has been contested by Kasp-
Grochowska et al., 1972), although more recent evidence suggests that such 
cross~reactions may initiate recurrent attacks of rheumatic fever (Gowrishkar 
and Agarwal, 1980; Appleton, 1985). Regarding myosin as a cross-reactive 
autoantigen, the presence of autoantibodies to this protein in several other 
diseases (see Chapters 2 and 3), casts an element of doubt on its pathogenicity 
in rheumatic fever . A causative role for a cellular autoimmune mechanism in 
rheumatic fever has also not been proven (McLaughlin et al., 1972; Dale and 
Beachey, 1981) although more recent studies are quite convincing (Hutto and 
Ayoub, 1980; Kotb et al., 1989). 
Part of the problem in defining causative factors in rheumatic fever, may be due 
to confounding genetic variables . The fact that only 1-3 % of all patients with 
group A streptococcal pharyngitis develop rheumatic fever, seems to suggest a 
genetic predisposit ion or host factor(s) in such patients. However, HLA linkage 
has not been established (Murray et al., 1978; Falk et al., 1973; Ward et al., 
1976) . Studies of identical twins have shown a concordance rate of less than 
20 %, which is lower than that found in twins with infectious diseases such as 
tuberculosis (Stollerman, 1975, 1986; Taranta, 1976). The most convincing 
evidence of a genetic factor for susceptibility to rheumatic fever, has been the 
detection of a B cell alloantigen (designated 883) in 75 % of rheumatic fever 
patients compared to 16.5% of normal subjects (Pattarroyo et al., 1979) . This 
antigen, defined by a monoclonal antibody (D8/17) is not associated with the 
human MHC system, and has an autosomal recessive mode of inheritance 
(Khanna et al., 1989). 
Rheumatic fever may therefore involve a subtle "interplay between host, 
genetics and microbe" (Zabriskie, 1985). Such an interplay may manifest in 
molecular mimicry between antigens expressed by the group A streptococcus 
and human host genetic systems. How specific microbial antigens might 
initiate an autoimmune response in only certain hosts leading to cardiovascular 
disease, is an intriguing question presumably of relevance to other rheumatic 
and autoimmune disorders . The ensuing discussion reviews the role of 
antigenic mimicry and autoantibodies in autoimmune disease. 
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B. ANTIGENIC MIMICRY, AUTOANTIBODIES AND AUTOIMMUNE 
DISEASE 
1.B.1 Introduction 
The term "autoimmunity" refers to the reaction of the immune system with the 
host's own tissues. Autoimmunity could be the natural consequence of self-
tolerance (for the immune system to "know itself" it must have "seen itself"), 
and according to present concepts self-reactive T cells and autoantibodie$ are 
integral components of the normal immune repertoire. 
In some instances, autoimmunity can lead to disease. One way in which this 
can happen is through "antigenic mimicry", a term originally coined to refer to, 
"that particular situation in which microbes and mammalian tissues share 
antigenic determinants" (Zabriskie, 1982). This review is a discussion of. some 
concepts in autoimmunity, and in particular of the role and nature of 
autoantibodies and autoantigens in provoking disease through the mechanism 
of antigenic mimicry (or cross-reactivity). 
1.8.2 Antigenicity, Cross-reactivity & Antigenic Mimicry 
Cross-reactivity has been defined as, "the ability to react with ligands other 
than the immunogen" (Bersofsky et al., 1989). Although one may speak of 
cross-reactive antibodies, more usually cross-reactivity is discussed from the 
point of view of the antigens. Cross-reactivity can only be defined with 
reference to a corresponding antibody or antiserum. Two antigens are said to 
be cross-reactive because they bind to the same antibody. 
Cross-reactivity between two antigens does not imply any functional or 
evolutionary relationship between them. The presence of similar epitopes on 
two proteins may be entirely fortuitous. The scope for cross-reactivity is 
immense when one considers that an antibody can recognize a determinant as 
short as 4-7 amino acids (Atassi, 1975; Crawford et al., 1982). It has been 
calculated that, assuming all the amino acids are randomly distributed, a 
particular sequence of four amino aciqs would appear once in every 204 
tetramers, a particular pentamer once in every 205 pentamers, and a particular 
sequence of six amino acids once in every 106 hexamers (Atassi, 1975). 
Wilson et al. ( 1984) searched over 2500 amino acid sequences in a particular 
protein data base found 2469 hexamers, 186 septamers and 17 octamers with 
homologies. Cross-reactions defined particularly by monoclonal antibodies 
could be quite common between such sequences. Srinivasappa et al. ( 1986) 
examined the cross-reactivity with host tissues of over 600 mAbs to various 
viral polypeptides and found that 4% of these mAbs cross-reacted with 
determinants expressed on uninfected host tissues. These data demonstrate 
that cross-reactivity (antigenic mimi'Cry) occurs quite frequently. 
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Besides such perfect homologies, two unidentical but similar epitopes may 
display cross-reactivity by binding the same antibody with different affinities 
(Lane and Koprowski, 1982). This increases the spectrum of potential cross-
reactions and may explain the phenomenon of multiple organ reactivity reported 
with mouse and human monoclonal antibodies (Haspel et al., 1983; Satoh et 
al., 1983). Antibodies were shown to recognize either the identical molecule in 
different organs or else similar epitopes on unidentical molecules in different 
organs. 
Conceivably, also similarities in the aggregate effect of the charged amino acid 
groups of two antigens, could make them cross-reactive. Such an interaction 
could. occur heedless of the exact sequence of amino acids (homologous 
between their epitopes). Kabat ( 1986), investigating cross-reactivity between 
N-acetyl-neuraminic acid and denatured DNA, suggested that "similarities and 
differences in charge distribution could be responsible for immunological cross-
reactions among what have been generally considered diverse and structurally 
unrelated substances". 
In assessing the potential for cross-reactivity, account should also be taken of 
the effect of the interacting surface of the antibody. Contrary to static lock-
and-key models of molecular recognition, antibody and antigen molecules have 
some flexibility to exist in different conformations, and can cooperate in such a 
way as to induce a better complementary fit. Such a process may involve side-
chain movements of the antigen and possibly also of the backbone 
conformation (Getzoff et al., 1988). Strickland et al. ( 1987) reported a mutant 
antibody that had lost its original idiotope but expressed it again after binding 
to another anti-idiotype. This effect may have been induced by a 
conformational change in the antibody. 
Another source of potential cross-reactivity in the antigen-antibody interaction 
lies in the polyreactive nature of antibodies (Van Regenmortel, 1989). The 
polyvalency of the antibody binding site may contribute to permitting the 
antibody to cross-react with various closely related epitopes or haptens 
(Talmage, 1959; Cameron and Erlanger, 1977). 
Assay dependent variables can have an influence on the in vitro detection of 
cross-reactions. Van Regenmortel (1989) has argued that most studies 
purporting to measure "antigenicity per se" are instead actually measuring 
-"cross-reactive antigenicity". Except for X-ray crystallography which visually 
portrays the spatial arrangements of the antibody-antigen interaction, most 
investigations are based on functional assays involving operationally-defined 
binding measurements. Such studies are dependent on assay conditions which 
can vary and thus have a determining influence on whether particular residues 
are interpreted as being part of a specific epitope. Such functionally-defined 
epitopes are usually comprised of only 3-8 residues whereas epitopes 
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structurally defined by crystallographic analysis, comprise on average 1 5 
residues. The smaller average number of residues comprising functional 
epitopes thus exerts a major bias towards detection of cross-reactions. 
Experimentally determined cross-reactions may have an artefactual component, 
and therefore caution is needed in interpreting their biological significance. For 
instance, although antigen is recognised in vivo in a denatured state, when it 
sticks to plastic in solid-phase assays it may fold or denature differently so as 
to create an artefactual set of (conformational) epitopes that cross-react 
spuriously. 
Some cross-reactions can have survival value for the organism. Cross-
reactivity in the form of antigenic mimicry between parasites and their hosts 
can confer on the parasite "a degree of molecular camouflage against the 
host's immune system" (Damian, 1987), thereby promoting its survival in the 
host. An example is the homology between Plasmodium falciparum antigens 
containing repetitive amino acid sequences that cross-react with the host 
protein thymosin-A 1 (a thymus peptide hormone implicated in T cell 
maturation). The similarity of the parasite's antigens to those of the host could 
lead to a weakening of the antibody response, or possibly even interference in 
the host's immune response (Dubois et al., 1988). Similarly, in rheumatic fever 
it is possible that antigenic mimicry between streptococcal M proteins and 
human heart antigens such as myosin and sarcolemmal membrane antigens, 
may have the effect of weakening the immune response to the streptococcal 
pathogen. 
The fact that such antigens often do provoke an (auto)antibody (or T cell) 
response, is perhaps more surprising than elusion of the host's defence system 
due to the mimicry of autoantigens. How a microbial antigen can break the 
host's . self-tolerance by mimicking a self-antigen, and trigger autoimmune 
_disease, is a question that needs to be answered to understand how antigenic 
mimicry leads to autoimmune disease. 
Discrimination between self and non-self is central to autoimmune disease, 
which represents a· breakdown in such discernment. Antigeri1c mimicry could 
provoke such a breakdown. 
1.B.3 Structural Properties of Cross-reactive Antigens 
Are there structural features of antigens that make them more cross-reactive? 
Antigens with regularly repeating structures and high epitope densities such as 
bacterial lipopolysaccharides (LPS) and DNA tend to be implicated in cross-
reactions. Bacterial LPS is highly antigenic and elicits lgG and lgM monoclonal 
antibodies, whereas DNA is weakly immunogenic and generally elicits lgM 
monoclonals (Ghosh and Campbell, 1986). DNA often cross-reacts with 
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proteins, particularly cell surface proteins and with haptens, and cross-
reactivity with cardiolipin is known to be due to the similarity in spacing 
between two phosphate groupings (Rauch et al., 1984). The high density of 
epitopes on both DNA and LPS is likely to generate low affinity antibodies. 
Such low affinity cross-reactions are readily detectable in sensitive laboratory 
assays and may be biologically irrelevant. 
Similarly, some eukaryotic structural proteins with tandemly repeated 
sequences such as myosin (Delozanne et al., 1985), intermediate filaments 
(Marchuk et al., 1984), nuclear lamins (Fisher et al., 1986) and tropomyosin 
(Stone and Smillie, 1978) have been implicated in cross-reactions. These are 
all coiled-coil proteins sharing a common structure comprised of tandem 
repeats of 7 amino acids, with hydrophobic residues at the first and fourth 
positions. Of these proteins, myosin and tropomyosin have been shown to 
cross-react with streptococcal M proteins implicated in rheumatic fever (Dale 
and Beachey, 1986; Fenderson et al., 1989). 
Polymorphism is · a second feature associated with increased cross-reactivity of 
antigens. Polymorphic antigens such as the histocompatibility antigens tend to 
elicit antibodies capable of binding similar but not identical antigens. A 
monoclonal antibody against HLA-827 (the Class I MHC antigen associated 
with Reiter's disease and ankylosing arthritis) was shown to be cross-reactive 
with an antigen on Yersinia pseudotuberculosis (Chen et al., 1987). Similarly, 
some Klebsiella bacteria have been shown to cross-react with HLA-827 
(Ogasawara et al., 1986). How such cross-reactions trigger autoimmune 
arthritic lesions is not known; however this is only one of several possible 
,mechanisms by which these lesions may be induced. 
Ghosh and Campbell ( 1986) list the following features of antigens and 
antibodies which can make them more susceptible to irrelevant cross-reactions 
under experimental conditions (especially in solid phase binding assays): (1) 
antibodies of low affinity for the original immunogen have an increased 
potential for irrelevant cross-reactions; (2) antibodies of the lgM class, due to 
their multivalence, have a higher potential for nonspecific cross-reactivity; (3) 
the presence of Fe receptors on cell surfaces can bind the constant region of 
lgG antibodies nonspecifically; (4) antigens with a repeating structure or 
present at high concentrations in the assay, have an increased potential for 
nonspecific cross-reactivity. Genuine cross-reactions are experimentally best 
verified by kinetic analyses of the intrinsic affinities between antibodies and 
antigens, and by the reproducibility of the cross-reaction under identical 
conditions using pure antibody and identical amounts of the two antigens. 
Genuine cross-reactions may be fortuitous and biologically irrelevant, or they 
may be "a reflection of functional or evolutionary relationships between the 
cross-reacting proteins" (Nigg et al., 1982). Antigenic mimicry may aid 
parasites and infective bacteria in eluding the host's immune system (Damian, 
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1987), and it is thought that such mimicry between S.pyogenes M proteins and 
human antigens assists the bacteria in eluding phagocytosis in rheumatic fever. 
In some instances, cross-reactivity may lead to autoimmune disease with 
production of autoantibodies (and possibly autoreactive T cells). The ensuing 
discussion examines the role of autoantigens and autoantibodies in provoking 
(or indeed preventing) autoimmune disease. 
1.8.4 Autoantigens 
Autoantigens are the self~antigens to which autoantibodies bind. They are not 
restricted to any particular macromolecular species, but may be proteins, 
nucleic acids, carbohydrates, glycoproteins, lipoproteins, phospholipids or 
steroids. They tend to be phylogenetically conserved rather than autospecific, 
and can be grouped into ubiquitous or organ specific autoantigens. Examples 
of ubiquitous autoantigens are nuclear antigens such as ribonucleoproteins and 
nucleic acids that are present in various eukaryotic cell types as well as in 
bacteria. Organ (or cell) specific autoantigens are acetylcholine receptors, 
insulin and less well-defined determinants on platelets and pancreatic B cells. 
Some highly conserved autoantigens control vital cellular functions such as 
DNA repair and RNA splicing (Tan, 1989), but the autoantibodies to these 
antigens do not appear to disrupt cellular function. 
Foreign proteins can also elicit autoantibodies. For example, Nisonoff et al. 
(1967) showed that rabbits immunized with mouse cytochrome c produced 
antibodies not only to the "foreign" murine epitopes, but also contained 
autoantibodies to rabbit cytochrome c. The highly conserved nature of 
autoantigens is borne out by similar experiments in which rabbit antisera to 
cytochrome c were shown to bind the same stretch of residues in all 
mammalian cytochrome e's (Jemmerson et al., 1985). 
By what mechanisms might autoantigens trigger an immune response? Bach· 
(1989) described five possible mechanisms: (1) sequestered autoantigens or 
those appearing late in development may be recognised as foreign because 
they were not exposed to the immune system during embryonic life for the self-
tolerance to be established; (2) autoantigens may become immunogenic 
through modification by chemical or infectious agents; (3) cross-reactions with 
foreign determinants may permit T cell help for production of antibodies against 
identical or similar autoantigens; (4) autoantigen modification may be 
endogenous (as in the case of abnormal lgG glycosylation patterns of RA 
patients); (5) autoantigens may be rendered immunogenic through their 
association with aberrantly expressed class II MHC products. 
Weckerle (reported in Cohen, 1989) recently defined three characteristics of 
pathogenic autoantigens pertaining specifically to experimental autoimmune 
encephalomyelitis (EAE): ( 1) the autoantigen should be presentable by tissue 
cells at the site of the disease (2) the autoantigen elicits a strong T-cell 
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response under the control of Ir (MHC) genes; (3) autoantigens can evoke a 
cytotoxic T-cell response of either CD4 or CD8 phenotype. 
The pathogenicity of .a particular autoantigen may not always be immediately 
evident. Conceivably, an immunogen might cause the release of a sequestered 
autoantigen which could evoke a chronic autoimmune response - what 
Oldstone (1987) called a "hit-and-run event". A released "sequestered 
antigen" may elicit autoantibodies and mediate other forms of immunological 
assault on the tissue, wi.thout itself having been the initial immunologic target. 
Zabriskie ( 1982) propounded such an hypothesis for rheumatic fever. He 
postulated that "crypto-antigens" could be uncovered following an 
. inflammatory insult to the heart by streptococcal antigens, initiating a 
" ... vicious cycle of damage ... (that) would generate a chronic autoimmune 
process, perhaps exacerbated by intercurrent microbial infections". 
The presence of pathogenic autoantigens prompts the question as to how 
natural or .innate tolerance of autoantigens is achieved and maintained. For 
tolerance to be ·achieved under physiological conditions, it is thought that an 
autoantigen must at some stage have been in contact with lymphocytes and 
should therefore be potentially immunogenic. It is plausible that B and T cells 
sensitized to the autoantigen could be held in check by suppressor T cells that 
have also "seen" the antigen (Harris et al., 1982; Cairns et al., 1986). There is 
however some controversy about such a role for suppressor T cells and even 
about their existence (Sercarz, 1987). Coutinho (reported in Cohen, 1989) has 
proposed an alternative hypothesis whereby self-tolerance is maintained 
paradoxically by self-reactivity or "self-assertion": by interconnected 
autoantibodies and lymphocytes that recognize each other and autoantigens 
and thereby maintain a dynamic equilibrium. 
1.8.5 Autoantibodies 
1.8.5.1 Natural/Physiologic Autoantibodies 
Avrameas (1986) has argued that it is through recognition of autoantigens that 
the immune system derives its ability to recognize and respond to foreign non-
self antigens. Whereas it was previously thought that recognition of self would 
lead to self-destruction th.rough autoimmune disease (Burnet, 1959), it is now 
certain that such recognition is an integral part of normal immune function. 
Natural autoantibodies are thought to be a healthy component of the normal 
immune repertoire. 
Cohen ( 1984) has termed this form of immune self-recognition "physiologic 
autoimmunity" to distinguish it from "pernicious autoimmunity", or pathologic 
autoimmunity in which recognition of self is destructive. Two examples of 
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physiologic autoimmunity essential to the normal function of the immune 
system are the ·following. 
1. Recognition of self antigens of the MHC. This system differs from other 
forms of signal transfer between cells (such as those regulating the 
endocrine system) in that it is a form of true adaptive immunity. The 
receptors that recognise self MHC are clonally distributed among classes 
of lymphocytes, and subpopulations of T cells which recognize an 
antigen in associa_tion with a particular MHC allelic product as a self 
signal for cell cooperation. Furthermore, as a signal for cell cooperation, 
the MHC responds to a particular environment of differentiated 
lymphocytes with an adaptive flexibility that is different to physiologic 
recognition systems (Cohen , 1984). 
2. The anti-idiotypic network. In this system, idiotypic antibodies can be 
recognised as self-antigens, and their expression regulated, by anti-
idiotypic antibodies (Eichmann, 1978; Binz et al., 1976). The anti-
idiotypic response thus entails self-recognition that can be considered as 
a form of physiologic autoimmunity conducive to the healthy function of 
the immune system (Cohen, 1984). 
Natural autoantibodies could be considered another example of physiologic 
autoimmunity. Typically these antibodies bind highly conserved self-antigens 
such as albumen, nucleic acids, cytoplasmic filaments, cytochrome C, collagen 
and actin (Guilbert et al., 1982; Avrameas et al., 1983). They are mostly lgM 
antibodies, have a low affinity for autoantigens and display widespread cross-
reactivity even with bacterial antigens and haptens (Avrameas et al., 1983). 
Their presence in hybridomas derived even from normal, newborn, germ-free 
mice suggests that natural autoantibodies may be fundamental to the normal 
function of the immune system. Although they may possibly be the result of 
V-gene rearrangements, random mutations and junctional imprec1s1ons 
(Schwartz, 1986), their evolutionary conservation suggests a biological role for 
them. Hypotheses explaining their function include the following: (1) they act 
as a first line of defence against invading pathogens (Avrame-as et al., 1983); 
(2) they may be involved in the disposal of catabolic products from the 
organism (Grabar et al., 1983); (3) they may be the precursors of antibodies to 
exogenous antigens - their cross-reactivity with these exogenous antigens may 
give the immune system a potential advantage in eliminating them (Naparstek 
et al., 1986) (4) they may blind the immune system to self antigens, thereby 
preventing autoimmune disease that might occur through mimicry with invasive 
bacterial epitopes (Cohen and Cooke, 1986); (5) they may play a regulatory 
role in the humoral immune response (Mahana et al., 1988). 
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1.B.5.2 Origin of Autoantibodies 
What is the source of these natural autoantibodies? Possibly through random V 
gene rearrangements producing the immensely diverse antibody repertoire, 
some variable regions· are created capable of binding autoantigens. The 
presence of autoantibody-producing B cells indicates that such recombinations 
are expressed and form part of the actual V gene n~pertoire. 
It appears that at least some physiologic autoantibodies are encoded by 
germline V genes . There do not however appear to be abnormalities or 
disease-specific V genes in the antibody repertoire, accounting for 
autoantibodies. Analyses of over 100 autoantibodies deriving from different V 
gene families has not revealed any particular bias. In addition, analysis of V 
gene sequences of autoantibodies to determine whether these antibodies arise 
by mutation, indicates that they can arise from unmutated germline genes 
{Reininger et al., 1987) 
The CD5 + (Leu-; 1) subset of human B cells (and their Ly-1 + B murine 
counterparts) appear committed to the production of polyreactive antibodies 
that bear many features of autoantibodies (Casali et al., 1987; Casali et al., 
1988; Casali and Notkins, 1989). This is not the sole source of autoantibodies 
since it is known that Ly-1- and CD5- cells also produce them. However, the 
polyreactive antibodies produced by CD5 + /Ly-1 + cells are similar to 
autoantibodies in being mostly lgM, and in binding with low intrinsic affinity to 
a range of self and exogenous antigens including ssDNA and rheumatoid factor 
(Casali et al., 1987, 1988). Although, the antibodies produced by CD5 + /Ly-
1 + cells do bind autoantigens, this is only one of their functions (Casali arid 
Notkins, 1989). 
The association of CD5 + /Ly-1 + cells with pathogenic autoantibodies and 
autoimmune disease, is based on the striking increase in their numbers in 
autoimmune disorders such as rheumatoid arthritis, in humans and in lupus-
prone NZB mice. In RA these cells constitute 27-52 % of the circulating B cells 
(Hardy et al., 1987; Burastero et al., 1988) and in lupus-prone NZB mice they 
are increased 5-to 10 fold (Hayakawa et al., 1984). However,».the increase in 
CD5 + cells in RA could not be correlated with clinical disease activity (Plater-
Zyberk, et al., 1985). Furthermore, there is no increase in the proportion of 
CD5 + cells in SLE and, in these patients, high affinity lgG anti-ssDNA 
antibodies are produced by CD5- cells. The polyreactive antibodies produced 
by their CD5 + cells . are similar to those found in healthy subjects. It would 
seem that polyreactive low affinity autoantibodies produced by CD5 + cells are 
functionally different to the monoreactive, high affinity autoantibodies 
characteristic of various autoimmune diseases. Possibly, pathogenic 
autoantibodies derive from lymphocytes that have been positively selected 
through somatic point mutations, and are a result of an antigen-driven process. 
It seems in any case unlikely that CD5 +\Ly-1 + cells by themselves cause the 
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development of autoimmune disease, but they probably do play a role as a first 
line of defence in a primary, low affinity, lgM response against infectious 
pathogens. 
In summary, CD5 + \Ly-1 + cells are one source of autoantibodies but not the 
exclusive source. It has been suggested that they could be the major source of 
physiologic natural autoantibodies whereas pathogenic autoantibodies could 
derive from mature CD5-/ly-1- cells (Bach, 1986), but there is also evidence of 
pathogenic autoantibodies deriving from Ly-1 + cells (Stall et al., 1986). 
1.B.5.3 Pathogenic Autoantibodies 
Pathogenic autoantibodies are usually lgG, of higher affinity and frequently 
express private idiotypes (Tron et al., 1982, 1983), in contrast to physiologic 
autoantibodies which are lgM, polyspecific, encoded by germline genes and 
more often express public idiotypes. Whether the postulated difference in 
pathogenicity between the two types of autoantibody is a function of differing 
affinities or specificities, and whether autoantigen triggers formation of 
pathogenic autoantibodies, are unanswered questions. 
Autoantibodies may be produced by polyclonal B cell activation. In systemic 
autoimmune diseases, such B cell activation occurs frequently, although in 
organ specific autoimmune diseases autoreactive clones to specific antigens 
proliferate preferentially (Klinman and Steinberg, 1987; Dziarski, 1988). It is 
known that in vitro polyclonal B cell activation does lead to formation of 
autoantibodies such as anti-DNA antibodies, rheumatoid factor and anti-
erythrocyte antibodies (Schwartz and Datta, 1989). B cells could possibly be 
activated through mitogenic stimulation, through T cell lymphokines or may be 
inherently different to other B cells. Bacteria and parasites can produce 
mitogens, and the autoantibodies produced in trypanosomiasis (Kazyumba et 
al., 1986) and malaria (Playfair, 1982) are probably the result of B cell 
polyclonal activation. 
The correlation of autoantibodies with autoimmune diseases does not imply 
that they are pathogenic. Indeed, as Cohen and Cooke (1986)'-argue they may 
play a protective role. Possibly, different mechanisms of B cell activation may 
produce either physiologic or pathogenic autoantibodies. It has been suggested 
that polyclonal activation .of B cells might increase production of physiologic 
autoantibodies, whereas T-cell dependent activation may be necessary for 
generation of pathogenic lgG autoantibodies (Schwartz and Datta, 1989). 
Do autoantibodies associated with particular autoimmune disorders, actually 
cause the disease? Schwartz and Datta (1989) have suggested five methods 
(in descending order of experimental rigor) for determining the pathogenicity of 
autoantibodies: (1) reproduction of the lesion through administration of the 
autoantibody to healthy control subjects (2) production of lesions by 
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immunization with the purified autoantigen (3) simulation of lesions in vitro (4) 
isolation from the disease lesions of the relevant autoantibody (5) correlation of 
autoantibody levels with clinical disease activity. 
Induction of autoimmune lesions in animals through injection of the relevant 
human autoantibodies, has been demonstrated in the case of pemphigous 
vulgaris in mice (Anhalt et al., 1982) and in Goodpasture's syndrome where 
autoantibodies specific for glomerular capillary basement membrane were 
shown to bind glomerular membranes in monkeys in identical fashion to the 
human lesions (Wilson and Dixon, 1973). Induction of autoimmune disease 
through injection of the autoantigen, however, applies only to organ specific 
diseases. It is well-established now that immunization of mice with 
thyroglobulin can produce inflammatory lesions in the thyroid, that resemble 
those seen in Hashimoto's thyroiditis. Similarly, immunization with the 
autoantigen myelin can produce encephalomyelitis in animals. On the other 
hand, it has n_ot been possible to induce non-organ specific (systemic) 
autoimmune diseases (e.g. SLE) in animals by immunization with any of the 
implicated autoahtigens. Possibly the correct autoantigens have not been tried 
or the animals used were not susceptible to the disease; or else the 
autoantibodies may be non-pathogenic, arising from polyclonal B cell activation 
consequent upon some prior pathogenic event. 
The presence of autoantibodies in disease lesions can be an important clue to 
their pathogenicity. In acute rheumatic fever there is mass deposition of 
immunoglobulin along sarcolemmal membrane, but there is no evidence that 
these are autoantibodies. In contrast, the immunoglobulin isolated from 
kidneys of patients with lupus glomerulonephritis are autoantibodies. Although 
some autoantibodies correlate with development of clinical disease (e.g. anti-
DNA antibodies in_ SLE), others, though regularly associated with the disease 
(e.g. rheumatoid factor in rheumatoid arthritis), cannot be shown to cause 
lesions. 
Some of the mechanisms by which autoantibodies operate to provoke 
autoimmune disease are through opsonization, immune complex formation, 
complement-dependent cell cytotoxicity, receptor blockade or sfimulation. 
1.B.5.4 Polyclonal B cell Activation 
The control exerted by the immune system through tolerance and suppression 
on B cells, is not as stringent as that exerted on T cells. Nonetheless, despite 
the nonspecific expansion of B cells, autoantibodies do display preferential 
specificities in many autoimmune diseases. A more truthful representation of 
autoantibody production might therefore combine models of polyclonal B cell 
activation and induction of such antibodies by autoantigen. 
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Dziarski (1988) has proposed such a combined model: individuals prone to 
autoimmune disease may have B cells intrinsically more sensitive to polyclonal 
activators (such as mitogens) and accessory signals (such as lymphokines); 
these activators may stimulate the cells to differentiate into polyclonal 
antibody-(and autoantibody) secreting cells; finally, autoantigens and 
lymphokines (possibly more readily "available" in autoimmune-prone individuals) 
may expand these clones by an antigen-driven selection process, at the same 
time causing a switch to lgG and lgA production. More simply, lshigatsubo et 
al. (1988) have · suggested that possibly the effects of polyclonal B cell 
activation "create an environment in which autoantigens are better able to 
magnify and perpetuate the production of specific autoantibodies". Polyclonal 
activation may be a primitive form of immunity that immediately produces a low 
affinity cross-reactive antibody before maturation of specific, high-affinity 
antibodies (Dziarski, 1988). 
Whatever the m_echanism, it is puzzling that polyclonal expansion of B cells 
should lead to development of nephritis in one SLE patient, and to 
thrombocytopenia in another; or, perhaps analogously, to carditis in one 
rheumatic fever patient and chorea (without any cardiac involvement) in 
another. Why do not all SLE patients produce anti-Sm antibodies; why do only 
60-80% of ARF patients have antibody to heart antigens? Possibly such 
variable manifestations reflect an interplay between genetic and environmental 
factors in these diseases. 
1.8.6 Antigenic Mimicry and Autoimmune disease 
Antigenic mimicry can provoke an autoimmune response only when the foreign 
antigen is at once sufficiently similar to the host (auto)antigen to be cross-
reactive, and yet dissimilar enough to break the host's immunologic self-
tolerance. 
This suggests a more complex relationship between foreign and host antigen 
than can be gleaned from their amino acid sequences. For instance, it has 
been suggested that the cross-reactive foreign epitopes might consist of a 
"self" (similar) domain binding the B cell, and a "foreign" (dissimilar) domain 
that binds a T cell receptor and thereby subverts tolerance (Schwartz and 
Datta, 1989). Another suggestion, is that a foreign antigen may mimic 
conformations of autoantigens without mimicking their peptide sequences 
(Cohen, 1989). 
Another example of a complex interaction between foreign and self antigen 
was shown by Stetler and Jacob (1985). Rabbits immunized with purified RNA 
polymerase enzyme developed not only antibodies to this enzyme but also 
distinct non-crossreactive population of antibodies reacting with nucleic acids 
(including DNA). The lack of shared epitopes between RNA polymerase and 
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nucleic acids, suggests that the immunogenicity of the latter derives from 
physical association with the former. 
Antigenic mimicry ca!"' induce an autoimmune response without provoking 
disease. For example, a 10-residue peptide of myelin basic protein was 
demonstrated to share homology with a six-residue section of hepatitis B virus 
polymerase, and antibodies raised in rabbits to the latter viral protein cross-
reacted with myelin basic protein, but the animals developed no signs of the 
disease (Fujinami and Oldstone, 1985). 
Antigenic mimicry may require only a "hit-and-run" event by an immunogen 
(such as a virus) to induce a cross-reaction that perpetuates immunologically 
mediated tissue injury (Oldstone and Notkins, 1986). After clearance of the 
foreign antigen, components of the immune system could continue to assault 
host tissue, leading to release of more host antigens and production of 
antibodies, and so on. Alternatively such a "hit-and-run" event may release 
sequestered immunologically privileged antigens that could induce and 
perpetuate an autoimmune response in the host. Another scenario of a chronic 
or progressive autoimmune response, could occur with viruses or parasites that 
cyclically or continuously express cross-reactive (virulent) antigens while 
persisting in host tissues. 
By way of contrast, an example of antigenic mimicry in which there is a high 
degree of sequence homology between foreign and self antigens, is found 
between host and pathogen heat shock proteins (HSP). It has been shown that 
a population of human T cells specific for the 65 kD heat shock protein of 
Myocbacterium leprae could also recognize the kindred human HSP which is 
possibly preferentially expressed in stressed monocytes-macrophages (report by 
Palla and Young, 1989). Such stressed human cells could upregulate their 
HSPs which might become available for recognition by T cells or antibodies, 
and induce an autoimmune response. Homology of the pathogen's HSP with 
that of the host could have evolutionary significance in rendering the pathogen 
less vulnerable to environmental stresses inside the host cell (Palla and Young, 
1989). 
"'·· 
Are there then any particular characteristics that pathogenic autoantigens have 
in common? One enigma concerns the dominance of particular autoantigens 
(e.g. HSP65, myelin basic _protein and thyroglobulin). Why in the pancreas are 
only the B cells of the islets attacked; why of all the multifarious antigens in the 
thyroid, are only thyroid peroxidase, thyroid stimulating hormone and 
thyroglobulin implicated in disease? This bias towards particular autoantigens 
illustrates what Cohen ( 1989) refers to as, "the unexpected regularity of 
autoimmunity", and it hints at a more complex interaction between foreign 
antigen and components of the immune system, that cannot be gleaned from 
structural considerations of the antigens alone. 
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One such immunodominant autoantigen may be myosin. Structural features of 
this muscle protein, and some related molecules, may play a role in determining 
their dominance as autoantigens. Molecules like myosin, tropomyosin, nuclear 
lamins and intermediate filaments, all have tandemly repeated structures which 
may be highly immunogenic and thus be targets of an autoimmune response 
(Dropcho et al., 1987). 
Myosin has been implicated as a cross-reactive autoantigen in rheumatic fever 
(Krisher and Cunningham, 1985; Dale and Beachey, 1985; Cunningham et al, 
1986; Dale and Beachey, 1986), and as a non-cross reactive autoantigen in 
Coxsackie 83-induced autoimmune myocarditis (Alvarez et al., 1987; Rose et. 
al., 1988). In addition, antibodies to myosin have been found in patients 
following cardiac surgery (De Scheerder, 1985). 
Other dominant autoantigens include keratin (Cunningham et al., 1984; 
Fenderson et aL, 1989) which is also found as an autoantigen in rheumatic 
fever; vimentin which cross-reacts with measles phosphoprotein (Fujinami et 
al., 1983) and also shares homology with vaccinia virus haemagglutinin (Dales 
et al., 1983); and heat shock proteins (Sheshberadaran and Norrby, 1984). 
Whether these autoantigens themselves induce autoimmune disease or are 
merely innocent targets of an autoimmune response elicited by some other 
mechanism, is difficult to establish. Whereas myosin has not been shown to 
be capable of causing rheumatic fever, some studies have shown that 
immunization with myosin, of mice genetically predisposed to post Coxsackie 
83 myocarditis, induced a severe myocarditis similar in appearance to the 
natural disease (Neu et al., 1987). 
1.B.7 Cross-reactivity: Serum and Monoclonal Antibodies 
Finally, since cross-reactions are defined with respect to a particular antibody 
or antiserum (Berzofsky et al., 1989; Van Regenmortel, 1989), characteristics 
of the antibodies defining the reaction should be examined. Berzofsky and 
Schechter ( 1981) defined two forms of cross-reactivity. Type I or "true 
crossreactivity" occurs when two ligands react at the same Site on the same 
antibody molecule but with different affinities. The example mentioned is the 
cross-reactive binding of the haptens dinitrophenyl · (DNP) and trinitrophenyl 
(TNP) to the anti-DNP antibodies, but with different affinities (Little and Eisen, 
1969). Type II cross-reactivity ("partial cross-reactivity or shared reactivity") 
takes account of heterogeneous antibody populations (i.e. most conventional 
sera) where the cross-reactive ligands can react with all or only a subpopulation 
of the antibodies present. Monoclonal antibodies usually display Type I cross-
reactivity. 
In the experimental analysis of cross-reactivity, monoclonal antibodies have the 
advantage that the molecules in a sample are homogeneous and all have the 
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same variable region structure. This homogeneity can permit a more 
sophisticated analysis of specificity not possible with polyclonal sera. They can 
be used to detect both similarities and distinctions between related antigens. 
Whereas a homogen.eous sample of (monoclonal) antibodies may reveal 
similarities between ligands, these may be concealed by the competing 
antibody reactivities in polyclonal sera. For example, using monoclonal 
antibodies Pierres et al. (1981) could show that the I-A and 1-E antigens in the 
mouse MHC shared determinants, whereas this cross-reaction could not be 
shown using polyclonal sera. 
Similarly, mAbs have been used to distinguish closely related specificities in 
class I and class II MHC that could not be defined using polyclonal sera (Pierres 
et al., 1981). In trying to absorb out irrelevant reactivities from polyclonal 
sera, there is the risk of at the same time losing reactivity. This could not 
occur in a homogeneous antibody sample, where all molecules have the same 
reactivity. 
Fine specificity analysis of epitope clusters can be achieved by using groups of 
mAbs in competitive binding assays. Such an analysis using mAbs was made 
of the epitope clusters on the CD4 molecule of T cells (Sattentau et al., 1986). 
However, this fine specificity of mAbs can in some instances be a 
disadvantage. mAbs will display cross-reactivity not only between the 
numerous antigens of identical chemical structure but, can also cross-react 
with determinants whose associated chemical properties (e.g. surface charge, 
conformation) permit such binding (Ghosh and Campbell, 1986). 
Furthermore, unwanted cross-reactions obtained with mAbs cannot be 
abolished by absorption without removing all reactivity (Berzofsky et al., 1989). 
Irrelevant cross-reactions can often be absorbed from polyclonal sera without 
adversely affecting relevant binding. Indeed, the removal of such (competing) 
reactivities from polyclonal sera could conceivably enhance their specificity. 
Finally, polyclonal sera can bind multivalent antigens more effectively (where 
this is important) than might monoclonal antibodies, which may display a 
weaker univalent interaction with the antigen. 
It has been suggested that the most useful antibody reagent for detection of 
cross-reactions may be a mixture of monoclonal antibodies judiciously chosen 
according to their known (.and often overlapping) specificities (Berzofsky et al., 
1989). Such concoctions are however not often available. 
In conclusion, the differing results obtained through the use of either polyclonal 
sera or monoclonal antibodies in studies of cross-reactivity/antigenic mimicry, 
bear out Van Regenmortel's ( 1989) contention that such assays are based on 
operationally-defined binding measurements and that the conditions of each 
particular assay wil.l have a large influence on whether cross-reactivity/antigenic 
mimicry is detected. 
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2.1 INTRODUCTION 
The enzyme-linked immunosorbent assay (ELISA) and other techniques were 
used in this study to measure antibodies in rheumatic fever patient and control 
sera against cardiac and streptococcal antigens that have been implicated in 
antigenic mimicry in the pathogenesis of rheumatic fever. The findings of 
previous investigations using similar ELISA techniques for measuring antibodies 
to several of these antigens are reviewed in this section. 
The ELISA technique has been used by several investigators to measure 
autoantibodies in both healthy individuals and in various diseases (Guilbert et 
al., 1982; Dighiero et al, 1982., 1985; Avrameas et al., 1981; Matsiota et al., 
1987). The technique is sensitive and suited to screening large numbers of 
sera, but there are some potential pitfalls that should be considered in 
interpreting results. Three of these are the following. 
1. Due to the sensitivity of the technique, it has been argued that irrelevant 
binding properties of the antibodies may be exaggerated (RS Schwartz, 
1986). Controls and optimal conditions for all stages of the assay should 
therefore be determined, and the antigen should preferably be well-
defined (Gripenberg and Kurki, 1986). This may present a problem when 
using ill-defined autoantigens. 
2. Even highly purified antigens may "behave" artefactually depending on 
the assay conditions. Denaturation may occur through binding of the 
antigen to plastic or through excessive detergent concentrations (in wash 
buffers for instance). Antigenic determinants may be lost, or else the 
antigen may exhiqit new binding sites. Such artifacts can lead to a 
confusing variability in specificity. For instance, Guilbert et al. ( 1982) 
found that anti-cytochrome C and anti-collagen antibodies were not 
inhibited at all by their respective antigens, except when these antigens 
we,re immobilized on plastic. 
3. The specificities of pathologically or experimentally induced antibodies 
and natural autoantibodies may differ. Autoimmune disease may induce 
autoantibodies of a different specificity to the natural autoantibodies 
against the same antigen. For example, Guilbert et al. (1982) discovered 
differences in the specificities and avidities of induced and natural anti-
actin autoantibodies. Induced antibodies tended to react more strongly 
or at a higher rate than natural antibodies with antigen coated onto 
plates. Knowledge of such effects could be important in investigations 
aimed at trying to determine the pathogenicity of particular 
autoantibodies. 
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Despite these shortcomings however the ELISA is well suited for screening 
large numbers of sera against both purified antigens and crude antigenic 
extracts, and was used in this study to examine and compare antibody levels to 
various cardiac autoantigens and streptococcal products among different 
groups of rheumatic fever and control subjects. 
2. 1. 1 Myosin ELISA 
Dale and Beachey (1985b) found that ARF sera at a dilution of 1 :400 in ELISA 
contained higher mean titres of antibodies to myosin (from rabbit heart), than 
either controls or AGN patients. Patients with carditis had the highest titres of 
anti-myosin antibodies. In addition, it was shown that streptococcal pep M5 
rabbit immune sera cross-reacted with myosin in this ELISA, and could be 
inhibited by pep M6 and pep M19 but not by pep M24, indicating that these 
three streptococcal M protein all shared epitopes with myosin. lmmunoblotting 
studies showed that human cardiac myosin also contained epitopes that 
crossreacted with pep M5. 
Similarly, Cunningham et al. (1988) showed that ARF serum antibodies affinity-
purified against myosin cross-reacted in ELISA with pep M5 and whole group A 
streptococci, as well as with DNA and crude extracts of heart. -Interestingly, 
these cross-reactive antibodies were also present in normal sera, although at a 
much lower concentration, . suggesting that they may occur as natural 
autoantibodies. The finding of cross-reactivity between myosin and M type 5 
S.pyogenes antigens was confirmed in ELISA using murine mAbs evoked by 
these streptococcal antigens (Cunningham and Swerlick, 1986), and using 
human monoclonal antibodies (Cunningham et al., 1988). Dale and Beachey 
( 1986b) used rabbit immune sera to pep M5 in ELISA inhibition experiments 
against myosin, to localise the myosin-reactive epitopes on pep M5. 
Antibodies to myosin are not unique to rheumatic fever, but are also found in 
sera of patients with polymyositis (Wada et al., 1983) and coxsackievirus 8-
induced myocarditis (Neu et al., 1987), as well as in about 30% of patients 
who have had cardiac surgery (De Scheerder et al., 1985). Patients with acute 
myocardial infarction have been found to have antibodies to tropomyosin 
(Cummins et al., 1981 ), an associated molecule which has also been found to 
share reactivity with S.pyogenes M5 antigens and has been considered to be of 
relevance to rheumatic fever (Fenderson et al., 1989). 
Anti-myosin antibodies are thus not unique to rheumatic fever but occur in 
other diseases, and have also been found as natural autoantibodies in healthy 
individuals (Dighiero et al., 1983). Nonetheless, the cross-reactivity this 
molecule displays with group A streptococcal antigens associated with 
rheumatic fever, suggest that it may be implicated in antigenic mimicry with 
S.pyogenes. 
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2.1.2 Actin ELISA 
Antibodies to actin have been found both as natural autoantibodies in normal 
sera (Avrameas et al., 1981; Guilbert et al., 1982) and in diseases such as 
chronic active hepatitis (Gabbiani et al., 1973; Bretherton et al., 1983), 
myasthenia gravis (Williams et al., 1986), alcoholic cirrhosis (Cunningham et 
al., 1985) and Waldenstrom's macroglobulinemia (Avrameas et al., 1981 ). In 
addition, De Scheerder et al. (1985) demonstrated anti-actin antibodies in 25% 
of patients who had undergone cardiac surgery. 
As a major muscle protein of heart, actin may be relevant as an autoantigen in 
rheumatic fever, but evidence for this is only indirect. Its mol.wt. (42 kD) 
corresponds to that of a constituent in immunoblotted crude heart extracts 
which react with rabbit antisera and murine mAbs to group A streptococcal M5 
protein (Cunningham et al. 1984; Sargent et al. 1987) (see Table 3.1 ). 
Furthermore, some murine and human mAbs evoked by M5 protein, have been 
found to cross-react with actin (Cunningham and Swerlick, 1986; Fenderson et 
al., 1989; Cunningham et al., 1988). These same mAbs also reacted with 
myosin. 
Human sera have been found to react only weakly with actin in ELISA (Kurki, 
1978; Guilbert et al., 1982). It has been suggested that the human antibodies 
react mainly with native actin, and that this is denatured in ELISA (Gripenberg 
and Kurki, 1986). In rabbits, on the other hand, it was found that anti-actin 
antibodies could be evoked only by immunization with the denatured molecule, 
suggesting that in this species the immunogenic epitopes are hidden in the 
native protein (Lazarides and Weber, 1974). Human and rabbit sera thus 
appear to react quite differently to actin. 
Kurki ( 1978) found that human sera reacted similarly with human or bovine 
actin, and that there did not appear to be differences in reactivity to monomeric 
(G) or polymeric (Fl actin. In chronic active hepatitis and in alcoholic cirrhosis, 
however, anti-actin antibodies seem to be directed to G-actin (Cunningham et 
al., 1985; Bretherton et al., 1983). 
Concerning the potential pathogenicity of anti-actin antibodies, it has been 
shown that cytoplasmic intermediate filaments (comprised of actin) are capable 
of activating complement (Linder et al., 1979). It has also been suggested that 
actin may be expressed on the cell surface (Oweri et al., 1978) and that tissue 
damage may be caused by antibody-mediated complement lysis (Toh, 1979). 
These studies suggest that actin may be a relevant autoantigen in rheumatic 
fever. 
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2.1.3 Collagen Type II ELISA 
It is now well-established that some patients with rheumatic disorders have 
autoimmunity to collagen. Both humoral and cellular reactivity to collagen have 
been found (Steffan et al., 1963; Andriopoulos et al., 1976; Stuart et al., 
1983). It is also known that antibodies to collagen form part of the natural 
autoantibody repertoire (Guilbert et al., 1982). 
Antibodies to type II collagen from patients with rheumatoid arthritis have in 
some cases been shown to be arthritogenic. When injected into mice, these 
purified antibodies were capable of inducing arthritis (Wooley et al., 1984). It 
has not been resolved whether the antibodies to type II collagen which appear 
in some RA patients, merely reflect a change in the immunologic response of 
the host, or whether they precede the onset of clinical disease and are 
pathogenic (M6tt6nen et al., 1988). 
In rheumatic fever, polyarthritis has been shown to occur in about 75% of 
patients during the initial attack (Schaller and Szer, 1989). Whether these 
patients have raised levels of antibody to collagen is not known. Both murine 
and human monoclonal antibodies reactive with cardiac and streptococcal M5 
antigens showed no cross-reactivity with collagen (Cunningham and Swerlick, 
1986; Cunningham et al., 1988). 
The frequency of anti-collagen antibodies in human sera is now thought to be 
considerably lower than was originally estimated. The frequency of anti-type II 
collagen antibodies in RA patients was reported at anywhere between 3-50%, 
but is now generally considered to be closer to 3%. In RA, antibodies to type 
II collagen are predominantly of the lgM class (Clague et al., 1981). Although 
they occur at the highest frequency in active and destructive forms of RA, it 
has not so far been possible to show a correlation between these antibodies 
and the clinical stage of the disease (Clague et al., 1981) or to ascribe them a 
pathogenic role (M6tt6nen, 1988). Since rheumatic fever is often viewed as a 
connective tissue disease, antibodies to collagen may be relevant to the 
aetiology of the disease. 
2. 1.4 Heart Extract ELISA 
ELISAs for the measurement of antibody to crude extracts of human heart have 
been used for screening monoclonal antibodies reactive with streptococcal 
antigens (Cunningham and Russell, 1983; Cunningham et al. 1984). 
Recently, Shastry et al. ( 1988) used sodium deoxycholate extracts of human 
heart as solid-phase antigen in an ELISA and showed elevated titres of lgG and 
lgM heart-reactive antibodies in sera of ARF and RHO patients. 
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2.1.5 Group A Streptococcus ELISA 
Cunningham and Russell ( 1983) screened murine monoclonal antibodies against 
whole group A streptococci using an ELISA based on methods described by 
Voller et al. ( 1980). The method entails fixation of whole bacteria as a solid 
phase antigen to polyvinyl chloride microplates using glutaraldehyde, in a 
peroxidase-conjugated second antibody system. 
Cunningham et al. (1988) screened human mAbs against group A streptococci 
using this ELISA, and also used this method to compare the reactivity of a 
panel of heart-reactive murine mAbs, against different groups of streptococci 
(Cunningham et al., 1984) . 
2.1.6 Streptococcal M Protein ELISA 
Dale et al. ( 1980, 1982) and Beachey et al. ( 1981) developed a sensitive ELISA 
for measuring antibodies to various streptococcal M proteins, based on the 
original protocol of Russel et al. ( 1976). 
M proteins were coated onto polystyrene tubes, and binding of test antibody 
detected using an alkaline phosphatase conjugated second antibody and p-
nitrophenyl phosphate substrate solution. Most ELISAs for M protein 
antibodies have followed this protocol. 
Bisno et al. ( 1982) used this ELISA to measure type specific antibodies to pep 
M types 5, 6 and 24 in Chilean ARF patients and found that 32% had a 
positive titre to M5 compared to only 3% of normal age-matched control 
subjects. 38% of ARF patients and 29% of controls had antibodies to M type 
6 protein, whereas neither patients nor controls had antibodies to M24. (There 
was no correlation in individual sera between anti-M5 and anti-M6 antibodies as 
measured by this ELISA). In this Chilean population of ARF patients, M5 was 
therefore an important "rheumatogenic" streptococcal serotype. Type 5 has 
also been found to be the major rheumatogenic serotype in England and the 
United States (Bisno, 1980). The importance of type 5 M protein as a 
rheumatogenic serotype in South Africa has not been reported. 
2.1.7 ASO and anti DNAse antibodies 
Although elevated streptococcal antibody titres are not diagnostic of rheumatic 
fever, the absence of a group A streptococcal infection makes the diagnosis of 
·rheumatic fever based on the Jones criteria doubtful, except where the disease 
is discovered only long after the antecedent streptococcal infection as in 
Sydenham's chorea or low-level carditis (Bisno, 1979). 
The ASO test is the most widely used of the streptococcal antibody tests. It is 
however susceptible to false positive titres associated with liver disease, 
growth of certain bacteria in the serum, and oxidation of the streptolysin 0 
Chapter 2 Cardiac/Nuclear/Streptococcal antibodies / 26 
reagent. The DNAse B test is not subject to such false positive titres, and is 
often considered the best single test for the serological detection of recent 
group A streptococcal infection. Normal values for both tests can vary with 
age of the subject, season of the year and geographical area. 
Stollerman et al. (1956) found that in serum samples taken within 2 months of 
onset of the disease, 80 percent of patients with ARF had ASO titres of greater 
than 200 Todd units/ml. If three different anti-streptococcal antibody tests 
were performed, elevated titres of anti-streptococcal antibody could be found in 
more than 95 percent of ARF patients. 
Anti-cardiolipin antibodies (ACA) have been found both as natural 
autoantibodies (Yadin et al., 1989) and have been associated with SLE ·and 
various connective tissue disorders as well as with arterial and venous 
thrombosis and ischaemic heart disease (Asherson and Harris, 1986; Colaco 
and Male, 1985; Hamsten et al., 1986). Whereas Hamsten et al. (1986) 
concluded that elevated ACA are a marker for recurrent cardiovascular 
conditions rather than a risk factor, Morton et al. (1986) suggested that they 
may be the result of an immunological response to myocardial necrosis. Klemp 
et al. ( 1988) suggested that myocardial ischaemia can also induce an 
immunological response leading to production of ACA. 
Since ACA are known to be raised in autoimmune conditions such as SLE and 
other connective tissue disorders, as well as in certain pathologies involving 
damage to the heart, measurement of these autoantibodies seemed appropriate 
to the investigation of autoantibodies ifl rheumatic fever. Zabriskie ( 1967) 
showed that anti-heart antibodies cross-reactive with certain streptococcal 
strains in rheumatic fever patients, were specifically reactive with cardiolipin. 
Chapter 2 Cardiac/Nuclear/Streptococcal antibodies / 27 
2.2 RESULTS AND DISCUSSIONS 
2.2.1 STUDY DESIGN AND STATISTICAL ANALYSES. 
2.2.1.1 Study Design 
Sera from seven groups of 20 subjects each were investigated in the assays 
described here. The objectives were, to compare autoantibody profiles in 
rheumatic fever and control groups of subjects as well as to compare levels of 
antibodies to various streptococcal antigens among these groups. An 
additional objective was to identify rheumatic fever sera with high titres of 
antibodies to both heart and streptococcal antigens, for the purpose of 
screening human heart cDNA expression libraries for cross-reactive antigens 
(Chapter 5). 
The assays used were ELISAs, tissue immunofluorescence and 
immunoperoxidase staining and immunoelectrophoresis. 
All sera were tested in duplicate in the ELISAs, and at three ten-fold dilutions. 
Both the "no-antigen" and the "no-serum" ELISA blanks were subtracted from 
each result. This is a very rigorous control for nonspecific binding, and 
explains why the reported optical density readings are often low and sometimes 
negative. 
Results are discussed here only in terms of statistical P values (Table 2.1 ;see 
page 29) without stating the confidence intervals. These can however be 
gleaned from the box plot graphs and from Appendix A, which presents the 
statistical parameters of all results, as well as a synopsis of the statistical 
methods applied. 
2.2.1.2 Patient Sera 
Serum was prepared by standard procedures from blood freshly drawn from 
patients in the study groups, aliquoted and · stored at -20°C. Sera from 20 
patients in each group were studied. Ethical approval to conduct this research 
was obtained from the Ethics and Research Committee of the University of 
Cape Town Medical School, and with the consent of all subjects and their 
parents where applicable. The criteria for admission of patients to the study 
are presented in Appendix C. 
Group 1: Acute Rheumatic Fever (ARF). 
Sera from children with acute rheumatic fever were obtained 
within two weeks of the onset of acute symptoms, and all had 
evidence of clinical carditis. The diagnosis of acute rheumatic 
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Heart Association, 1984) (see Table 1.1 ). One patient had chorea 
and six had polyarthritis. Clinical and demographic particulars of 
the ARF patients are summarised in Appendix B. The children 
were all seen at Red Cross War Memorial Children's Hospital in 
Cape Town. Their mean age was 9.1 years (SD 3.6). 
Acute Glomerulonephritis (AGN). 
Sera were obtained from children seen at Red Cross War Memorial 
Children's Hospital who had a clinical diagnosis of acute 
glomerulonephritis. This consisted of an acute illness with oedema 
and haematuria of less than a week's duration. Most had 
oligaemia and hypertension and all had abnormal urea and 
creatinine levels, and did not have signs of the nephrotic syndrome 
or other renal pathology. Cultures for streptococcal infection were 
not obtained on most of these children. Mean age was 7 .1 years 
(SD 3.6). 
Chronic Rheumatic Fever - Children (CRF-c). 
Serum was obtained from children attending the Rheumatic Fever 
Clinic at Red Cross War Memorial Children's Hospital. All had 
rheumatic valvular heart disease and none had any evidence of 
acute illness or had had previous cardiac surgery. Mean age was 
11. 7 years (SD 3.2). 
Chronic Rheumatic Fever - Adults (CRF-a). 
·serum was obtained from patients assessed at the Cardiac Clinic, 
Groote Schuur Hospital, by clinical and historical criteria to have 
rheumatic valvular heart disease. None had undergone cardiac 
surgery or had signs of acute illness. Mean age was 38.2 years 
(SD 9.7). 
lschaemic Heart Disease (IHD). 
Sera were obtained from patients attending the Card iac Clinic at 
Groote Schuur Hospital, who were assessed to have ischaemic 
heart disease. None had cardiac. surgery or were in the immediate 
convalescent phase following myocardial infarction. Mean age 
was 56.0 years (SD 8.8). 
Child Control (CONT-c). 
Sera were obtained during a study on the epidemiology of asthma 
from healthy (non-asthmatic) Black rural schoolchildren . These 
children came from the Transkei in South Africa, and none had any 
history of rheumatic fever or cardiac disease, or signs of heart 
disease on clinical examination. Subjects in this group thus came 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Cardiac/Nuclear/Streptococcal antibodies / 30 
Impetigo is a common problem in this area and risk · of 
streptococcal infection is increased. 
Adult Control (CONT-a). 
Serum was obtained from healthy laboratory and hospital staff at 
the Red Cross War Memorial Children's Hospital. None had any 
history of rheumatic fever or rheumatic heart disease, or any other 
form of heart disease or illness affecting the immune system. 
Mean age was 34.5 years (SD 5.6). 
Rabbit Hyperimmune and Nonimmune Control Sera 
Rabbit hyperimmune sera for use as positive method controls, were obtained 
either commercially or were raised in the laboratory according to procedures 
described in Materials and Methods (section 7.A.1 ). A pool of five non-immune 
rabbit sera was used as a negative control. 
2.2.1.4 Patient Sera: lmmunoglobulin Concentrations 
lmmunoglobulin concentrations were measured using a Behring Nephelometer 
Analyzer (Software Version N 1 .4). 
The ARF and adult CRF patients showed raised levels of lgG compared to 
normal children and adults (ARF, p = 0 .0011; CRF-a, p = 0.0007). lgA levels 
were significantly raised in all · rheumatic fever sera compared to normal child 
and adult contr9ls (ARF: p = 0.0372; CRF-c: p = 0.0002; CRF-a: p = 0.0032). 
lgA was also increased in IHD patients (p = 0.0082). There were no statistically 
significant differences in lgM concentrations in any of the groups. These 
results are graphically presented in Fig 2.1. 
Raised levels of lgG and lgA in rheumatic carditis are known features of 
rheumatic fever (Benatar et al., 1988). Raised lgA may be partly due to 
pharyngeal infection by S.pyogenes. In Chagas disease, an autoimmune 
disease also involving the heart, increased concentrations of lgA are known to 
occur (Sa Ferreira, et al., 1983). lgA deficiency on the other hand (which is 
fa irly common in the normal population) occurs at a disproportionately high 
· frequency in autoimmune diseases such as rheumatoid arthritis (Bluestone et 
al., 1970), SLE (Cassidy et al., 1969) and Sjogren's syndrome (Katka et al., 
1988). Interestingly, healthy subjects with lgA deficiencies have been reported 
.to have high a incidence of certain autoantibodies (Yewdall et al., 1983). 
Since immunoglobulin concentrations can vary with age, sex, heredity and 
environment, in addition to being susceptible to technical errors in the assays 
(Rose and Friedman, 1980), interpretation of these data are problematical. 
Generally, however, raised immunoglobulins (especially lgG) are indicative of 
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Fig. 2.1 Serum immunoglobulin concentrations in the seven groups of patients and normal subjects. 
Serum concentrations (g/1) of lgG, lgM and lgA were measured by nephelometry in 20 individuals in 
each of the seven groups of patients and control subjects (section 2.2 .1.4). 
Results of statistical comparisons between groups are presented in Table 2.1, and descriptive 
statistics for each group are given in Appendix A. The figure shows box plot graphs depicting the 
statistical mean ( + ), the median (horizontal bar), the interquartile range (IOR: the boxed area 
comprising values falling within the 75th-and 25th percentiles) and outlying values. (See Appendix A 
for annotated description of the box plot and Abbreviations for serum "group" designations). 
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2.2.2 CARDIAC AUTOANTIGENS 
2.2.2.1 Heart Extract ELISA 
Human heart detergent (CHAPS) extract (section 7 .A.11) was coated onto flat 
bottom PVC plates at a concentration of 5µg/ml. Sera were tested for 
reactivity to this antigenic extract as described in Materials and Methods 
(section 7.A.6). 
As a method control, a rabbit antiserum raised to the heart extract was used. 
(It reacted more than three times as strongly in the ELISA as the pool of five 
nonimmune rabbit sera). To control for interassay variability, each assay also 
included a particular ARF serum with high reactivity to heart in ELISA and by 
immunocytochemistry (section 7 .A.18). 
It was shown that, at a serum dilution of 1: 100, the CRF adult patients 
contained raised titres of heart-reactive antibodies (HRA), compared to the 
other adult groups (Table 2.1. CRF-a; CONT-a, p = 0.0011; CRF-a:IHD, 
p =0.0072). Similarly, both child rheumatic fever groups had raised HRA at a 
1: 100 serum dilution, compared to the non-rheumatic child groups (ARF:CONT-
c, p = 0.0029; ARF:AGN, p = 0.0411; CRF-c:CONT-c, p = 0.0002; CRF-c:AGN, 
p =0.0253). These trends are graphically presented in Fig 2.2, in which the 
markedly higher HRA mean titre of the adult CRF patients can be seen. 
This ELISA thus presents evidence, in rheumatic fever patients, of raised HRA 
to detergent extracts of human heart. These results confirm the findings of 
Shastry et al. ( 1988) who found that both ARF and CRF patients (various 
subgroups) had raised HRA (lgG and lgM), compared to AGN patients and 
controls. The present study measured only lgG antibodies, since pathogenic 
antibodies are generally considered to be of this class (Avrameas, 1986). 
Shastry et al. ( 1988) showed that the incidence of lgG HRA in rheumatic fever 
patients was higher than lgM. Their assay used sodium deoxycholate extracts 
of human heart, and was able to detect significant differences in HRA titre 
between rheumatic and ·control subjects in dilutions of up to 1 :36000 
compared to only 1: 1000 in the present assay. This contrasts with the dilution 
of between 1: 100 and 1 :400 used by Zabriskie and Friedman (1983) for 
detection · in ELISA of HRA to a purified 43 kD antigen in saline extracts of 
bovine heart. 
Interestingly, Shastry et al. ( 1988) found that HRA persisted in all groups of 
rheumatic patients irrespective of whether they were on penicillin prophylaxis, 
in clinical remission or in a quiescent state with a history of the disease of 2-14 -
years standing. 
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Fig. 2.2 Heart extract ELISA 
The reactivities of the 20 sera in each of the seven groups of subjects (section 2.2.1.2) were 
tested in ELISA against crude extracts of human heart (sections 7 .A.6) at dilutions of 1: 100, 
1: 1000 and 1: 10000.' The figure summarises and compares the statistical mean, median and 
interquartile range (and outlying values) of the optical density readings (OD 405 nm) of each of 
the groups of 20 sera at dilutions of 1 : 100 and 1: 1000. 
(See also Table 2.1 for statistical P values of comparisons between groups, and Appendix A for 
univariate descriptive statistics for each group of sera). 
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In addition, they found both lgG and lgM HRA in sera of normal individuals 
ranging in age from 8-35 years. They speculated that · these were natural 
autoantibodies, and cite the report of Leuker et al. ( 1975) who found an 
increase in activated B lymphocytes in acute and chronic rheumatic fever, 
which may be associated with the production of autoantibodies. In this study, 
HRA were also found in normal children and adults as well as in the non-
rheumatic disease control groups (AGN, IHD), as seen in Fig. 2.2. 
The relevance of HRA in the pathogenesis of rheumatic heart disease, an.d the 
significance of these antibodies in control subjects, has not been elucidated. 
The high mean titre in the adult CRF groups suggests that these antibodies may 
play a role in ongoing chronic disease, and it has been suggested that they may 
be implicated in the formation of local immune complexes thereby causing 
cardiac damage (Yoshinoya et al., 1980; Shastry et al., 1988). 
2.2.2.2 Myosin ELISA 
Serum antibodies to bovine muscle myosin (Sigma) were measured in ELISA as 
described in Materials and Methods (section 7 .A.6). A commercially-available 
rabbit antiserum to whole myosin (Sigma) was used as a method control. At a 
dilution of 1: 100, it reacted consistently with a reading greater than three times 
that of the pool of five nonimmune rabbit sera. 
Among the adult groups, only adult CRF patients had significantly raised titres 
of anti-myosin antibodies (AMA) (Table 2.1: CRF-a:CONT-A, p =0.033; CRF-
a:IHD, p =0.0019). Although none of the child rheumatic fever groups had 
raised AMA by comparison with the child control group, the mean AMA titre of 
the ARF group (OD4o5 = 167.7, SD 129.2) was virtually equivalent to that of 
the adult CRF group (OD4o5 = 177.2, SD 81.3). This can be seen in Fig.2.3. 
Statistical correlations between AMA and antibodies to other streptococcal and 
cardiac antigens, showed a possible correlation only in the CRF adult group, 
between AMA and heart reactive antibody (r = 0. 793). 
These results can be compared to the study of Dale and Beachey (1985b) who 
found that ARF patients had raised AMA in ELISA at serum dilutions of 1 :400, 
compared to AGN and normal controls. Patients with carditis had the highest 
AMA . Cunningham et al. ( 1988) affinity purified AMA from ARF sera and 
showed that they cross-reacted with group A streptococci, M type 5, pep M5 
protein as well as with heart extracts. 
The finding in this study of antibodies to myosin in normal subjects suggests 
that they occur as natural autoantibodies in humans. Whereas autoantibodies 
to actin occur at high frequency (Dighiero et al. 1982; 1983), the incidence of 
natural autoantibodies to myosin is much lower (Dighiero et al., 1983). Fairfax 
et al. ( 1977) found that among fifty-five patients with various cardiac and 
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Fig. 2.3 Myosin ELISA 
The reactivities of the 20 sera in each of the seven groups of subjects (section 2.2.1.2) were 
tested in ELISA against bovine muscle myosin (Sigma) (section 7.A.6) at dilutions of 1: 100, 
1: 1000 and 1: 10000. The figure summarises and compares statistical mean, median and 
interquartile range (and outlying values) of the optical density readings (OD 405 nm) of each of 
the groups of 20 sera at a dilutions of 1: 100 . 
• (See also Table 2.1 and Appendix A far statistical for comparative and univariate statistics). 
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One of the reasons adduced for the low incidence of AMA, is that damaged 
cardiac muscle has been found to bind and absorb out this antibody when the 
sarcolemma is disrupted (Khaw et al., 1979). It is possible that in rheumatic 
fever antibodies to myosin may be absorbed out of the serum resulting in 
lowered titres of circulating AMA. It is also known that the muscle and 
cytoplasmic myosins differ in their chemical and physical properties, and this 
may result in a variety of different autoantibodies (Pollard and Weihing, 1974). 
Thus, an individual AMA assay may detect only subpopulations of myosin 
autoantibodies. 
This study presents some evidence of anti-myosin antibodies in rheumatic fever 
sera, which is in agreement with the findings of other investigators. Myosin 
appears to be an important autoantigen implicated in antigenic mimicry with S. 
pyogenes. Cross reactivity between myosin and group A streptococcal 
antigens was investigated by immunoblotting and is reported in chapter 3. 
2.2.2.3 Actin ELISA 
An ELISA was developed for measuring lgG antibodies to actin (section 7.A.4). 
A commercially-available rabbit anti-actin hyperimmune serum (Biomakor) was 
used as a method control, and reacted at a dilution of 1 :5000 with the same 
intensity as a 1: 100 dilution of a pool of 5 normal rabbit sera. 
As a positive control, twenty sera from patients with chronic active hepatitis 
(CAH) (mean age 28 years, SD 5.4) were tested in this ELISA since it has been 
shown that about 30% of these sera contain anti-actin antibodies (Bottazzo et 
al., 1976). Their mean reactivity at a dilution of 1:100 (OD405=0.142; SD, 
0.026) was 2.5-3 times greater than that of both normal control groups of sera 
(Appendix A). 
ARF and AGN sera showed elevated levels of anti-actin antibodies (AAA) 
compared to child controls, at dilutions of both 1: 100 and 1: 1000 (ARFs 
p=0.0057 and p=0.002; AGN; p=0,0049 and p=0.0002). Fig. 2.4 shows 
box plots comparing AAA in groups of sera at dilutions of 1: 100 and 1: 1000. 
Antibodies to actin have been found both as natural autoantibodies in healthy 
individuals, as well as in patients with diseases such as CAH. They are 
frequently elevated in patients following cardiac surgery (section 2.1.2). De 
Scheerder (1985) found a correlation between lgG AAA (as well as anti-myosin 
antibodies) and a cross-striational immunofluorescence pattern on frozen 
sections of monkey heart. (The results of the actin ELISA and 
immunocytochemistry could not be statistically compared in this study because 
of differences in the data systems, but it was noted that one of the ARF sera 
(patient No. 53) with the highest AAA titres, also had a high anti-myosin 
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The reactivities of the 20 sera in each of the seven groups of subjects (section 2 .2.1.2) were 
tested in ELISA against rabbit cardiac actin (Sigma) (section 7 .A.4) at dilutions of 1: 10, 1: 100 
and 1: 1000. The figure depicts the resu.lts for the serum dilutions at 1: 100 and 1: 1000. 
(See legends to Figs. 2.1-2.3 for descriptions of statistical parameters depicted in figure. See 
Table 2.1 and Appendix A). 
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The presence of AAA in ARF sera has not previously been reported. However 
Fenderson et al. ( 1989) found that mouse monoclonal antibodies evoked by 
streptococcal M5 membranes (and reactive with tropomyosin) were cross-
reactive in immunoblotting with actin. Also, two human mAbs developed by 
Cunningham et al. ( 1988) were cross-reactive with heart and group A 
streptococcal antigens, and were inhibited in immunoblotting assays by actin 
(T7 .1 and T6; see Table 3.1). 
Actin has therefore been indirectly implicated as an autoantigen in rheumatic 
fever. The present study shows evidence for raised titres of AAA in the ARF 
(and AGN) sera, but the reactivity was not intense. This finding may be due to 
low affinity antibodies associated with acute infection. 
2.2.2.4 Phosphorylase b ELISA 
Preliminary investigations showed evidence by immunoblotting that ARF 
patients have antibodies to· muscle phosphorylase b. Dale and co-workers 
(Veterans Administration, Memphis, Tennessee USA) found that approximately 
60% of ARF sera tested by ELISA had significant levels of anti-phosphorylase b 
antibodies (personal communication to DW Beatty, 1987). 
In this study, autoantibodies to phosphorylase b (Sigma) were measured by 
coating it onto flat-bottom PVC plates at a concentration of 20µg/ml, and 
performing the ELISA as described in Materials and Methods (section 7.A .6). 
The rabbit antiserum raised to the heart extract (section 7 .A. 1) was found to 
react strongly with this protein (both in immunoblots and ELISA), and was 
therefore used as a method control. An ARF serum reacting strongly with the 
enzyme was included on each plate as an interassay control. 
All rheumatic fever groups of sera were shown to have significantly elevated 
levels of anti-phosphorylase b antibodies (APA) when compared to adult and 
chi ld control groups . In ARF patients, APA were elevated at a serum dilution of 
1:1000 by comparison with normal children (p=0.0241). In adult CRF 
patients, APA were significantly raised compared to normal adults at dilutions 
of both 1:100 and 1:1000 (p=0.0055 and p~0.0039, respectively). Similarly, 
at these dilutions, the child CRF group had raised APA compared to controls 
(p =0.0002 and P =0.0056, respectively). APA in AGN patients were 
significantly lower than in any of the rheumatic groups. These results are 
graphically presented by box plots in Fig . 2.5 
Statistical correlation analyses between APA and antibodies to other tested 
cardiac and streptococcal antigens, showed that in all patient groups with 
cardiac disease, there was some correlation between raised APA and raised 
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Fig. 2.5 Phosphorylase b ELISA 
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The reactivities of the 20 sera in each of the seven groups of subjects (section 2.2.1.2) were 
tested in ELISA against phosphorylase b (Sigma) (section 7 .A. 6) at dilutions of 1 : 100, 1 : 1000 
and 1: 10000. The figure depicts the results for the serum dilutions at 1: 100 and 1: 1000. 
(See legends to Figs. 2.1-2.3 for description of statistical parameters depicted, and see Table 
2. 1 and Appendix A for comparative and univariate statistics). 
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Phosphorylase b may possibly therefore be an important cardiac autoantigen. 
Its pathogenic relevance is brought into question by the presence of APA in 
both normal child and adult sera, although in significantly lower titres (Fig.2.5 
and Table 2.1). No correlations among groups of sera could be found between 
APA and antibodies to streptococcal antigens. However, comparing individual 
sera, it was noticed in this study that the two ARF sera with the highest APA 
titres also had among the highest titres of antibodies to all the streptococcal M 
proteins. Dale and co-workers were able to show, using antisera to pep M5, 
cross-reactivity between phosphorylase b and pep M5, M6 and M19 proteins 
(personal communication to D. W. Beatty, 1987). 
2.2.2.5 Anticardiolipin Antibodies (ACA) 
lgG and lgM antibodies to cardiolipin were measured by an ELISA technique 
first described by Lockshin et al. ( 1985) and modified by Klemp at al. (1988). 
Briefly, cardiolipin (Sigma) dissolved in ethanol was air-dried under nitrogen 
onto microtitre plates (Cooke system), incubated with serum and positive 
binding was detected using alkaline phosphatase conjugated second antibodies. 
Normal ranges for anti-cardiolipin lgG (ACAG) and anti-cardiolipin lgM (ACAM) 
were established by Klemp et al. ( 1988) by standardizing sera from over one 
hundred controls (average age 30.83 years) to a single positive serum sample. 
Levels above 34 units for ACAG, and above 37 units for ACAM were regarded 
as elevated. 
By comparison with these levels, only four sera in the present study showed 
elevated ACA levels: three child controls and one IHD. Comparisons of ACA 
levels between groups, showed that the control child group had significantly 
raised levels of ACAG compared to the ARF group (p =0.0262). Similarly, the 
adult controls have marginally raised ACAM compared to the adult CRF patients 
(p =0.0462). 
The elevated ACA levels in the adult control group in this study, may be in 
agreement with the findings of Manoussakis et al. ( 1987) who found evidence 
of raised ACA in normal elderly individuals. However, Klemp et al. (1988) 
could find no evidence o_f such age-related trend, and the high ACA levels in 
the child control group in the present study, supports this view. 
The results in this study do not indicate a role for anti-cardiolipin antibodies in 
the pathogenesis of rheumatic fever. 
2.2.2.6 Collagen ELISA 
The ELISA method of Boissier et al. ( 1987) was used (with modifications) to 
measure antibodies to type II collagen. Bovine type II collagen (Southern 
Chapter 2 Cardiac/Nuclear/Streptococcal antibodies / 41 
Biotechnology Associates) was coated onto Nunc lmmuno Maxisorp plates 
overnight at 4°C at a concentration of 1 Oµg/ml (section 7 .A.5). Sera were 
reacted with the collagen for 2 hours at room temperature at a dilution 1: 100, 
and binding detected using an Fab' 2 goat anti-human lgM (µ) peroxidase-
conjugated second antibody (Zymed). 
A goat antiserum to bovine type II collagen (Southern Biotechnology 
Associates) was used as a method control. In addition, twenty rheumatoid 
factor positive sera from patients with rheumatoid arthritis were tested in this 
ELISA, and showed a mean reactivity four to five times greater than that of the 
normal adult group (mean OD405 =0.11; SD, 0.02). To control for interassay 
variability, each plate also included two human sera with high titres of anti-
collagen -type II antibodies (a gift from Dr. PJL Holt, Department of 
Rheumatology, University of Manchester, U.K.). 
There was insufficient serum from the child control group to include these in 
the collagen ELISAs. Statistical comparisons were therefore made against the 
normal adult group and against a new control group of child surgical patients. 
(Not one of the main study groups. Mean age 5.2, SD 2.1 ). 
Only the CRF adult group showed raised lgM antibodies to collagen, compared 
to both the adult normal and IHD groups (p = 0.0033 and p = 0.0133, 
respectively). None of the child groups showed elevated titres when compared 
against either the normal adult group, or against the child surgical control 
patients. Results of these ELISAs were in general very low. 
Antibodies to type II collagen have been reported to be predominantly of the 
lgM class (Clague et al., 1981 ), but other investigators have found lgG 
antibodies (Watson et al., 1986; Mottonen et al., 1988). In rheumatoid 
arthritis, Mottonen et al. ( 1988) could find no association between clinical 
onset of the disease and anti-collagen antibodies, which often appeared years 
before the disease. In the present study, the presence of anti-collagen 
antibodies in only the adult CRF group, would similarly seem to preclude a 
pathogenic role for these antibodies. 
Although in rheumatoid arthritis both lgG and lgM antibodies to collagen are 
usually raised in the same patient (Clague et al., 1981 ), it is possible that lgG 
anti-collagen antibodies may show a different pattern of reactivity in rheumatic 
fever. 
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2.2.3 GROUP A STREPTOCOCCAL ANTIGENS 
2.2.3.1 ASO and anti-DNAse B Titres 
The presence of antibodies to group A streptococcal products is a part of the 
Jones Criteria for diagnosing rheumatic fever (Chapter 1). Antibodies to 
streptolysin O (ASO) and to DNAse B (anti-DNAse 8) were measured using 
commercially available kits (Cooper Biochemical, USA; Wampole Laboratories, 
USA). 
It was shown that ARF patients had significantly raised ASO titres compared to 
normal children (p =0.009). ASO titres of the child and adult CRF groups were 
not raised since their rheumatic streptococcal infection was not recent. The 
significantly raised ASO in IHD patients (p =0.0001 ), is inexplicable. 
Anti-DNAse 8 antibody levels followed a different trend. In particular the 
normal child group had a mean antibody titre and range virtually identical to the 
ARF group (Appendix A. ARF: mean= 1451.4, IQR 1440; CONT-c: 
mean= 1385.3, IQR 1860). This is clearly seen in Fig 2.6 Statistical 
comparisons against this control group masked the high titres of antibody 
evident in the other child groups (AGN and CRF-c). 
The differences in antibodies to streptococcal antigens shown by the ASO and 
DNAse B assay among the groups, is partly due to the geographical selection 
bias of the normal child group. These Black rural children came from an area 
where impetigo, an S.pyogenes skin infection, is common. It is known that 
low levels of ASO are found in streptococcal skin infections, and this may 
explain why anti-DNase B titres are higher than ASO in this group. 
2.2.3.2 Group A Streptococcus ELISA 
An ELISA method for measuring antibodies to whole group A streptococci was 
adapted from Cunningham and Russell ( 1983) who used it for screening murine 
hybridomas evoked by type M5 streptococcal membranes (see Chapter 4). 
Group A streptococci were cultured from the throat-swab of one of the patients 
with rheumatic carditis, and fixed using glutaraldehyde to flat bottom PVC 
microtitre plates. Antibodies to whole streptococci were measured as 
described in Materials and Methods (section 7.A.3). A rabbit hyperimmune 
serum raised to this culture (section 7.A.1 ), as well as a commercially available 
rabbit typing serum to group A streptococci (Wellcome Diagnostics), were used 
as positive method controls. To control for interassay variability, an ARF and 
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Fig. 2.6 Antistreptolysin O and anti-DNAse B streptococcal antigen titres 
In all 20 sera in the seven groups of patients, antibodies to the group A streptococcal products 
streptolysin O (ASO) and DNAse B (anti-DNAse B) were measured by standard procedures using 
reagents purchased from Cooper Biochemical (USA) and Wampole Laboratories (USA). Anti-
streptolysin O antibodies are given in Todd units/ml, and anti-DNAse B antibodies in reciprocal 
titre units. 
(See legends to Figs. 2.1-2.3 for description of statistical parameters depicted, and see Table 
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Fig. 2. 7 Group A streptococcus ELISA 
The reactivities of the 20 sera in each of the seven groups of subjects (section 2.2.1.2) were 
tested in ELISA against whole group A streptococci isolated from the throat swab of a patient 
· with acute rheumatic fever (section 7 .A.3) at dilutions of 1: 100, 1: 1000 and 1: 10000. The 
- figure depicts the results for the 1: 100 serum dilution. 
(See legends to Figs. 2.1-2 .3 for description of statistical parameters depicted, and see Table 
2.1 and Appendix A for comparative and univariate statistics). 
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Marginally elevated levels of antibodies to group A streptococci were found in 
only the adult CRF group at a serum dilution of 1: 1000, and in none of the 
other rheumatic fever groups (p =0.0458). Statistical correlation analyses, 
showed some association in the child CRF group, between antibodies to GAS 
(1: 1000 dilution) and heart-reactive antibody (HRA: 1: 100 dilution) (r = 0.824). 
The relatively high reactivity of the child normal sera can be seen in Fig 2. 7, 
and was probably due to the high incidence of streptococcal infections in this 
group of rural children (eg impetigo - also an S.pyogenes infection). Statistical 
comparisons against this group thus masked the comparatively high titres of 
anti-GAS antibodies in ARF and AGN sera . 
It was subsequently shown that antisera to streptococcal groups B, C, D and G 
(Wellcome Diagnostics) cross-reacted with group A streptococci in this ELISA. 
Th is non-specificity may explain why all groups of sera displayed reactivity in 
this ELISA. 
To compare reactivity of rheumatic fever and control groups of subjects against 
different streptococcal antigens, antibodies to purified M proteins were 
measured. 
2.2.3.3 M Protein ELISAs 
lgG antibodies to various streptococcal M proteins (M1, M3, M5, M6, M12, 
M18, M19 and M24) were measured by Dr. James Dale according to methods 
described by Dale et al. ( 1980, 1982). The method uses alkaline phosphatase 
conjugates which are more sensitive than the horseradish peroxidase 
conjugates used in the other ELISAs in this study. 
It was shown that compared to normal adults, CRF adult patients have raised 
antibod ies to all the tested M proteins. IHD patients had raised titres to M 12, 
M18 and M19. Among the child groups, the control group had relatively high 
t itres of antibody to all M proteins, except M5 and M6 (see Appendix A and Fig 
2 .8). As in the other streptococcal antibody assays (above), this high level of 
anti-streptococcal antibodies in the child control group had the effect of 
obscuring the relatively high levels of anti-M protein antibodies in the other 
child groups. In statistical comparisons between the child groups of sera and 
the normal adult group (which had low levels of antibodies to streptococcal 
-antigens) the ARF and AGN groups showed significantly raised antibodies to all 
the tested M proteins (except M24). 
Compared to AGN sera, the child rheumatic fever sera were shown to have 
significantly higher levels of antibodies to proteins M5 and M6. These were 
also the two M proteins to which the child control group did not have elevated 
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Fig . 2.8 (a & bl Group A streptococcal M protein ELISAs 
The reactivities of the 20 sera in each of the seven groups of subjects (section 2.2.1.2) were 
tested in ELISAs against each of the purified group A streptococcal M proteins (section 2.2.3.3) 
at a dilution of 1 :500 . 
(See legends to Figs. 2 .1-2.3 for description of statistical parameters depicted, and see Table 
2.1 and Appendix A for comparative and univariate statistics) . 
(a) ELISA results of antibodies to M proteins M5, M6 and M19 which have been associated 
with rheuryiatic fever . (continued overleaf) 
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(b) ELISA results of antibodies to streptococcal M proteins M 1, M3 amd M 1 8 (see previous 
page for legend). 
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rheumatogenic serotypes in rheumatic fever patients in Cape Town. Type M5, 
and to a lesser extent M6, are predominant serotypes among Chilean ARF 
patients; and M5 is the major serotype in England and the USA (see 
Introduction). 
2.2.4 NUCLEAR AUTOANTIGENS 
2.2.4.1 Antinuclear Antibodies (ANA) 
Antibodies to nuclear antigens were determined by indirect 
immunofluorescence against HEp-2 cells, a human epithelial cell line with a 
large easy-to-read nucleus that binds a broader range of antibodies than tissue 
section substrates (Kazin et al., 1980). 
The AFT HEp System (200 Test) supplied by Behring Diagnostics was used, 
together with an affinity purified goat anti-human lgG (H + L) FITC conjugate 
(Zymed) . As a positive control, twelve SLE sera were tested. Sera from all 
groups were tested at a dilution of 1 :40. There was no background 
fluorescence in the no-serum controls. lmmunofluorescence staining patterns 
were scored as depicted in Table 2.2 
TABLE 2.2 
HEp-2 Antinuclear Autoantibody System: positive immunofluorescence patterns 
(Adapted from Behring Diagnostics, AFT HEp System) 
Code Pattern Possible Autoantibody Disease Association 
No. Specificity 
1 . Homogeneous Histone nDNA Drug induced lupus 
Single-stranded DNA High levels in SLE 
Deoxyribonucleoprotein Also seen in other connective 
tissue diseases (in lower titres) 
2 . Peripheral/rim nDNA SLE 
3 . Speckled Smith antigen (Sm) SLE 
- fine Ribonucleoprotein (RNP)l Mixed Connective Tissue 
Disease (MCTD) 
Scl-70 SS-B Scleroderma 
Sjogren's Syndrome 
Polymyositis 
4 . Speckled Centromere Scleroderma - CREST 
- discrete Syndrome 
5. Nucleolar 4 - 6s RNA Progressive systemic sclerosis 
Sjogren's Syndrome 
6 . Cytoplasmic Mitochondria Primary biliary cirrhosis 
- speckled Chronic active hepatitis 
7 . Fine fibrous Smooth muscle 
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Positives that were ambiguous or displayed more than one staining pattern 
were titrated, and the predominant pattern at the highest dilution was scored. 
Although this selected scoring was somewhat biased, only five of the 
rheumatic fever patients displayed more than one staining pattern. These five 
all showed predominantly fine speckling (pattern 3) and in addition showed fine 
fibrous staining (pattern 7) and/or the speckled cytoplasmic staining indicative 
of mitochondrial autoantibodies. 
Table 2.3 shows the number and percentage of sera in each group, staining 
with a particular pattern of immunofluorescence. A high percentage of 
rheumatic fever sera show evidence of ANA (ARF, 77 .8%; CRF-a, 84.6%; CRF-
c, 57 .9%) compared to normal children and adults (CONT-c, 12.5%; CONT-a, 
0%). Most rheumatic fever sera displayed a fine speckled pattern of staining 
(pattern 3) similar to that shown in Fig 2.9b. One ARF serum showed distinct 
evidence of mitochondrial autoantibodies (pattern 6), and another displayed a 
nucleolar pattern of binding (pattern 5, usually associated with Sjogren's 
syndrome or progressive systemic sclerosis). 
The fine speckled pattern seen with the rheumatic fever sera has generally 
been associated with diseases such as mixed connective tissue disease, SLE 
(Fig.2.9a), Sjogren's syndrome and scleroderma (Table 2.2). However, patients 
w ith rheumatoid arthritis as well as some normal individuals, are known to 
contain ANA at low serum dilutions ( < 1 :20). 
These results present evidence of autoantibodies to nuclear antigens in 
rheumatic fever sera. Although these patterns were seen at relatively high 
serum concentrations of 1 :40, and (except for some of the fine speckled 
staining of pattern 3) were no longer observable at a 1 :80 serum dilution, the 
high percentage of these sera containing ANA compared to normal adults and 
children would seem to indicate that these patterns are not due to artefactual 
binding but specific. 
Other investigators reported autoantibodies to mitochondrial and smooth 
muscle antigens in rheumatic fever (Boonpucknavig et al., 1984). The wide 
range of ANA binding seen among the adult CRF patients (Table 2.3) is 
consistent in this study with their generally high reactivity to various other 




Fig. 2.9 Antinucleat antibodies 
Antibodies to nuclear antigens were determined by indirect immunofluorescence against HEp-2 cells as the substrate, using the AFT HEp System supplied by Behring Diagnostics, together w ith an affinity purified goat anti-human lgG (H + L) FITC-conjugated second antibody. The slides were examined under a Nikon Optiphot microscope using a PlanApo 60X/1.4 oil lens. Positive slides were photographed using the attached camera (FX-35A, with automatic lightbox) 
and Kodak 400 ASA colour film (Kodacolor VR) . 
Twelve SLE sera were tested as positive controls . Sera were tested at a dilution 1 :40 and ambiguous positives were titrated. 
The immunofluorescence patterns against HEp-2 cells and the scoring codes are summarised in Table 2.2, and the results of this study are summarised in Table 2.3. 





(continued from previous page) 
(b) lmmunofluorescence staining pattern of an ARF serum (dilution 1 :40) showing the fine speckled staining pattern (3) which was observed in 66.7% of ARF sera, 57.9% of CRF-c and 61 .5% of CRF-a (Table 2.3). Cytoplasmic speckled staining (6) can also be seen (bottom of photograph). 
(c) Fine speckled immunofluorescence staining (4) showing antibody binding to centromeres, observed with one adult CRF serum (Table 2.3). 
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TABLE 2.3 
Antinuclear Antibodies (ANA) Using HEp-2 Cell Substrate: Positive 
Fluorescence Patterns in Different Groups of Patients 
{Number of patients and percentage in each group presented) 
GROUP 
Staining ARF AGN CRF-C CRF-A IHD CONT-C CONT-A SLE-Con t 
pattern n = 18 n = 12 n = 19 n = 13 n = 19 n = 16 n = 8 n = 12 
1 - 1 - - 1 - - 2 
(8.3%) (5.3%) (16.7%) 
2 - - - - - - - 2 
(16.7%) 
3 12 4 11 8 3 2 - 6 
(66.7%) (33.3%) (57.9%) (61.5%) (15.8%) (12 .5%) (50%) 
4 - 1 - 1 - - - 2 
(8.3%) (7.7%) (16.7%) 
5 1 - - 1 - - - -
(5 .6%) (7.7%) 
6 1 - - - - - - -
(5.6%) 
7 - - - 1 1 - - -
(7.7%) (5.3%) 
Total% 14 6 11 11 5 2 0 12 
with ANA (77 .8%) (50%) (57 .9%) (84.6%) (26.3%) (12.5%) (0%) (100%) 
Code of Staining Pattern (see Table 2.2 for description of code) 
1 . Homogeneous 
2. Peripheral or rim 
4. Speckled - discrete 
5. Nucleolar 
7. Smooth muscle - fine 
fibrous staining 
3. Speckled - fine 6. Cytoplasmic - speckled 
2.2.4.2 Extractable Nuclear Antigens (ENA) 
Antibodies to the extractable nuclear antigens, Sm (Smith antigen) and RNP 
(ribonuc!eoprotein) were measured in the rheumatic fever patients (ARF, CRF-c; 
CRF-a) and in the child and adult control groups, by counter-
immunoelectrophoresis. Antibodies to these antigens are known to occur in 
certain systemic rheumatic diseases such as SLE, mixed connective tissue 
disease, Sjogrens' syndrome and scleroderma. 
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Of all the sera tested , only two patients (both ARF) showed evidence of 
antibodies to these nuclear antigens - one to SM and one to RNP. Neither 
patient had any history · or clinical evidence of SLE. Both showed a fine 
speckled immunofluorescence pattern in the HEp-2 ANA assay (indicative of 
autoantibodies to Sm or RNP) but neither had anti-DNA antibodies. These 
patients both had raised ASO and DNAse titres, and the RNP-positive patient 
stained heart tissue intensely (4 +) in the biotin-streptavidin-peroxidase assay 
(section 7.A.18). 
Since rheumatic fever may also be viewed as a connective tissue disease, 
antibodies to RNP are plausible. Antibodies to the Sm antigens are surprising 
since this antigen is regarded as a diagnostic marker for SLE. Both Sm and 
RNP antigens are comprised of several interactive proteins associated with 
RNA, and have been implicated in mRNA splicing (Tan, 1989b). The presence 
of these autoantibodies in ARF sera has. not previously been reported, but as 
only two patients were positive their pathological significance is doubtful. 
2.2.4.3 Anti-DNA Antibodies 
Anti -DNA antibodies are not known to occur in rheumatic fever. The finding in 
this study of antinuclear antibodies (ANA) as well as antibodies to Sm and RNP 
antigens, prompted this investigation of anti-DNA antibodies in rheumatic sera . 
Antibodies to native double-stranded DNA were measured in all groups of sera 
by the standard Crithidia luciliae assay. 
Only three sera in the entire study group contained antibodies to ds-DNA: two 
from the IHD group and one AGN child. 
2.2.4.4 lmmunocytochemistry:Biotin-Streptavidin-Peroxidase and 
lmmunofluorescence 
All sera were tested for antibodies binding human heart sections, using a biotin-
streptavidin-peroxidase system described in Materials and Methods (section 
7.A.18). 
Sera were tested at an optimal dilution of 1 :5 and scored, on a scale from 1 + 
to 4+, according to their intensity of staining (see Table 2.4; Fig.2.10a,b,c,d). 
It was found that trypsinization of the sections (0.1 % trypsin at 37°c for 12 
minutes) to expose cross-linked antigens considerably enhanced the staining, 
as did pre-treatment with 0.3% hydrogen peroxide to inhibit endogenous 
peroxidases. 
A commercially available rabbit anti-actin antiserum (Biomakor) was used as a 
positive method control. It reacted with an intense speckled pattern, showing 
some evidence of striational binding (Fig 2.1 O.e). Since antisera to denatured 
antigens often react more strongly in immunocytochemical assays (probably 
because fixation procedures denature tissue antigens), a rabbit antiserum raised 
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to the detergent extract of heart (section .7.A.1) was also used. It reacted with 
a similar speckled pattern of binding, but without evidence of striational binding 
(Fig 2.10. f). To control for interassay variability, two strongly-reactive (4 + 
staining) ARF sera were included in each assay. 
TABLE 2.4 
Staining of Human Heart Sections by Biotin-Streptavidin-Peroxidase 
GROUP 
Intensity of ARF AGN CRF-C CRF-A IHD CONT-C CONT-A 
staining n = 20 n = 19 n = 20 n = 16 n = 21 n = 33 n = 10 
4 + 6 5 
30%) (25%) 
3+ 3 3 3 2 
(15%) (15%) (15%) (12.5%) 
2+ 7 3 5 2 1 4 1 
(35%) (15%) (25%) (12 .5%) (5%) (12%) (10%) 
1 + 1 2 3 6 1 5 4 
(5%) (10%) (15%) (37.5%) (5%) (15%) (40%) 
Total% with 17 8 16 10 2 9 5 
staining (85%) (42%) (80%) (62 .5%) (10%) (27%) (50%) 
Intensities scored as follows : 
4 + Intense staining throughout the section and/or presence of striations 
3 + Strong staining in parts of the section 
2 + Diffuse/patchy staining 




Fig.2.10 Biotin-streptavidin-peroxidase immunocytochemical staining of human heart paraffin 
embedded sections 
Sera were tested at a dilution of 1 :5 for antibodies binding to heart using a biotin-streptavidin-
peroxidase assay (section 7.A.18) . Intensity of the reaction was scored visually as one to four 
pluses. (Results are summarised in Table 2.4). 
(a) 4 + intensity of staining by an ARF serum of human heart tissue in cross-section showing 
staining of muscle bundle fibres and no staining of connective tissue. (b) 4 + staining by ARF 
se_rum of longitudinal section showing striational binding pattern. (continued overleaf) 
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(continued from previous page) 
(c) Example of 1-2 + staining of heart section by a non-rheumatic fever serum showing diffuse 
colour reaction in comparison with (a). 
(d) The no-serum control reaction showing no nonspecific binding of the biotinylated second 
antibody or streptavidin-peroxidase conjugate to the tissue. 
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e 
(continued from previous page) 
(e) Reaction of rabbit anti-actin antibody (Biomakor) with human heart section showing intense 
speckled patterns with patches of striational staining. 
(f) Reaction of rabbit anti-crude heart extract antibody (section 7 .A.1) showing a speckled 
staining pattern. (No evidence of striations) 
Chapter 2 Cardiac/Nuclear/Streptococcal antibodies / 58 
Table 2.4 shows that antibodies to heart were present in all groups of sera, but 
the incidence and intensity of staining differed markedly. 85% of ARF and 
80% of child CRF patient$ showed evidence of heart-reactive antibody ·(HRA) 
compared to 27% of normal children. Furthermore, whereas none of the 
controls showed staining more intense than 2 +, 40-45 % of the child rheumatic 
fever sera stained with an intensity of 3+ or 4+ (Fig.2.10a, b). The adult CRF 
sera also showed a higher incidence and intensity of staining compared to 
normal adults. Interestingly, the reactivity of the AGN pa~ients was somewhat 
higher than might be expected (Table 2.4). Interpretation of these results is 
arguably somewhat subjective, and competition experiments might have 
permitted more sophisticated analyses. 
Examples of these binding patterns are shown in Fig 2.1 O(a,b,c,d). Intense 
staining of muscle fibres, both in longitudinal and in cross-section, can be 
clearly seen. The staining is not distinctly sarcolemmal but appears to 
permeate the cytoplasm of the cells. This could be an artefact of peroxidase 
staining of tissue sections, since the immunofluorescence staining depicted in 
Fig 2.11 shows a greater intensity of staining of the sarcolemmal membranes, 
which is in accord with previous reports of ARF serum reactivity against heart 
(Zabriskie 1985). 
In preliminary investigations, indirect immunofluorescence was used, but the 
streptavidin-peroxidase method was preferred since there was no background 
binding, the method was sensitive and the staining was permanent (for future 
reference). Fig 2. 11 compares the immunofluorescence and streptavidin-
peroxidase staining of heart sections by a high titre ARF serum. 
This study shows that the biotin-streptavidin-peroxidase assay for detection of 
heart-reactive antibody is sensitive and reproducible. The findings are in 
agreement with previous studies using indirect immunofluorescence, showing 
that up to 85 % of ARF sera contained antibody binding to sections of normal 
heart. This assay also shows the presence of these antibodies in some normal 
individuals and children with acute glomerulonephritis. Although striational 
binding patterns were seen with several ARF sera, sarcolemmal · binding was 




Fig. 2.11 Comparison of immunofluorescence and biotin-streptavidin-peroxidase staining 
patterns of human heart tissue sections by an ARF serum. 
(a) Frozen section of human heart incubated with an ARF serum diluted 1:10 (section 7.A .17), 
and stained with an Fab'2 goat anti-human lgG (H + L) FITC-conjugated antibody (Zymed). Slides 
were observed under a Nikon Optiphot microscope using a PlanApo 60X oil lens, and 
photographed (FX-35A : Kodak 400 ASA). (b) Biotin-streptavidin-peroxidase staining (4 +) of 
human heart tissue (section 7.A .18). Photographed using Nikon Optiphot microscope with FX-
35A camera attachment (20 X magnification) and Kodak 400 ASA colour film. 
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2.3 CONCLUSIONS 
In this study of sera from seven groups of rheumatic fever {RF) patients and 
control subjects: 
1. All RF patients showed elevated concentrations of lgA. ARF and CRF-a 
patients also showed elevated levels of lgG. 
2. All RF groups of sera, at a dilution of 1: 100 in ELISA, contained raised 
levels of heart-reactive antibodies {HRA). CRF-a patients showed the 
highest mean titres at all dilutions. 
3. CRF-a sera showed raised levels of anti-myosin antibodies {AMA) in 
ELISA at a 1: 100 dilution, and these appeared to be correlated with 
raised heart-reactive antibodies. 
4. ARF and AGN sera at dilutions of 1: 100 and 1: 1000 showed evidence of 
antibodies to actin in ELISA. 
5. All RF groups of sera at a dilution of 1: 1000 showed raised levels of 
antibodies to phosphorylase b {APA) compared to normal control groups; 
CRF-c and CRF-a sera also showed raised levels at a dilution of 1: 100. 
In groups of sera with heart disease, these antibodies showed some 
correlation with heart-reactive antibodies. 
6. Antibodies to cardiolipin do not appear to have a role in rheumatic fever. 
7. Anti-streptolysin O {ASO) antibodies were significantly raised in ARF 
sera. Although ARF patients also had high titres of anti-DNAse B 
antibodies, the effect was obscured by statistical comparison with the 
control group of rural children who had exceptionally high anti-DNAse B 
titres. 
8. An ELISA for detection of antibodies to whole group A streptococci, 
showed marginally elevated titres among CRF-a patients. However this 
assay also detected antibodies to other groups of streptococci. 
9. CRF-a sera showed raised levels of antibodies to all eight streptococcal 
M proteins tested in ELISA. ARF and AGN sera also showed high titres 
to all M proteins {except M24) but the effect was obscured by the high 
titres to these proteins in the rural child control group. Antibodies to 
proteins M5 and M6 were raised in ARF patients compared to AGN and 
adult controls. These streptococcal serotypes may possibly be important 
among South African rheumatic fever patients. 
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1 O. There was evidence of antinuclear autoantibodies (ANA) in all groups of 
RF sera at dilutions of up to 1 :80, as shown by fine speckled 
immunofluorescence .staining against HEp-2 cell substrates. Individual RF 
sera also showed evidence of autoantibodies to mitochondria, 
centromeres arid smooth muscle. 
11. Among RF sera, one ARF patient contained antibodies to Sm antigen, 
and another to RNP antigen. 
12. None of the RF patients showed any evidence of antibodies to double-
stranded DNA. 
13. 85% of ARF sera (and 80% of CRF-c) contained antibodies binding to 
sections of normal human heart, in a biotin-streptavidin-peroxidase 
assay. 40-45% of these showed intense staining. Several of these sera 
showed striational binding along the muscle fibre, but in cross-section a 
sarcolemmal pattern of binding was not distinctly evident. 
14. Among the adult CRF patients, the raised levels of antibodies to several 
of the antigens investigated in this study may be indicative of polyclonal 
B cell activation. This does not necessarily preclude an antigen driven . 
response. 
15. RF sera showed binding to several streptococcal and cardiac antigens 
but antibodies to these antigens were also usually evident (although 
often at a lower frequency, or intensity of reaction) in normal and 
related-disease control sera. The pathological relevance of the anti-heart 
autoantibodies and their relationship to the anti-streptococcal antibodies 
in antigenic mimicry, remains to be elucidated. 
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3. IMMUNOBLOTTING: CARDIAC AND STREPTOCOCCAL ANTIGENS 
AGAINST RHEUMATIC FEVER AND CONTROL SERA 
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3. 4 
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3.1. INTRODUCTION 
lmmunoblotting has proven to be an important technique for the 
characterization of autoantigens and autoantibodies in numerous autoimmune 
diseases (Elkan et al., 1987). It has been used to identify autoantigens such as 
nuclear antigens (e .g. Habets et al., 1983), muscle proteins (Koga et al., 1987), 
thyroid antigens (Kotani et al., 1986) and bullous pemphigoid autoantigens 
(Labib et al., 1986). In addition to the efficient fractionation of autoantigens, 
the class, subclass, idiotype and specificity of autoantibodies can be 
determined. 
The aim of this project was to analyse the reactivity of rheumatic fever (and 
control) sera to antigens from extracts of human heart tissue. Crude detergent 
extracts of human heart following separation on polyacrylamide gel slabs· were 
electroblotted onto nitrocellulose, and the separated antigens were tested for 
reactivity with the seven groups of sera (described in Chapter 2). Various 
purified cardiac and streptococcal antigens were also studied using this 
method. 
This section reviews previous reports of immunoblotting using patient sera, 
rabbit immune sera and monoclonal antibodies as probes to constituents of 




IMMUNOBLOTTING OF CARDIAC ANTIGENS: CRUDE EXTRACTS, 
SARCOLEMMAL MEMBRANE AND PURIFIED PROTEINS 
Extracts of Heart Tissue: Procedures 
Crude Extracts 
The method of extraction of heart tissue antigens may affect the detection of 
autoantigens. Various extracts of heart tissue antigen have been used. These 
include: saline extracts (Kusher and Kaplan, 1967; Zabriskie and Friedman, 
1983); 3 M KCI sarcolemmal membrane extracts (Van de Rijn et al., 1977); 
dilute acid extracts (Zabriskie and Freimer, 1966; Espinosa and Kaplan, 1968), 
SOS (Dale and Beachey, 1983; Ayakawa et al., 1985; Doyle et al., 1986), 
Triton X-100 (Cunningham et al., 1983; 1984) and sodium deoxycholate 
methods (Shastry et al., 1988). 
Recent investigators have favoured detergent extracts, although the 
zwitterionic detergent CHAPS (used in this study) has not previously been tried. 
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3 .1.1.1.2 Sarcolemmal Membrane Extracts 
A number of studies have localised the heart epitope(s) in rheumatic fever to 
the sarcolemmal membrane (Kaplan and Meyerserian, 1962; Kaplan, 1963; 
Zabriskie and Freimer, 1966; Zabriskie et al, 1970; Van de Rijn et al, 1977; 
Dale and Beachey, 1982a). 
lmmunoblotting of sarcolemmal membrane extracts has therefore been used in 
several studies to identify these antigens. In most studies, the membranes 
have been isolated by the method of Van de Rijn et al., ( 1977), and SOS 
extracts reacted by immunoblotting with monoclonal antibodies and rabbit 
hyperimmune sera (Dale and Beachey, 1982a; Cunningham et al., 1984; Dale 
and Beachey, 1985a; Sargent et al., 1987). 
3.1.1.2 lmmunoblotting of Heart Antigen Against Human Sera and 
Monoclonal Antibodies 
Table 3.1 (pages 73-81) summarises reports in the literature of the molecular 
weight constituents present in human heart and streptococcal antigenic 
extracts, that have been found reactive with rabbit immune sera and 
monoclonal antibodies raised against such antigens. Except in the study by 
Zabriskie and Friedman (1983), none of these investigations by immunoblotting 
have used patient sera. This is remarkable because patient sera could be 
considered the most relevant to the pathogenesis of the disease. 
3.1.1.2.1 Crude Extracts of Heart 
Antibody-reactive constituents in immunoblotted heart and streptococcal 
antigenic mixtures can be grouped into three or four major mol. wt. regions. 
These are summarised below and in Table 3.1. The majority of immunoblotting 
experiments have been performed under reducing conditions of the antigen and 
it is possible that some of the minor constituents may be breakdown products 
of these antigens. Dale and Beachey (1982a) for instance, found differences in 
antibody reactivity against heart extracts separated under reducing and 
nonreducing conditions. Possibly, proteolytic cleavage might also produce 
spurious reactivities, although protease inhibitors are usually included in 
extraction procedures. 
1. <40 kD molecular weight 
(i) 30 kD constituent : in Triton X-100 extracts of human heart, 
reactive with rabbit hyperimmune serum to M5 and M25 
protein (Cunningham et al., 1984). 
(ii) 38 kD: in saline extracts of bovine heart, reactive with ARF 
sera (Zabriskie and Friedman, 1983). 
(iii) 27 kD: in SOS extracts of sarcolemmal membranes, reactive 
with (pep M5) rabbit antiserum affinity purified to the cloned 
M5 protein (Poirier et al., 1985). 
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(iv) 32 kD: in SDS extracts of crude heart, reactive with antisera 
to S.mutans. 
2. 40-45 kD molecular weight 
(i) 40 kD constituent: in Triton X-100 extracts of human heart 
reactive with rabbit hyperimmune serum to M5 protein. 
Also present in skeletal muscle but not in kidney. Also 
faintly reactive with normal rabbit serum (Cunningham and 
Russell, 1983). 
(ii) 40 kD: in SDS crude extracts of human heart, reactive with 
antisera to M protein fragment SM5 ( 164-197)C (Sargent et 
al., 1987). 
(iii) 40 kD: in Triton X-100 extracts of human heart and in SDS 
extracts of sarcolemmal membranes, reactive with murine 
mAbs (49.8.2 and 49.8.9) evoked by streptococcal M5 
membranes (Cunningham et al., 1984). 
(iv) 40 kD as one of multiple-bands: in SDS crude extracts of 
human heart, reactive with rabbit sera to pep M5. (Dale and 
Beachey, 1985a). 
(v) 40 kD: in SDS crude extracts of human heart, reactive with 
antisera to S.mutans wall-membrane complexes (Ayakawa 
etal., 1985). 
(vi) > 40 kD: in Triton X-100 extracts of human heart, reactive 
with rabbit anti-M 25 antiserum (Cunningham et al., 1984). 
(vii) 43 kD: in saline extracts of bovine heart reactive with ARF 
sera (Zabriskie and Friedman, 1983). 
3. 67-70 kD molecular weight 
(i) > 67 kD: in Triton X-100 extracts of human heart, reactive 
with rabbit hyperimmune sera to M 5 protein (Cunningham 
and Russell, 1983). 
(ii) 70 kD: in Triton X-100 extracts of human heart; reactive 
with rabbit antiserum protein M25 (Cunningham and Russell 
1983). 
(iii) 69 kD (and faint 68 kD): in SOS extracts of human heart 
atrial appendage, reactive with sera to S.mutans wall-
membrane complexes (Ayakawa et al., 1985). 
Chapter 3 lmmunoblotting / 67 
4. 200 kD molecular weight 
This constituent in SDS crude extracts of heart has been identified 
as myosin (Dale and Beachey, 1985a). 
3.1.1.2.2 Sarcolemmal Membrane Preparations 
Indirect immunofluorescence on frozen sections of heart showed that rabbit 
antisera evoked by group A streptococci cross-reacted with sarcolemmal 
membranes (Kaplan, 1963; Zabriskie and Freimer, 1966). 
Dale and . Beachey ( 1982a) showed that rabbit antisera to pep M5 reacted 
specifically with 1 % SDS extracts of cardiac sarcolemmal membranes. The 
reaction could be inhibited by purified M5 and M19 proteins. The cross-
reactive sarcolemmal antigen was a large polypeptide of 21 5 kD composed of 
four subunits (78 kD, 71 kD, 65 kD, 58 kD) cross-linked by disulphide bonds. 
This was the first evidence of specific cross-reactivity between streptococcal M 
proteins and a sarcolemmal membrane protein. 
Using murine mAbs evoked by type M5 streptococcal membranes, Cunningham 
et al. ( 1984) detected a component of the same mol. wt. in similar SDS extracts 
of sarcolemmal membranes. lmmunoblot inhibition experiments by Dale and 
Beachey ( 1985a) showed that this antigen was myosin. Other investigators 
have shown myosin associated with the internal membrane surface of the 
sarcolemma (Fallon and Nachmias, 1980).· 
This summary of the literature shows that antisera react with numerous 
constituents in heart extracts and it is therefore difficult to know which are of 
significance to antigenic mimicry in rheumatic fever . 
3.1.1.2.3 Purified Cardiac Antigens 
Since crude antigenic extracts may contain numerous irrelevant cross-reactive 
epitopes, specificity of cross-reactive antigens detected in such extracts should 
be verified using purified proteins (Lampson ·and Fisher, 1985). In rheumatic 
fever, two purified proteins that have been shown to be cross-reactive with 
streptococcal antigens are myosin and tropomyosin. 
3.1 .1.2.3.1 Myosin 
3.1.1.2.3.1 .1 Using Rabbit Antiserum 
Krisher and Cunningham ( 1985) provided the first evidence that purified myosin 
was cross-reactive with streptococcal M protein. A murine monoclonal 
antibody (54.2.8) evoked by type 5 M protein, was found to react with myosin 
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(extracted from rabbit heart and skeletal muscle). The same mAb reacted with 
a high molecular weight protein in SOS crude sarcolemmal extracts of human 
heart. It was suggested that this component too was cardiac myosin. 
Examination of the structures of myosin and type 5 M protein by Manjula et al. 
(1985) showed homologies in the amino acid periodicity and the coiled-coil 
structure of the two molecules. 
Further evidence was adduced by Dale and Beachey ( 1985a) who showed that 
only the 200 kD band from sarcolemmal extracts, displaying multiple bands in 
immunoblots, disappeared on pre-absorption of the sera with cardiac myosin. 
It was shown, more specifically, that this reactive component was the heavy 
chain of myosin. Reactivity of anti-pep M5 sera with this heavy chain could be 
partially inhibited by pep M6 protein, but not by pep M25, myosin light chains, 
actin or tropomyosin. 
Using synthetic peptide deri~atives of pep M5, Dale and Beachey ( 1986b) 
mapped the myosin-reactive M protein epitope to a stretch within 33 amino 
acids. The peptide SM ( 164-197) completely inhibited reactivity of anti-M5 
sera with myosin heavy chain, whereas other peptides had no effect. 
More recently, Cunningham et al. ( 1989) have mapped the myosin cross-
reactive epitopes of the pep M5 molecule to an epitope within the fourteen 
residue carboxy terminus, which appears to involve the sequence GLN-L YS-
SER-L YS-GLN. 
3.1.1.2.3.1.2 Using Monoclonal Antibodies 
The above results, obtained using rabbit antisera, were corroborated using 
monoclonal antibodies evoked by streptococcal antigens. 
Cunningham et al. ( 1984) showed that murine mAbs evoked by type M5 
streptococcal membranes reacted with a 200 kD band in SOS extracts of 
sarcolemma. Krisher and Cunningham (1985) demonstrated reactivity between 
one of these mAbs and myosin. Interestingly, this series of mAbs was shown 
to react more intensely with sarcolemmal extracts from rheumatic fever heart 
than from non-rheumatic heart. 
Similar to rabbit immune sera to M5 protein, the murine mAbs were found to be 
reactive with only the heavy chain of myosin (Cunningham et al., 1985). mAb 
36.2.8 reacted with skeletal light meromyosin, whereas mAb 58.2.8 reacted 
with skeletal and cardiac heavy meromyosin. Neither reacted with myosin light 
chain or was inhibited by myosin light chain and neither of the mAbs inhibited 
the .ATPase activity of myosin. 
Van de Rijn et al ( 1977) demonstrated cross-reactivity between heart and 
S.mutans, and Doyle et al. (1986) have shown that the cardiac antigen 
implicated may be myosin. Murine mAbs raised to S.mutans (mAb 22C4 and 
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mAb D159) reacted with a 200 kD constituent in extracts of heart, as well as 
with myosin and S.pyogenes. (The significance of this cross-reaction for 
rheumatic fever is not clear, although it has obvious implications for 
development of potential vaccines). 
Human monoclonal antibodies, selected for their cross-reactivity between 
cardiac and group A streptococcal antigens, also reacted with myosin heavy 
chain (Cunningham et al., 1988). 
These investigations present some compelling evidence that myosin 
(specifically the heavy chain) may be a relevant autoantigen implicated in 
antigenic mimicry in rheumatic fever. 
3.1.1.2.3.2 Tropomyosin 
Manjula and Fischetti ( 1980) revealed structural similarities between 
tropomyosin and M proteins of S.pyogenes, and these findings were 
substantiated immunologically by the demonstration that M5 and M6 shared 
epitopes with tropomyosin, and other a-helical coiled-coil proteins (Fenderson 
et al., 1989). 
Murine mAbs evoked by purified M5 streptococcal membranes, and specific for 
either pep M5 or cloned M6 protein, reacted with tropomyosin. All were also 
reactive with myosin and some of them also reacted with actin, keratin or DNA. 
The immunologic relationship between these M proteins and the mammalian 
muscle proteins (myosin and tropomyosin) could be of relevance to antigenic 
mimicry in rheumatic fever. Manjula and Fischetti ( 1980) suggested that the 
structural similarities between these proteins, might be responsible for the 
antiphagocytic property of the M protein. 
It is known that the energy for phagocytosis is generated by a similar 
biochemical pathway to that of muscle contraction (Silverstein et al., 1977), 
and it is suggested that through their structural resemblance to tropomyosin, M 
proteins might interfere with the contractile machinery of leukocytes. It has 
been shown that in the absence of actin, the troponin-tropomyosin complex 
from muscle can confer Ca2 + -regulated Mg2 + -ATPase activity upon myosins 
isolated from guinea pig leukocytes and mouse fibroblasts (Stossel and Pollard, 
1973; Adelstein et al., 1972). These findings suggest an interesting 
mechanism by which antigenic mimicry between S.pyogenes and muscle 
proteins may be implicated in the pathology of rheumatic fever - but they have 
as yet not been substantiated. 
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3.1.2 IMMUNOBLOTTING OF STREPTOCOCCAL ANTIGENS 
3. 1.2. 1 Crude Extracts and Purified M Proteins 
S.pyogenes antigens have also been analysed by immunoblotting, using similar 
monoclonal antibodies and rabbit antisera applied in the analyses of heart 
antigens. These studies indicate a broad region of reactivity in the mol. wt. 
range of 50-70 kD in SOS extracts of group A streptococci. 
Murine mAbs evoked by streptococcal M5 membranes, react~d with a triplet at 
58 kD and a group of bands between 62-67 kD (Cunningham and Swerlick, 
1986). Two of these mAbs were shown to be reactive in immunoblotting with 
myosin (Krisher and Cunningham, 1985). Similarly, Jones and Fischetti (1987) 
showed that a mAb raised to MG protein (E.co/i-cloned), reacted with 
streptococcal constituents in the range 57-77 kD. 
The reactive constituents in these streptococcal extracts have not been 
identified, but it is noteworthy that the mAbs which they bound were evoked 
by M proteins and showed cross-reactivity with myosin. 
3.1.3 SPECIAL APPLICATIONS OF IMMUNOBLOTTING 
lmmunoblotting was also used in this study for the purpose of affinity purifying 
antibodies; for separating antigens to immunize rabbits; and for analyzing 
constituents in antigenic mixtures capable of stimulating lymphocytes (results 
not reported). These applications are briefly discussed here. 
3. 1.3. 1 Affinity Purification of Antibodies 
Sera can be affinity purified on immunoblots of antigenic extracts to give 
monospecific populations of antibodies (Olmsted, 1981; Smith and Fisher, 
1984). The technique can be used as an expedient alternative to monoclonal 
antibodies or affinity chromatography. The nonspecific binding in whole serum, 
as well as the potential multispecific binding of monoclonal antibodies, may be 
averted. 
The technique is also suited to the study of cross-reactivity between antigens: 
antibody can be eluted from one nitrocellulose band and reacted against 
~mother, to reflect whether the antigens share epitopes (Query and Keene, 
1987). In a variation of the technique (see Chapter 5), antibody is eluted from 
purified plaques of a cDNA expression library, and reacted against 
immunoblotted antigens (Ozaki et al., 1986) or against tissue sections by 
immunofluorescence (Stanley et al., 1988) 
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3.1.3.2 Immunization 
lmmunoblotted antigens can be injected into animals to raise antibodies. The 
nitrocellulose band can be cut into small pieces or dissolved to a slurry in 
organic solvent, before immunization (Parekh et al., 1985). Alternatively, the 
antigen can be eluted from the nitrocellulose with dimethylsulphoxide or 
nonionic detergent (Knudsen, 1985; Anderson, 1985), or else implanted 
subcutaneously as an immunogen (Chiles et al., 1987). Antibodies raised by 
this method can be used to purify more of the original antigen. 
3.1.3.3 Antigens Recognized by T Lymphocytes 
Assays for the recognition of immunoblotted antigens by T cells have been 
developed by Young and Lamb (1986) and Lamb et al., (1988). Excised 
antigen bands are dissolved in dimethyl sulphoxide (DMSO) and precipitated 
into fine particles before being added to the wells in a lymphocyte proliferation 
assay (Abou-Zeid et al., 1987). Alternatively, they can be sterilized, cut into 
pieces of appropriate size, and then added to the lymphocyte cultures (Young 
and Lamb, 1986). By this technique, one can test the ability of antigens 
separated from a complex extract to induce a T cell response. (Results of 
these experiments are not reported in this study). 
3.1.4 CROSS-REACTIVITY AND IMMUNOBLOTTING: SOME PITFALLS 
The application of immunoblotting, a solid phase technique, to the study of 
cross-reactivity has some pitfalls which should be taken into account in 
interpreting results. These are discussed by Lampson and Fisher (1985), Van 
Regenmortel ( 1989) and Ghosh and Campbell ( 1986) and summarised below. 
(1) Irrelevant, misleading cross-reactions may be detected in complex protein 
extracts, especially using monoclonal antibodies. Possibly, the dense 
concentration of antigen into a narrow band on the nitrocellulose, and 
the use an amplifying second antibody may contribute to this effect 
(Lampson and Fisher, 1985; Van Regenmortel, 1989). 
(2) The relatively high concentration of irrelevant cross-reactions present in 
complex protein mixtures may obscure the effect of the antigen of 
interest. Antibody specificities should therefore be evaluated using not 
only the complex extract, but also purified proteins (Lampson and Fisher, 
1985). 
(3) Competition between different antibody subpopulations in serum, may 
obscure specificities detectable using monospecific or monoclonal 
antibodies. For instance, antigens detectable by human mAbs, might not 
be detected by the patient's serum. 
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(4) Denaturation of antigen by SOS during the electrophoresis, may both 
either destroy epitopes (especially conformational ones) or reveal new 
potentially cross-reactive epitopes (Lampson and Fisher, 1985). Binding 
of antigen to nitrocellulose paper may have similar effects (Ghosh and 
Campbell, 1986). 
Bands on immunoblots will often vary in intensity in different immunoblots. It 
is important therefore to control for such effects by: ( 1) using antibody 
preparations of appropriate concentration and isotype; (2) using consistent 
antigen extracts that are protected against proteolysis; (3) using, where 
possible, purified proteins to confirm cross-reactions detected in crude extracts. 
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TABLE 3.1 (see following 8 pages) 
IMMUNOBLOTTING: Summary of Published Reports on the Reactivity of Patient 
Sera, Rabbit Hyperimmune Sera and Monoclonal Antibodies Against Cardiac 
and Streptococcal Antigens. 
The table summarises information reported in the literature on constituents of specific molecular 
weights (mol. wt.band) contained in various antigenic extracts of heart and streptococci 
which have been found by immunoblotting to be reactive with ARF patient sera, 
monoclonal antibodies (murine and human) or rabbit hyperimmune sera evoked by 
various streptococcal and cardiac antigens. Control antibody preparations used are shown. 
Various antigens cross-reactive with or inhibiting the reactions of the antibody reagents are 
listed (other reactivities, inhibitions). References describing the immunoblotting 

















M : streptococcal M protein 
pep M5 (or 6, 19, 24 etc): pepsin digests of the streptococcal M protein 
SM5 ( 164-197)/(84-116)/( 1-35) : these refer to synthetic peptides of streptococcal M5 
protein comprising the given residue numbers 
("36.2.2" and "T7", etc refer to designations of particular mAbs described in the quoted 
reference) 
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3.2 RESULTS 
lmmunoblotting has been extensively used to investigate cross-reactivity in 
rheumatic fever, but remarkably few of these studies have used patient serum 
to detect the antigens. Monoclonal antibodies and rabbit immune sera have 
been preferred because of their known specificity and the high titre of 
potentially relevant antibodies they contain. Patient serum could, however, be 
considered more relevant to the disease. 
The objective of this study was to compare the immunoblotting binding 
patterns of rheumatic fever and control sera to various cardiac and S.pyogenes 
antigens, in order to determine whether unique reactivities existed in the 
disease. 
The same seven groups of sera analysed for reactivity to these antigens by 
ELISA and immunocytochemistry (Chapter 2), were used to analyze reactivity 
of autoantibody isotypes against separated cardiac polypeptides by 
immunoblotting. In addition, immunoblotting was used to analyse cross-
reactivity between cardiac and group A streptococcal antigens, using patient 
(and rabbit immune) sera. 
3.2.1 Human Heart Detergent Extracts 
. 
3.2.1.1 Non-rheumatic Heart Extract 
Crude extracts of postmortem human heart without any evidence of rheumatic 
(or other) heart disease, were prepared using the detergent CHAPS (3-[(3-
cholamidopropyl)-diemthylammonioJ-1-propane-sulfonate), as described in 
Materials and Methods (section 7 .A .11 ). 
3.2.1.1.1 Preliminary Investigations 
Preliminary investigations in this study examined the reactivity patterns of 
rheumatic fever and . control sera against immunoblotted extracts of human 
heart, prepared using the following extractants: 4% Triton X-100, 4% SOS, 3M 
KCI, 5 mM octyl glucoside and 5 mM CHAPS dete.rgent. 
·compared to the other methods, heart tissue extracted with CHAPS 
demonstrated the most consistent differences in patterns of reactivity between 
rheumatic fever and control sera. This method of extraction was therefore 
standardly used in this study. In addition to its efficient solubilization of 
proteins, this zwitterionic detergent is efficient at breaking up artefactual 
protein aggregates, is only mildly denaturing and its electrical neutrality leaves 
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intact the natural charge properties of the protein. Furthermore, CHAPS is 
compatible with charge fractionation techniques such as SOS PAGE. 
Protease inhibitors (thymol and PMSF) were added to extracts, which were 
aliquoted and stored at -80°C, and not refrozen after being thawed for initial 
use. No change in the binding patterns of the extracts was seen even if they 
were left at room temperature overnight before use (or after several months of 
storage at -80°C), suggesting that no major proteolysis occurred in the extract. 
Preliminary control studies also involved a comparison of serum reactivities 
against extracts from five different human hearts (all obtained at postmortem 
within 8 hours after death). Although (compared to each other) sera reacted 
with different patterns, any particular serum reacted with the same pattern on 
all five heart extracts. Differences in reactivity patterns were thus not 
attributable to allotypic differences among individual heart donors. None of the 
five donors had postmortem evidence of rheumatic heart disease. Extracts 
were prepared so as to include tissue from different areas of the heart. 
The staining pattern of individual sera was distinctive and reproducible with 
respect to both mol. wt. and intensity of staining. Preliminary studies also 
showed that the use of different blocking reagents (2% BSA; 5% BLOTTO; 1 % 
gelatin; 3% FCS - all containing, in addition, 1 % goat serum and 0.05% Tween 
20) affected only the intensity but not the pattern of binding. Since the same 
distinctive pattern was obtained with repeated testing of particular sera against 
different hearts, the observed pattern was peculiar to the serum tested. 
The initial use of a combined lgG, lgA, lgM peroxidase conjugate (Cappel) failed 
to reveal clearly discernible differences in binding between the groups of sera, 
and therefore separate class-specific Fab' 2 fragment peroxidase conjugates 
were used (Cappel). 
3.2.1.1.2 Main Investigation 
Twenty sera in each of the seven groups of subjects, were compared for lgG, 
lgM and lgA autoantibody isotype reactivity with antigens in the heart extract. 
3.2.1.1.2.1 Identification and Descriptions of Antigen Bands 
Eleven major bands of reactivity were distinguishable. Fig. 3.1 shows an 
Amido Black protein stain of these immunoblotted antigens from extracts of 
both normal heart and postmortem acute rheumatic fever heart · (section 
7.A.11 ). The mol.wt. (as well as the designated number) of each of the eleven 
bands stained by sera, are depicted. The mol. wt. of the stained antigens 
ranged from 116 kD to 28 kD. (Proteins smaller than 20 kD may have been 












ARF Norm. Band No. MW 
} 
} 
1 ............ 116 
2 ........... 85 
3 .......... 77 
4 ........... 67-70 
..-5 ......... 
6 ......... 
~ .......... ......... 
9 ........ . 









Fig. 3.1 Amido Black protein stains of immunoblotted crude extracts of normal and rheumatic 
fever heart showing the eleven bands reactive with rheumatic fever sera. 
Extracts of postmortem normal and acute rheumatic fever heart were prepared using CHAPS 
detergent as described in section 7 .A.11. The extracts were separated by 10% SDS PAGE, 
transferred to nitrocellulose (section 7.A.9) and stained with Amido Black (0.1 % w/v in 2% 
acetic acid) followed by destaining in hot 2% acetic acid. Low .and high molecular weight 
markers (Pharmacia) were likewise blotted and stained. The mol. wts. of the eleven major bands 
reactive with rheumatic fever sera were determined and designated Bands No.1-11. 
Chapter 3 lmmunoblotting / 85 
The intensity of staining of each serum was scored as one to three pluses { +, 
+ +, + + +) by visual comparison. An average of two {and in many cases 
three) determinations was made for each serum, and intensities were scored by 
two independent observers. 
Results, presented in Table 3.2, are presented as the percentage of sera in 
each group staining the eleven protein bands in the extract, at a particular 
intensity score . 












Mal. Wt. and General Description of Staining: 
116 kD : A faint doublet 
85 kD A singlet except with ARF sera which appeared to 
stain it as a broad doublet. 
77 kD: A faint and often diffuse band 
67-70 kD: A prominent band at 67 kD, with a narrower 
sharp band above it at 70 kD . 
50-58 kD: A broad area of reactivity comprised of about 3-5 
narrow bands . 
45 kD: A broad band staining strongly but nonspecifically 
with lgG {the peroxidase conjugate in the no-serum control 
also stained it) . lgM binding was specific although less 
intense. 
43 kD : A narrow sharp band showing strong lgG binding but 
faint with lgM. 
38-40 kD: A prominent broad band reactive with all three 
antibody isotypes. 
33 kD: Stained as a singlet by most sera, but by ARF sera 
usually as a broad doublet. lgM reactivity with this band 
appeared unique to ARF sera. 
30 kD: A band stained by some sera as a broad doublet 
{especially by ARF sera); recognised by both lgG and lgM 
antibodies {and less intensely by lgA) in most sera except 
AGN and IHD. 
Chapter 3 
No.11 
lmmunoblotting / 86 
28 kD: A faint diffuse band recognized by lgG and lgM class 
antibodies mainly in ARF sera, but also present (less 
intensely) in normal sera. 
The antibody classes lgG, lgM and lgA thus recognised generally the same 
protein bands, but there were differences in the frequency, intensity and 
pattern of staining among the different groups of sera. 
3.2.1.1.2.2 lgG Binding 
lgG binding to the heart antigens was stronger than lgM and lgA in all groups 
of sera, both in terms of the total number of bands recognised and in the 
intensity of staining (Table 3.2a). Within groups of sera, there was 
considerable heterogeneity in the staining of individual bands. This 
heterogeneity was greatest among the ARF and adult CRF sera which also 
recognised some additional constituents, other than the eleven major ones (Fig. 
3.2). 
However, comparing the serum groups as a whole there were no remarkable 
differences in lgG recognition of these heart antigens. 
3.2.1.1.2.3 lgA Binding 
lgA binding to the antigens was generally weak (Table 3.2c). The intensity and 
number of antigens recognised was greatest among ARF and adult CRF sera, 
whereas the response of the AGN sera was remarkably lower than any of the 
other groups of sera. The response of the normal adult sera also showed an 
unexpectedly low response compared to the other control groups. 
3.2.1.1.2.4 lgM Binding 
lgM binding showed the most pronounced differences in staining between the 
groups. ARF sera stained all eleven bands at a higher frequency and intensity 
than any of the other groups (Table 3.2b). Some bands were not bound at all 
by lgM in certain groups of sera, notably by IHD and both adult and child CRF 
sera (Fig. 3.2). 
In the mol.wt. range above 70 kD and below 40 kD, ARF sera showed 
evidence of unique lgM binding (Fig. 3.2). lgM recognition of band No.9 (33 
kD) appeared unique to ARF sera, which stained it as a .broad doublet. 
Excepting for one adult CRF serum (Fig.3.2c) and three normal adult sera 
(Fig.3.2e), which stained this band as a singlet, none of the other sera showed 
lgM binding to this antigen. Table 3.1 c shows that the lgG response of ARF 
sera to this antigen was also more intense than that of the other groups. 
lgM binding to bands No.4 (67-70 kD), No.8 (38-40 kD) arid No.10 (30 kD), 
were also markedly more intense· among ARF sera than in the other groups 
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(Table 3.2b). Although the intensity of staining of band No.1 (116 kD) was riot 
great, the frequency of lgM recognition of this band (85%) among ARF sera 
was distinctly higher than that of other groups ( 10%) (Table 3.2b). Similarly, 
100% of ARF sera showed lgM binding to band No.2 (85 kD), compared to 
between 5-and 30% in other groups. 
Bands No.9, No.10 and No.11 were not recognised by lgM antibodies in AGN 
and IHD sera (Table 3.2b). 
TABLE 3.2 (A, B, C) (see following 3 pages) 
lmmunoblotting of human heart extract against patient sera 
Human heart CHAPS detergent extract (section 7.A.11) was separated by 10% SDS PAGE and 
transferred to nitrocellulose (section 7.A.9). Twenty sera in each of the seven groups of 
subjects (section 2.2 .1.2) were compared for lgG, lgM and lgA autoantibody isotype reactivity 
(Table 3.2 A, B & C respectively) with antigens in the immunoblotted extract. Eleven major 
bands of reactivity were discernible (see Fig 3 .1) and were designated bands No.1-11. The 
intensity of staining was scored as one to three pluses ( + , + + , + + + ) by visual comparison 
(average after two or three determinations). The percentage of patients in the various serum 
groups staining each band at a particular intensity was scored separately for each antibody 





n = number of patients tested in each group 
The percentage of patients in each group giving a positive reaction at intensities scored 
as one to three pluses ( + + + , + +, or + ) . Scores are the results of visual 
comparisons made by three independent observers of two to three separate 
determinations. 
; The number of patients in each group that reacted with none of the protein bands 
mentioned in the table. 
• The designated number and apparent molecular weight of the eleven major protein 
bands detected by sera in the various groups. 




No. 1 +++ 
116K ++ 
+ 
No. 2 +++ 
85K ++ 
+ 
No. 3 +++ 
77K ++ 
+ 
No. 4 +++ 
67 - ++ 
70K + 
No. 5 +++ 
50 - ++ 
58K + 
No. 6 +++ 
45K ++ 
+ 
No. 7 +++ 
43K ++ 
+ 
No. 8 +++ 
38 - ++ 
40K + 
No. 9 +++ 
33K ++ 
+ 
No. 10 +++ 
30K ++ 
+ 






TABLE 3.2A : lgG BINDING TO HEART ANTIGENS 
Percentage of patients in each group whose sera stained 
specified protein bands at different intensities 
ARF• AGN CRF-C CRF-A IHD 
n=20* n=20 n=20 n=20 n=20 
- - - - -
t20 - - - -
80 40 60 100 100 
- - - - -
20 - - - 20 
70 20 60 60 80 
- - 10 - -
- - 10 - -
70 5 50 60 100 
40 - - - -
25 - 60 60 20 
30 40 30 30 80 
- - - - -
10 - - 10 -
70 45 60 80 85 
40 - - 10 -
50 30 100 80 100 
10 30 - 10 -
- - - - -
20 - 30 55 -
75 - 70 40 100 
- - - - -
85 20 40 60 -
10 40 60 40 100 
- - - - -
90 - - 10 -
10 10 50 55 20 
- - - - -
50 - 50 70 -
50 10 50 30 -
- - - - -
- - - - -
100 - 50 80 -
- - - - 2 








































No. 1 + + + 
116K ++ 
+ 
No. 2 + + + 
85K ++ 
+ 
No. 3 + + + 
77K ++ 
+ 
No. 4 + ++ 
67 - + + 
70K + 
No. 5 +++ 
50 - ++ 
58K + 
No. 6 + ++ 
45K ++ 
+ 
No. 7 ++ + 
43K ++ 
+ 
No. 8 + + + 
38 - ++ 
40K + 
No. 9 +++ 
33K + + 
+ 
No. 10 + ++ 
30K ++ 
+ 
No. 11 +++ 





TABLE 3.2B : lgM BINDING TO HEART ANTIGENS 
Percentage of patients in each group whose sera stained 
specified protein bands at different intensities 
ARF• AGN CRF-C CRF-A IHD 
n=20* n=20 n=20 n=20 n=20 
- - - - -
10 - - - -
75 10 - - -
- - - - -
20 10 - - -
80 20 - 5 -
- - - - -
- - - - -
90 25 - 10 5 
10 - - - -
75 - - - -
10 90 20 25 -
- - - - -
20 - - - -
80 70 10 10 10 
- - - - -
- - - 5 -
80 70 10 10 -
- - - - -
25 10 - - -
70 80 - 10 5 
10 - - - -
60 - - - -
30 75 45 50 -
- - - - -
20 - - - -
80 - - 10 -
50 - - - -
50 - 10 20 -
- - 70 60 -
- - - - -
95 - - - -
5 - - - -
- - - 7 7 








































No. 1 + + + 
116K ++ 
+ 
No. 2 ++ + 
85K ++ 
+ 
No. 3 +++ 
77K ++ 
+ 
No. 4 + ++ 
67 - ++ 
70K + 
No. 5 +++ 
50 - ++ 
58K + 
No. 6 +++ 
45K ++ 
+ 
No. 7 +++ 
43K ++ 
+ 
No. 8 + ++ 
38 - ++ 
40K + 
No. 9 + ++ 
33K ++ 
+ 
No. 10 +++ 
30K ++ 
+ 






TABLE 3.2C : lgA BINDING TO HEART ANTIGENS 
Percentage of patients in each group whose sera stained 
specified protein bands at different intensities 
ARF• AGN CRF-C CRF-A IHD 
n=20* n=20 n=20 n=20 n=20 
- - - - -
- - - - -
45 - 20 25 30 
- - - - -
- - - - 15 
40 - 30 35 25 
- - - - -
- - - - 10 
55 - 45 35 25 
- - - - -. 
- - 5 - -
50 - 45 40 40 
- - - - -
5 20 10 25 25 
80 15 40 20 15 
- - - - -
5 - - - -
50 30 50 45 40 
- - - 5 -
5 10 - 20 -
80 40 50 25 50 
- - - - -
15 20 - 20 -
60 20 15 30 15 
- - - - -
- - - - -
45 25 - 35 -
- - - - -
5 - - 5 -
30 - - 40 -
- - - - -
- - - - -
- - - - -
1 - 1 - 3 




















































Fig. 3 .2 lmmunoblotting of human heart extracts against sera from the seven groups of 
patients and controls. 
Extracts of human heart (section 7.A.11) were separated by 10% SOS polyacrylamide gel 
electrophoresis (section 7 .A .10), and immunoblotted against sera (dilution 1: 100) from the 
seven groups of patients and control subjects, ARF, CRF-c, CRF-a, IHD, AGN, CONT-c and 
CONT-a (see section 2.2 .1 ). Each serum was assayed for binding of lgG (r), lgM (µ) and lgA (a) 
antibody using peroxidase-labelled class specific second antibodies (section 7 .A.9). The 
intensities and frequencies of these binding reactions for each of the groups of sera are 
presented in Table 3 .2 
This figure illustrates representative immunoblots of the lgG (r) and lgM (µ) reactivities of 
rheumatic fever (ARF, CRF-c, CRF-a) and control sera (CONT-c, CONT-a) against the heart 
extract. 
indicated. 
The numbers of the eleven major reactive bands in the extract (see Fig.3.1) are 
The minus first antibody controls are shown in Fig . 3.2(e). (The photographs 
represent a reduction down to 40% of the original size of the blots, hence some reduction in 
resolution compared to the original blots.) 
(a) Representative immunoblots of sera from acute rheumatic fever patients showing lgM (µ) 











CRF -a j 







(continued from previous page) 
Fig. 3.2 (b & c). lmmunoblots of sera from chronic ·rheumatic heart disease child and adult 
· patients (CRF-c and CRF-a) against human heart extract, showing lgM (µ) and lgG (r) antibody 
binding. (See legend beneath Fig.3.2 (a)) . 
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Fig. 3.2 (d & e). lmmunoblots of normal child and adult sera (CONT-c and CONT-a) against 
. human heart extract showing lgM (µ) and lgG (r) antibody binding. The minus first antibody 
controls are indicated by "C". (See legend beneath fig. 3.2 (a)). 
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3.2.1.2 ARF Heart Extract 
Postmortem heart tissue was obtained from a patient who had died in the acute 
phase of rheumatic fever. Extracts of this heart were separated alongside 
extracts from normal heart on 10% SOS PAGE gels. 
The protein banding pattern of the two extracts appeared identical. No 
additional or missing bands could be detected between them even when 
stained with the protein stain AuroDye forte (Janssen Life Sciences). Amido 
Black stains of the two electroblotted heart extracts are compared in Fig.3.1. 
3.2.2 Cross-reactivity: Human Heart and S.pyogenes Antigens 
To test · for cross-reactivity between cardiac and S.pyogenes antigens, 
antibodies were eluted from heart antigen bands and reacted against 
immunoblotted streptococcal antigens. 
Antibody was eluted from two heart antigen bands: 
1. Band No 9 (33 kD): lgM recognition of this antigen was almost 
unique to ARF sera, and lgG reactivity was also more intense with 
ARF sera (Table 3.2). 
2. Band No.8 (38-40 kD): Cardiac antigen(s) of this mol.wt. have 
been reported by several investigators to be cross-reactive with 
streptococcal M proteins (see Introduction and Table 3.1 ). In this 
study, both ARF and normal child sera reacted with this band. It 
was important to ascertain whether different subpopulations of 
antibodies in the two sera might be involved in binding this 
antigen. 
Nitrocellulose bands No.8 and No.9, excised from single well immunoblots, 
were incubated separately both with a pool of five ARF sera and a pool of five 
normal sera (1 :50 dilution_; 2 hour incubation at- room temperature). After 
washing, specific antibody was eluted in three steps (low pH; detergent; 3 M 
KSCN) and immediately neutralised to pH 7.4 (section 7.A.13). Residual 
nitrocellulose strips were developed with peroxidase-conjugated antibody to 
determine the efficacy of the elution, and the protein concentration of the 
eluate was determined to confirm this. 
3.2.2.1 Eluted Antibody: Reactivity with lmmunoblotted S.pyogenes 
Antigens 
Eluted antibody was reacted against the following immunoblotted S.pyogenes 
antigens: type M5 protein, pep M5, pep M24, purified cell membranes, purified 
cell walls. (The M proteins were a gift from Dr. James Dale, University of 
Tennessee, Memphis, USA; the membrane and wall preparations were a gift 
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from Dr. John Zabriskie, Rockefeller University, New York). Positive binding 
was detected using an affinity purified goat anti-human combined lgG, lgA, lgM 
peroxidase-conjugated antibody (Kierkegaard and Perry). 
Fig.3.3 shows the reactivity with streptococcal antigens of ARF serum antibody 
eluted from heart antigen band No. 8 (38-40 kD). The eluted antibody reacted 
with: (1) a 40 kD band in pep M5 digests; (2) a 34 kD band in pep M24; (3) a 
43 kD antigen in the purified membrane extract (faint). The reaction with the 
40 kD constituent in pep M5 digests was the most intense. Normal serum 
antibody eluted from band No.8 was unreactive with any of these streptococcal 
antigens. 
Neither ARF nor control antibody eluted from band No.9 (33 kD) reacted with 
any of the streptococcal antigens. 
3.2.2.2 Eluted Antibodv:. lmmunofluorescence Staining of Heart 
Antibody eluants from bands No.8 and No.9, were examined by indirect 
immunofluorescence against sections of normal human heart (section 7.A.17). 
The eluted antibody was first concentrated to a volume of 200 µI using an 
Amicon stirred ultrafiltration cell with a YM30 filter. Positive binding of 
antibody was detected using an affinity purified goat anti-human lgG (H + L) 
FITC-conjugated antibody (Zymed). Nonspecific protein binding sites on the 
t issue were blocked with 20% goat serum in PBS. 
ARF antibody eluted from band No.8 (38-40 kD) bound to membranous 
structures of human heart as detected by immunofluorescence (Fig.3.4a,b). 
The pattern was not typically sarcolemmal. Normal serum antibody eluted from 
this band also appeared to stain membranous structures along the fibre of the 
muscle, but the binding was more diffuse than that of the ARF antibody, and 
also stained more connective tissue (Fig.3.4c). 
Antibody eluted from band No. 9 (33 kD) did not bind to heart specifically. 
There was negligible nonspecific binding of the FITC-conjugated antibody to the 
tissue. 
3.2.3 Sarcolemmal Membranes 
There are no reports showing reactivity of ARF patient sera against 
immunoblotted cardiac sarcolemmal membranes, whereas such reactivity has 
been shown by several investigators, using monoclonal antibodies and rabbit 
hyperimmune sera evoked by streptococcal antigens (see Introduction and 
Table 3.1 ). 
M5 pepM24 membr wall pep M5 





Fig. 3.3 Reactivity of ARF serum antibodies, eluted from heart extract band No.8, against 
immunoblotted group A streptococcal antigens. 
A pool of five acute ARF sera was reacted against band No.8 (38-40 kD) (see Fig.3. 1). the 
bound antibody was eluted according to the procedures described in section 7.A.13, and 
reacted against the immunoblotted group A streptococcal antigens M5, pep M5, pep M24, 
purified cell membranes and cell walls. Appropriate control elutions are described in section 
3 .2.2. 
The eluted antibody is seen to react strongly with a 40 kD band in the pep M5 digest, and 





-Fig. 3.4 lmmunofluorescence staining of human heart tissue sections by ARF serum antibody 
eluted from immunoblotted heart extract band No.8. 
(a & b) A monospecific population of ARF serum antibodies eluted the immunoblotted heart 
extract band No.8 (see legend to Fig.3 .3) was concentrated by ultrafiltration and then tested by 
indirect immunoflourescence for binding to frozen sections of human heart, according to 
methods described in section 7 .A. 17. Binding to membranous structures can be seen in two 




(continued from previous page) 
Fig 3.4 (cl lmmunoflourescent- staining of heart tissue by normal serum antibodies eluted from 
heart extract band No.8. 
Normal serum antibody eluted from heart extract band No.8 (see legend to Fig.3.3) was tested 
by indirect immunofluorescence for binding to sections of human heart, and showed a different 
pattern of binding compared to the eluted ARF antibody. Diffuse binding is seen along the fibre 
of the muscle and nonspecifically to connective tissue. 
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To demonstrate such reactivity in ARF sera, sarcolemmal membranes were 
purified from human heart (obtained freshly at transplant surgery) according to 
the method of Van de Rijn ( 1977) as described in Materials and Methods 
(section 7 .A.12). 
The purity of the membranes was assessed visually by electron microscopy. 
Fig.3.5 shows an electron micrograph of purified sarcolemmal membrane 
sheaths, indicating a fairly good degree of purity with minimal contamination by 
other cellular organelles or Z-band material. Purified membrane preparations 
were stored lyophilized, and reconstituted in sterile distilled water for use. 
Membranes were separated by 10% SOS PAGE and reacted by immunoblotting 
against the twenty sera in each of the seven groups of subjects. Binding of 
lgG and lgM antibodies to the sarcolemmal membranes was detected using 
Fab' 2 class-specific peroxidase-conjugated antibodies (Cappel). 
Rheumatic fever sera demonstrated binding of lgG to a 200 kD constituent in 
the membrane extracts . This band was absent in all the other groups of sera. 
Sixteen of the twenty ARF sera, twelve adult CRF and eleven child CRF sera 
displayed reactivity with this constituent. Fig.3.6 {a) compares the reactivity of 
normal and ARF sera against these immunoblotted membranes, indicating 
reactivity of ARF sera with the 200 kD constituent. In addition, lgG reactivity 
with a 40 kD constituent was evident in 80% of ARF sera (and 50-70% of CRF 
sera) compared with 30% of AGN sera, 25% of IHD and 30-40% of the child 
and adult normal sera. 
Binding of lgM antibody was faint or absent in all groups of sera, and there was 
no binding to the 200 kD and 40 kD constituents (Fig.3.6 b). 
3.2.4 Nuclear Antigens 
Several autoimmune diseases are characterized by the production of 
autoantibodies to intracellu-lar proteins and nucleic acids (Tan 1989a; 1989b). 
Autoantibodies to nuclear proteins are routinely detected by tissue 
immunofluorescence or cellular (e.g. HEp-2 cells) immunofluorescence assays, 
but immunoblotting allows more precise identification and characterization of 
these antigens. 
In this study, nuclear extracts were prepared from both Girardi heart cells and 
from a primary culture of human heart cells (section 7.A.15). (These cells were 
not cardiomyocytes but comprised of endothelial-like and fibroblastic cells) . 
The nuclear protein extraction method of Dignam (1983) was used, with some 
modifications (section 7 .A.14). The extracts were aliquoted, stored at -ao0 c, 
and not refrozen after initial thawing. 
100 
Fig. 3.5 Electron micrograph of purified sarcolemmal membranes. 
Membranes were purified from human heart according to the method of Van de Rijn et al. 
(1977) (section 7 .A .12) . Numeorus membrane vesicles can be seen, with relatively little 
contamination by other cellular organelles. (Magnification 25000X) 
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Fig. 3.6 lmmunoblotting of purified cardiac sarcolemmal membranes against ARF and normal 
sera. 
Purified sarcolemmal membranes (section 7 .A.12 and Fig . 3.5) were separated by 10% SOS 
PAGE (section 7.A.10) and immunoblotted (section 7.A.9) against sera from the seven groups 
of patients and control subjects (section 2.2 .1 ). Representative blots of ARF and normal sera 
reacted against the sarcolemmal membranes are shown. (The no-serum controls are shown by 
the lanes marked "C"). (a) ARF sera showed unique lgG (r) reactivity with a 200 kD 
constituent in these extracts compared with sera from the other groups. A higher frequency of 
lgG (r) reactivity against a 40 kD constituent was also seen among ARF sera. (b) lgM (µ) 
binding to the membrane extracts was negligible in all groups of sera. 
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Extracts from both cell lines were separated by 10% SOS PAGE, transferred to 
nitrocellulose and tested against twenty ARF sera, twenty adult control and 
twenty child control sera at dilutions of 1: 100. Positive binding was detected 
using Fab' 2 goat anti-human lgG and lgM class-specific peroxidase-conjugated 
antibodies (Cappel). Protein stains of the electroblotted antigens, using the 
sensitive AuroDye forte stain (Janssen), showed no differences in the protein 
composition of the two extracts (results not shown). 
Results showed considerable heterogeneity in the binding patterns of sera to 
nuclear antigens. lgM antibodies in ARF sera bound to more antigen bands in 
both cell extracts than did the normal sera, and the staining also appeared more 
intense. Furthermore, about 70% of the ARF sera had lgM antibodies to a 
narrow band at n:,ol. wt. 140 kO in the primary cell extracts (Fig .3. 7a). This 
constituent was also very faintly discernible in the Girardi cell extracts 
(Fig.3. 7b). None of the adult or child normal sera showed binding to this 
antigen. 
There were no discernible differences in lgG reactivity to the two nuclear 
extracts, between the ARF and normal sera. lgG did not bind the 140 kO 
antigen in any of the sera. 
3.2.5 Reactivity of Anti-Streptococcal Sera with Heart Extract 
Several investigators have used monoclonal antibodies and rabbit hyperimr;nune 
sera evoked by S.pyogenes antigens, to demonstrate cross-reactivity between 
these antigens and cardiac antigens by immunoblotting (see Introduction). 
Most have used SOS and Triton X-100 extracts of heart. 
The purpose of this investigation was to examine the reactivity of rabbit anti-
group A streptococcal antigen hyperimmune sera against various antigenic 
extracts of heart, and against purified cardiac myosin. The following cardiac 
antigen preparations were separated by 10% SOS PAGE and transferred to 
nitrocellulose for immunoblotting: 
1. CHAPS detergent extract of human heart (section 7.A.11 ). 
2. Human heart purified sarcolemmal membranes (section 7.A.12). 
3. Heart cell nuclear extracts (section 7 .A.14) 
4. Myosin (rabbit heart) (Sigma) 
The antigens were reacted against the following rabbit antisera: (1) antiserum 
to whole group A streptococci; (2) antiserum to the synthetic streptococcal 
peptides SM5 (164-197), (3) SM 24, (4) M19; (5) non-immune serum. Positive 
binding was detected using an affinity-purified goat anti-rabbit lgG (H + L) 
peroxidase-conjugated antibody (Cappel). 
Primary Cells 
(a) 
Normal C ARF 
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Fig. 3. 7 lmmunoblotting of nuclear protein extracts from Girardi and primary culture heart cells against 
ARF and normal sera. 
Nuclear proteins extracted from a primary culture of human heart cells (a) and Girardi heart cells (b) 
(section 7 .A. 14) were immunoblotted against ARF sera, normal child and normal adult sera (section 
3 .2.4). 70% of the ARF sera showed evidence of lgM (µ) reactivity with a 140 kD constituent in extracts 
of the primary culture extracts (faintly visible in the Girardi cell extracts). (The no-serum controls are 
shown by "C"). 
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Fig.3.8 shows the binding of these antisera to the various heart antigens. 
{A) Anti-whole group A streptococcus antiserum: This antiserum was raised 
to S.pyogenes cultured from a throat-swab of an ARF patient with severe 






Fig.3.8 {c) indicates faint reactivity of this immune serum with a 40 kD 
constituent present in both nuclear antigen extracts. 
The nuclear extracts also displayed reactivity at 43 kD, at 36 kD and a 
broad region between 91 kD and 100 kD. 
Antiserum to SM5 ( 164-197): This antiserum to a 33-amino acid 
synthetic peptide of pep M5, was reactive with a series of polypeptides 
in both nuclear extracts: 140 kD, 49 kD, 46 kD, 43 kD, 40 kD, 34 kD, 
33 kD and 29 kD. {The 46 kD and 43 kD bands appear nonspecific 
since they are also present in the non-immune serum). 
The serum also reacted with a 53 kD constituent present in the crude 
extract of heart and in both nuclear extracts. 
A11tiserum to M 19: This antiserum reacted intensely with constituents of 
55 kD and 50 kD in the nuclear extracts. Similar to the other rabbit 
immune sera, it reacted with polypeptides in the range 33-36 kD in both 
nuclear extracts . 
This was the only serum that reacted with antigens in the sarcolemmal 
membrane preparations, showing intense staining with a range of 
antigens between 72-and 200 kD (The major bands discernible occurred 
at 170 kD, 130 kD, 81 kD and 72 kD). 
Antiserum to SM24: Antigens of mol. wt. 36 kD and 33 kD in the nuclear 
extracts reacted with this serum. In addition, it reacted strongly with a 
40 kD constituent in the crude heart extract. 
Myosin: None of the sera reacted with rabbit cardiac myosin. However, 
protein staining of the gel and nitrocellulose indicated that the protein 
had not transferred well to the membrane. 
Rabbit Non-immune Serum: A pool of five non-immune rabbit sera was 
used to identify nonspecific {or natural autoantibody) binding to the heart 
antigens. 
Faintly reactive bands were discernible in the nuclear antigen extracts at 
70 kD, at 44-46 kD (a doublet) and at 30 kD. Reactivity with these 
bands by the immune sera may therefore be nonspecific. 
105 
Control R.non-imm. R ex Strep A 




97 97 .._ 
67 67 




Rex SM5 R ex M19 Rex SM24 
HSGPM H SG PM HSGPM 
140 .... 170 
97 97 97 
67 4967 67 - ~ . 55 
~ *= 43 ~43 50 43 40 ...... 33-36 ~ 
~ 33 13,-36 .._ 
30 2930 .... 30 
(d) Ce)---~~--- (f).._____~____. 
Fig. 3.8 , Cross-reactivity of rabbit anti-group A streptococcal immune sera with various immunoblotted cardiac antigens. 
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3.2.6 Additional Experiments 
3.2.6.1 Reactivity to Human Collagen Types II, Ill and VI 
The reactivity of rheumatic fever sera and normal sera to highly-purified human 
collagen types II, Ill, and VI (Heyl, West Berlin) was also investigated by 
immunoblotting, but failed to indicate reactivity among any of the sera. 
3.2.6.2 Ca2 + ATPase Binding 
There has been some speculation on the possible implication of muscle and 
membrane ATPase enzymes in antigenic mimicry in rheumatic fever (see 
Introduction and Discussion). Sarcolemmal membranes contain a 
Na+ /K + ATPase, and ATPase activity is associated with the globular headpiece 
and light chains of myosin. Ca2 + ATPase has a sequence similar to that of the 
a-subunit of Na+ /K + ATPase and is mechanistically similar to it. It has a 
mol. wt. of 114 kD. 
This simple investigation was undertaken to examine whether ARF sera contain 
antibodies to ATPase enzymes. Ca 2 + ATPase enzyme isolated from rabbit 
skeletal muscle (a gift from Dr.David MacIntosh, Dept of Chemical Pathology, 
University of Cape Town) was separated by 10% SOS PAGE, electroblotted 
onto nitrocellulose and then reacted against ten ARF and ten normal sera. 
Antibody binding was assayed using both lgG and lgM class specific 
peroxidase-conjugated Fab'2 goat anti-human antibodies (Zymed). 
Extremely intense lgG binding was observed with one ARF serum (patient No. 
53; Appendix B). Fig.3.9 shows the intense binding to the 114 kD ATPase 
protein with this serum. The reactions of three ARF and three normal sera are 
shown. Faint binding to the enzyme was discernible with the other sera. The 
band at 45 kD represents calsequestrin, an associated co-purifying anionic 
protein. 
107 
Normal ARF kD 
114 
45 
1 2 3 4 56 
Fig. 3.9 lmmunoblotting of muscle Ca2+ATPase against ARF and normal sera. 
ca2 + ATPase isolated from rabbit skeletal muscle was separated by 10% SDS PAGE and 
immunoblotted against 1 0 · ARF and 10 normal sera. One ARF serum showed intense reactivity 
with the 114 kD Ca2 + ATPase enzyme and the 45 kD co-purifying protei~ calsequestrin. The 
reactivity of this serum is shown in comparison with representative normal and ARF sera. 
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3.3 DISCUSSION 
3.3.1 Human Heart Detergent Extracts 
There have been few reports in the literature on the reactivity by 
immunoblotting of ARF sera against heart antigens. Possibly the polyspecificity 
and frequently low titre of the relevant antibody in patient serum, account for 
the preferential use of monoclonal antibodies and hyperimmune sera used in 
most studies (see Introduction). 
3.3.1.1 lsotype Binding Patterns of Groups of Sera 
Table 3.2- gives an indication of the polyspecificity of the patient sera to the 
immunoblotted heart antigens. Most of the eleven protein bands (except in the 
lower mol. wt range) were recognised by all seven groups of sera, . even if only 
faintly and by just one class of antibody. All three immunoglobulin classes 
bound to the same heart antigens, but there were differences in the frequency 
and intensity of band staining among the different groups of sera. 
ARF sera, compared to the other groups, showed a markedly higher frequency 
and intensity of lgM heart-reactive antibody. This finding is perhaps 
unexpected in view of reports (using immunofluorescence) that antibody bound 
to heart tissues is primarily lgG (Kaplan et al., 1961; Hess et al., 1964; 
Ehrenfeld et al., 1961 ). Increased lgG might be expected instead, unless 
deposition of lgG in heart tissue removes it from circulation. 
During a conventional immune response there is often a shift from lgM, to lgG 
and lgA production as the disease progresses. Such a shift has, for instance, 
been found to occur in anti-histone antibody profiles among SLE patients 
(Fellows et al., 1988) . hi .this study, such a shift may explain the change from 
lgM to lgG production discernible in the child and adult CRF groups (Figure 3.2 
b & c). In both groups, there is very little binding of lgM to heart antigens. 
Whether the raised lgM heart-reactive antibodies in ARF sera, and the shift to 
lgG in CRF sera, is of significance to the aetiology of rheumatic fever is not 
known. Natural autoantibodies are often lgM, whereas autoantibodies 
associated with disease tend to be lgG (Clough and Valenzuela, 1980). In 
animal models, it has been shown that effective T-cell function is essential for 
normal switchover from lgM to lgG production (Schimpl et al., 1973), and it 
has been suggested that abnormal T-cell function in SLE may affect this 
switchover resulting in high ratios of lgM to lgG anti-DNA antibodies (Clough 
and Valenzuela, 1980) . It is thought that the poor regulation by lgG on lgM 
production, permits production of low affinity lgM antibody to DNA, and that 
th is results in formation of long-lasting immune complexes leading to renal 
disease. The pathogenic effect is thus a consequence, not of the lgG molecule 
itself, but of its low concentration that impedes the switching off of lgM. 
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Although there are reports of abnormal B and T cell function in rheumatic fever, 
especially in response to extracellular streptococcal products (Gray et al., 
1981), it is not known whether this affects the ratio of lgM to lgG heart-
reactive antibodies. The raised lgM heart-reactive antibodies among ARF 
patients may be pathologically important. Diseases in which lgM 
autoantibodies clearly have pathological relevance include haemolytic anemia in 
cold agglutinin disease (Duggan and Schattner, 1986), a vasculitis caused by 
self-associating lgM cryoglobulins (Winfield, 1983) and peripheral neuropathy 
caused by anti-nerve autoantibodies (llyas et al., 1985). 
An hypothesis for the pathological relevance of raised lgM antibodies to cardiac 
antigens {such as myosin and sarcolemmal membranes) in acute rheumatic 
fever, is presented below. 
3.3.1.2 Hypothesis: Raised lgM Anti-heart Antibodies 
It is known that lgM antibody can specifically enhance the humoral response to 
antigen, and it has been suggested that this may be achieved by a mechanism 
similar to normal immunization with antigen alone (Henry and Jerne, 1968; 
Heyman et al., 1985). lgM might concentrate antigen in the spleen thereby 
increasing its availability to cells involved in antibody production (Wason, 1973; 
Dennert, 1971 ). 
The presentation to immunocompetent cells of suboptimal doses of heart 
antigen could potentiate the production of high-affinity lgG antibodies. Such 
suboptimal doses of heart antigen might be products of natural catabolism of 
heart cells being cleared by natural lgM autoantibodies (Grabar et al., 1983); or 
they may occur as a result of tissue injury; or they might be presented in 
immune complexes. 
It has been suggested that, due to its poor solubility at physiological salt 
concentrations, myosin can persist in areas of cell necrosis, thus providing a 
stimulus for a chronic immune response (Alvarez et al., 1987). Conceivably, 
natural lgM autoantibodies, while "clearing" persistent small doses of myosin, 
could potentiate production of high affinity pathogenic lgG antibodies. With 
regard to the anti-sarcolemmal antibodies consistently found in ARF patients, it 
is interesting that myosin (previously considered to be an intracellular protein) 
has more recently been found to be associated with the internal membrane 
surface of the sarcolemma (Fallon and Nachmias, 1980). 
Evidence for regulation of the humoral immune response by lgM natural 
autoantibodies, has been presented by Mahana et al. (1988). They were able 
to induce in mice, immunized with small doses of polyspecific monoclonal 
natural lgM autoantibodies, titres of specific anti-myosin lgG antibody 
(following challenge with myosin) that were significantly increased compared to 
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mice not neonatally pre-immunized with these autoantibodies. It was 
suggested that the altered anti-myosin response was the result of an early 
disturbance of an anti-idiotypic network in the newborn mice following injection 
of the monoclonal autoantibodies. Similarly, natural lgM autoantibodies have 
been shown to affect the intracellular metabolism of lymphocytes, leading to a 
modified immune response (Rosenblatt et al., 1985). 
In rheumatic fever, one might speculate that individuals with particular anti-
heart lgM autoantibodies (or raised levels of heart-reactive autoantibodies), 
might potentiate high affinity lgG anti-heart antibodies (through a mechanism 
such as described above). These may be the lgG anti-heart antibodies detected 
by immunofluorescence in rheumatic fever (Kaplan et al., 1961). A pathogenic 
mechanism such as described above might lead to the chronic destruction of 
heart valves and muscle seen in rheumatic heart disease. 
3.3.1.3 Individual Protein. Bands Recognised 
The ensuing discussion describes the reactivity of the different groups of sera 
to some of these antigen bands, and compares them with antigens of similar 
mol. wt. reported by other investigators. (Such comparisons of mol. wt. are 
obviously superficial, and by no means imply identity of the antigens). 
(a) Band No 1 (116 Kd): 
The presence of lgM antibodies to this protein in 85% of ARF sera, compared 
to only 10% (or its complete absence) in other groups of sera, suggests that 
lgM recognition of this constituent may be distinctive of rheumatic fever. 
There are no reports in the literature of heart autoantigens of this mol. wt. 
Cunningham et al. ( 1984) describe the reactivity of anti-streptococcal murine 
mABs (the "54 series") with three major proteins in the range 100 kD to 200 
kD - but they do not state exact mol.wts. 
(b) Band No.2 (85 kD): 
Whereas lgG antibody to this protein was similar in most serum, lgM reactive 
antibody was noticeably greater in ARF sera compared to other groups ( 100% 
in ARF, compared to 30% in AGN, 5% IHD and 20% adult controls). 
Heart antigens in this mol. wt. region have been shown to cross-react with 
S.mutans antigens. Doyle et al. ( 1986) demonstrated that murine mAbs 
evoked by S.mutans reacted with 82 kD and 85 kD human. heart proteins. 
Similarly, Ayakawa et al. (1985) demonstrated that rabbits immunized with 
human heart homogenate, reacted with an 82 kD protein in homogenates of 
S.mutans. These findings indicate that antigens cross-reactive with human 
heart are present in streptococcal species other than S.pyogenes. Such cross-
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reactions are of obvious importance to the development of vaccines against 
S.pyogenes (Van de Rijn et al., 1976). 
(c) Band No 4 (67-70 kD): 
Both rabbit antisera and murine mAbs evoked by streptococcal antigens, have 
been shown in various studies to react with heart antigens in this mol. wt. 
region. 
Rabbit antisera to streptococcal M5 and M25 proteins react with proteins of 
mol.wt. 67-70 kD in Triton X-100 extracts of human heart (Cunningham and 
Russell, 1983), and a 71 kD protein in SOS extracts of sarcolemmal membranes 
has been shown to react with rabbit immune serum to streptococcal M5 protein 
(Dale and Beachey, 1982). 
More interestingly, 70 kD corresponds to the mol. wt. of tropomyosin and 60 
kD to keratin, which have been found in immunoblotting inhibition assays to 
react with murine mAbs evoked by streptococcal M5 protein (see Introduction 
and Table 3.1 ). 
(d) Band No.7 (43kD): 
This band may correspond to the 43 kD bovine heart protein reactive with ARF 
sera, described by Zabriskie and Friedman (1983). 
Actin has a similar mol.wt (42 kD). Some evidence of anti-actin antibodies in 
rheumatic fever sera was found in this study (Chapter 2), and both murine and 
human monoclonal antibodies reactive with S.pyogenes antigens have been 
shown to cross-react with actin (Fenderson et al., 1989; Cunningham et al., 
1988). 
(e) Band No.a (38-40 kD): 
This study showed that all seven groups of sera contained autoantibodies 
reactive with a 40 kD cardiac antigen. Especially ARF sera showed strong lgM 
binding to this constituent. 
There have been numerous reports, using both murine mAbs and rabbit 
antisera, of cross-reactivity between streptococcal M5 protein and a 40 kD 
heart antigen (Cunningham and Russell, 1983; Cunningham et al., 1984; 
Sargent et al., 1987). Furthermore, Zabriskie and Friedman (1983) showed 
that ARF sera reacted with a 38 kD protein in saline extracts of bovine heart. 
Sargent et al. ( 1987) showed that rabbit immune sera raised to the 
streptococcal synthetic peptide SM5( 164-197) reacted · with a 40 kD 
constituent in crude extracts of heart, and the identical antiserum was shown 
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in this study to react with 40 kD antigens in nuclear extracts of heart cells 
(Fig.3.8). 
(f) Band No 9 (33 kDl: 
Antibodies to this constituent of heart, occur at a higher frequency and 
intensity in ARF patients than in any of the other groups of sera (Tables 3.2). 
Both lgG and lgM bind this antigen in all ARF sera. 
Autoantibody binding to a cardiac antigen of this mol. wt., has not been 
previously reported in rheumatic fever. An interestingly speculation is that this 
doublet may correspond to the two 32 kD subunits of tropomyosin . 
(g) Bands No 10 and 11 (30 kD and 28 kDl: 
ARF sera also displayed the greatest intensity and frequency of binding 
(particularly lgM) to these two cardiac antigens than the other groups of sera. 
Cunningham and Russell (1983) demonstrated reactivity of rabbit anti-M5 
antisera to a 30 kD protein in Triton X-100 extracts of human heart. 
3.3.1.4 Specificity and Pathological Relevance of Antigens 
The incidence of autoantibodies in the normal adult sera in this study is perhaps 
higher than expected. Other investigators, using immunocytochemistry (Kaplan 
and Svec, 1964), have reported that only about 2% of normal adult sera 
contain heart-reactive antibodies. lmmunoblotting is however a more sensitive 
technique, and this discrepancy illustrates the need for caution in interpreting 
and comparing the results of different solid-phase binding assays (Van 
Regenmortel, 1989; see Chapter 1 ). In particular, detection of cross-reactivity 
may be dependent on assay-specific variables, and irrelevant cross-reactions 
may be detected at a higher frequency in crude extracts of protein (see 
Introduction). 
The rheumatic fever sera examined in this study do nonetheless show a 
noticeably different pattern of reactivity against cardiac antigens, compared 
with both the normal and related-disease control sera. These results showed 
some evidence of apparently unique recognition of particular constituents in the 
crude extracts by lgM antibodies in ARF sera. lmmunoblot inhibition 
experiments using certain purified proteins (such as performed by Dale and 
Beachey, 1985a, who used myosin to identify a 200 kD band in crude heart 
extracts) could be used to confirm guesses about the identity of these 
constituents. Such experiments remain to be done. 
The role of these immunoblotted antigens in the pathogenesis of the disease, 
might be further analysed using functional biological assays. In this project, an 
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extensive investigation was undertaken to examine the ability of immunoblotted 
antigen nitrocellulose bands to stimulate lymphocytes, using the methods of 
Abou-Zeid et al. (1987) and Young and Lamb (1986) (see Introduction). It was 
found that although the control antigens and mitogens used (ASO, BCG, PHA) 
stimulated the lymphocytes when spotted onto nitrocellulose prior to digestion 
with DMSO, neither these nor the heart and streptococcal antigens analysed in 
this study stimulated lymphocytes when separated by 10% SOS PAGE and 
immunoblotted (results not shown). Possibly stimulatory epitopes were 
denatured during immunoblotting. The pathological significance of these 
cardiac antigens is thus unknown. 
3.3.2 Cross-reactivity: Heart and S.pyogenes M Proteins 
3.3.2.1 Reactivity of HRA with lmmunoblotted Streptococcal Antigens 
The use of eluted heart-reactive antibody (HRA) to show antigenic mimicry 
between cardiac and S.pyogenes antigens, does not differentiate between "true 
crossreactivity" or "partial crossreactivity" (Berzofsky and Schechter, 1981; 
see Chapter 1) nor does it give any indication as to the biological significance 
of the reaction, but it might serve as clues to finer analyses such as epitope 
mapping. 
The finding, in this study, that antibody eluted from the 40 kD heart band 
cross-reacted with streptococcal M5 protein, concurs with findings in other 
studies using rabbit antisera. Sargent et al. (1987) used rabbit antisera to 
show cross-reactivity between a 40 kD protein in human heart, and the 
S.pyogenes M protein fragments, pep M5 and SM5(164-197). Similar cross-
reactions between a 40 kD cardiac antigen and streptococcal M5 and M25 
proteins were shown by Cunningham and Russell ( 1983) and Cunningham et al. 
(1984) (see Introduction). 
Some studies have shown that pep M5 and pep M6 have heart cross-reactive 
epitopes, but that pep M24 lacks such reactivity (Dale and Beachey, 1985a, 
1985b; Kotb et al., 1989). In this study, the binding of eluted HRA to a 34 kD 
fragment in pep M24 contradicts such findfngs. Although the staining was 
faint, eluted normal serum antibody showed no reactivity with this, or any of 
the other, streptococcal antigens. This cross-reaction may be a function of 
antibody affinities and assay conditions, and should be confirmed either by 
inhibition experiments or in the context of a different assay. 
The lack of reactivity of eluted HRA with the crude extract of protein M5 is 
puzzling. Possibly, it could be due to altered antigenicity following 
immobilization of the protein on nitrocellulose, or else the relevant epitopes may 
be masked under these specific assay conditions. 
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Although the almost unique lgM reactivity of ARF sera to the 33 kD heart 
protein made it seem promising as a cross-reactive autoantigen implicated in 
rheumatic fever, eluted antibody from the band failed to react with 
streptococcal antigens. Possibly, it may cross-react with other relevant M 
proteins, such as M6 and M19, which were not tested in this study. 
In summary, the strong reaction between eluted ARF serum antibodies from the 
40 kD heart antigen, with streptococcal pep MS protein, suggests that they 
may share cross-reactive epitopes. This finding is consistent with similar cross-
reactions of heart proteins of identical mol.wt. with streptococcal MS protein, 
defined using rabbit antisera and murine mAbs (see Introduction). 
3.3.2.2 . lmmunofluorescence Staining of Eluted Antibody Against Heart 
The recognition of membranous structures of heart tissue by ARF antibody 
eluted from the 40 kD band indicates that the autoantigen may be a membrane 
protein, although sarcolemmal membrane staining was not evident (Fig.3.4 a & 
b). The differences in immunofluorescence staining of heart, between ARF and 
normal serum antibody (Fig 3.4c) eluted from the 40 kD band, may indicate 
that the antibodies recognise different epitopes on the antigen, . or that different 
subpopulations of antibody in the two sera recognise the same epitope. 
3.3.3 Sarcolemmal Membranes 
The reactivity of rheumatic fever sera with constituents of 200 kD and 40 kD in 
human cardiac sarcolemmal membranes, is interesting since it concurs with 
similar findings using monoclonal antibodies and rabbit antisera (evoked by 
S.pyogenes antigens). This study presents the first evidence by 
immunoblotting of reactivity with these sarcolemmal proteins, using patient 
sera. 
Rabbit antisera to streptococcal MS protein and to M25 were reactive with a 
40 kD protein in Triton X-100 extracts of human heart (Cunningham and 
Russell, 1983). More specifically, an antiserum to the peptide SM5 ( 164-197), 
also reacts with a 40 kD polypeptide in such heart extracts (Sargent et al., 
1987). Dale and Beachey ( 1985) showed that antisera to pep MS, reacted 
with multiple bands between 40 kD and 200 kD in SOS extracts of 
sarcolemmal membranes. . Murine mAbs evoked by streptococcal MS 
membranes and cross-reactive with whole group A streptococci, reacted 
similarly at 40 kD (Cunningham et al., 1984). The finding of reactivity in 80% 
of ARF patient sera with a 40 kD constituent in these purified sarcolemmal 
membranes is therefore in agreement with previous findings using cross-
reactive mABs and rabbit immune sera. Reactivity with this constituent in up 
to 30% of control sera, may indicate natural autoantibody reactivity to this 
antigen. Whether this binding represents the same subpopulation of antibodies 
found in ARF sera is not clear. 
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The 200 kD protein band appeared unique to rheumatic fever sera (80% of 
ARF and 55-60% of CRF sera tested). A protein band of this molecular weight 
has also been found in sarcolemmal and crude heart extracts using mAbs and 
rabbit antisera to streptococcal antigens (see Introduction). Cunningham et al. 
(1988) showed by immunoblotting that 88% of ARF and 91 % of RHO sera 
were reactive with myosin (200 kD mol.wt.). A 200 kD protein detected in 
sarcolemmal as well as crude extract of heart was abolished by absorption of 
the sera with myosin (Dale and Beachey, 1982; D.oyle et ~I., 1986; Dale and 
Beachey, 1985a). These studies all used mAbs and rabbit antisera. The 
present study has identified a 200 kD protein in purified sarcolemm~I extracts 
using human rheumatic sera. This band may or may not correspond to myosin. 
A shortcoming of this study was that inhibition assays were not done to verify 
the identity of the band. Moreover, the reason this constituent was not 
discernible in the total heart extracts (Fig.3.1) may be due to either differences 
in the methods of preparation of the two antigenic extracts, or else to 
quantitative differences between the amounts of this constituent present in the 
purified sarcolemmal extracts compared with the crude extracts. 
Various studies have found cross-reactivity between myosin (mol. wt. about 
200 kD) and the streptococcal M proteins, using immunoblot inhibition assays. 
Myosin is relevant to cross-reactivity with sarcolemmal membranes since it has 
been found associated with the internal membrane of the sarcolemma (Fallon 
and Nachmias, 1980). Inhibition assays to determine cross-reactivity between 
myosin and M proteins were not done in this study. 
In summary, the 40 kD and 200 kD bands detected in ARF and CRF sera in this 
study, confirm findings that have been made using mAbs and rabbit antisera to 
streptococcal antigens and suggest that these may in fact be autoantigens 
relevant to rheumatic fever. Whether they are important to the pathogenesis of 
the disease is not known. 
3 .3.4 Nuclear Antigens 
There are no reports in which immunoblotting has been used to measure 
reactivity in ARF sera to nuclear antigens. The finding of a 140 kD polypeptide 
reactive with 70% of ARF sera but absent in normal sera, may be of 
significance to rheumatic fever, although this is a preliminary finding that needs 
to be substantiated using larger numbers of sera and variations in assay 
conditions. The detection of autoantibodies to nuclear antigens has been found 
to depend on the sensitivity of the assay and the precise conditions used - such 
as the serum dilution and the substrate used (Stott, 1985; Habets, 1986). 
Nonspecific binding due to the polyspecificity of the autoantibodies can 
complicate the interpretation of results, and adequate controls are therefore 
important. 
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3.3.5 Rabbit Anti-S.Pyogenes Serum Reactivity with Heart Antigens 
Several of the polypeptides that were found in this study to react with rabbit 
immune sera against S.pyogenes antigens, correspond in mol. wt. to 
polypeptides reactive with ARF sera. This does not necessarily mean that 
these epitopes and antibody populations are cross-reactive. 
Reactivity of the rabbit antisera to the nuclear antigen extracts was strikingly 
distinctive. Since binding of these rabbit anti-S.pyogenes sera to cardiac 
nuclear antigens has not previously been investigated, the significance of these 
specificities cannot be assessed in terms of published reports. Nuclear 
antigens are often markers for autoimmune disease (see Chapter 1 ). It would 
be extremely valuable if such markers of diagnostic significance could be found 
for rheumatic fever. All of the rabbit and anti-S.pyogenes sera reacted with a 
33 kD protein band in the nuclear extracts, but whether this protein might 
represent a significant autoantigen is unclear. 
The strong reaction of the anti-SM24 rabbit immune serum to a 40 kD 
constituent in crude extracts of heart (Fig.3.8f), appears to contradict previous 
reports that types 5 and 6 M protein but not type M24, share epitopes with 
human heart tissue (Dale and Beachey, 1985a). The elution experiments 
performed in this study (section 3.2.2.1) in which ARF serum antibody eluted 
from a 40 kD heart tissue polypeptide reacted with a 34 kD constituent in pep 
M24 digests (Fig.3.3), substantiate this finding that type 24 M protein may 
share epitopes with human heart tissue. 
3.3.6 Additional Experiments 
3.3.6.1 Ca2 + ATPase Binding 
The finding of extremely intense reactivity of an ARF serum with Ca2 + ATPase 
from sarcoplasmic reticulum is a preliminary finding that might be more 
thoroughly investigated. The possible implication of A TPase enzymes in 
antigenic mimicry in rheumatic fever has been raised by several investigators. 
Some of the arguments are the following. 
The detection of cross-reactivity between streptococcal M5 protein and myosin 
(see Introduction) has led to tentative speculation that the ATPase enzyme 
associated with the light chains of the molecule might be implicated in this 
cross-reaction. Cunningham et al. ( 1986) showed that murine mAbs evoked by 
purified membranes from M type 5 S.pyogenes, cross-reacted with the heavy 
chains of the molecule (both heavy and light meromyosin fragments), but failed 
to bind to the light chains of the molecule or to inhibit the ATPase activity of 
the globular headpiece associated with these molecules. The authors also 
speculated that the binding to sarcolemmal membranes by these mAbs could 
implicate the Na+ /K + ATPase enzyme associated with these membranes. It 
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was thought that the enzyme might share epitopes with myosin and M5, but 
this was not verified. 
Manjula and Fischetti ( 1980) suggested another way in which muscle ATPase 
enzymes might be implicated in antigenic mimicry between S.pyogenes and 
heart. The M protein has structural resemblance to (and is immunologically 
cross-reactive with) tropomyosin which, in the presence of actin, has been 
shown to confer Ca2 + -regulated Mg2 + -ATPase activity upon myosins in 
leukocytes (Stossel and Pollard, 1973; Adelstein et al., 1972). It was 
suggested that through its resemblance to this regulatory protein in muscle 
contraction, M protein might conceivably interfere with the contractile 
machinery of cells, and that this might be at the basis of antiphagocytic 
properties (see Introduction). 
Other evidence for the possible implication of ATPase enzymes in antigenic 
mimicry has been presented by Lane and Hoeffler ( 1980) who showed cross-
reactivity between SV40 virus T antigen and a 68 kD host cell protein with 
ATPase activity. It was suggested that mimicry of this ATPase-associated 
protein by the virus might change its function to suite the survival of the virus 
in the cell. 
The evidence for the involvement ATPase enzymes in antigenic m1m1cry in 
rheumatic fever has not been unequivocally shown, but the hypothesis is 
attractive in that it indicates a mechanism by which cross-reactivity between 
the bacterial and mammalian epitopes might lead to a pathological interference 
in cellular function in the patient. 
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3.4 CONCLUSIONS 
1. A .previously unreported procedure, in rheumatic fever studies, of 
preparing crude extracts of human heart, using the zwitterionic detergent 
CHAPS, was used to compare the lgM, lgG and lgA binding of sera from 
seven groups of rheumatic fever, related-disease and normal subjects to 
immunoblotted cardiac antigens. It was shown that: 
(i) ARF sera stained the immunoblotted heart antigens at a greater 
frequency and intensity, than any of the other groups of sera. In 
particular, lgM binding by ARF sera was stronger than that of 
other groups of sera. 
(ii) There were eleven major constituents in the heart extract with 
which sera reacted, ranging in mol.wt. from 116 kD to 28 kD. 
(iii) A doublet at 33 kD appeared to be uniquely recognised by lgM 
antibodies in all ARF sera. 
(iv) Both child and adult CRF sera showed very little lgM binding to 
heart, whereas lgG binding was intense. 
(v) lgA binding in all groups of sera was weak. 
(vi) Within all groups, there was considerable heterogeneity in the 
reactions of individual sera, particularly with regard to lgG binding. 
(vii) All seven gr.oups of sera contained antibodies that reacted with 
antigens in this heart extract by immunoblotting. 
(viii) Some of the antigens in the extract corresponded in mol. wt. to 
antigens in different types of heart extract reported by other 
investigators to be reactive with monoclonal antibodies and rabbit 
immune sera evoked by S.pyogenes antigens. 
2. Antibody derived from ARF sera and eluted from the 38-40 kD heart 
antigen, showed cross-reactivity with immunoblotted S.pyogenes antigen 
pep M5, and faint reactivity with pep M24 and purified group A 
streptococcal membranes. The eluted antibody showed binding to 
membranous structures of l;leart tissue by indirect immunofluorescence. 
3. lgG antibodies in ARF sera bound a 200 kD antigen in purified human 
heart sarcolemmal membranes, that was not recognised by normal sera. 
Chapter 3 lmmunoblotting / 119 
A 40 kD antigen was recognised also by normal sera, but at a higher 
frequency by ARF sera. 
4. lgM antibodies in ARF sera bound a 140 kD antigen in nuclear extracts of 
a primary culture of heart endothelial-like cells. The antigen was also 
faintly recognised in Girardi heart cells. The antigen was not recognised 
by any normal sera. 
5. Rabbit antisera to various S.pyogenes antigens, showed distinctive 
patterns of binding to various extracts of cardiac antigens. In particular, 
intense binding was observed to heart cell nuclear antigens. The 
antiserum to protein M24 bound a 40 kD antigen in the crude heart 
extract, thus indicating that this S.pyogenes protein may, contrary to 
previous reports, share epitopes with cardiac antigens. 
6. One ARF serum showed intense binding to an ATPase enzyme isolated 
from rabbit skeletal muscle. Cross-reactivity between S.pyogenes M 
proteins and enzymes involved in muscle contraction, may explain the 
antiphagocytic properties of the M protein. Such antigenic m1m1cry 
between bacterial and human proteins may provide clues to the 
pathogenesis of rheumatic fever. 
7. lmmunoblotting thus showed some binding reactions that appear unique 
to rheumatic fever sera and might provide clues to the pathogenesis of 
the disease. 
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4.1 INTRODUCTION 
Human monoclonal antibodies offer a tool to the understanding of how the 
human B cell repertoire functions, and have been used to analyse reactivity to 
autoantigens in diseases like SLE, rheumatoid arthritis, Hashimoto's thyroiditis, 
juvenile diabetes and rheumatic fever (Shoenfield et al., 1982; Sasaki et al., 
1984; Haskard and Archer, 1982; Eisenbarth et al., 1982; Satoh et al., 1983; 
Cunningham et al., 1988). 
This discussion reviews the application of human and murine monpclonal 
antibodies (mAbs) to the analysis of antigenic mimicry in rheumatic fever, and 
describes · some of the difficulties which have been encountered in developing 
human monoclonal antibodies. 
4.1.1 
4.1.1.1 
RHEUMATIC FEVER: USE OF MURINE AND HUMAN 
MONOCLONAL ANTIBODIES 
Mouse Monoclonal Antibodies 
The specificities of the several of mAbs mentioned here have been discussed in 
t he context of immunoblotting (Chapter 3) and are therefore mentioned only 
briefly again here. 
4 .1.1.1.1 Heart and S.pyogenes 
Cunningham and Russell ( 1983) developed a panel of thirteen hybridomas from 
mice immunized with whole S.pyogenes (type M5) or their membranes. The 
secreted mAbs were screened by ELISA against Triton X-100 extracts of heart 
and S.pyogenes, and two groups of reactivity were identified: those that 
reacted with only S.pyogenes, and those that reacted with both S.pyogenes 
and heart extract. Monoclonals derived from some of these "polyclones" 
(e.g.No. 36, 49 and 54) were used in several subsequent studies by 
Cunningham and co-workers. 
4.1.1.1.2 Myosin and Tropomyosin 
Krisher and Cunningham ( 1985) showed that a murine mAb against S.pyogenes 
-(derived from polyclone "54" in Cunningham and Russell, 1983), cross-reacted 
with skeletal and cardiac muscle myosin . This mAb reacted with the same high 
mol. wt. protein bands in heart extract as did a mAb raised to cardiac myosin, 
and immunoblot inhibition experiments showed that absorption with group A 
streptococci, abolished reactivity of this mAb to both these extract bands and 
to myosin. These results suggested a sharing of determinants between 
S.pyogenes and myosin. Structural resemblance between type M5 protein of 
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S.pyogenes and myosin was demonstrated by Fischetti and Manjula ( 1982) and 
Manjula et al. ( 1985), thus reinforcing the possibility of antigenic mimicry 
between these bacterial and mammalian proteins. 
Subsequently, mAbs to S.pyogenes were used to localise the cross-reactive 
determinants on myosin to subfragments (either heavy or light meromyosin) of 
the myosin heavy chain (Cunningham et al., 1986). These experiments 
showed a difference in the reactivity patterns of the mAbs to skeletal and 
cardiac myosin: some reacted with both skeletal and cardiac myosin whilst 
others were specific for skeletal myosin. 
More recently, murine mAbs evoked by M type 5 proteins have demonstrated 
cross-reaetivity with tropomyosin (Fenderson et al., 1989). Five mAbs reactive 
with tropomyosin were reactive with either pep M5 or M6 (£.coli-cloned) 
protein. The tropomyosin antigens were shown by immunoblotting to be either 
the 70 kD dimer or the 35 kD monomer, or both. Cardiac myosin and 
tropomyosin were also shown to share epitopes. 
4. 1. 1. 1 .3 Multispecificity of Anti-streptococcal mAbs 
Murine mAbs derived from the hybridoma polyclones of Cunningham and 
Russell (1983) were shown to react with antigens from other tissues 
(Cunningham and Swerlick, 1986; Fenderson et al., 1989). 
One mAb (54.2.8) reacted with myosin, DNA and synthetic nucleotide 
homopolymers, another (36.2.2) reacted with myosin and the a-helical coiled-
coil proteins keratin and actin, and a third reacted with vimentin and with 
cardiolipin (weakly). None reacted with rheumatoid factors or with collagen (a 
protein with a highly repetitive structure implicated in some autoimmune 
disorders). These cross-reactive anti-group A streptococcal mAbs were 
grouped into those that reacted, (1) with myosin, keratin and actin, a family of 
a-helical coiled-coil proteins, or (2) with DNA and myosin. 
Both groups of these heart-reactive mAbs, reacted with streptococcal M5 and 
M6 proteins. Protein structure analyses by Fischetti and Manjula (1982) and 
Manjula et al. (1985) provided a structural basis for these cross-reactions by 
identifying, in most M proteins, a periodicity of seven amino acid residues 
similar to that present in myosin, tropomyosin and the desmin-keratin family of 
a helical proteins. 
However, whether these cross-reactions between mammalian antigens and 
S.pyogenes are pathologically relevant to rheumatic fever is disputable. 
Avrameas and co-workers demonstrated cross-reactivity among such 
conserved mammalian autoantigens (myosin, actin, DNA, thyroglobulin, 
neurofilaments, renin and tubulin) using a panel of murine natural monoclonal 
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antibodies (Dighiero et al., 1983, 1985). This finding brings into question the 
pathological relevance of some autoantigens implicated in antigenic mimicry. 
4. 1. 1. 1.4 Reactivity with DNA 
Anti-DNA antibodies occur in autoimmune diseases like SLE but such antibodies 
have not been found in rheumatic fever patients sera. Cunningham et al. 
( 1988) however showed that human serum antibodies affinity purified against 
myosin did react with DNA, and furthermore that several of their human mAbs 
reactive with myosin were inhibited by DNA. Other studies have shown ( 1) 
that a murine mAb against myosin reacted with DNA (Lafer et al., 1981 ), and 
(2) that DNA-reactive mAbs derived from SLE-prone mice, reacted with 
endogeno.us bacteria, including S.faecalis (Carroll et al., 1985). Cross-
reactivity between myosin and DNA, and between bacterial antigens and DNA, 
may thus be specific but the significance of these cross-reactions in rheumatic 
fever is not evident. 
4.1.1.1.5 Human Sarcolemma 
Several studies have suggested that cross-reactive heart antigens in rheumatic 
fever are associated with the sarcolemmal membrane (Zabriskie and Freimer, 
1966; Dale and Beachey, 1982a; Zabriskie and Friedman, 1983). 
Murine mAbs evoked by S.pyogenes (type M5) membranes could be divided 
into two groups: strong reactors with streptococcal and sarcolemmal 
membranes, or weak reactors with these membranes (Cunningham et al., 
1984). The major reactive determinants in the sarcolemmal extracts were high 
molecular weight proteins of about 200 kD. These polypeptides may have 
included myosin which has been detected in similar extracts (Dale and 
Beachey, 1985a), and has been associated with the internal surface of the 
sarcolemma (Fallon and Nachmias, 1980). 
A comparison of mAb binding to extracts of normal and rheumatic sarcolemma, 
showed no differences in pattern but only in intensity of binding, indicating that 
the reactive epitopes were not unique to rheumatic heart. Furthermore, normal 
mouse sera also showed some binding to these antigens, suggesting natural 
autoantibody reactivity. 
4.1.1.1.6 Other Streptococcal Serotypes (and Myosin) 
Some evidence suggests that epitopes are shared between S.pyogenes, 
S.mutans, S.rattus and myosin. 
mAbs binding a 62 kD component in membrane extracts of S.pyogenes were 
found to bind components of mol. wt. 62-67 kD in SOS extracts of S.mutans 
and S.rattus (Ayakawa et al., 1988). Furthermore, reactivity to S.rattus 
extracts could be abolished by absorption of the mAbs with myosin. These 
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results concur with those of Doyle et al. (1986) who found that mAbs to 
S.mutans reacted with S.rattus and myosin, and substantiate other reports of 
possible antigenic mimicry between streptococcal antigens and myosin as a 
relevant human autoantigen. 
4. 1. 1. 1. 7 Shortcomings of Murine mAbs 
The application of murine mAbs to the study of human disease has some 
disadvantages. First, immunization of animals may entail preparation of the 
antigen in a manner that can result in loss or change of antigenicity (Seibert, 
1928; Wallis et al., 1989). Second, animal models show different patterns of 
infectivity, so that monoclonal antibodies derived from them could be 
unrepresentative and misleading. Third, even where the animal model closely 
resembles the human pattern of infection, the variation in the immunologic 
repertoires of the two species may result in different antibody responses. 
Human mAbs are more faithful representatives of the human autoantibody 
repertoire and are therefore likely to be better tools for studying human 
disease. 
4.1.1.2 Human Monoclonal Antibodies in Rheumatic Fever 
Cunningham et al. ( 1988) developed ten human mAbs from normal subjects 
and from patients with streptococcal infections (pharyngitis and cellulitis with 
raised ASO titres), and compared their specificities with those of murine mAbs 
evoked by streptococcal antigens (Cunningham and Russell, 1983; Cunningham 
et al., 1984; 1986). Both tonsillar lymphocytes and PBL were used. These 
human mAbs were screened by ELISA against human heart antigen and group 
A streptococci. 
The specificities of human mAbs and the murine mAbs were quite similar. Both 
types could be categorised into mAbs that reacted, ( 1) with myosin, keratin 
and/or actin, or (2) with myosin and DNA (Cunningham and Swerlick', 1986). 
Most of the human mAbs fell into the myosin-keratin-actin group. 
Several of these mAbs were derived from normal subjects with no evidence of 
· S.pyogenes infection (as judged by ASO titres), indicating that the lymphocytes 
capable of producing these cross-reactive autoantibodies are present in normal, 
uninfected individuals. This finding raises the· perplexing question of the 
significance of autoantibodies in health and disease (Chapter 1 ). Apparently 
however lymphocytes had to be stimulated with streptococcal antigens prior to 
cell fusion, in order to obtain hybridomas secreting anti-myosin antibodies. 
Human mAbs that reacted with DNA are puzzling in that no evidence for 
antinuclear antibodies could be found in sera of the ARF patients. Anti-myosin 
antibodies affinity-purified from ARF sera did however react with DNA and it 
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was suggested that reactivity of myosin antibodies with DNA could be due to 
its charge and configuration. The cross-reactivity these human mAbs showed 
between pep M5, M6, myosin and DNA may be similar to the cross-reactivity 
displayed by the murine mAbs between DNA, myosin and bacterial antigens 
(section 4. 1 . 1 .4). 
More recently, Cunningham et al. ( 1989) used overlapping synthetic peptides 
covering the entire pep M5 protein sequence to map the myosin-reactive 
epitopes recognised by these human and murine mAbs (as well as by affinity 
purified myosin-specific ARF and CRF patient sera). The majority of huma'n and 
mouse myosin cross-reactive antibodies recognised an epitope involving the 
sequence GLN-L YS-SER-L YS-GLN within the 14-residue carboxy terminus of 
pep M5 . . This exact sequence was not found in myosin itself, but it was 
argued that similar sequences or conformational epitopes might be recognised 
since previous work had clearly demonstrated cross-reactivity of these 
antibodies with the heavy chain of myosin (Cunningham et al., 1986). 
The human mAbs used in the above studies were not derived from patients 
with rheumatic fever, but from two patients with high ASO titres (one with 
repeated streptococcal pharyngitis and the other with recurrent cellulitis), and 
from normal subjects. The innovation of the present study was to develop 
human mAbs from lymphocytes of ARF patients . A number of difficulties were 
experienced in trying to isolate such mAbs, pertaining in particular to the 
source of lymphocytes (PBL from a young patient), the instability of the 
hybridomas in culture, and the expansion of the antibody-secreting hybrids in 
culture and in mice. These difficulties appear to be general problems in human 
mAb technology, and are briefly reviewed below. 
4.1.2 
4.1.2.1 
PROBLEMS IN DEVELOPMENT OF HUMAN MONOCLONAL 
ANTIBODIES 
Range of lmmunogens and Poor Source of Lymphocytes 
The range of immunogens that can be injected into humans as well as the 
immunization schedules applicable are obviously restricted (compared to animal 
models), and the source of immune lymphocytes is usually limited to peripheral 
blood lymphocytes (PBL) which perform less well than those from spleen and 
tonsils (Olsson et al., 1983). 
Various reasons have been postulated for the poor performance of PBL as 
hybridoma fusion partners: ( 1) insufficient memory or antigen specific B cells 
(Seigneurin et al, 1983; Olsson et al., 1983); (2) B cells not in an appropriate 
state of differentiation (Schwaber et al., 1984; Cote and Houghton, 1985); (3) 
existence of suppressor and cytotoxic T cells (Cote and Houghton, 1985); (4) 
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insufficient number and low mitotic activity of B cells (Burnett et al., 19.85; 
Westerwoudt, 1985). 
4.1.2.2 Instability of Human Hybridomas 
Human hybridomas secreting antibody have often been found to be unstable in 
culture and to lose the structural genes coding for immunoglobulin (Schwaber 
et al., 1984) or to become overgrown by non-secreting lymphocytes (Zurawski 
et al., 1978). Epstein-Barr virus transformation of B cells can result in the 
overgrowth by non-secretors (probably due to polyclonal activation of cells), 
whereas production of human mAbs through fusion with immortal partner cells 
can result in chromosomal instability with preferential loss of the human 
chromosomes (Kozbor and Croce, 1985; Teng et al., 1985). 
Possible reasons for loss or decrease in immunoglobulin production could be 
attributed to defects in synthesis (Sikora et al., 1983; Teng et al., 1985) or 
secretion (Kozbor and Croce, 1985; Gaffar et al., 1986b). Most studies have 
failed to investigate the possibility of immunoglobulin being present in the 
cytoplasm and have instead measured either total immunoglobulin or specific 
antibody in cell culture supernatants. Studies on the morphology of the human 
cell lines indicate that they often have many free polyribosomes and a poorly 
developed rough endoplasmic reticulum compared to mature plasma cells 
(Larrick et al., 1983; Kozbor et al., 1983). Such defects could impede efficient 
t ranslation, assembly and secretion of immunoglobulin. 
Other reasons - given for defective immunoglobulin synthesis by human 
monoclonal cell lines include: defects in relevant regulatory genes (Raison et 
al., 1982; Schwaber et al., 1984); improper combination of H and L chains 
(James and Bell, 1987); shortage of important differentiation and growth 
factors (Winger et al., 1983) and inhibitory effects of microorganisms such as 
mycoplasma (Van Meel et al., 1985) 
4.1.2.3 lmmortalization of Human B Cells 
Problems have been encountered in the choice of cell fusion partners for 
immortalizing human B cells. 
Human myelomas grow poorly in culture, and therefore in human-human 
hybridomas, Epstein-Barr virus transformed lymphocytes have been used 
. instead since they have the additional advantage that they secrete little 
immunoglobulin compared to myelomas (Kozbor et al., 1983). 
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A second strategy for immortalizing human lymphocytes has been to use 
heteromyelomas created by the fusion of lymphoblastoid lines with human or 
mouse myelomas. Such fusions (with mouse myelomas in particular) have 
produced a number of partner cells which form stable hybrid-hybrids with 
human lymphocytes (Teng et al., 1983; 1985). 
Thirdly, human lymphocytes have been fused with mouse myelomas instead of 
with human myelomas or mouse-human heteromyelomas (Wunderlich et al., 
1981; Thompson et al., 1986). The fusion rates are apparently higher with 
these mouse myelomas than with human partners (Cote et al., 1983, 1986). 
Such heterohybrids are known to preferentially lose their human chromosomes, 
but these cell lines can be stabilised by early cloning (Thompson et al., 1986). 
4. 1 .2.4 Expansion of Human Monoclonal Antibody Cell Lines 
While human/human hybridomas grow fairly well in stationary and suspension 
cultures, growth in immunodeficient (nude) mice is comparatively poor, despite 
some improvements such as co-inoculation with human fibroblasts (Olsson and 
Brams, 1985) or irradiating the mice prior to inoculation (Bogard et al., 1985). 
Human/mouse heterohybrids take quite readily in nude mice probably due to 
the fact that they don't express the human HLA antigens which would lead to 
immune rejection (Raison et al., 1982). 
In conclusion, although the development of stable antibody secreting human 
monoclonal antibody cell lines presents some serious technical difficulties, 
these antibodies have the advantage over murine mAbs in being more 
representative of the human immune repertoire and, in the study of 
autoimmune and infectious diseases, can offer a valuable inside view of 
antibody reactivity patterns in the disease. Furthermore, their homogeneity and 
potential specificity can make them more useful probes than whole serum for 
the identification of autoantigens. 
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4.2 RESULTS 
Human mAbs derived from patients with acute rheumatic fever were fused with 
mouse myeloma cells to form heterohybridomas which were screened against 
both S.pyogenes and human heart antigens. Two mAbs displaying cross-
reactivity between these antigens were cloned and characterised. The ensuing 
discussion describes the development of these mAbs, and the investigations 
performed to characterize them. 
4.2.1 SCREENING AND CHARACTERIZATION OF MONOCLONAL 
ANTIBODIES 
Purified and enriched populations of peripheral blood lymphocytes (PBL) from 
two patients with acute rheumatic fever were fused with SP2/0-14 mouse 
myeloma cells to form mouse-human heterohybridomas, according to 
procedures described in Materials and Methods (section 7 .A.21). 
4.2.1.1 ARF Patients 
ARF donor patients (designated M and VR) were children who fulfilled the 
Jones Criteria for diagnosis of rheumatic fever (Table 1.1 ), and had active 
carditis. Patient M, from whom both mAbs described in this study were 
derived, was 4 years old and had an ASO titre of 480 Todd units. 
4.2.1.2 Hybrid Screening and Selection 
Hybridomas were screened both against group A streptococci by ELISA 
(section 7 .A.3), and against sections of human heart by a peroxidase-
conjugated second antibody assay (section 7.A.23). Only hybrid clones 
demonstrating reactivity against both streptococci and heart tissue were 
selected for expansion and further characterization. 
Table 4.1 shows that, fourteen days after fusion, only hybrids derived from 
lymphocytes of patient M, secreted antibody reactive with both S.pyogenes 
and human heart. Since the objective of the study was to isolate only such 
cross-reactive mAbs, only these clones were selected for subcloning and 
characterization. After subcloning by limiting dilution, two clones secreting 
cross-reactive antibody were identified. The two monoclonal antibodies were 
designated MA6 and MB4. 
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TABLE 4.1 
Percentage of Seeded Hybridoma Clones Secreting Antibody Reactive with 
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Stability of Hybridomas in Culture 
Hybridoma MAG survived twenty passages. (Culture supernatant was collected 
over a period of three months before the cell line was frozen in liquid nitrogen). 
Hybridoma MB4 was unstable and survived only five culture passages. (It was 
t hus not fully characterised) . 
4.2.1.4 Karyotyping of Selected Hybrids 
Karyotyping of the hybridomas was done as described in Materials and 
Methods (section 7.A.2G). Hybridoma MAG had an average of 85 
chromosomes per cell compared with 70 chromosomes in the parent SP2/0- · 
Ag14 mouse myeloma cell line. 
Fig.4.1 shows karyotypes of: (a) an SP2/0-Ag14 murine plasmacytoma cell 
with acrocentric chromosomes and one large metacentric chromosome; (b) a 
normal human peripheral blood lymphocyte showing metacentric chromosomes; 
(c) an MAG hybridoma cell showing both murine acrocentric chromosomes and 
a few additional human metacentric chromosomes. 
4.2.1.5 Characteristics of lmmunoglobulin Produced 
Both selected hybridoma clones produced lgM antibody as determined in ELISA 
using heavy-chain specific anti-human lgG, lgA or lgM conjugates. The 
immunoglobulin concentration of hybridoma .MAG, measured by radial 
immunodiffusion four days after subcloning, was 28 µg/ml. 
The secreted and cytoplasmic immunoglobulins of MAG were determined by 
14
C-leucine labelling and immunoprecipitation of hybridoma cell lysates and 
culture medium, according to the method of Choi ( 1977). The radiolabelled 
immunoprecipitates, separated by 10% SOS-PAGE and autoradiographed, 
showed the presence of both cytoplasmic and secreted immunoglobulin light 
and heavy chains (Fig.4.2) . 
I/ 
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Fig. 4.1 Karyotyping of 
murine myeloma SP2/0-Ag 14 
cells, human peripheral blood 
lymphocytes and mouse-
human hybridoma cells. 
Cells were exposed to 
hypotonic treatment in 
0.075M KCI for 20 minutes, 
fixed and washed in acetic 
acid-methanol solution, 
spread on glass slides and 
then stained with Giemsa 
stain (section 7.A.26). 
(a) SP2/0-Ag14. murine 
plasmacytoma cell showing 
acrocentric chromosomes 
and one large metacentric 
chromosome (arrow). 
(b) Peripheral blood 
lymphocyte from acute 
rheumatic fever patient M 




showing numerous mouse 
acrocentric chromosomes, 
one large metacentric 
chromosome (arrow) and at 










Fig. 4.2 Autoradiograph of immunoprecipitated cytoplasmic and secreted immunoglobulin of 
hybridoma MA6. 
Hybridoma cell lysates and culture medium supernatants were immunoprecipitated following 
labelling with 14C-leucine, as described in section 7 .A .27 . The radiolabelled immunoprecipitates 
were fractionated by 10% SOS PAGE and subjected to autoradiography for 6 days. Similar 
control immunoprecipitations were performed on culture media derived from normal human PBL 
w hich had been stimulated for 6 days in culture with pokeweed mitogen (PWM) 
Lane 1: 
lanes 2 & 3: 
Lane 4: 
Lanes 5 & 6: 
mol. wt. markers 
culture medium from hybridoma MA6 
culture medium from PWM stimulated normal human PBL 
cell lysates of hybridoma MA6 
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Normal unfused PBL stimulated with pokeweed mitogen (lane 4) secreted 
proteins of mol.wt. 72 kD, 60 kD, 51 kD which may correspond to the 
mol.wts. of the heavy chains of lgM, lgG and lgA respectively. A fourth band 
at 25 kD corresponds to the mol.wt. of immunoglobulin light chains. The MA6 
hybridoma cell lysate (lanes 5 and 6) contained proteins of mol.wt. 70 kD, 46 
kD and 25 kD, whereas the culture supernatant of this hybridoma contained 
proteins of 72 kD and 25 kD (lanes 2 and 3). 
4.2.1.6 Propagation of Hybridomas in Nude Mice 
The mouse-human heterohybridomas failed to grow in pristane-primed BALB/c 
mice. They were propagated successfully in pristane-primed "nude" (athymic) 
mice, but several mice grew solid tumours and produced little or no ascit.es. In 
mice that developed ascites, the yield was generally between 1.5 and 2.5 ml 
per mouse. 
4.2.1.7 Stability of Antibody Production 
The stability of hybridoma antibody production was assessed by testing 
reactivity in the group A streptococcus ELISA after each passage of cells over a 
period of six months. A reduction of about 30% in ELISA antibody reactivity 
over this period was evident, indicating that the hybridomas were not 
completely stable in culture. 
4.2.1.8 CDS+ Cell Surface Marker 
The MA6 heterohybridoma was tested for the CD5 + cell marker using the 
monoclonal antibody T-1 (Dako: M705), and an FITC-labelled goat anti-mouse 
lgG antibody conjugate (Cappel). Results were negative. 
4.2.1.9 Anti-Streptococcal Antigen Reactivity 
4.2.1.10 Selection of mAbs against Group A Streptococci 
Hybridomas MA6 and MB4 were selected for reactivity against S.pyogenes by 
ELISA (section 7.A.3). These hybridomas were also reactive with heart tissue 
antigens. Table 4.1 shows that the percentage of wells positive in the 
streptococcal ELISA was four to five times greater than positives detected by 
immunocytochemistry. 
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4.2.1.11 Cross-reactivity with other Streptococcal Groups (B,C,D,G) 
The specificity of MAG for S.pyogenes was assessed by comparing its 
reactivity against the streptococcal groups A, B, C, D and G, using the similar 
ELISA procedure with whole bacteria glutaraldehyde-fixed to PVC plates 
(section 7.A.3). 
The reactivity of the monoclonal antibody was also compared with the lgG and 
lgM reactivity of serum from patient M. 
Results presented in Table 4.2, show that MAG reacted with all groups of 
streptococci, as did the donor patient's serum. Serum lgM absorbance (A405) 
readings yvere similar in all streptococcal groups, but lgG reactivity to groups 
A, C and G was noticeably stronger. The readings are generally low because 
both the no-antibody control and the no-antigen controls were subtracted from 
each value. 
TABLE 4.2 
Reactivity of mAb MAG and Serum "M" to Streptococcal Groups (A,B,C,D,G) in 
ELISA 
ANTIBODY ISOTYPE DIL. Streptococcal Groups 
A B C D G 
* MA6 lgM 1 :50 .152 .174 .281 .129 .215 
-
Serum M lgM 1: 100 .258 .241 .278 .265 .305 
Serum M lgG 1 :100 .469 .179 .493 .141 .494 
* Ammonium sulphate precipitated culture supernatant 
Table 4.3 compares the reactivity to group A streptococci of MAG and MB4 
(1 :2 dilutions) culture supernatants, with the reactivity of the PBL-donor patient 
serum (M) and a pool of five normal sera (5N). Both the no-antibody and the 
no-antigen controls were subtracted from each average value, giving low 
results. 
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TABLE 4.3 
Reactivity of MAG and MB4 and Patient Serum (M) to Various Antigens 
Comparison of Reactivity of Human mAbs and Human Sera with Various Antigens in ELISA (OD 
405nm) 
ANTIBODY ANTIBODY STREP A MYOSIN PHOSPHORYLASE B 
DILUTION 
mAb MA6 1 :2 .315 0 .513 
mAb MB4 1 :2 .163 0 .192 
HT medium 1 :2 . 151 .024 .034 
(control) 
Serum M 1: 100 .152 .045 .084 
Pool 5N 1:100 .185 .032 .065 
PBS-Tween .094 .013 .056 
(control) 
4.2.1.12 Cross-Reactivity with Non-streptococcal Bacterial Species: E.coli 
Both MA6 and MB4 cross-reacted with E.coli antigens. lmmunoblotting of 
culture supernatants against E.coli sonicates showed strong binding (to 
constituents of 35 kD and 38 kD; results not shown), and ELISA inhibition 
experiments (using E.coli sonicates in the S.pyogenes ELISA) showed similar 
cross-reactivity of MA6 with E.coli. Approximately 18 µg/ml of E.coli 
absorbant, compared to 13.5 µg/ml of S.pyogenes absorbant, was required to 
absorb 50% of MA6 binding to S.pyogenes (dilution 1 :500) . 
4.2.2 ANTI-HUMAN HEART ANTIGEN REACTIVITY 
4.2.2.1 Binding to Heart Sections: lmmunoperoxidase Sandwich Assay 
Hybridomas were screened against paraffin wax embedded sections of normal 
human heart (section 7.A.23). 
Table 4.1 shows that a smaller percentage hybridomas showed positive binding 
to heart, than to group A streptococci. All of the hybridomas derived from 
patient M that were positive by immunocytochemistry (8%) also cross-reacted 
in ELISA with group A streptococci, whereas none from patient VR were cross-
reactive. 
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4.2.2.2 lmmunoblotting of Heart Extract and Sarcolemma 
lmmunoblotting of MA6 and MB4 against CHAPS detergent extracts of human 
heart (section 7 .A.11) and against 3 M KCI extracts of cardiac sarcolemmal 
membranes (section 7 .A.12) showed strong binding to a 43 kD constituent in 
both extracts (Fig.4.3). Both mAbs also bound less strongly to a 48 kD 
constituent in the CHAPS extracts. (MB4 stained some additional bands 
between 60 kD and 140 kD in the CHAPS extract). 
4.2.2.3 Organ Non-Specificity of mAb Binding 
Neither MA6 nor MB4 were specific for heart tissue antigens, as both reacted 
by immunoblotting with human kidney antigens in detergent extracts (to 100 
kD, 94 kD and 90 kD constituents). 
4.2.2.4 Nonspecific Binding to Mammalian Tissue Antigens 
The specificity of MA6 and MB4 against mammalian antigens was further 
examined by reacting them against immunoblotted proteins derived from an 
SOS-PAGE molecular weight calibration kit (Pharmacia). Other investigators 
have noted irrelevant cross-reactive binding of mAbs to molecular weight 
standards (Ghosh and Campbell, 1986). The protein mixture included purified 
phosphorylase b (rabbit muscle), albumen (bovine serum), ovalbumen (egg 
white) and carbonic anhydrase (bovine erythrocyte). 
Fig.4.4 shows that both mABs bound phosphorylase b and carbonic anhydrase. 
MA6 also reacted with albumen and ovalbumen. 
Furthermore, ELISAs using myosin and phosphorylase b as solid phase antigens 
(section. 7 .A.6), confirmed strong reactivity of both mAbs to phosphorylase b 
(Table 4.3). Neither monoclonal bound myosin. Both these mAbs appeared 
therefore to lack specificity, or are possibly multispecific. 
4.2.3 CROSS-REACTIVE BINDING OF HUMAN MAB$ TO HEART AND 
STREPTOCOCCAL AGS 
Both mAbs were selected for the cross-reactivity they displayed between group 
A streptococci and human heart tissue antigens . 
4.2.3.1 lmmunoblotting 
Cross-reactive binding of MA6 to streptococcal and heart antigens was 
additionally demonstrated by its reactivity in immunoblots, with constituents in 
both extracts of mol.wts. of about 43 kD, 45 kD and 83 kD (Fig.4.5). The 










1 :2 1 :2 1 :2000 
MA6 S/N MB4 S/N MAB Ase Medium 
SL H SL H SL H SL H SL 
3 4 5 6 7 8 9 10 1 1 
Fig. 4.3 lmmunoblotting of human mAbs MA6 and MB4 against crude extracts of human heart 
and purified cardiac sarcolemmal membranes. 
Crude CHAPS detergent extracts of human heart (H) (section 7 .A. 11) and purified human 
cardiac sarcolemmal (SL) membranes (section 7 .A.12). were separated on 10% SDS 
polyacrylamide gels and immunoblotted against the human mAb MA6 and MB4 supernatants 
tS/N) and nude mouse ascitic fluids (ASC) . A strongly reactive constituent of 43 kD present in 
both extracts was detected at concentrations of 1 :2 in culture medium supernatants of both 
mAbs (lanes 4-7). The constituent was detected at concentrations of up to 1 : 1000 of ascitic 
flu id of the mAbs, but was no longer evident at dilutions of 1 :2000 (lanes 8 & 9). Undiluted 
pure medium showed no binding (lanes 10 & 11 ). Amide Black staining of the extracts showed 
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Fig. 4.4 Nonspecific cross-reactive binding of human monoclonal antibodies MA6 and MB4 to 
various proteins. 
Purified proteins contained in a molecular weight calibration kit (Pharmacia) (phosphorylase b, 
albumen, ovalbumen, carbonic anhydrase, trypsin inhibitor) were separated by 10% SOS PAGE, 
transferred to nitrocellulose and reacted against the human mAbs MA6 and MB4 according to 
procedures described in section 7 .A.9. Both mAbs reacted with phosphorylase b (94 kD) and 
carbonic anhydrase (30 kD), and MA6 also reacted weakly with albumen (67 kD) and 
ovalbumen (43 kD) (lanes 3 & 4) . Serum from the PBL donor ARF patient (Ms) did not react 
w ith these proteins, nor did a pool of 5 normal sera (Ns) and the negative control (minus first 
antibody). 
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Fig. 4.5 Reactivity of human mAbs with crude extracts of human heart and with sonicates of 
group A streptococci. 
Crude extracts of human heart (H) (section 7 .A.11) and sonicates of group A streptococci (S) 
. (section 7 .A .30), were separated by 10 % SDS PAGE and immunoblotted against the human 
mAbs MA6 and MB4 at ascitic fluid dilutions of 1 :5000 and 1: 10000. Neither of the mAbs 
were specific for any particular constituent but showed binding to several bands in both these 
extracts, the most prominent of which occured at mol.wts. of about 43 kD, 45 kD and 83 kD. 
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4.2.3.2 ELISA Inhibition Assay 
The inhibition of binding of MA6 ( 1 :600 of ascites) to heart antigen in ELISA, 
was measured following absorption of the antibody with increasing 
concentrations of S.pyogenes homogenate. 
Fig. 4.6 shows a proportional decrease in binding of MA6 to heart extracts in 
the ELISA, following pre-absorption of the mAb with a dilution range of 
S.pyogenes absorbant (undiluted: E470 5.0) (section 7.A.30). It was calculated 
that a 1 :8 dilution of absorbant inhibited binding by 74%, and a 1: 16 by 31 %, 
with no further inhibition after a 1: 128 dilution of absorbant. 
4.2.4 BINDING TO NUCLEAR ANTIGENS 
Antibodies to nuclear antigens have been found in several autoimmune disease 
(Chapter 1 and section 2.2.4.1 ). 
mAb MA6 was tested for reactivity against nuclear antigens in the HEp-2 
cellular immunofluorescence system (Behring Diagnostics) (section. 7 .A. 7), as 
well as by immunoblotting against nuclear extracts of Girardi and primary 
culture heart cells (section.7.A.15). 
There was no evidence of binding to nuclear antigens in the HEp-2 
immunofluorescence assay and binding to multiple bands in the immunoblotted 
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Fig. 4.6 ELISA inhibition assay: inhibition of binding of human mAb MAG to human heart 
extracts in ELISA, following preabsorption with sonicate_s of group A streptococci 
The graph shows a result of a typical ELISA inhibition experiment, in which a 1 :600 dilution of 
MA6 was absorbed with a dilution range of a sonicate of S.pyogenes (undiluted concentration: 
E470 5.0) and then incubated in ELISA against human heart extract (section 7.A.6.2). At a 1 :8 
dilution of the streptococcal absorbant, binding of MA6 to the heart extract was inhibited by 
74% . 
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4.3 DISCUSSION 
4.3. 1 Characterization of Monoclonal Antibodies 
4.3.1.1 Stability of Heterohybridomas 
Because of their instability, many human hybridomas have not been adequately 
characterized and their specificity is therefore unclear. This seems particularly 
true of mAbs raised to autoantigens (James and Bell, 1987). 
In this study, difficulty was experienced in producing stable antibody-producing 
heterohybrids, despite early and repeated subcloning. The use of PBL as cell 
fusion partners may have contributed to this effect, since these lymphocytes 
give rise to fewer antibody-secreting clones than lymphocytes from other 
tissues (Lagace and Brodeur, 1985). Peripheral blood appears to contain fewer 
antigen-specific B cells in an appropriate state of differentiation, and possibly 
the young age (4 years) of the PBL donor patient used in this study may have 
exacerbated this shortcoming. 
Another source of instability in heterohybrids is that they appear to lose 
regulatory genes and segregate human chromosomes (Kozbor and Croce, 
1985). The few human compared to mouse chromosomes found in the 
heterohybrids of the present study (Fig.4.1 c) concurs with findings of other 
studies in which five times as many mouse as human chromosomes were found 
in heterohybrids· (Raison et al., 1982). The lambda light chain phenotype of 
MA6 also fits in with the finding of Croce et al. ( 1980) that heterohybrids 
usually lose chromosome 2 (coding for the kappa light chains) and retain 
chromosome 14 (coding for the heavy chain). 
Most studies however tend to favour a loss or defect in regulatory genes (or 
some other aspect of regulation) rather than a loss of structural genes, as the 
main reason for the instability of heterohybrids (Raison et al., 1982; Schwaber 
et al., 1984). The presence of such a regulatory defect was shown in the case 
of a non-secreting mouse/human heterohybrid that retained the heavy chain 
chromosome (No. 14) and could be stimulated (with lipopolysaccharide) to re-
express immunoglobulin (Raison et al., 1982). The problem with many 
hybridomas appears to be one of defective antibody synthesis and secretion 
(Winger et al., 1983; Sikora et al., 1983), and examination of the cytoplasmic 
1mmunoglobulin of hybridoma MA6 showed some evidence of what may 
possibly be aberrant immunoglobulin synthesis. 
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The morphology of human hybridomas often shows structural abnormalities, 
such as poorly developed rough endoplasmic reticulum and the presence of free 
polyribosomes, which could be responsible for these defects in immunoglobulin 
production (Kozbor et al:, 1983; Sikora et al., 1983; Larrick et al., 1983). 
Although the morphology of hybridoma MA6 was not examined in this study, 
the 46 kD cytoplasmic protein in immunoprecipitates of the cell lysates, may 
represent a product of aberrant immunoglobulin synthesis. This protein was 
noticeably smaller than the 51 kD protein in the PWM control, thought to 
correspond to the heavy chain of lgG (Fig.4.2). Hybridoma cells have been 
known to express more than one antibody isotype, and cells expressing up to 
seven have been detected (Male et al., 1987). Whether this smaller molecule 
represents a product of defective lgG synthesis is not certain, but defects such 
as these may explain the instability of heterohybridomas. 
The growth of the hybridomas only in nude (athymic) mice but not in BALB/c 
mice, may be due to the expression of the mouse H-2 haplotype but 
nonexpression of the human HLA antigens which would otherwise have led to 
rejection in nude mice (Raison et al., 1982). 
Finally, the decrease with time in reactivity of MA6 antibody against 
S.pyogenes in ELISA could not be attributed to artefacts of prolonged storage 
of antigen-coated plates (Viljanen and Punnonen, 1989), since freshly coated 
plates displayed the same decreased reactivity. 
4.3.1.2 Cross-reactivity/nonspecificity of Binding 
These mAbs reacted with a wide range of antigens and were therefore probably 
nonspecific. Reasons for this nonspecificity may be the following. First, they 
were selected during screening for cross-reactivity between S.pyogenes and 
heart antigens. Second, the hybridomas were derived from a young patient 
whose antibodies might have been generally more cross-reactive than those of 
an older patient. Studies by Klinman et al. (1988) have shown that the 
expressed B cell repertoire of 1-to 5 week old mice produced antibodies 
generally more cross-reactive than those of older mice, and newborn mice have 
been reported to have very high frequencies of natural autoantibodies (Dighiero 
et al., 1985). If these findings pertain to humans, then the young age of the 
patient may have contributed to cross-reactivity of these mAbs. Third, these 
multivalent mAbs, because they were of the lgM class, would have a greater 
potential for nonspecific cross-reactive binding. Fourth, the nonspecificity of 
these mAbs may have been exacerbated by assays in which they were exposed 
to high densities of antigen (such as occur in crude extracts or in 
immunocytochemistry) with many potentially cross-reactive epitopes (Lampson 
and Fisher, 1985). Fifth, cross-reactivity could be the result of binding to an 
extremely common epitope. 
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4.3.2 Anti-Streptococcal Antigen Reactivity 
The cross-reactivity of MA6 to other groups of streptococci (Table 4.2), is 
another indication of its lack of specificity. 
Cunningham et al. ( 1984) found that although murine mAbs evoked by 
S.pyogenes also reacted with other groups of streptococci in ELISA, the 
reaction against group A streptococci was the strongest. This stronger 
reaction is perhaps attributable to the active immunization of mice with 
S.pyogenes, compared to natural infection in the case of the human mAbs. In 
this study the lower binding of monoclonal MA6 to group A streptococci, is 
reflected in the serum reactions (lgG and lgM) of the donor patient (M) which 
also showed higher reactivity to other groups of streptococci (Table 4.2). The 
human mAbs developed by Cunningham et al. ( 1988) were not tested for 
reactivity against other groups of streptococci. (Absorbance readings in the 
ELISAs of the present study were low compared to the those obtained by 
Cunningham and coworkers, since both the no-serum and the no-antigen 
control readings were subtracted from each value, and because peroxidase 
rather than the more sensitive alkaline phosphatase conjugates were used). 
In addition to cross-reacting with other groups of streptococci, MA6 also 
displayed intense reactivity in immunoblotting with two E.coli antigens. Such 
cross-reactivity between mAbs (murine and human) and E.coli antigens 
(especially B-D-galactosidase) has been noted by other investigators (Golding et 
al., 1987; Wallis et al., 1989). 
4.3.3 Reactivity with Human Heart Antigens 
The 43 kD constituent present in both crude heart extract and in sarcolemmal 
membranes with which both MA6 and MB4 reacted (Fig.4.3), may correspond 
to a constituent of the same mol. wt. in saline extracts of bovine heart that 
reacted with ARF patient sera (Zabriskie and Friedman, 1983). Possibly this 
band corresponds to actin (42 kD) since there is some evidence that ARF 
patients have anti-actin antibodies (Chapter 2). This constituent also occurs in 
a region of reactivity (40-and 43 kD) in Triton X-100 and SOS extracts of heart, 
with which rabbit immune sera to M5 and M25, as well as murine mAbs to M5 
proteins, have been found to react (Cunningham and Russell, 1983; 
Cunningham et al., 1984; Sargent et al., 1987; Dale and Beachey, 1985a) 
(Chapter 3 and Table 3.1 ). (Neither MA6 nor MB4 reacted with M5 by 
immunoblotting, although they might have displayed reactivity in ELISA). 
The fact that neither MA6 nor MB4 were specific for heart, but bound also 
kidney antigens, is further evidence of their nonspecificity. Serum antibodies in 
rheumatic fever however are not organ specific but bind components in joints, 
caudate nucleii, heart muscle, connective tissue and blood vessels (Zabriskie, 
1985). 
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Likewise, binding of MA6 and MB4 to phosphorylase b, albumen and carbonic 
anhydrase may be irrelevant cross-reactive binding. Cross-reactive 4-7 amino 
acid sequence determinants would quite likely be present in these highly 
conserved proteins (Atassi, 1975: see Chapter 1 ). The cross-reaction with 
phosphorylase b however could possibly be important, since both in this study 
(Chapter 2) and in others (James Dale - personal communication to D W 
Beatty, 1987), ARF sera have been found to contain antibodies to this protein. 
Natural autoantibodies to albumen have been described by Dighiero et al. 
( 1982) and others. There are no reports of autoantibodies to C'Brbonic 
anhydrase. Thus, although autoantibody binding to these proteins is known, 
these mAbs are not specific for any of them. 
These human mAbs do not therefore appear to fit in with either of the groups 
of reactivity displayed by human mAbs developed by Cunningham et al. 
(1988), namely those reacting with (1) myosin and DNA, or (2) myosin, keratin 
and/or actin. Possibly the strong binding of these mAbs to the 43 kD 
constituent in crude heart· extracts and sarcolemmma (Fig.4.3), may be 
significant and merit further investigation. 
4.3.4 Cross-reactivity: Group A Streptococcus and Heart 
4.3.4.1 lmmunoblotting 
The recognition of constituents of similar mol. wt. in heart extract and 
S.pyogenes sonicates (Fig.4.5), is no proof of cross-reactive binding. 
Interestingly, the major constituents (43 kD 45 kD and 83 kD) do correspond in 
mol.wt. to components of S.mutans (42 kD, 46 kD and 82 kD) that react with 
rabbit sera raised against extracts of human heart (Ayakawa et al., 1985). 
S.mutans is known to cross-react with human heart (Van de Rijn et al., 1976), 
and Ayakawa et al. (1988) used murine mAbs to show that S.mutans and 
S.pyogenes share immunodeterminants. Cunningham et al. ( 1984) described a 
43 kD component in S.pyogenes M5 homogenates to which murine mAbs 
evoked by M5 membranes bound; and ARF sera also recognise a 43 kD 
constituent of heart (Zabriskie and Friedman, 1983). 
In summary, there is some evidence of constituents in extracts of heart and 
S.pyogenes, that are of similar mol. wt. and may contain cross-reactive 
epitopes. 
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4.3.4.2 ELISA inhibition Assay 
The inhibition of binding of MA6 to heart extract antigen in ELISA by 
S.pyogenes absorbent, suggests a possible sharing of epitopes in these two 
extracts that are recognised by this mAb. Since these are crude extracts there 
is an increased likelihood, in this instance too, that these reactions may be 
nonspecific. Absorption experiments using purified proteins would provide a 
clearer indication of shared reactivity between such proteins and constituents 
in the heart extract. 
4.3.5 Nuclear Antigen Reactivity 
Neither MAG nor MB4 were positive in the HEp-2 immunofluorescence assay, 
and therefore do not appear to be antinuclear antibodies, and the multiple 
binding pattern they displayed to heart cell nuclear antigens, appeared to be 
nonspecific. 
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4.4 CONCLUSIONS 
1. Two human lgM mAbs displaying cross-reactivity between human heart 
and S.pyogenes antigens were isolated from heterohybridomas 
developed by the fusion of mouse myeloma cells and the lymphocytes 
from an ARF patient. Several difficulties pertaining to the instability of 
heterohybridomas were experienced in the process of cloning them. 
2. The mAbs were not specific for group A streptococci but cross-reacted 
with other groups of streptococci as well as with E.coli proteins. 
3. The mAbs were not specific for heart antigens but reacted with antigens 
in other organs as well. 
4. Both monoclonals reacted strongly with 43 kD constituents in crude 
extracts of human heart and in purified cardiac sarcolemmal membranes. 
Antigens of a similar mol. wt. have been found by other investigators in 
different preparations of heart extract, using ARF sera, mAbs and rabbit 
immune sera raised to S.pyogenes antigens. This constituent may 
possibly therefore represent an autoantigen pathologically relevant to 
rheumatic fever, and may merit further investigation. 
5. The reactivity of MAG with phosphorylase b may be important since ARF 
sera were also found to contain antibodies reactive with this protein 
(section 2.2.2 .4) . 
. 
6. ELISA inhibition experiments using crude extracts of heart and 
S.pyogenes suggested the possibility of cross-reactive antigens in these 
extracts, but these findings should be verified using defined purified 
proteins . (lmmunoblotting of MAG against these extracts showed a 
multiple binding pattern of reactivity). 
7. These mAbs were not specific for any particular antigen in nuclear 
extracts of heart cells, nor did they display reactivity with nuclear 
antigens by immunofluorescence. 
· 8. These mAbs lacked specificity and their usefulness as probes for 
analyzing antigenic mimicry in rheumatic fever (or for screening cDNA 
expression libraries of heart cell genes - Chapter 5), is therefore in doubt. 
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5.1 INTRODUCTION 
This study presents a molecular approach to the identification of heart antigens 
implicated in rheumatic fever. 
Compared to immunofluorescence by which Kaplan ( 1963) demonstrated heart-
reactive antibodies in rheumatic fever, ELISA and immunoblotting (Chapters 2 
and 3) are superior techniques. The latter methods are both exquisitely 
sensitive, and in immunoblotting the response to separate antigenic 
components can be measured. However, despite these advances, the heart 
antigens i_n rheumatic fever remain poorly defined, with the possible exception 
of myosin. Table 3.1 presents antigens of a wide range of mol. wts. that have 
been implicated in rheumatic fever. Results presented in the immunoblotting 
study (Chapter 3) showed evidence that ARF sera react with at least eleven 
major constituents present in a crude extract of human heart. 
Molecular cloning offers a more precise approach to the definition and 
characterization of autoantigens (and specific epitopes) in rheumatic fever, and 
to the analysis of cross-reactivity with streptococcal antigens. The feasibility 
of using autoantibodies from patients in order to isolate cDNA, and ultimately 
genes, corresponding to poorly defined human antigens, has been 
demonstrated for several autoimmune and infectious diseases. Examples 
include autoimmune thyroid disease (Hirayu et al., 1987), bullous pemphigoid 
(Stanley et al., 1988), connective tissue diseases (Habets et al., 1987; Netter 
et al., 1988), Hashimoto's thyroiditis (Kaufman et al., 1989), enterococcal 
endocarditis (Burnie and Clark, 1989), Sjogren's syndrome (Chambers et al., 
1988) and SLE (Chambers and Keene, 1985). 
In rheumatic fever, the amino acid sequences of several of the streptococcal M 
proteins have been known for some time (Beachey et al., 1978). The 
antigenicity of these sequences and the homologies between them have been 
analyzed (Beachey et al., 1983; Miller et al., 1988; Hollingshead et al., 1987), 
and types M6, M12, M5 and M24 have been cloned (Fischetti et al., 1983; 
Scott and Fischetti, 1983; Spanier et al., 1984; Kehoe et al., 1985; Mouw et 
al., 1988). Poirier et al. (1985) were able to show that expressed polypeptides 
of the cloned M5 protein cross-react with human heart sarcolemmal membrane 
antigens. 
Most of the molecular cloning analyses in rheumatic fever have concentrated 
on the streptococcal antigens rather than on the human cardiac antigens. 
Knowledge of the amino acid sequences of the streptococcal M proteins 
allowed for synthesis of oligonucleotide probes thereby greatly facilitating 
cloning of the genes. This probably explains why most of the effort has been 
concentrated in this area. 
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To identify the cardiac antigens, without knowledge of their protein sequence 
or structure, the best approach was to use antibodies to screen a cDNA 
expression library of human heart cell genes. The purpose of this study was to 
construct such a cDNA library, and to screen it for antigens cross-reactive 
with group A streptococcal antigens, using three types of antibody probe: (1) 
ARF patient sera; (2) murine and human monoclonal antibodies to S.pyogenes 
antigens; (3) rabbit hyperimmune sera to various S.pyogenes antigens. Of the 
three types of antibody probe, patient sera were considered the most relevant 
to the disease. 
This study describes the construction of two .Agt11 cDNA libraries derived from 
human heart mRNA sequences, their screening using an ARF patient serum, 
and the isolation and characterization of three positive clones. 
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5.2 RESULTS 
5.2.1 cDNA SYNTHESIS AND CONSTRUCTION OF ~GT11 LIBRARIES 
5.2.1.1 RNA Extraction 
RNA for cDNA synthesis was extracted from human heart tissue using the 
method of Chomczynski and Sacchi (1987). 
Since it was important to construct a highly representative cDNA library for 
immunoscreening, careful attention was paid to isolating high yields of 
undegraded RNA. Heart tissue obtained at surgery was snap-frozen in liquid 
nitrogen within 30 seconds of excision and pulverized under liquid nitrogen. 
RNA was isolated as described in Materials and Methods (section 7.8.1.1 ). 
Instruments and utensils used in the isolation were meticulously treated against 
ri bonucleases according to the recommendations of Blumberg (1987). 
Only RNA preparations which showed no signs of degradation, as judged by 
the intactness of the 18S and 28S ribosomal RNA bands on formaldehyde-
agarose gels (section 7 .B.5 .1) were considered for purification of poly (A)+ 
RNA (section 7.8.1.2) . The yields and purity of the RNA were measured 
spectrophotometrically. Only relatively pure extracts, with A 260/280 ratios 
between 1.8 and 2.0, were used. 
Concentrations of RNA extracted from atrial appendage of heart were generally 
not as high per gram of tissue as could be expected. Extractions were 
t herefore also made from a heart removed at transplant surgery (from a patient 
with no history or clinical evidence of rheumatic fever). Not only were higher 
yields obtained from this tissue, but pieces of tissue from different parts of the 
heart could be included in the extraction, thus potentially enhancing the range 
of protein-coding sequences in the cDNA library. 
5.2.1.2 cDNA Synthesis 
cDNA was synthesized by three different methods in th is study. These were: 
(1) the S1 nuclease method, in which the 3'-end loop of the first strand is used 
as a primer for second strand synthesis before being digested away using S1 
nuclease; (2) the RNAse H method, in which RNA in the RNA:DNA . hybrid is 
nicked to create primers for second strand synthesis;(3) the random priming 
method, in which the first strand is primed randomly from several internal 
positions within the RNA molecule rather than from the 3'-end, as in the former 
two methods. 
cDNA synthesized by these methods was used to construct two expression 
libraries in bacteriophage .Agt11. Library A was a pool of three libraries each 
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constructed from cDNA synthesized by a different one of the three metho"ds. 
Such a pooled library, it was thought, would possibly be more representative of 
the total population of heart mRNA sequences, and any bias towards a 
particular population of cDNA, as a result of its method of synthesis, would be 
reduced. Library B was constructed from cDNA synthesized by the RNAse H 
method (which was found to be the most efficient method), using mainly 
reagents and procedures prescribed by Promega Biotec (Madison, USA). 
Results of synthesized cDNA used in these two libraries are summarised in 
Table 5.1 below. 
TABLE 5.1: 
Yields of cDNA Used in Construction of .Agt11 Libraries 
cDNA mRNA 1st cDNA 2nd cDNA % mRNA % 1st TOTAL 
METHOD strand strand into 1st strand cDNA 
µg ng ng strand into 2nd ng 
I. LIBRARY A: 
SI 
Nuclease 2 476 310 23.8% 65% 620 
RNAse H 2 610 536 30.5% 88% 1072 
Random 
primers 2 250 242 12.5% 96% 484 
II. LIBRARY B: 
RNAse H 4.1 952 856 23.2 98 1712 
cDNA was prepared for cloning into ..\gt11 by methylation with EcoR I 
methylase, the addition of EcoR I linkers and subsequent digestion with EcoR I 
as described in Materials and Methods (section 7.8.2). These steps in the 
cloning procedure are depicted in Fig.5.1. 
Yields of cDNA were substantially reduced following chromatography through 
Sepharose CL-48 (to remove excess EcoR I linkers and cDNA molecules smaller 
than 500 bp in length). These reduced yields were due to removal of smaller 
.molecules, as well as to probable losses incurred during manipulations of the 
preceding reactions. Table 5.2 shows amounts of cDNA available, following 
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Fig. 5.1 Schematic presentation of cDNA cloning into Agt11 (Adapted from Amersham 
Research News Issue 5). 
The procedures involved in the cloning are described in section 7.8.2 of Materials and Methods. 
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TABLE 5.2: 














5.2.1.3 Cloning of cDNA into Bacteriophage .Agt11 
To determine the optimal cloning efficiency for each particular cDNA 
population, a range of quantities of each (25ng, 50ng, 1 OOng) was ligated into 
dephosphorylated .Agt11 vector arms, according to the scheme (see Table 
7.2.6) and procedures described in Materials and Methods (section 7.8.2.6). 
Ligation mixtures were packaged using Gigapack Plus packaging extracts 
(Stratagene), and the resultant libraries were titrated on agar plates in the 
presence of IPTG and X-gal for colour selection of recombinants (section 
7.8.2.8). These cloning procedures are depicted in Fig.5.1. 
Cloning efficiencies of the plated libraries were calculated as follows: 
Cloning Efficiency = (Number of recombinant plaguesX 1000) 
ng of cDNA used 
Table 5.3 presents the cloning efficiencies of the optimal amounts of cDNA 
population ligated into .Agt11. 
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TABLE 5.3: 
.Agt11 Library Cloning Efficiencies of Each cDNA Population 
DNA Library titre % recombinants 
Insert & total pfu pfu/µg ...\gt11 
amount 
I. LIBRARY A: 
SI Nuclease 7.1 X 106 85% 
(50 ng) 
RNAse H 8.5 X 106 89% 
(50 ng) 
Random Primers 1.6X106 79% 
(25 ng) 
II. LIBRARY 8: 
RNAse H a.1x106 94% 
(50 ng) 


















1.4 X 108 
1.7 X 108 
6.4 X 107 
1.6 X 108 
1.2 X 108 
1.ax108 
The control wild type ...\gt11 packaging reaction in all cases yielded virtually 
only blue non-recombinant plaques on plating. The relatively high titre of a 
typical reaction shown above was a reflection of the general efficiency of the 
packaging reaction (6.1 X 108 pfu/µg DNA) . By comparison, packaging of the 
dephosphorylated ...\gt11 vector arms without any DNA insert, yielded low titres 
(typically between 1 o3 and 104 pfu/µg arms) reflecting the generally low 
background of the cloning reactions. 
The ligation control showed that the dephosphorylated ...\gt11 arms were 
efficient DNA clon ing vectors, whereas the cloning control gave an indication 
of the efficiency for these cloning procedures of a non-cDNA blunt-ended 
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insert. (These control reactions were important in preliminary experiments for 
optimizing the cloning procedures). 
5.2.1.4 Analysis of cDNA Inserts 
Ten recombinant clones from each library were analysed for the range of their 
cDNA insert sizes. DNA was extracted from liquid (or plate) lysates (section 
7.8.2.10.1), and separated on 1.5% agarose gels. 
Fig. 5.2 (bl shows DNA extracted from recombinant clones in library-A and 
digested with Kpn I and Sac I. The EcoR I cloning site in J\gt11 is located in a 
2 kb Kpn. I/Sac I fragment (see Fig.5 .3). Clones containing inserts therefore 
show variously larger sizes of this fragment. The ten clones shown contained 
inserts ranging in size from 0.5 to 1.1 kb. Additional bands seen in some 
recombinants (lanes 6-9) are the consequence of partial digestion by the 
restriction enzymes. 
Recombinant clones from Library-8 were digested with restriction endonuclease 
Miu I. Fig. 5.2 (a) shows ten such digested recombinant clones from this 
library separated on a 1.5% agarose gel and stained with ethidium bromide. 
The cloning site is contained in a 2.0 kb Miu 1 fragment in the wild type J\gt11 
and thus varies in size among the recombinants (Fig. 5.3) . The size range of 
cDNA inserts for this library was from 0.2 to 1.5 kb. 
These analyses confirmed that both libraries contained cDNA inserts (derived 
from heart mRNA sequences) of a suitable size and range for immunoscreening. 
5.2.2 SCREENING OF ..tGT11 CDNA EXPRESSION LIBRARIES WITH 
ANTIBODIES 
Both libraries were screened with three types of antibody reagents : 
( 1) sera from patients with acute rheumatic fever and chronic rheumatic 
heart disease (used either separately or as pooled sera) . 
· (2) rabbit hyperimmune sera to streptococcal antigens (against S.pyogenes, 
raised as described in section 7 .A.1; and antisera to the proteins SM5, 
SM24 and M19, gifts from Dr J. Dale, University of Tennessee, USA). 
(3) a murine monoclonal antibody to the purified streptococcal M protein pep 
M5 (designated 187, a gift from Dr James Dale); and a murine mAb to 
the ARF-associated B cell alloantigen (designated DB/17, a gift from Dr 
John Zabriskie, Rockefeller University, New York). The human 
monoclonal antibodies developed in this study (Chapter 4) were not used 
as they lacked specificity. 
Kb AH 1 
Fig. 5.2 Analysis of cDNA 
cloned insert sizes from 
kgt11 library-A and library-B 
(a) library-8: ethidium 
bromide stained 1 . 5 % 
agarose gel of Miu I digested 
DNA extracted from 11 
randomly selected 





8. The DNA was extracted 2 .3 
from the recombinant clones 2.0 
as described in section 
7. 8.2.10.1. The . cloning site 
is contained in a 2 kb Mlul 
site which thus varies in size 
among the recombinants (see 
Fig. 5.3). The size range of 
the cDNA inserts in the 0.5 
library was between 0.5 and 
1.1 kb UH :wild type lambda 
DNA cut with Hindlll, used 
as markers). (a) 
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(b) library-A: ethidium 







1 .5% agarose gel of 
DNA extracted as in 
(a) above, from 9 
randomly selected 
clones in library-A 
and digested ' with 
Kpnl and Sacl. The 
cloning site is located 
in a 2 kb Kpnl/Sacl 
fragment which is of 
variable size among 
the recombinants. 
The size range of 
cD~A inserts in the 
library was between 
0.2 -and 1.5 kb. (The 
additional bands seen 
0.5 in lanes 6~9 are due 
to partial digestion by 
these low salt 
( b) enzymes). 
Cloning site --
() ..... 
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Restriction endonuclease cleavage sites are designated in kilobase pairs from
 the 3' end. The 
EcoRI cloning site is indicated, and is flanked by the Kpnl, Sacl and Mlul restr
iction sites used in 
size analysis of cloned cDNA inserts . 
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Of these antibody reagents, the patient sera were considered to be the most 
relevant to the disease. Three clones reacting positively with a particular ARF 
serum were purified to homogeneity and characterised. The detection and 
characterization of these clones are described here. 
5.2.2.1 Expression of Recombinant Fusion Proteins 
Prior to immunoscreening, both libraries were analyzed for expression of 
recombinant fusion proteins. 
Ten recombinant clones were randomly selected from each library for isolation 
of lysogens (section 7.B.4.1 ). Phage were introduced as lysogens into E.coli 
strain Y1089 at a multiplicity of infection greater than 5. Following incubation 
overnight at 32°C, 25 clones of each recombinant were streaked onto each of 
two plates, one of which was incubated overnight at 32°C and the other at 
43°C. Lysogenic clones were identified by their ability to grow at 32°C but not 
at 43°C. 
Fig.5.4 shows the result of a representative recombinant incubated at these 
different temperatures. Whereas all colony streaks grew at 32°C, 10 out of 25 
(40%) failed to grow at 43°C. These were identified as lysogens, and one of 
these from each of the ten original recombinants was selected for extraction of 
fusion proteins. 
Fusion proteins were induced by raising the temperature of E:coli Y1089 
lysogen cultures to 45°C for 20 minutes, then adding IPTG to 5 mM and 
incubating at 37-38°C for a further 45-60 minutes (section 7.B.4.1.2). 
Bacterial lysates of the clones were analyzed for the presence of fusion protein, 
by immunoblotting using a murine monoclonal antibody to B-galactosidase. 
Fig. 5.5 shows immunoblotted recombinant fusion proteins selected from 
library-A, indicating a size range of up to 162 kD compared to the 116 kD wild 
type B-galactosidase protein. 
These results indicated that the cDNA libraries were producing recombinant 
protein that was immunologically detectable. 
5.2.2.2 Detection of Clones Reactive with ARF Patient Serum 
A sensitive immunoscreening assay was established using an affinity-purified 
alkaline phosphatase conjugated goat anti-human lgG (H + L) second antibody 
system (section 7.8.3). 
159 
A gtll Lysogens 
32° C 43°c 
Fig. 5.4 Isolation of recombinant lysogens in E.coli Y1089. 
Phage-competent Y1089 £. coli were prepared as described in section 7. 8.4. 1 . 1 . Cells were 
infected at a m.o.i of 5 phage/cell and plated overnight at 32°C. Twenty-five colonies from the 
plate were randomly selected and streaked at similar locations onto two separate L-agar 
ampicillin plates. One plate was incubated at 32°c and the other at 43°C. Lyogenic clones 
were identified by their ability to grow at 32°c but not at 43°c. Such lysogens are ringed in the 
figure. Single lysogens were selected for isolating fusion proteins (section 7 .8.4.1 .2) 
1 2 3 4 5 6 7 8 










Nine randomly selected recombinant clones from library-A were introduced as lysogens into 
E.coli Y1089 (section 7.B.4.1 .1 ). Fusion proteins in recombinant lysogenic clones were induced 
with IPTG (section 7.B.4.1.2), and bacterial lysates of the lysogens were separated by SDS 
7.5% PAGE, and immunoblotted against a murine mAb to B-galactosidase (Promega). Positive 
binding was detected using a peroxidase conjugated Fab' 2 goat anti-mouse lgG (H + L) (Zymed) 
second antibody. Lanes 1 -7 show fusion proteins from these clones of a larger mol. wt. than 
the 116 kD wild type (WT) non-recombinant B-galactosidase protein. (The staining in lane 9 is 
faint since most of the protein was lost when the lysogen lysed during isolation). 
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Positive clones were detected using a highly suitable ARF serum (designated 
ARF-S1) at a dilution of 1 :50. The patient was a twelve year old female with a 
recurrent attack of acute rheumatic fever, with severe carditis and an ASO titre 
of 1280 Todd units (see section 2.1. 7). 
Four positive clones were detected in screening twelve 150 mm plates 
containing about 50 000 plaques each. These clones were purified to 
homogeneity, but two of these clones (POS7 and POS8) were discovered to 
have identically-sized DNA inserts and fusion proteins, and partial sequencing 
of the cDNA suggested that these clones were identical. This particular 
positive is thus referred to in this study as POS7, POS8 or POS7/8. The other 
two positive clones are referred to as POS5 and POS6. 
Fig. 5.6 shows the purification of one of these positive clones (POS6), from a 
single plaque to homogeneity. Positive binding is shown by plaques staining 
dark purple against the fainter plaque background. This contrasting signal to 
noise ratio permitted precise location of positive clones for purification. 
5.2.2.3 Analysis of Positive Clones 
The size of the cDNA inserts, as well as the recombinant fusion proteins, in 
each of three positive clones was ascertained. 
5.2.2.3.1 Size Analysis cDNA Inserts 
Extracted DNA from each of the positives was digested with either Miu I or 
with EcoR I, and fractionated on 1.5% agarose gels alongside wild type lambda 
DNA markers (digested with Hind Ill, Pvu II, or with Hind Ill and EcoR I). 
Fig.5. 7 (a) shows fractionation of the three positives digested with Miu I 
indicating an insert size of 1 kb for POS5 and of 1 .4 kb for POS6. The 
additional band visible in POS7 /8 suggested that the insert contained an 
internal Miu I site, and the size of the insert was therefore measured by EcoR I 
digestion of the DNA (see b below). 
Fig. 5. 7 (bl shows effective release of the cDNA inserts from each positive 
clone by EcoR I digestion of both .Agt11 and (following subcloning of the insert 
for sequencing) of pUC 19 (section 7 .B.4.2.1.1 ). This analysis confirmed the 




Fig. 5.6 Isolation and purification of positive clones by immunological screening. 
A positive clone (POS6) was detected in library-A using an ARF patient serum (ARF-S1: see 
section 5.2.2.2) using the screening procedures described in section 7.8.3 . Recombinant 
phages were plated initially at a density of 5X 1 04 pfu/1 50 mm diameter plate (about 250 
pfu/cm2) onto 12 plates. 
(a) a dark purple staining positive clone (arrow) was detected against the fainter background 
and cored out using a pasteur pipette. 
(b) Phage were eluted and re plated at a density of about 200 pfu/plate and rescreened in order 
to isolate single clones for purification. 
(c,d,e) The process of replating and rescreening was repeated until recombinant clones were 
purified to homogeneity, as demonstrated by the positive staining of all the pl~ques at high 
density screening (e). 




(continued from previous page) 
(b) Phage were eluted and replated at a density of about 200 pfu/plate and rescreened in order 




(continued from previous page) 
(c,d,e) The process of replating and rescreening was repeated until recombinant clones were 
purified to homogeneity, as demonstrated by the positive staining of all the plaques at high 
density screening (e). 
Fig. 5. 7 Size analysis and subcloning of cDNA inserts 
of positive clones 
DNA was extracted from positive Agt11 clones as 
described in section 7 . 8.2. 10, and digested with Mlul 
(a) and with Eco RI (b) to . determine the size of the 
cDNA inserts, and to isolate the cloned EcoRI fragments 
for subcloning into pUC19. The digested DNA was 
fractionated on 1 % agarose gels and visualised by 
ethidium bromide staining of the gel. 
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and 8, showing inserts of 1 kb (POS5) and 1.4 kb 2 .3 
(POS6) larger that the 2 kb Mlul fragment containing the 2 . O -
cloning site. Positives 7 and 8 (POS7 /8) show an 
additional band indicating an internal Mlul site in the 
insert. The two positive clones were shown to be 
identical. Digestion with EcoRI of positive 8 (POSS) 
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(b) DNA from Agt11 positive clones 
digested with EcoRI and fractionated 
on a 1 % agarose gel (A lanes). The 
"P" lanes show inserts from the 
pos1t1ve clones subcloned into 
pUC19 and released with EcoRI. (A 
DNA inserts are only faintly visible). 
A lambda DNA 
p pUC 19 DNA 
WT wild type lambda and 
plasmid DNA 
AH lambda DNA cut with 
Hindi II 
AP lambda DNA cut with 
Pvull 
(b) 
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5.2.2.3.2 Size Analysis of Fusion Proteins 
The three positives were introduced as lysogens into E.coli strain Y1089 as 
described in Materials and Methods (section 7 .B.4.1), and colonies of each 
were selected for extraction of fusion protein by their ability to grow at 32°C 
but not at 43°C (see Fig. 5.4). 
Production of fusion proteins was induced with IPTG, and bacterial lysates of 
the clones were analyzed by immunoblotting against a murine anti-B-
galactosidase mAb, to measure the size of the fusion proteins. 
Fig.5.8 (a) is an electroblot of the bacterial lysates stained with the protein 
stain AuroDye forte (Janssen Life Sciences). Additional protein bands, 
representing the fusion proteins, are evident in the lysates of the positive 
clones (lanes 3-6) compared to the non-recombinant wild type (lane 2). 
Fig. 5.8 (bl is an immunoblot of these lysates reacted with the anti-B-
galactosidase mAb (dilution 1: 10 000) and stained with a peroxidase 
conjugated goat anti-mouse lgG (H + L) (Zymed). The apparent mol.wts. of the 
fusion proteins were 145 kD, 120 kD and 138 kD, for POS5, POS6 and 
POS7/8 respectively. These correspond to cloned proteins of 29 kD, 4 kD and 
22 kD larger than the wild type 116 kD B-galactosidase molecule. 
5.2.3 REACTIVITY OF FUSION PROTEINS WITH SERA 
The specificity of the positive clones for ARF sera, as well as their cross-
reactivity with streptococcal antigens, was tested in the following assays . 
5.2.3.1 Purified Plaque Assay: specificity for ARF Sera 
The specificity of the purified positive plaques for ARF sera was tested by 
preparing nitrocellulose lifts of the homogeneous plaques, and cutting them into 
8 sectors, each of which was reacted with a different ARF or child normal 
serum. As controls , filters bearing wild type Agt11 or the irrelevant chicken 
ovalbumen clone (Clontech Laboratories) we·re likewise prepared and reacted 
against the ARF and normal sera. In this way, each of the three positives (and 
the control clones) were tested against 24 ARF and 24 normal sera. 
fig.5.9 shows representative stains of three ARF sera and one normal serum 
against the clones: (a) a normal serum reactive with none of the clones; (b) an 
ARF serum reactive with only POS5; (c) an ARF serum reactive with the three 
positive clones but not with the controls; (d) an ARF serum reactive with both 
the positive and the control clones. 
Fig . 5.8 Isolation and size 
analysis of positive clone 
fusion proteins 
Fusion proteins of the positive 
clones (POS5, POS6, POS7 
and POS8) were induced with 
IPTG (section 7.8.4 .1.2), and 
lysates of the lysogens were 
fractionated on 7 . 5 % SOS 
polyacrylamide gels and 
electro blotted onto nitro-
cellulose (section 7.A .9). 
(a) E.coli Y1089 lysates 
immunoblotted and stained 
with AuroDye forte (Janssen) . 
The arrows indicate the larger 
sized fusion proteins 
compared to the wild type 
(WT) and mol. wt . marker 11 6 












(b) The extracts shown in (a) were 
immunoblotted against a murine 
monoclonal antibody to B-d-
galactosidase, and positive binding 
detected using a peroxidase 
conjugated second antibody as 
described in the legend to Fig. 5.5 . 
The larger size of the fusion proteins 
compared to the wild type (WT) 
protein can be seen . 
The sizes of the fusion proteins are: 
POS5 = 145 kD, POS6 = 120 kD, 





Fig. 5.9 Reactivity of ARF and normal sera against purified plaques of positive clones 
Nitrocellulose lifts of purified plaques of POS5, POS6, POS7 and POSS were prepared and cut 
into 8 sectors, each of which was reacted with a different ARF or normal serum according to 
procedures described in section 7 .8.3.1. Similarly prepared filters bearing wild type Agt11 or an 
irrelevant chicken ovalbumen clone were used as controls and reacted against the same ARF 
and normal sera. 24 ARF and 24 normal sera were tested . (See Table 5.4) 
(a) Reaction of a normal serum against the clones showing no reactivity with any of them. 






(Fig 5.9 continued from previous page) 
(c) An ARF serum reactive with only the cloned proteins and not with the wild type or irrelevant 
ovalbumen clones. 
(d) An ARF serum reactive with all positive clones and the control clones. 
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As shown in Table 5.4, none of the pos1t1ves were specific (at the level of 
plaque reactivity) for only ARF sera since all of them reacted also with some 
normal sera. Certainly, a higher percentage of the ARF sera are reactive with 
the positive plaques, but this higher level of reactivity extends to the control 
clones as well. 
TABLE 5.4: 
Purified Plaque Assay: Specificity Analysis of Positive and Control C!ones 
Against 24 ARF and 24 Normal Sera 
(The number and percentage of reactive sera in each group are presented). 
CLONE wild type oval- POS5 POS6 POS7 
Agt11 bumen 
ARF sera 1 4 21 16 20 
(n = 24) (4%) (17%) (87%) (67%) (83%) 
Normal sera 0 2 11 10 14 
(n = 24) (0) (8) (46%) (42%) (58%) 
/ 
5.2.3.2 Fusion Proteins: lmmunoblots Against ARF and Normal Sera 
Since specificity was not evident at the level of plaque reactivity, the cloned 
antigens were electrophoretically separated for testing against ARF sera by 
immunoblotting. Conceivably, fusion protein epitopes thus exposed on 
nitrocellulose might be more readily available for detection by sera. 
5.2.3.2.1 lmmunoblots of Bacterial Lysogen Lysates 
Lysates of IPTG-induced lysogens of the three positive clones, were separated 
on 7.5% SOS PAGE gels and immunoblotted against ARF and normal sera 
(dilution 1 :100). 
Each positive was reacted against ten ARF and ten normal child sera which had 
been pre-absorbed with purified B-galactosidase (Sigma) at a concentration of 1 
· mg/ml (for 1 hour at 37°C followed by 18 hours at 4°C). Antibody binding was 
detected using a peroxidase conjugated goat anti-human lgG (H + L) affinity 
purified antibody (Zymed). 
Fig.5.10 shows representative reactions of ARF and normal sera against the 
positive lysogen lysates. Despite pre-absorption with purified B-galactosidase 
to remove reactivity with the bacterial portion of the fusion proteins, normal 
sera also reacted with these recombinant proteins. 
Fig. 5.10 Reactivity of ARF and 
normal sera against fusion 
proteins in lysates of the positive 
lysogen clones 
Lysates of the IPTG induced 
lysogens of the three positive 
clones in Y1089 were 
immunoblotted (section 7.A.9) 










(b) and {c) lmmunoblots of ARF 
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(a) Representative 
immunoblots of 4 ARF and 
4 normal sera against a 
lysogen lysates of POS5, 
indicating a somewhat more 
intense reaction of ARF sera 
compared to normal sera 
with the fusion protein 
(indicated by arrow) . 
POS 8 
ARF Control 
1 23 456 
171 
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However, the reactivity of ARF sera against POS5 fusion protein is noticeably 
more intense than that of the normal sera, indicating that the absorptions may 
possibly not have been extensive enough. 
The first lane of the ARF sera in each of the blots is that of the original 
screening serum, ARF-S 1 . Its reactivity with POS7 /8 was much more intense 
than that of the other sera. 
5.2.3.2.2 lmmunoaffinity Purification of Fusion Proteins 
Attempts to affinity purify the fusion proteins on columns containing anti-B-
galactosidase mAb attached to agarose beads (Protosorb LACZ column, 
supplied _by Promega Biotech), were unsuccessful. Inclusion of nonionic 
detergent (0.05 % Triton X-100) in all . buffers to expose possibly hidden 
epitopes for binding to the column, were likewise unsuccessful in binding the 
fusion proteins. 
5.2.3.3 Plaque Selected Antibodies: cross-reactivity with streptococcal 
antigens 
To test whether antibody specific for purified positive plaques, cross-reacted 
with streptococcal antigens, a method similar to the "plaque antibody 
selection" technique of Ozaki et al (1986) was used. 
Nitrocellulose lifts ( 1 50 mm) of each of the purified clones were prepared and 
reacted with the original screening serum, ARF-S1 (dilution 1 :50), for 6 hours 
at 4°C. (Anti-E.co/i antibodies had been pre-absorbed from the serum by 
pseudoscreening, as described in section 7.8.3.3). Filters were then washed 
three times for 15 minutes each, in TBS buffer (containing immunoscreening 
blocking solution minus goat serum). Specifically bound antibody was eluted 
from the plaques in 5 ml of 0.2 M glycine-HCI pH 2.5 for 2 minutes and then 
immediately neutralized in 750 µI of 2 M Tris pH 10. Eluted antibody was then 
reacted against immunoblotted streptococcal M proteins. 
Fig.5.11 shows the results of immunoblotting these antibodies eluted from 
cloned heart fusion proteins, against streptococcal M proteins M5, M6, M 19 
and M24. 
All eluted antibodies reacted with the same two bands (67 kD and 33 kD) in 
the M24 extract. Only antibody el_uted from POS6 was reactive with M5 (30 
kD). POS6-eluted antibody was also reactive with a protein in the M19 extract 
(31.5 kD) and with streptococcal M6 proteins (55 kD and 29 kD). POS7/8-
eluted antibody was reactive with M19 (65 kD, 60 kD and 35 kD). No 
reactivity was observed with antibody eluted from the control wild type Agt11 
or the irrelevant ovalbumen clones. 
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Fig. 5.11 Cross-reactivity between streptococcal M proteins and ARF serum (ARF-S 1) affinity 
purified on plaques of positive clones 
Nitrocellulose plaque lifts of each of the homogeneous positive clones were prepared and 
reacted with serum ARF-S1 . Bound antibody was eluted as described in section 5.3.3, and 
reacted against immunoblotted streptococcal M proteins MS, M6, M 19 and M24. As controls, 
antibody was also eluted from wild type tlgt 11 plaques (WT) and from the irrelevant chicken 
ovalbumen clone (OV) . Eluted antibodies cross-reacted with the M proteins with distinct 
patterns. (The mol.wts. of the reactive M protein constituents are given beneath each lane). 
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5.2.4 DNA SEQUENCE ANALYSIS OF POSITIVE CLONES 
The positive cDNA inserts were released from Agt11 by EcoR I digestion {see 
Fig. 5.7 b), subcloned into pUC19 by in-gel ligation {section 7.B.4.2.1) and 
sequenced using the modified T7 polymerase, Sequenase {section 7.B.4.2.2). 
The full sequence of the POS6 cDNA insert was completed, while sequencing 
of POS5 and POS7 /8 is still in progress. 
Computor-assisted analysis of the cDNA sequences was performed using the 
University of Wisconsin Genetics Computor Group Sequence Analysis Software 
Package {Version 6) (Devereux et al., 1984, 1989). The FastA program of 
Lipman and Pearson (1985) was used to search the European Molecular Biology 
Laboratory {EMBL) and GenBank nucleic acid databases for similarity of 
sequences in the databases with the cloned DNA sequence. The National 
Biomedical Research Foundation {NBRF) protein bank was searched for 
homologies with the deduced amino acid sequence. 
The most striking nucleic acid homology based on the above searches was with 
human cytokeratin 8, which showed virtually 100% identity in about a 1 kb 
overlap. A section of the cloned sequence is shown in Fig. 5.12, and the 
sequence showing identity with human cytokeratin 8 is depicted in Fig. 5.13. 
Homology searches of the amino acid sequence of human cytokeratin 8 with 
sequences of other a-helical coiled-coil proteins putatively relevant to antigenic 
mimicry in rheumatic, disclosed homologies of between 40-and 50% with the 
heavy chain of human cardiac myosin, tropomyosin and streptooccal M5, M6 
and M24 proteins. 
A computor search of the NBRF protein bank, for the recently reported myosin 
cross-reactive pentameric sequence GLN-L YS-SER-L YS-GLN contained in pep 
M5 protein (Cunningham et al., 1989), demonstrated that this sequence was 



























Fig. 5 .12 Nu~leotide sequence of POS6 showing section homologous 


























301 CCCAGGAGAAGGAGCAGATCAAGACCCTCAACAACAAGTTTGCCTCCTTC 350 
111111111111111111 I I I I I I I I I I ..............•....... gaccctcaacaacaagtttgcctccttc . . . . . 
351 ATAGACAAGGTACGGTTCCTGGAGCAGCAGAACAAGATGCTGGAGACCAA 400 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 111111111111111 atagacaaggtacggttcctggagcagcagaacaagatgctggagaccaa . . . . . 
401 GTGGAGCCTCCTGCAGCAGCAGAAGACGGCTCGAAGCAACATGGACAACA 450 
I I I I I I I I I I I I I I I I 1111111111111111111111111111111111 gtggagcctcctgcagcagcagaagacggctcgaagcaacatggacaaca 
451 TGTTCGAGAGCTACATCAACAACCTTAGGCGGCAGCTGGAGACTCTGGGC 500 
I I I I I I I I I I I I I I I I I I I I I I I I 11111111111111111111111111 tgttcgagagctacatcaacaaccttaggcggcagctggagactctgggc 
176 
501 CAGGAGAAGCTGAAGCTGGAGGCGGAGCTTGGCAACATGCAGGGGCTGGT 550 (a) 
11111111111111111111111111111111111111111111111111 caggagaagctgaagctggaggcggagcttggcaacatgcaggggctggt . . . . . 
551 GGAGGACTTCAAGAACAAGTATGAGGATGAGATCAATAAGCGTACAGAGA 600 
11111111111111111111111111111111111111111111111111 ggaggacttcaagaacaagtatgaggatgagatcaataagcgtacagaga . . . . . 
601 TGGAGAACGAATTTGTCCTCATCAAGAAGGATGTGGATGAAGCTTACATG 650 
11111111111111111111111111111111111111111111111111 tggagaacgaatttgtcctcatcaagaaggatgtggatgaagcttacatg . . . . . 
651 AACAAGGTAGAGCTGGAGTCTCGCCTGGAAGGGCTGACCGACGAGATCAA 700 
11111111111111111111111111111111111111111111111111 aacaaggtagagctggagtctcgcctggaagggctgaccgacgagatcaa . . . . . 
701 CTTCCTCAGGCAGCTGTATGAAGAGGAGAT ..•................. 730 
11111111111111111 1111111111111 cttcctcaggcagctgtatgaagaggagatccgggagctgcagtcccaga 
. . . . . 
551 TCGCCACCTACAGGAAGCTGCTGGAGGGCGAGGAGAGCCGGCTGGAGTCT 600 
.......................................... UU!U! . . . . . 
601 GGGATGCAGAACATGAGTATTCATACGAAGACCACCGGCGGCTATGCGG 649 
111111111111111111111111111111111111 111 11111 I cgggatgcagaacatgagtattcatacgaagaccaccagcgcgtatgcag . . . . . 
650 GTGGT.TTGAGCTCGGCCTATGGGGACCTCACAGACCCCGGCCTCAGCTA 698 
11111 I 1111 11::: 11111111 1111111 111111111111111 gtggtctagagctcnnnctatgggggcctcacaagccccggcctcagcta . . . . . 
699 CAGCCTGGGCTCCAGCTTTGGCTCTGGCGCGGGCTCCAGCTCCTTCAGCC 748 
11111111111111111111111111111111111111111111111111 cagcctgggctccagctttggctctggcgcgggctccagctccttcagcc . . . . . 
749 GCACCAGCTCCTCCAGGGCCGTGGTTGTGAAGAAGATCGAGACACGTGAT 798 
111111111111111111111111111111111111111111: 1111111 gcaccagctcctccagggccgtggttgtgaagaagatcgaganacgtgat 
Fig. 5.13 Nucleotide sequence of POS6 
(lower line) showing homology with human 
cytokeratin 8 mRNA (upper line). Two 
clones of cytokeratin 8 in the databases 
searched were homologous with POS6. (a) 
HUM8KER1 representing the 5' end of 
human keratin 8 mRNA, 100% homologous 
with POS6; (b) HUMKER8 representing the 
complete coding sequence of human 
cytokeratin 8 mRNA (derived from the 
human vulvar carcinoma cell line A-431 ) 
showing 98% homology with POS6. 
799 GGGAAGCTGGTGTCTGAGTCCTCTGACGTCCTGCCCAAGTGAACAGCTGC 848 (b) 
I I I I I I I I I I I I I I I I I I I I I I 1111111111111111111111111111 gggaagctggtgtctgagtcctctgacgtcctgcccaagtgaacagctgc . . . . . 
849 GGCAGCCCCTCCCAGCCTACCCCTCCTGCGCTGCCCCAGAGCCTGGGAAG 898 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 111111111111111 ggcagcccctcccagcctacccctcctgcgctgccccagagcctgggaag . . . . . 
899 GAGGCCGCTATGCAGGGTAGCACTGGGAACAGGAGACCCACCTGAGGCTC 948 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 1111111111111111111 gaggccgctatgcagggtagcactgggaacaggagacccacctgaggctc . . . . . 
949 AGCCCTAGCCCTCAGCCCACCTGGGGAGTTTACTACCTGGGGACCCCCCT 998 
I I I I I I I I 111111111111111111111111111111111111111111 agccctagccctcagcccacctggggagtttactacctggggacccccct . . . . . 
999 TGCCCATGCCTCCAGCTACAAAACAATTCAATTGCTTTTTTTTTTTGGTC 1048 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 1111111111111111111 tgcccatgcctccagctacaaaacaattcaattgctttttttttttggtc 
1049 CAAAATAAAACCTCAGCTAGC ••.... : ....•.. :.: ...... •• • : • • 1069 
I I I I I I 111111111111111 
caaaataaaacctcagctagctctgccaatgttcaaaaaaaaaaaaaaaa 
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5.3 DISCUSSION 
5.3.1 CDNA SYNTHESIS AND CONSTRUCTION OF ~GT11 EXPRESSION 
LIBRARIES 
In this study, two efficient human heart cDNA expression libraries were 
constructed in .Agt11, for the purpose of screening with antibodies relevant to 
rheumatic fever. 
The efficiency of the libraries can be judged from the high number of 
recombinants obtained per microgram of cDNA cloned (78-94% recombinants 
in librarie~ containing about 108 pfu; see Table 5.3), as well as from the range 
of insert sizes in the two libraries (see Fig 5.2) 
Efficient synthesis of cDNA was achieved by paying meticulous attention to the 
isolation and purification of undegraded mRNA so as to generate libraries 
containing as many as possible heart autoantigen-coding sequences. Table 5.1 
presents the results of synthesis of the cDNA cloned in these libraries . Starting 
with 2 µg of poly (A)+ RNA, the amount of double-stranded cDNA obtained 
ranged between 484 ng and 1072 ng, the most efficient method of synthesis 
being the RNAse H method. 
The rationale for pooling three libraries each constructed from cDNA 
synthesized by a different method, was to generate a library (library-A) that 
would avert any_ bias towards a particular population of cDNA as result of the 
method of synthesis. Such a library could therefore be potentially more 
representative of the available cardiac mRNA sequences. 
5.3.2 SCREENING OF LIBRARIES AND DETECTION OF POSITIVE 
CLONES 
Prior to screening the libraries, it was established that both were expressing 
antigenically detectable fusion proteins (Fig. 5.4). 
The alkaline phosphatase antibody detection system used in screening, was the 
most sensitive of the various systems tried (peroxidase-conjugated antibodies; 
streptavidin-biotin-peroxidase complex; 1-125 labelled protein A antibodies) . 
.Mierendorf et al. ( 1987) showed that alkaline phosphatase was about ten times 
more sensitive than peroxidase-conjugated antibody detection systems, and 
could readily detect 20-50 pg of antigen. The system had the additional 
advantages, (1) that the reaction could be developed over many hours (thus 
enhancing its sensitivity), (2) that the signals were not subject to fading or 
bleaching, (3) that the contrasting signal to noise ratio of dark purple-staining 
plaques against a lighter background allowed the precise location of positive 
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plaques. By comparison, potential positives detected by the peroxidase 
antibody systems were subject to fading and proved difficult to locate and 
purify to homogeneity, whereas the protein A 1-125 conjugates produced 
numerous false positives. 
The ARF serum (ARF-S1) used to detect the three positives was carefully 
selected. Not only did the patient have a severe carditis and a high ASO titre, 
but (more importantly) she was in the acute phase of a second attack of ARF 
(clinically referred to as "acute-on-chronic"). Such a patient, it was thought, 
might have higher affinity anti-heart antibodies than either a patient with an 
initial attack of ARF or one with chronic rheumatic heart disease. Such high 
affinity antibodies would be ideal for screening. Rabbit hyperimmune sera and 
monoclonal antibodies are often preferred to patient sera in screening 
expression libraries since they frequently contain antibodies of higher affinity. 
Although this ARF-S 1 serum did not belong to the group of sera screened in 
the ELISA and immunoblotting assays (Chapters 2 and 3), it was shown by 
immunoblotting to react strongly with all eleven major bands in the CHAPS 
(section 3.2.1 .1) detergent extracts of heart, and to react intensely with 
sections of human heart by immunocytochemistry (4 + staining in the biotin-
streptavidin-peroxidase assay - section 7 .A.18). 
The use of this highly suitable patient serum for screening these cDNA 
expression libraries by the sensitive alkaline phosphatase antibody system, 
contributed to the detection and purification of the three positive clones. 
5.3.3 CHARACTERIZATION OF POSITIVE CLONES 
The following experiments to determine the specificity of the positive clones 
were performed before sequencing of the DNA was completed. 
5.3.3.1 Specificity of Positive Fusion Proteins 
5.3.3.1.1 Specificity of Purified Plaques for. ARF Sera 
The reactivity of ARF and normal sera against the purified positive plaques 
showed that (at the level of plaque reactivity) none of the positive clones were 
specific for only ARF sera but also reacted with about half of the normal sera 
(Table 5.4). Although a higher percentage of ARF sera were reactive with the 
positive plaques, some of these sera were also more reactive with the control 
Agt11 wild type and ovalbumen clones. 
This overall higher reactivity could be indicative of a polyclonal B cell response 
in the ARF sera, and corresponds to their pattern of higher reactivity in the 
ELISAs against streptococcal and autoantigens (Chapter 2). It is possible, 
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however, that despite their reactivity with bacterial antigens, the ARF sera 
contain antibody subpopulations specific for the cloned antigens. In some 
studies, the specificity of positive clones has been established by extensively 
absorbing out such nonspecific antibodies to bacterial antigens (Hirayu et al., 
1987). 
Hirayu et al. ( 1987), in determining the specificity of a thyroid disease-related 
antigen, experienced great difficulty in removing nonspecific binding to 
bacterial proteins. Optimal absorption concentrations of E.coli lysates had to 
be determined for individual sera, in order to establish the specificity of clones. 
This contrasts with similar studies on immunoscreening for autoantigens, in 
which such nonspecific binding was not a problem (Habets et al., 1987; 
Stanley et al., 1988). 
5.3.3.1.2 lmmunoblots of Bacterial Lysogen Lysates 
To test the reactivity of sera against the immunoblotted fusion proteins, sera 
were pre-absorbed with purified B-galactosidase (Fig.5.9). The more intense 
reactivity of ARF sera (compared to normal sera) against POS5 fusion protein, 
suggests that more extensive absorptions against B-galactosidase might have 
established the specificity of the clone. 
All activity to B-galactosidase could however not be removed using the 
available 1 mg/ml concentration of the protein. Even extensive absorptions 
against the wild-type Agt11 and E.coli proteins by pseudoscreening (section 
7 .B.3.3) failed to remove all anti-B-galactosidase reactivity. The specificity of 
the positive clones for ARF sera could thus not be conclusively established. 
The inability to affinity purify the fusion proteins on agarose columns of anti-B-
galactosidase mAbs (for the purpose of testing cell mediated responses of ARF 
patients to the cloned antigens) may have been due to peculiarities of the 
fusion protein imposed on it by the cloned polypeptide moiety. For instance, 
hydrophobic regions may cause portions of the protein to be membrane 
associated. However, inclusion of Triton-X 100 in the buffers did not enhance 
the purification significantly. Possibly, the higher affinity column (Protosorb 
LACZ High Affinity Column - Promega Biotech) may have bound the fusion 
protein more efficiently for purification. (During this period however, Promega 
withdrew both columns from supply indefinitely). 
5.3.3. 1.3 Cross-reactivity of Plaque-Selected Antibodies with Streptococcal 
Antigens 
The reactivity of antibodies eluted from the purified positive plaques against 
immunoblotted M proteins, suggests that the cloned antigens may contain 
epitopes cross-reactive with these strepotococcal antigens. 
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To establish whether this is true cross-reactivity (Berzofsky and Schechter, 
1981 ), would require more sophisticated analyses of the epitopes involved. 
The different patterns of reactivity observed with the three eluted antibody 
populations (together with the fact that they did not react with the control 
clones), indicates that these reactions may be specific. 
These are clearly preliminary findings, and the pathological significance to 
rheumatic fever of the antibodies and epitopes involved would require more 
detailed investigations, using functional biological assays. 
5.3.3.2 cDNA and Deduced Amino Acid Sequence of Positive Inserts 
The striking homology between POS6 and human cytokeratin 8 is interesting in 
t he context of studies on antigenic mimicry in rheumatic fever. Keratin, which 
is antigenically related to cytokeratin (Kurki and Virtanen, 1984), is a member 
of the a helical coiled-coil family of proteins which have been found to have an 
greater potential for cross-reacitvity (Chapter 1). It falls into one of the two 
groups (myosin/keratin/actin and myosin/DNA) showing reactivity with human 
and murine mAbs evoked by group A streptococcal antigens (Cunningham and 
Swerlick, 1986; Cunningham et al., 1988) (see Chapters 3 and 4) . Work by 
Fischetti and Manjula ( 1982) and Manjula et al. ( 1985) on the structure of 
streptococcal M proteins identified them as a helical coiled-coil proteins with a 
seven amino acid periodicity similar to that of myosin, tropomyosin and the 
desmin-keratin group of a-helical proteins. Recent work using murine mAbs 
has shown serologic cross-reactivity between streptococcal pep M5 and M6 
proteins and tropomyosin, and some of these mAbs were also shown to cross-
react with keratin, actin and myosin (Fenderson et al., 1989) (see Chapters 3 & 
4 and Table 3.1 ). Homology searches in this study showed that human 
cytokeratin 8 is about 43% _ homologous with M protein and 42% with human 
cardiac myosin heavy chain. 
Regarding the possible pathologic significance of the antigenic m1m1cry 
between streptococcal M proteins and these a-helical coiled-coil proteins, 
Manjula and Fischetti ( 1980) proposed that the resemblance between M protein 
and muscle regulatory proteins such as tropomyosin, may be responsible for 
the anti-phagocytic property of the streptococcal protein (section 3.3.6.1 ). 
One might speculate that antigenic mimicry between M proteins and 
cytokeratin may analogously impair immune cell function. Defects in 
cytoskeletal organization are known to be capable of disrupting cell function 
(Sturgess et al., 1980), and may be characteristic of some pathological 
processes (Runger-Brandle and Gabbiani, 1983). 
Keratins are part of a group of five distinct types of intermediate filament 
constituting the cytoskeleton in almost all higher eucaryotic cells (reviewed in 
Steinert and Roop, 1988). Type I (acidic) and type II (neutral-basic) keratins 
occur in epithelial cells, are comprised of a group of about 20 different 
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polypeptides and are the most evolutionarily divergent intermediate filament 
type showing only 25-30% homology with the other three types (which share 
60-70 % homology with each other) (Marchuk et al., 1984). 
Antibodies to cytoplasmic proteins have often been associated with 
autoimmune diseases. Whereas antinuclear antibodies are considered 
important markers for some rheumatic diseases, antibodies to cytoplasmic 
structures have been associated with organ-specific autoimmune diseases 
(Kurki and Virtanen, 1984). There appears to be a high incidence of antibodies 
to cytoskeletal proteins in human sera suggesting that they form part of the 
natural autoantibody repertoire . Indeed, this may (at least in the case of POS6) 
explain the immense difficulty experienced in trying to absorb out from the sera 
nonspecific binding to the fusion proteins, in the process of trying to establish 
whether the clones were specific for ARF sera. Souroujon et al. ( 1988) 
demonstrated such natural autoantibodies to keratin in A/J mice. However, 
these autoantibodies tend to be of the lgM class, whereas anti-cytoskeletal 
antibodies in pathological conditions appear to be lgG (Kurki et al., 1983). The 
incidence of anti-cytokeratin antibodies in humans appears to be increased in 
diseases such as alcoholic liver disease and in rheumatic diseases, but what 
their role is remains unknown (Kurki et al., 1983). It has been suggested that 
they may contribute to the chronicity of the inflammation in these diseases 
(Kurki and Virtanen, 1984). 
Antibodies binding to the cytokeratin fusion protein in the present study were 
detected using an lgG (H + L) second antibody and may therefore be such 
"pathological" autoantibodies. One might also speculate that the 67 kD 
reactive constituent detected in heart extracts in this study may be type II 
keratin (see Tables 3.1 and 3.2). In this study a constituent of this mol. wt. 
was found to be reactive with ARF patient sera, and in other studies 
constituents of this mol. wt. were reactive with mAbs and rabbit immune sera. 
Whether keratin is implicted in cross-reactivity between streptococcal antigens 
and human skin in group A streptococcal skin infections, such as in scarlet 
fever and psoriasis (Swerlick et al., 1986), is another interesting speculation. 
In the final analysis, the detection of a human cytokeratin 8 autoantigen clone 
using an ARF patient serum in screening human heart cDNA libraries, raises 
the vexing question (see Chapter 1) as to the nature of autoantibodies in health 
and disease, and what role they play in antigenic mimicry in rheumatic fever. It 
could be argued that: ( 1) cross-reactivity between a-helical coiled-coil proteins 
like cytokeratin and streptococcal M proteins are irrelevant experimental 
artefacts due to the high propensity such proteins generally have for cross-
reactive binding (Chapter1 ), and that is not indicative of antigenic mimicry; (2) 
that antibodies to the mammalian proteins form part of the natural/physiologic 
autoantibody repertoire and are pathologically irrelevant; (3) that they form part 
of the natural autoantibody repertoire, but that such autoantibodies can be 
triggered into being pathogenic; (4) that even though these proteins have a 
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high propensity for cross-reactivity and may form part of the natural 
autoantibody repertoire, they may nontheless still harbour epitopes (continuous 
or discontinuous) that are truly cross-reactive (Berzofksy and Schechter, 1981) 
with microbial epitopes and can lead to autoimmune disease through antigenic 
mimicry. Such epitopes could be precisely mapped. 
Whatever the significance of cytokeratin 8 is to rheumatic fever is not clear but 
the identification ol this cardiac autoantigen by molecular biological techniques 
is interesting both because of the implication of keratin in antigenic mimicry in 
rheumatic fever (using monoclonal antibodies and structural studies), and in 
view of its known implication as a conserved protein recognised by natural 
autoantibodies. Whether this heart antigen is pertinent to the pathogenesis or 
aetiology -0f rheumatic fever remains to be determined. 
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5.4 CONCLUSIONS 
1. High quality intact poly (A)+ RNA was isolated from normal human 
heart, and cDNA was synthesized from it by three different methods, 
referred to as the S1 nuclease, RNAse H and random primers methods. 
2. The cDNA was cloned into .Agt11 and two expression libraries of high 
efficiency were selected for screening with antibodies . Library A was a 
pool of three libraries each derived from cDNA synthesized by a different 
method; library B was derived from cDNA synthesized by the RNAse H 
method. 
3. The libraries were screened with rheumatic fever patient sera, as well as 
monoclonal antibodies and rabbit immune sera raised against S.pyogenes 
antigens. 
4. Using serum from an acute-on-chronic ARF patient with severe carditis 
and a high ASO titre, three positive clones were detected and purified to 
homogeneity. 
5. The three clones were introduced into E.coli as lysogens, induced with 
IPTG, and lysates of the lysogens tested for reactivity against ARF and 
normal sera. Although control sera also reacted with the induced fusion 
proteins, the reactivity of ARF sera against some of the recombinants 
was shown to be stronger, following pre-absorption to remove non-
specific binding. 
6. Antibodies eluted from the purified plaques were tested against 
immunoblotted S.pyogenes M proteins, and showed different patterns of 
cross-reactivity. 
7. The derived amino acid sequence of one positive clone (POS6) was 
virtually 100% homologous with human cytokeratin 8, an alpha-helical 
coiled-coil protein, and 40-50% homologous with the coiled-coil proteins 
myosin, tropomyosin and streptococcal M5 protein. Since streptococcal 
M proteins have been found, using monoclonal antibodies, to cross-react 
immunologically with alpha helical coiled proteins such as myosin, actin 
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6.1 Study Objectives 
The objective of this study was to identify cardiac antigens that may be 
implicated in the pathogenesis of rheumatic fever, and in addition to examine 
and compare the autoantibody profiles of rheumatic fever patients against a 
range of cardiac and nuclear antigens (and streptococcal antigens), with those 
of related-disease and normal subjects. 
The investigations performed were based on the established hypothesis that 
antigenic mimicry between antigens of the group A streptococcus and human 
heart antigens, initiates an autoimmune response leading to cardiac damage in 
certain individuals. 
6.2 Novelty of the Approach 
The approach adopted was innovative in the following respects: (1) 
Autoantibody levels against. these cardiac and nuclear antigens have not 
previously been measured and compared in these groups of rheumatic fever 
patients and control subjects; (2) lmmunoblotting was used to compare the 
antibody isotype reactivity patterns of the patient and control sera against 
crude and purified cardiac and nuclear antigens. No previous reports have 
compared the reactivity of rheumatic fever patient sera against cardiac antigens 
by immunoblotting, although numerous investigations have used monoclonal 
antibodies and rabbit immune sera (see Table 3.1 ); (3) Lymphocytes of patients 
with acute rheumatic fever were used to isolate human monoclonal antibodies 
cross-reactive with group A streptococcal antigens. Previous reports have not 
used ARF patient lymphocytes; (4) .Agt11 cDNA expression libraries of human 
heart genes were constructed and screened with ARF patient sera to identify 
cardiac antigens. No previous reports have adopted this approach. 
6.3 Salient Findings 
This study presents evidence that sera of patients with acute rheumatic fever 
and rheumatic heart disease contain raised levels of antibodies to various 
cardiac, nuclear and group A streptococcal antigens. The original finding by 
other investigators using immunofluorescence. to show that patients with acute 
rheumatic fever have antibodies to heart (see Chapter 1 ), was confirmed in this 
study by ELISA, immunoblotting and by a sensitive biotin-streptavidin-
peroxidase immunocytochemical assay. 
ELISAs were used to measure antibody titres in rheumatic fever sera against 
crude heart extracts and purified cardiac. It was shown that acute and chronic 
rheumatic fever patients have elevated titres of antibody to crude extracts of 
heart antigens and to myosin, actin and phosphorylase b, whereas antibody 
levels to cardiolipin and type II collagen (and Ill and VI) were not significantly 
elevated in these patients. (Adult chronic rheumatic fever patients however 
showed some evidence of lgM antibodies to type II collagen). Regarding 
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nuclear antigens, in all the groups rheumatic fever sera antinuclear antibodies 
(using the HEp-2 cell substrate) were found although mostly only at low 
dilutions. Two ARF patients had antibodies to the Sm (Smith) or RNP 
(ribonucleoprotein) nuclear antigens. None of the rheumatic fever patients had 
anti-DNA antibodies . Antibody levels to group A streptococcal antigens were 
elevated in all groups of rheumatic fever patients (as expected) but were also 
found in the related-disease and normal control subjects. The raised antibodies 
to proteins M5 and M6 may indicate that these group A streptococcal 
serotypes are predominant among rheumatic fever patients in Cape Town. 
A consistent, and important finding, in these investigations was that normal 
subjects in many cases also contained antibodies to the tested antigens. 
A lthough .the titres of antibody were usually lower than in patient sera, the 
presence of these antibodies in normal sera may indicate that they form part of 
the natural/physiologic autoantibody repertoire. The relevance of natural 
autoantibodies to autoimmune disease and their relationship to pathogenic 
autoantibodies are unsolved questions, and hence the pathological significance 
of the autoantibodies measured in this study are difficult to assess. The finding 
that adult chronic rheumatic fever patients demonstrated the highest titres of 
antibody to several of these autoantigens, suggests that these antibodies may 
be a consequence of polyclonal B cell activation (possibly initiated by 
streptococcal antigens) and contributed to the chronicity of the systemic 
autoimmune disease. 
lmmunoblotting of these rheumatic fever and control sera against extracts of 
human heart, showed that the lgM isotype binding pattern of ARF sera to the 
eleven major constituents in the extract differed markedly in intensity and 
frequency of detection compared to the other sera. However normal sera also 
showed lgM binding although at lower intensity and frequency, indicating that 
these may be natural autoantibodies . Whether the ARF and normal sera 
recognise the same epitopes is not known. The dramatic shift to lgG anti-heart 
antibodies among the chronic rheumatic fever patients, may be a consequence 
of the natural progression of the disease from the acute to the chronic phase. 
Conceivably, this shift may represent a switch from natural/physiologic lgM 
autoantibodies to pathogenic lgG autoantibodies. lgM autoantibodies may 
potentiate the lgG response, and one might postulate that either the high titre 
or the nature of anti-heart lgM autoantibodies in certain hosts may be 
associated with increased susceptibility to the disease (see also section 
3 .4.1.1 /2). lgM autoantibodies can however be pathogenic and are known to 
occur in certain diseases. Whether the anti-heart autoantibodies in rheumatic 
fever (either those deposited in heart tissues in vivo, or in the serum) are 
pathogenic, has never been established, and it is unfortunate that adoptive 
transfer experiments using the eluted antibody to prove this cannot be done 
w ithout a suitable animal model of the disease. 
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The composition of the eleven heart extract constituents recognised by patient 
sera was not investigated, but immunoblot inhibition experiments using purified 
antigens might be used to identify some of them. Thus the 38-43 kD region of 
reactivity may contain actin (42 kD), the 67-70 kD band may be comprised of 
keratin and it would be particularly pertinent to other reports in rheumatic fever 
if the 33 kD doublet was shown to be comprised of the two chains of 
tropomyosin (35 kD). 
lmmunoblotting of purified human heart sarcolemmal membranes revealed a 
200 kD constituent uniquely recognised by lgG antibodies in ARF sera. This 
constituent may be myosin, which has been found associated with sarcolemmal 
membranes, and immunoblot inhibition experiments such as performed by Dale 
and Beachey ( 1985a) are being planned to verify this. 
Such inhibition experiments are nonetheless severely limited in their capacity to 
identify relevant cardiac antigens. Epitope mapping, such as recently applied 
by Cunningham et al. ( 1989), offers a more sophisticated approach. Due to 
the immense scope that exists for cross-reactivity between antigens (Atassi, 
1975) and due to the "operational nature" of solid phase binding assays (Van 
Regenmortel, 1989), evidence of antigenic mimicry between cardiac and 
streptococcal antigens based on immunoblotting and ELISAs alone cannot be 
accepted as definitive. Thus the cross-reaction of the antibodies eluted from 
the 38-40 kD heart extract constituent with streptococcal antigens in a second 
immunoblot (section 3.2.2), cannot be accepted as proof of molecular mimicry 
between these antigens. 
Shared epitopes between microbial and host antigens may be fortuitous and are 
no proof of an evolutionary relationship between the molecules, nor of the 
pathological relevance of the cross-reaction. It is somewhat puzzling that the 
numerous investigations into the cross-reaction between myosin and 
streptococcal M5 protein, have seldom been supported by hypotheses 
explaining how such antigenic mimicry might initiate a pathologic autoimmune 
response leading to the cardiovascular damage. Antibodies cross-reactive with 
the Ca 2+ ATPase enzyme associated with the light chains of myosin offers an 
attractive hypothesis which might account for the muscle damage seen in 
rheumatic fever, and this study presents evidence of one ARF patient with high 
titres of antibody to the enzyme. Antibodies against this enzyme are known to 
occur in Chagas disease in which anti-heart antibodies have been found (Rose 
et al., 1988). 
There are no previous reports in rheumatic fever in which patient lymphocytes 
have been used to develop human mAbs. Unlike murine mAbs, human 
monoclonals can offer an inside-view of the antibody repertoire relevant to the 
disease. Shortcomings of the present study would appear to be that the 
lymphocytes were derived from too young a patient (which may have 
contributed to the nonspecific cross-reactive nature of the mAbs) and the use 
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of peripheral blood lymphocytes rather than tonsillar lymphocytes which may 
have contributed to the instability of the hybridoma clones (section 4. 1 . 2). The 
lgM mAbs isolated may be part of the natural autoantibody repertoire in these 
patients. This does not necessarily preclude them from being of relevance to 
rheumatic fever, since the relationship between natural and pathogenic 
autoantibodies appears to be complex and has yet to be elucidated (Chapter 1 ). 
These mAbs do not fall into either of the groups of reactivity (myosin/DNA or 
myosin/keratin/actin) described in a previous report on human mAbs in 
rheumatic fever (Cunningham et al., 1988). Possibly the most relevant result 
from this aspect of the study, is the binding by MAG of a 43 kD constituent in 
both crude extracts of heart and in purified sarcolemmal membranes, since 
cardiac antigens in this mol. wt. region have been identified in several other 
studies using mAbs and rabbit immune sera (see Table 3.1 ). 
The construction of two highly efficient Agt11 cDNA expression libraries of 
human heart genes, and the screening of them using monoclonal antibodies, 
rabbit immune sera and patient sera, offered the most productive and precise 
approach to the definition of cardiac antigens, and potentially to the 
identification of the cross-reactive epitopes in rheumatic fever. Patient serum 
containing high titres of antibodies to both heart autoantigens and to 
S.pyogenes, was considered the most relevant reagent for analysing antigenic 
mimicry. Serum ARF-S 1 from an ARF patient with high titres of antibodies to 
cardiac and streptococcal antigens, was used to isolate three positive clones, 
using a sensitive alkaline phosphatase second antibody detection system. One 
of the clones identified was virtually 100% homologous with human 
cytokeratin 8, and 40-50% homologous with the a-helical coiled-coil proteins 
myosin, tropomyosin and streptococcal M proteins, all of which have been 
strongly implicated in antigenic mimicry in rheumatic fever. Keratin, which is 
antigenically related to cytokeratin, has been identified as a member of one of 
the two groups of host antigens (myosin/DNA and myosin/keratin/actin) binding 
murine and human mAbs cross-reactive with group A streptococcal antigens. 
Antigens with regular repeating structures such as these coiled-coil proteins are 
known to have a greater potential for binding cross-reactive antibodies, and 
one might argue that these cross-reactions are fortuitous and irrelevant to the 
disease. However, the streptococcal M protein possesses such a coiled-coil 
structure, and the host antigens it putatively mimics could be expected to have 
a similar structure. 
It is also known that intermediate filaments such as cytokeratin and . vimentin 
are major targets for autoantibodies in rheumatic diseases, and also occur in 
normal subjects (Kurki et al., 1983). It could be argued that there is no 
biological mimicry between cytokeratin (or other coiled-coil proteins) and 
S.pyogenes, and that the cross-reactivity is a fortuitous consequence of 
autoantibody production in the host. This leaves unanswered the question as 
to the function and the relationship between physiologic and pathogenic 
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autoantibodies. In any event, autoantibodies directed against intermediate 
filaments such as cytokeratin offer some attractive hypotheses as to how 
cellular function might be impaired and initiate autoimmune disease. 
Characterization of the other two positive clones detected in these libraries, as 
well as screening with other patient sera, is in progress and may disclose more 
about the nature of cardiac autoantigens in rheumatic fever. It will then be 
possible to determine whether these autoantigens share epitopes with the well-
characterised streptococcal M proteins (or other S.pyogenes antigens), and 
perhaps to determine whether antibodies to these epitopes are cytotoxic. 
6.4 Difficulties in the Study of Antigenic Mimicry 
Some of the difficulties encountered in this study of antigenic m1m1cry in 
rheumatic fever might be summarised as follows: ( 1) the limitations of solid 
phase binding assays in which assay conditions have a determining influence 
on whether binding is observed or not, and hence on whether particular 
residues are scored as being part of the epitope (Van Regenmortel, 1989); (2) 
the frequent unavailability of adequate positive control sera, other than rabbit 
immune and human related-disease sera, for measuring and evaluating the 
relevance of cross-reactive autoantibody binding; (3) the presence of 
natural/physiologic autoantibodies in normal human and animal sera which 
makes it difficult to ascertain whether the patient autoantibodies are 
pathogenic; (4) the immense scope that exists for cross-reactivity within the 
antigenic universe, considering that determinants as short as 4-7 amino acids 
can be recognised by antibodies (Atassi, 1975); (5) the lack of an animal model 
of rheumatic fever to assess the pathogenicity of cross-reactions (associated 
with this is the difficulty of determining which of the many streptococcal 
products are pathologically important to the disease); (6) the problem of 
experimentally establishing cause and effect within a complex biological system 
(perhaps demonstrated in rheumatic fever by the inability as yet to establish 
whether the cardiac autoantibodies are the cause or the consequence of the 
disease). 
6.5 Rheumatic Fever as a Model of Autoimmunity and Immune 
Function 
The study of this complex relationship between microbe and host, and of 
antigenic mimicry as a possible pathogenic mechanism leading to autoimmune 
disease and cardiovascular damage in rheumatic fever, may offer some valuable 
clues to the understanding of other infectious and autoimmune diseases and 
lead to a deeper understanding of physiologic autoimmunity (Chapter 1) and the 
natural functioning of the immune system. 
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7 .A AUTOANTIBODIES AND IMMUNOBLOTTING (CHAPTERS 2, 3) 
7 .A.1 Raising Rabbit Hyperimmune Sera 
Antisera were raised in female New Zealand White rabbits to the following 
antigens: (a) sonicates of group A streptococci (section 7 .A.30); (bl purified 
cell walls and membranes of group A streptococci; (c) human heart detergent 
extract (section 7.A.11 ). 
(a ) Group A streptococcal sonicates. 500 µI of sonicate (50 µg/ml) 
emulsified in Freund's incomplete adjuvant (FIA) (1 :1 ), was injected 
int ramuscularly (i.m.) into each limb of the rabbit. Six weeks later, 250 µI per 
limb of sonicate was injected i.m., and then at 4-week intervals booster 
injections in FIA were administered s.c. at six sites along the back. Test 
bleeds were done very 2 weeks. 
(b ) Streptococcal cell wall and membrane. Antisera were raised by the same 
procedure as for streptococcal sonicates (above) except that antigens were 
emulsified in FCA for the first injection. 
(c) Heart extract. Antisera were raised as for (a) above, but instead of s.c. 
injections, a final boost was given intravenously to the marginal ear vein 5 days 
before the final bleeding. 
7.A.2 ASO and DNAse B Antibody Titres 
7.A.2.1 Anti-streptolysin O antibodies (ASO) 
Anti-streptolysin O antibody titres were measured using Streptolysin 0 
Reagents supplied by Technicon (New York, U.S.A.), according to instructions. 
7.A.2.2 Anti-DNAse B antibodies (DNAseB) 
Anti-DNAse B antibodies were measured using the Streptonase-8 kit supplied 
by Wampole Laboratories (New Jersey, USA), according to instructions. 
7.A.3 Group A Streptococcus ELISA 
~treptococci were grown in chemically defined medium (Van de Rijn and 
Kessler, 1980), washed four times in sterile PBS pH 9 (PBS-9), suspended to a 
concentration of A55o=0.6, and then 50 µI per well (2.5 X 106 cfu) was added 
to polyvinyl chloride microtitre plates (Falcon). The bacteria were fixed by 
centrifuging the plate for 1 minute at 100 X g before adding 0 .25% 
glutaraldehyde for 5-10 minutes. Plates were washed three times w ith sterile 
PBS-9, and nonspecific protein binding sites blocked with 1 % BSA, 100 mM 
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glycine, 1 % goat serum, for 1 hour at room temperature. The plates were 
rinsed once, sealed and stored at 4 °c until used (within 1 week). Patient sera 
were tested in the ELISA at an optimal dilution of 1: 100 in PBS pH 7.4 for 2 
hours at room temperature. The plates were washed 6 times with PBS-7 .4 
containing 0.01 % gelatin and 0.05% Tween 20, before addition of the 
peroxidase conjugated antibody, goat anti-human lgG (H + L) (Cappel), for 1 
hour at room temperature. After washing 10 times, the reaction was 
developed with ABTS for 1 hour, and the optical density was measured at 405 
nm in an SL T ELISA reader. A rabbit hyperimmune serum to S.pyogenes was 
used as a method control (section 7.A.1 ). 
7.A.4 Actin ELISA 
Actin from rabbit heart (Sigma) at a concentrations of 10 µg/ml in bicarbonate 
buffer pH 9.5, was coated onto polyvinyl chloride microtitre plates (Falcon) (50 
µI/well), and the sealed plates incubated overnight at 4°C. The plates were 
then washed 3 times with PBS-7 .4, and nonspecific protein binding sites were 
blocked with 1 % BSA, 1 % goat serum, 100 mM glycine for 1 hour at room 
temperature. The plates were rinsed 3 times with PBS, and sera were added in 
duplicate at dilutions of 1: 10, 1: 100 and 1: 1000, and incubated in a moist 
chamber for 2 hours at room temperature. After washing 6 times with PBS-
7 .4, peroxidase conjugated Fab' 2 goat anti-human lgG (H + L) (Cappel) antibody 
was added for 1 hour. The plates were washed 10 times, developed with 
ABTS, and . the optical density was measured at 405 nm in an SL T ELISA 
. reader. A rabbit anti-actin antiserum (Biomakor) was used as a method control. 
7.A.5 Collagen Type II ELISA 
Antibodies to type II collagen were measured using an ELISA method adapted 
from Boissier et al.(19871. NUNC lmmuno Maxisorp plates were coated with 
bovine type II collagen (Southern Biotechnology Associates) at a concentration 
of 1 Oug/ml in sterile PBS (50 µI /well), and incubated overnight at 4°C. The 
plates were rinsed 3 times with sterile TBS (0.1 M Tris, 0.15 M NaCl) and 
nonspecific antibody binding sites were blocked by adding 0.25% BSA for 1 hr 
at room temperature. Plates were rinsed as above and first antibody diluted 
1: 100 in TBS was added (50µ1/well) and the plates were incubated overnight in 
· a moist chamber at 4°C. After rinsing 5 times with TBS, peroxidase conjugated 
Fab'2 goat anti-human lgM (µ) (Cappel) (dilution 1 :1000) was added for 1 hr at 
room temperature. The plates were washed 10 times, developed with ABTS 
for 1 hr and the optical density read at 405 nm in an SL T ELISA reader. Goat 
antiserum to bovine type II collagen (South Biotechnology Associates) was 
used as a method control. 
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7.A.6 ELISAs to Cardiac Autoantigens 
The following are brief descriptions of ELISAs developed for measuring 
antibodies to myosin, crude heart extract and phosphorylase b. The ensuing 
ELISAs were performed using variations of the following basic protocol. 
Polyvinyl chloride (PVC) flat bottom plates (Falcon) were coated with the 
antigens appropriately diluted in bicarbonate buffer pH 9.5, and incubated 
overnight at 4°C. Alternate rows on the plate received no antigen and were 
incubated with buffer alone (no-antigen control). The plates were rinsed with 
PBS pH 7.4 containing 0.01 % Tween 20 (PBS-Tween buffer) and nonspecific 
antibody binding sites on the plastic were blocked using a solution of 1 % BSA, 
1 % goat serum, 100 mM glycine (blocking buffer) for 1 hour at room 
temperature. Plates were washed once, and first antibody at dilutions of 
1: 100, 1: 1000 and 1: 10000 in PBS-Tween buffer were added in duplicate to 
the wells ( 100 µI/well) and incubated for 2 hours at room temperature. A set 
of wells received no first antibody and were incubated with only diluent buffer 
(no-serum control). Plates were washed 6 times and a peroxidase conjugated 
Fab' 2 goat anti-human lgG (r) antibody (Cappel) diluted 1 :500 in PBS-Tween 
buffer ( 100 µI/well) was added for 1 hour at room temperature. Plates were 
washed 10 times, and ABTS!H202 substrate solution (100 µI of 40 mM ABTS 
added to 10 ml citric acid pH 4.0 with 100 µI of 30% H20 2) was added for 1 
hour at room temperature . Optical density was measured at 405 nm in an SL T 
ELISA reader. Both the no-antigen and the no-serum controls were subtracted 
from each value, and the average of the duplicates calculated for each dilution . 
Various rabbit and human sera mentioned below were used as positive 
controls. 
7 .A.6.1 Myosin 
Bovine muscle myosin (Sigma) was coated onto plates at a concentration of 5 
µg /ml and a rabbit antiserum to whole myosin (Sigma) together with a goat 
anti-rabbit lgG peroxidase conjugated antibody (Cappel) was used as a method 
control. 
7 .A.6.2 Heart Extract 
Plates were coated with CHAPS crude extracts of human heart (section 
7 .A .11) at a concentration of 5 µg/ml and the rabbit antiserum raised to this 
ext ract (section 7 .A.1) was used as a control. In addition an ARF serum found 
to react strongly with the extract in this assay (and in immunocytochemistry; 
section 7 .A.18), was included on each plate to control for interassay variability . 
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7 .A.6.3 Phosphorylase b 
Phosphorylase b (Sigma) was coated onto plates at a concentration of 20 µg/ml 
and the rabbit antiserum raised to the crude extract of heart (section 7 .A.11), 
which reacted relatively strongly with this protein compared to a pool of five 
nonimmune rabbit sera, was used as a control. An ARF serum demonstrating a 
relatively high titre of antibodies to this protein, was included on each plate to 
control for interassay variability. 
7.A.7 Antinuclear Antibodies 
Antinuclear antibodies were measured by indirect immunofluorescence against 
t he human epithelial cell line HEp-2 as a substrate, using the Behring AFT HEp 
System (Behring Diagnostics). Sera diluted 1 :40 in PBS were added to slides 
and incubated in a moist chamber for 30 minutes at room temperature. The 
slides were rinsed and then washed with PBS in a Coplin jar with gentle stirring 
for 10 minutes. Excess mQisture was wiped off and the FITC-conjugated 
labelled goat anti-human lgG (H + L) antibody conjugate was added, for 30 
minutes at room temperature. The slides were washed as before, mounted in 
glycerol, and examined under a Nikon Optiphot microscope (PlanApo 60 X / 1.4 
oil lens) with camera attachment (FX-35A and Kodak 400 ASA colour film). 
Sera from SLE patients were used as a positive control. Sera demonstrating 
more than one pattern of binding were titrated . 
7 .A.8 Bacterial Cell Cultures 
Group A streptococci (S.pyogenes) were cultured from a throat swab of a 
patient with acute rheumatic fever. This culture was grown in Todd-Hewitt 
broth or in chemically defined medium (Van de Rijn and Kessler, 1980) and was 
used as the solid phase antigen in the Group A Streptococcal ELISA (section 
7 .A.3) as well as for preparing cell sonicates (section 7 .A.30). 
A panel of streptococcal group serotypes comprised of group B (S.agalactiae), 
group C (S.equisimitis), group D and group G (S.auginosi) were obtained from 
the South African Institute for Medical Research (SAIMR) in Johannesburg, and 
from the Department of Bacteriology at Red Cross Children's Hospital in Cape 
. Town, South Africa . Escherischia coli were obtained from the American Type 
Culture Collection (ATCC: 25922). These bacteria were maintained in TSB 
broth. 
7.A.9 I mmunoblotting 
Proteins were separated by SOS polyacrylamide gel electrophoresis (section 
7 .A.10) and transferred to nitrocellulose by electroblotting. The gel was 
equilibrated for 30 minutes in transfer buffer (0.05 M Tris, 0.3 M glycine, 20% 
v /v methanol) before transfer onto nitrocellulose (Schleicher and Schuell BA85, 
0 .45 µm) in a "sandwich" comprised of layers of 3MM Whatman paper and 
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scotchbrite pads. Transfers were done at 600 mA constant current for 3 hours 
at 4°C, or else overnight at 100 mA. Duplicate blots were made to assess the 
efficiency of the transfer, by staining the membrane with either Amido Black or 
with AuroDye forte (Janssen Life Sciences). Nonspecific protein binding sites 
on the unstained membrane were blocked with 2% BSA, 1 % goat serum, 
0.05% Tween 20 in TBS buffer (20 mM Tris-HCI, 0.9% NaCl, pH 7.5) for 1 
hour at room temperature. The blots were briefly rinsed in TBS, and incubated 
with the first antibody diluted in 0.2% BSA, 0.1 % goat serum, 0.05% Tween 
20, for 2 hours at room temperature, with shaking. After three 10-minute 
washes in TBS, the blots were incubated with the peroxidase conjugated 
second antibody for 1 hour at room temperature, washed again as before, and 
developed with 4-chloro-1-napthol (section 7 .C). 
7.A.10 SDS Polyacrylamide Gel Electrophoresis 
Separating gel 10%: 
For a 10% separating gel the following solution was mixed: 
acrylamide:bisacrylamide (39: 1) 
1 M Tris-HCI pH 8.8 






This mixture was degassed, and the following added and mixed: 
10 % sos 
TEMED 




The gel was cast in a Hoefer 600 SE vertical slab gel apparatus, and allowed to 
set (covered with a thin layer of water) before addition of the stacking gel. 
Stacking Gel (4%): 
For a 4% stacking gel the following solution was mixed: 
acrylamide: bisacrylamide (39: 1) 
0.125 M Tris-HCI pH 6.8 
3.0 ml 
26.7 ml 
The solution was degassed before the following were added and mixed: 
10% sos 
TEMED 




The stacking gel was poured on top of the set separating -gel, a comb was 
inserted and the gel left to set at room temperature. 
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Protein samples (20-50 µg protein) were prepared in an equal volume of sample 
buffer comprised of 48 mM Tris-HCI, 2.5% SOS, 20% glycerol, 0.25% 
bromophenol blue and 5 % B-mercaptoethanol. Samples were boiled for 3-5 
minutes and loaded immediately. The gel was run in SDS-PAGE running buffer 
(0.025 M Tris-HCI, 1.5% glycine, 0.1 % SOS, pH 8.3). The gel was run at 25 
mA until samples had just entered the separating gel and thereafter at 35 mA. 
The gel was stained in 0.1 % Coomassie brilliant blue (R250) in 33% methanol 
and 11 % trichloroacetic acid (w/v). Oestaining was done in 20% ethanol, 
0.7% acetic acid. 
7.A.11 Heart Antigen Extract 
Heart tissue was obtained either at transplantation surgery or at autopsy 
(within 8 hours of death) and stored in liquid nitrogen. The tissue was ground 
to a powder under liquid nitrogen using a mortar and pestle, and then 
homogenized on ice using an Ultra Turrex homogenizer at maximal setting (for 
three 30-second bursts) in heart extract homogenization buffer (20 mM Tris-
HCI, 150 mM NaCl, 1 mM CaCl2, 1 mM PMSF pH 8.0). The homogenate was 
centrifuged at 800g for 10 minutes and the supernatant filtered through a 
double layer of cheesecloth. The filtrate was centrifuged at 800g for 5 
minutes, passed through cheese-cloth as before, and centrifuged at 10 000g 
for 60 minutes in a Beckman L8-70 ultracentrifuge. The pellet was 
resuspended ( 1 ml/gram of original tissue) in heart extract solubilization buffer 
(20 mM Tris-maleate, 150 mM NaCl, 1 mM CaCl2, 1 mM PMSF, 1 mM thymol, 
pH 7.25) contaiJ1ing 5 mM CHAPS detergent (Sigma). The solubilization 
proceeded for 1 hr at 4°C on a Coulter roller. The extracted proteins were 
centrifuged at 10 OOOg for 5 minutes, and the supernatant aliquoted into sterile 
tubes and stored at -70°C. 
7 .A. 12 Sarcolemmal Membrane Purification 
Sarcolemmal membranes were purified from human and rabbit heart essentially 
by the method of Van de Rijn et al. ( 1977). 10 g of heart tissue (obtained at 
surgery or postmortem) was pulverised under liquid nitrogen using a mortar and 
pestle and then homogenised in 50 ml of 0.05 M CaCl2 using an Ultra Turrex 
. homogenizer (two 30.:.second bursts). The slurry was washed three times in 
cold PBS pH 7 .2 by centrifugation at 2000g for 10 minutes at 4°C. The final 
pellet was resuspended and incubated for 3 hours at 4°C in PBS pH 7.2 
~ontaining 5 mM CaCl2, 20 µg/ml ONAse I, 20 µg/ml RNAse. The suspension 
was centrifuged at 14 000g for 30 minutes in an SW27 rotor (Beckman L8-70 
Ultracentrifuge), and the pellet was suspended at 100-fold weight/volume 
concentration in distilled water containing 1 mM PMSF for 24 hours at 4°C, 
with stirring. The slurry was centrifuged at 14 000g for 30 minutes, and the 
pellet frozen in liquid nitrogen and lyophilized. The membrane extraction was 
done by incubating 1 g of lyophilized heart extract with 100 ml of 3 M KCI for 
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18 hours at 4°C. The extract was centrifuged at 10 000g for 30 minutes, the 
supernatant was kept, and the pellet re-extracted with 50 ml of 3 M KCI for 8 
hours at 4°C, followed by centrifugation as before. The second supernatant 
was also kept, and the pellet extracted with 25 ml of 3 M KCI for 16 hours at 
4°C, followed again by centrifugation. The third supernatant was pooled with 
the first two, dialyzed extensively against 0.01 M ammonium bicarbonate, and 
lyophilized. 
7 .A.13 Affinity Purification of Antibody on lmmunoblots 
A modification of the three-step procedure for elution of antibody from 
nitrocellulose bands described by Smith and Fisheer ( 1984) was found to be 
more effective than the single step low pH elution originally described by 
Olmsted (1981). 
Protein extracts were separated in a single well by SDS PAGE, transferred to 
nitrocellulose, and the relevant polypeptide bands were located by developing 
vertical strips from either side of the nitrocellulose. The excised strips were 
incubated in TBS buffer (20 mM Tris-HCI, 0.9% NaCl) containing 2% BSA and 
0 .05% Tween 20 for 1 hour at room temperature, followed by brief rinsing. 
The strips were incubated with first antibody diluted 1 :50 in TBS for 2 hours at 
room temperature, then washed 3 times for 10 minutes each in TBS/0.05% 
Tween 20, and the bound antibody was eluted in three, using ( 1) 500 µI of 5 
mM glycine-HCI pH 2.3 and 500 mM NaCl, for 3 minutes, followed by 
immediate neutralization of the eluate in 50 mM Na2 HP04 and 2% BSA; (2) 
500 µI of 0.5% Tween 20 in TBS for 3 minutes; (3) 500 µI of 3 M KSCN, 150 
mM KCI, 10 mM Na PO 4, for 3 minutes. Between each step, the remaining 
nitrocellulose strip was immediately rinsed in TBS, and the eluates were pooled. 
To accumulate sufficient eluate for probing secondary immunoblots, additional 
elutions were done from new antigen transfers. 
7 .A.14 Nuclear Extracts from Cultured Heart Cells 
Crude extracts of nuclear proteins were prepared from both Girardi heart cells 
(ATCC: CCL-27) and from a primary cultures of human heart (endothelial-like) 
cells (section 7.A.15). Cells were grown to confluence and harvested by 
. scraping with a rubber policeman, washed with cold PBS and centrifuged at 
2000 rpm for 10 minutes at 4°C. The pelleted cells were suspended in 5 cell 
volumes of PBS and centrifuged again as before. The cells were resuspended 
in 5 volumes of Dignam buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 
mM KCI, 0.5 mM OTT), left on ice for 10 minutes and again centrifuged. The 
cells were suspended in 2 volumes of buffer A and then lysed with 10-1 5 
strokes of a Dounce homogenizer. Homolysis of the cells was checked 
microscopically. The homogenate was centrifuged as before to pellet the 
nucleii, the supernatant was discarded and the pellet recentrifuged at 25 OOOg 
for 20 minutes to remove residual cytoplasmic debri. The pellet containing the 
nucleii was then suspended in 3 ml/1 o9 cells of Dignam buffer C (20 mM 
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HEPES pH 7.9, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25% v/v glycerol, 
0.5 mM DTT, 0.5 mM PMSF). Nucleii were homogenised by 10 strokes of a 
Dounce homogenizer, the suspension gently stirred on ice for 30 minutes, and 
then centrifuged at 25 000g for 30 minutes. The supernatant was dialysed for 
5 hours against 50 volumes of Dignam buffer D (20 mM HEPES, 0.1 M KCI, 
0.2 mM EDTA, 20% v/v glycerol, 0.5 mM DTT, 0.5 mM PMSF). The dialysate 
was centrifuged at 25 000g for 20 minutes, and the supernatant stored in 50 
µI aliquots at -80°C. 
7.A.15 Primary Culture of Human Heart Cells 
A primary culture of cells derived from heart tissue was developed using the 
method of Kasten (1973). Heart tissue obtained at surgery (Fallot's tetralogy) 
was washed in Minimum Essential Medium (MEM), weighed, cut into 1 mm2 
pieces and digested with 0.125% trypsin in an Erlenmeyer flask for 10 minutes 
at 37°C with stirring. The supernatant was removed and . 20 ml of fresh trypsin 
per gram of original tissue was added for 15 minutes at 37°C. The digest was 
centrifuged at 1300 rpm and the supernatant decanted and inactivated with 2 
ml MEM. The trypsinization was repeated on the remaining digest, and the two 
supernatants were pooled. The entire process was repeated again on the 
residual tissue and the two sets of supernatants were pooled, washed twice in 
fresh MEM and the cell concentration adjusted to about 6 X 1 o5 cells/ml. Cells 
were plated into petri dishes at 1 .5 X 1 o5 cells/ml and maintained in MEM 
containing 10% FCS, 20 mM HEP ES and antibiotics (section 7 .A.19). The 
differential attachment technique recommended for obtaining higher yields of 
myocardial cells was not successful, and electron microscopy showed that the 
cells were endothelial in morphology. 
7.A.16 Processing of Tissue for lmmunocytochemistry 
All slides were first thoroughly cleaned in chromic acid followed by methanol, 
and rinsing in water. 
7.A.16.1 Paraffin Wax Sections 
Tissue obtained from surgery was fixed in Carson's formal buffered saline 
. (40% formaldehyde, 120 mM NaH2P04 .H20, pH 7.2). It was then processed 
to wax (Shandon Processor 2LE) and 4 µm sections were cut on a microtome 
(Reichert-Jung 2040), picked up on glass slides and incubated at 65°C for 20 
minutes. Slides were stored at room temperature. 
7.A.16.2 Frozen Sections 
Tissue excised at surgery was immediately frozen in liquid nitrogen, and 4 µm 
thick cryostat sections were cut, picked up on glass slides and stored at -20°C. 
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7.A.17 lmmunofluorescence on Tissue Sections 
Sections of frozen tissue were cut and lifted onto glass slides, as described 
(section 7.A.16.2). Nonspecific antibody binding sites were blocked by 
incubating sections for 30 minutes in a moist chamber with 20% goat serum in 
PBS (if the second antibody was raised in goat). The blocking solution was 
blotted off gently and the first antibody, optimally diluted in PBS, was added to 
sections and incubated for 30 minutes in a moist chamber at room temperature. 
Slides were rinsed, avoiding cross-contamination between wells, and then 
immersed in a bath of fresh PBS for 10 minutes with gentle stirring. Excess 
moisture was removed from around the wells, while ensuring the sections 
remained moist, before addition of the FITC-conjugated second antibody for 30 
minutes. Slides were rinsed and washed as before, mounted in sterile 30% 
glycerol in PBS, and examined and photographed using a Nikon Optiphot 
microscope with camera attachment (Nikon FX-35A). 
7.A.18 lmmunocytochemistry: biotin-streptavidin-peroxidase 
Paraffin wax sections of human heart tissue (section 7 .A.16.1) were dewaxed 
in xylene, rehydrated and washed in a bath of PBS pH 7.4 with gentle stirring. 
Endogenous peroxidases in the tissue were inhibited by immersing the slides for 
10 minutes in 0.3% H202 in methanol followed by rinsing and washing for 5 
minutes in bath of tap water. To expose cross-linked antigens, sections were 
immersed for 12 minutes in a freshly prepared 37°C solution of 0.1 % trypsin 
(Sigma type II) in 0.1 % CaCl2 pH 7 .8. Slides were then immediately rinsed 
under cold tap water, transferred for 5 minutes to a bath of distilled water at 
4°C, and washed twice for_ 5 minutes in a bath of PBS at room temperature. 
Nonspecific antibody binding sites were blocked by incubating the slides for 10 
minutes with 10% nonimmune goat serum in PBS. The solution was blotted 
off gently and the sections were incubated with the first antibody (sera diluted 
1 :5 in PBS) overnight in a moist chamber at 4°C. Sections were washed 3 
times for 10 minutes each in fresh baths of PBS, excess fluid was wiped off, 
and the biotinylated goat anti-human (or rabbit) lgG (H + L) second antibody 
(Zymed) was added at a dilution of 1: 100 in PBS for 10 minutes at room 
temperature. The streptavidin-peroxidase conjugate (Zymed) was added for 5 
minutes at room temperature. The slides were washed twice for 5 minutes 
. each in PBS, and the H2D2-AEC substrate-chromogen mixture was added for 15 
minutes at room temperature. Slides were washed twice for 5 minutes each in 
distilled water, counterstained with haematoxylin for 3 minutes, rinsed again in 
tap water and then mounted in GVA solution and examined using a Nikon 
Optiphot microscope with camera attachment (FX-35A). 
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MONOCLONAL ANTIBODIES (CHAPTER 4) 
7.A.19 Cell Culture 
Cells were cultured at 37°C in a humidified air incubator in 95% air:5% CO2. 
1 . The mouse myeloma cell line Sp2/0-Ag-14 was cultured in RPMI 1 640 
supplemented with 20 mM HEPES, 0.2% bicarbonate, 15% heat-
inactivated FCS (Flow), azaguanine ( 15 µg/ml) and antibiotics ( 100 U/ml 
penicillin; 100 µg/ml streptomycin). Two days before cell fusion, the 
cells were seeded at a concentration of 2 X 105cells/ml. 
2 . The· hybridoma cell lines were routinely seeded at 2 X 105 cells/ml in 100 
mm diameter dishes (Falcon) and cultured in HT medium with 15% FCS. 
They were subcultured twice weekly using Versene (section 7.C). 
3 . Girardi heart cells (ATCC: CCL-27) were cultured in Minimum Essential 
Medium (MEM) supplemented with 5% FCS, 20 mM HEPES buffer and 
antibiotics (penicillin 100 U/ml; streptomycin 100 µg/ml). The cells were 
subcultured twice weekly by detaching them with 0.05% trypsin in PBS 
containing 10 mM EDTA. They were split at ratios between 1 :7 and 
1: 10. 
4 . A primary culture of human heart (endothelial-like) cells was prepared by 
the method of Kasten ( 1973) using human heart tissue obtained at 
surgery from a child with a congenital heart defect (section 7.A.15). The 
cells were maintained in Minimum Essential Medium supplemented with 
10% FCS, 20 mM HEPES and antibiotics (penicillin 100 U/ml; 
streptomycin 100 µg/ml). 
7 .A.20 EAC Rosettes: B cell purification 
Lymphocytes were separated by centrifugation at 800g for 15 minutes through 
Ficoll-lsopaque according to standard procedures, and the cell count adjusted 
to 15 X 106 cells per ml. 
Fresh sheep red blood cells (SRBC) were washed three times ( 1200 rpm) in ice-
cold 0.15 M PBS (pH 7.4), adjusted to 5% (v/v) in 10 mis of PBS and 
centrifuged at 2500 rpm for 10 minutes at 4°C. 2 ml of a 4% sterile solution 
of AET (pH 9) was added to the supernatant and gently mixed. The cells were 
incubated at 37°C for 15 minutes, washed again as above ( 1500 rpm) with a 
final wash in 10 ml of RPMI containing 20 mM HEPES, 20 mM bicarbonate, 
10% FCS, pH 7.3. 500 µI of these packed cells were diluted in 10 ml of the 
same RPMI buffer (without FCS) to give a 5% AET-SRBC suspension . Equal 
volumes of 5% AET-SRBC and separated lymphocytes were mixed, centrifuged 
at 250g for 5 minutes and left ·at room temperature for 2 hours. The 
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suspension was centrifuged through Ficoll-lsopaque at 400g for 40 minutes· at 
20°c, the supernatant was removed and the nonrosetted B cells at the 
interface were washed twice in RPMI and resuspended in GKN buffer at a 
concentration of 2 X 106 cells/ml, for hybridoma cell fusion. 
7.A.21 Monoclonal Antibody Cell Fusions 
Equal concentrations (2 X 106 cells/ml) of non-rosetted PBL and SP2 mouse 
myeloma cells were mixed in GKN buffer (Dulbecco's PBS, 2 g/1 glucose, 10 
mg/I phenol red) and warmed at 37°C for 5 minutes. The mixture was 
centrifuged at 650 rpm for 5 minutes, the supernatant removed and the pellet 
gently resuspended . The cells were fused by adding 1.5 ml of 50% 
polyethylene glycol (PEG) mol.wt. 4000 (Merck) in RPMI 1640 for 2 minutes, 
and then gradually diluting them with 10 volumes of GKN buffer over a period 
of 5 minutes. The volume was made up to 45 ml with GKN buffer and the 
suspension centrifuged at 650 rpm for 3 minutes. The pellet was diluted to a 
concentration of 1.6 X 106 cells/ml in H.A. T medium (10-4 M hypoxanthine, 4 
X 1 o-7 M aminopterin, 1.6 X 1 o-5 M thymidine, 3 X 1 o-6 glycine, 1 o-3 M 
sodium pyruvate) containing 20% FCS and 20% SP2 conditioned medium 
(about 25 ml). The cell suspension was seeded at 0.5 ml/well into 24-well 
plates (Costar) and an additional 0 .5 ml/well of H.A. T medium added, giving a 
final concentration of 8 X 105 cells/ml in each well. The plates were incubated 
at 37°C, and after 7 days 0.5 ml of the medium was replaced with fresh HAT 
medium. After a further 3 days, cultures were replenished with 0.5 ml of HT 
medium containing 20% FCS. Supernatants were then screened for antibody 
production. 
7 .A.22 Hybridoma Screening against Heart and S.pyogenes 
Screening generally commenced 10-14 days after cell fusion, and was 
repeated every 2 days till day 20. Hybridoma supernatants were assayed for 
antibody against whole group A streptococci by ELISA (section 7 .A.3) and 
against paraffin-embedded human heart sections by an immunoperoxidase 
second antibody assay (section 7 .A.23). Positive clones were subcloned within 
2 days at dilutions of 10-and 3 cells per well for the first subcloning, and at 3-
and 0.5 cells per well subsequently . Culture wells were screened for antibody 
· 11 -14 days after each subcloning. Selected clones were expanded in HT 
medium at seeding densities of 2 X 105 cells/ml, and assayed for antibody 4 
days later. Confirmed positive clones were injected intraperitoneally ( 107 
~ells) into pristane-primed nude mice to produce ascites, which was usually 
ext racted about 3 weeks later. 
7.A.23 lmmunoperoxidase Sandwich Assay 
Paraffin-embedded sections of human heart (section 7 .A.16.1) were dewaxed 
and hydrated, and nonspecific antibody binding sites were blocked by the 
addition of 20% goat serum in PBS pH 7.4 for 40 minutes at room 
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temperature. The blocking solution was blotted off, and sections were 
incubated with neat hybridoma culture fluid for 40 minutes in a moist chamber 
at room temperature. After washing in PBS for 10 minutes, sections were 
incubated with a peroxidase conjugated Fab'2 goat anti-human lgG, lgA, lgM 
antibody (Cappel) (dilution 1 :50) for 40 minutes at room temperature. After 
washing as before, the aminoethylcarbizole AEC/H202 substrate was added for 
30 minutes. The slides were rinsed in PBS, counterstained in Mayer's 
haematoxylin and mounted. 
7 .A.24 Production of Ascites 
Hybridomas failed to grow in BALB/c mice and were therefore grown in nude 
mice. Mice were primed for development of ascites by injecting 0.5 ml of 
pristane (2,6, 10, 14-tetramethyldecanoic acid) (Sigma) into them 
int raperitoneally at least 2 weeks prior to introducing the hybridomas ( 107 cells 
in 0.5 ml PBS). 2-3 weeks later, ascites was extracted (after killing the mice 
by cervical dislocation), centrifuged to remove cells, aliquoted and stored at -
80°C. 
7 .A.25 Cryopreservation of Hybridoma Cells 
Hybridoma clones were preserved either within the plate by removing the 
supernatants, adding 200 µI/well of 10% DMSO in HT medium containing 15% 
FCS (at 4°C), and then storing the sealed plate at -80°C; or by storing 
individual clones in the same DMSO solution at densities of 1-5 X 106 cells/ml. 
7.A.26 Karyotyping of Hybridomas 
Hybridoma cultures in logarithmic phase of growth were arrested in mitosis by 
treatment with 0.2 µg/m[ of colcemid (Gibco) for 45 minutes at 37°C. The 
cells were pelleted at 1 500 rpm for 5 minutes and lysed in hypotonic solution 
(0.075 M KCI) for 20 minutes at room temperature . After centrifugation, cells 
were washed 4 times in cold fresh methanol:glacial acetic acid (3: 1 ), 
suspended in 0.5 ml of this fixative and dropped from 40 cm onto cold glass 
slides. Chromosomes were trypsin-Giemsa banded by immersing slides in 
0 .05% trypsin for about 30 seconds. The stides were washed twice in PBS, 
. air-dried, stained in 2% Giemsa pH 6.8 for 7 minutes, and mounted in DPX 
(BDH) . 
7.A.27 lmmunoprecipitation of Hybridoma lmmunoglobulin 
lmmunoprecipitations of hybridoma cell lysates and culture · supernatants were 
performed according to a method adapted from Choi ( 1977). Approximately 5 
X 106 hybridoma cells in logarithmic phase of growth were labelled with 5 µCi 
of 14C-leucine for 24 hours. Cells were harvested by scraping and lysed in 1 
ml of 1 % Nonidet P-40 in 50 mM Tris, 25 mM KCI, 5 mM MgCl2 pH 7 .6. The 
cell lysate and supernatant were preprecipitated first for 1 hour at 37°C then 
Chapter 7 Materials and Methods / 204 
overnight at 4°C, using anti-chicken ovalbumen serum and a suboptimal 
concentration of chicken ovalbumen (Behring). Specific precipitations were 
performed for 3 hours at room temperature with the addition to the supernatant 
and lysate of optimal concentrations of Fab' 2 goat anti-human lgG (H + L) 
(Cappel) as well as total human gamma globulin (1 :50 dilution). The 
radiolabelled precipitates were washed once with 0.5% Nonidet P-40 followed 
by three washes with PBS, dried overnight at 37°C and electrophoresed on 10 
% SOS polyacrylamide gels. The gels were dried and exposed to X-ray film 
(Kodak XR-Xomat5). (As a control, PBL from a normal individual were 
stimulated with pokeweed mitogen in culture for 6 days prior to being similarly 
immunoprecipitated). 
7 .A.28 Indirect lmmunofluorescence: Cell Surface Antigens 
7.A.28.1 Cell surface immunoglobulin 
Hybridoma cells were washed in PBS and resuspended in 200 µI at a density of 
5 X 106 cells/ml in 4 separate Falcon tubes. Fab' 2 rabbit anti-human 
immunoglobulin lgG, lgM and lgA class specific antibodies (Cappel) were added 
to the separate tubes, the suspensions were mixed, and incubated for 30 
minutes at 4°C. The cells were centrifuged twice in 2 ml of cold PBS at 400g, 
and the pellet suspended in 100 µI of PBS. 20 µI of a 1 :20 dilution of goat 
anti-rabbit Fab' 2 FITC-conjugated antibody (Cappel) was added to each tube, 
and the suspension was incubated for 30 minutes at 4°C. Cells were washed 
twice as before, mounted in 30% sterile glycerol in PBS and examined under an 
Olympus BH2 microscope with epifluorescent illumination. 
7.A.28.2 CD5 + Antigen 
Hybridomas were tested for CD5 + antigen essentially by the same method 
(above) using a murine anti-CD5 monoclonal antibody (Dako:M705) and a FITC-
conjugated goat anti-mouse lgG (r) second antibody (Cappel). 
7.A.29 Tissue Absorptions 
. Protein extracts of kidney and liver tissue for use as absorbents in determining 
antibody specificity, were prepared using CHAPS detergent by the same 
procedure as for the heart extract (section 7 .A. 11). Tissues were obta'ined at 
autopsy (less than 8 hours post mortem) and stored in liquid nitrogen until 
processed. The absorbent was made by mixing equal concentrations of the 
two extracts, centrifuging the mixture in a microfuge for 5 minutes, and 
washing the pellet three times in Tris-maleate buffer pH 7 .25. The pellet was 
suspended in PBS in the same volume as the original mixture, aliquoted and 
lyophilized. 
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To remove nonspecific antibody binding (to heart), 10 µI of freeze-dried liver-
kidney absorbent was added to 200 µI of serum diluted 1: 10 in PBS pH 7 .4. 
(Rabbit antisera were diluted 1: 1000 for absorptions). The absorption mixtures 
were gently rotated on a Coulter Roller at 4°C overnight, and then centrifuged 
in a microfuge for 10 minutes to remove the absorbent with bound nonspecific 
antibody. 
7.A.30 Bacterial Antigen Sonicates 
Bacterial cultures in logarithmic phase of growth were washed twice in 0.01 M 
Tris-HCI pH 7.4 by centrifugation for 10 minutes at 10 000g. The density of 
the cultures was adjusted to a turbidity of E470 5.0. Bacteria were sonicated 
on ice at 18 microns (six 1-minute bursts with 30 second intervals) and 
unbroken cells were removed by centrifugation at 4000 rpm for 10 minutes. 
The supernatant was centrifuged at 48 000g for 45 minutes and the pellet 
consisting of bacterial cell walls was adjusted to a turbidity of E470 5.0 in 0 .01 
M Tris-HCI pH 7.4, and storea at -80°C. 
7.A.31 Bacterial Detergent Extracts: S.pyogenes and £. coli 
Bacterial cultures in logarithmic phase of growth were washed 3 times in sterile 
normal saline and adjusted to a turbidity of 00660 = 600 in a volume of 3 ml 
saline (equivalent to about 2.5 X 108 S.pyogenes cells and 3.6 X 108 E.coli 
cells). Suspensions were sonicated on ice at 20 microns (three 1-minute bursts 
with 30 second intervals), and then incubated with 5 mM CHAPS for 30 
minutes at 4°C. The cell debris was removed by centrifuging in a microfuge for 
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AGT11 CDNA LIBRARIES: CONSTRUCTION AND 
IMMUNOSCREENING (CHAPTER 5) 
Preparation of RNA and Synthesis of cDNA 
All RNA was handled in an RNAse-free environment as described in detail by 
Blumberg { 1987). 
7.B.1.1 RNA Extraction 
RNA was extracted by the method of Chomczynski and Sacchi (1987). Heart 
tissue was snap-frozen in liquid nitrogen within half-a-minute of excision at 
surgery. Isolations were made either from accumulated tissue derived from 
atrial appendage of non-rheumatic hearts, or from a heart removed at transplant 
surgery. 
5 g of frozen tissue was crushed, and ground to a powder under liquid nitrogen 
and homogenized in 50 ml of RNA extraction solution D (4 M guanidinium 
isothiocyanate; 25 mM sodium citrate pH 7; 0.5% sarcosyl, 0.1 M B-
mercaptoethanol) using an Ultra Turrex homogenizer. The following solutions 
were then added sequentially, with thorough mixing after each addition: 5 ml of 
2 M sodium acetate, 50 ml of water-saturated phenol and 10 ml of chloroform-
isoamyl alcohol mixture (49: 1). The final suspension was shaken vigorously 
and cooled on ice for 1 5 minutes, followed by centrifugation at 10 000g for 20 
minutes. The aqueous phase was removed, mixed with 50 ml of isopropanol, 
and placed at -20°C for at least 1 hour to precipitate the RNA. Following 
centrifugation at 10 000g for 20 minutes, the resulting RNA pellet was 
dissolved in 15 ml of solution D and precipitated with 1 volume of isopropanol. 
After centrifugation for 10 minutes at 4°C, the RNA pellet was washed twice in 
70% ethanol, vacuum dried and dissolved in 50 µI of 0.1 % SOS at 65°C for 10 
minutes. It was then either used immediately for poly {A)+ RNA isolation, or 
stored in 70% ethanol at -80°C. The RNA was checked by fractionation on a 
formaldehyde 1 % agarose gel (section 7.B.5.1), stained with ethidium bromide, 
and its integrity ascertained by the intactness of the 18S and 28S ribosomal 
RNA. 
7.B.1.2 Poly (A)+ RNA Isolation 
Great care was taken to prevent degradation of poly {A)+ RNA by RNAses, and 
to prevent loss of RNA through sticking to glass and plastic surfaces. 
Procedures recommended by Blumberg { 1987) for creating an RNAse-free 
environment were followed. All glassware used was pretreated by soaking for 
24 hours in 0.1 % diethylpyrocarbonate (DEPC), followed by autoclaving, and 
siliconization with 2% dimethylsilane in CCl 4 for 6 hours. It was then baked at 
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140°C for 3 hours, treated with 0.01 % DEPC followed again by baking a·nd 
autoclaving. 
The oligo-dT cellulose affinity column was prepared in a pasteur pipette, and 
plugged with silanized glass wool before addition of 0.5 g of oligo-dT cellulose 
(Collaborative Research) slurry in distilled water. The column was then washed 
with 10 ml of 0.1 M NaOH, and equilibrated with 10 ml of 0.01 M Tris pH 7.5, 
0.5 M NaCl. 
The RNA sample was centrifLJged for 10 minutes to remove insoluble 
precipitates before adjusting its concentration to about 20 00260 units/ml in 
equilibration buffer. The flow rate of the column was 20-30 ml/hr, and the 
RNA eluate was re-applied twice. Poly _ (A)- RNA was removed by washing 20 
ml of equilibration buffer through the column. The poly (A)+ RNA was then 
eluted from the column using a a low salt buffer (0.01 M Tris pH 7.5). 
Fractions of 1 ml were collected until there were no more traces of nucleic 
acids (A260 = 0). Fractions containing eluted RNA were pooled and 
precipitated with 1/10 volume of ammonium acetate pH 5.5, and 2.5 volumes 
of ethanol at -20°C. The poly (A)+ RNA was stored as a precipitate until 
needed, whereupon it was washed twice in 70% ethanol, dried and dissolved 
in sterile distilled water for immediate use. 
7 .8.1.3 Synthesis of cDNA 
cDNA was synthesized by three different methods referred to as: ( 1) the S 1 
nuclease method; (2) RNAse H method; (3) random hexanucleotide priming 
method. Reagents from various suppliers were used for the first two methods. 
The Amersham cDNA Synthesis System Plus was used for cDNA synthesis by 
the random hexanucleotide primers method (and also by the RNase H method). 
Several variations of each cDNA synthesis method were tried. The S 1 nuclease 
method used in Library A (see below) was adapted from Maniatis et al. ( 1982) 
and Efstratiadis et al. (1978); the RNAse H method used in Library B was based 
on a protocol recommended by Promega Biotec (Madison, USA); and the 
RNAse H and random priming methods used in Library A followed the 
instructions of the Amersham cDNA Synthesis System Plus. 
· (Avian reverse transcriptase supplied by Seikagaku, Promega or Amersham was 
used). 
7.B.1.3.1 S1 Nuclease Method 
Poly (A)+ RNA was dissolved in sterile water at 1 mg/ml, and 2 µI transferred to 
an RNAse-free, siliconized microfuge tube. 0.5 µI of 100 mM methylmercuric 
hydroxide was added, and the tube heated at 70°C for 5 minutes followed by 
quick cooling on ice. To a second sterile microfuge tube, 20 µCi of 32P-dCTP 
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( > 400 Ci/mmol) was added and the following reagents were added at room 
temperature, in order: 
dATP 10 mM 5 µI 
dGTP 10 mM 5 µI 
dTTP 10 mM 5 µI 
dCTP 1 mM 1 µI 
5 X RT buffer 20µ1 
OTT 200 mM 5 µI 
RNAsin 50 units 2 µI 
Oligo (dT) primer 1 mg/ml 1 µI 
Poly (Al+ RNA 1 mg/ml 2µ1 
Sterile H20 50µ1 
Reverse Transcriptase 40 units !..M! 
TOTAL VOLUME 100 µI 
The mixture was incubated at 41 °c for 1 hour, then heated at 1 oo0 c for 5 
minutes, cooled on ice and the denatured proteins pelleted by centrifugation for 
5 minutes. The supernatant was transferred to a microfuge tube containing 20 
µCi 32P-dCTP (dried down), and the following added: 
(supernatant) 

























The reaction was incubated at 18-20°C for 20 hours, extracted with chloroform 
and unincorporated nucleotides removed by chromatography through Sephadex 
G50. Fractions, checked by Cerenkov counting, showed two elution peaks the 
first of which (usually fractions 5-9) contained the cONA. These were pooled, 
lyophilized, and then reconstituted in 89 µI of sterile water. 10 µI of 10 X S 1 
nuclease buffer and 1 unit (1 µI) of S1 nuclease enzyme was added, and the 
reaction incubated at 37°C for 20 minutes. The mixture was again extracted 
with chloroform, fractionated on Sephadex G50 and fractions containing 
double-stranded cONA were pooled. (Calculation of cONA reaction yields was 
done as described below). 
7.B.1.3.2 RNAse H Method 
Synthesis of cONA by this method, was done either using the Amersham cDNA 
Synthesis System Plus according to instructions, or (more efficiently) following 
the protocol below, using mainly Promega Biotec reagents. 
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2 µg of Poly (A)+ RNA and 1 µg of oligo(dT) primer were added to an RNAse-
free microfuge tube, made up to 10 µI with sterile water and then heated at 
70°C for 5 minutes. The reaction was cooled to room temperature, briefly 
microfuged, and the following reagents added at room temperature to the 
annealed primer-template, in order: 
(RNA-oligo(dT) in water 
























Reagents were mixed and 5 µI removed to a separate tube containing 2-5 µCi 
( > 400 Ci/mmol) of 32P-dCTP, for measuring first strand synthesis by TCA 
precipitation (see below). Both tubes were incubated at 42°C for 1 hour and 
then placed on ice. To the 20 µI tube, add the following, in order: 
(First strand reaction 
























up to 100 µI 
100 µI 
Reagents were mixed gently, and incubated at 15°C for 2 hours. The reaction 
was stopped by heating at 70°C for 10 minutes, microfuged, cooled on ice and 
then 4 units of T4 DNA polymerase (2 units/µg RNA) were added and the tube 
incubated at 37°C for 10 minutes. The reaction was stopped by addition of 10 
µI of 0.2 M EDTA and placed on ice. 5 µI was removed for measuring second 
strand synthesis, and the remainder was extracted with phenol:chloroform and 
precipitated by addition of half a volume of 7 .5 M ammonium acetate and 3 
volumes of ice cold ethanol, followed immediately by centrifugation for 15 
minutes at room temperature. The supernatant was washed with 500 µI of 
cold 70% ethanol, dried and reconstituted in 25 µI of TE buffer. 
10 X First strand buffer: 500 mM Tris-HCI, pH 8.3; 750 mM KCI; 100 mM 
MgCl2; 5 mM spermidine 
10 X Second strand buffer: 500 mM Tris-HCI, pH 7.6; 1 M KCI; 50 mM MgCl2; 
100 mM ammonium sulphate; 500 µg/ml nuclease-free BSA 
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7 .B.1.3.3 Random Hexanucleotide Priming Method 
The Amersham cDNA Synthesis System Plus was used, according to 
instructions. Random hexanucleotide primers were used instead of an oligo(dT) 
primer in first strand synthesis; E.coli RNAse H was used in second strand 
synthesis; and E.coli T4 DNA polymerase was used to blunt-end the double-
st randed cDNA. 
7 .B.1.3.4 Calculation of cDNA Reaction Yields 
To measure cDNA reaction yields of first and second strand synthesis, 
radioactivity incorporated into each strand was estimated by TCA precipitation. 
Samples of 1 or 2 µI (or dilutions thereof, if the total cpm is too high) were 
spotted ohto glass fibre filters, dried, and then counted by Cerenkov counting. 
Filters were washed six times for 5 minutes per wash in 0.5 M Na2HP04, 
followed by two 1-minute washes in water and two 1-minute washes in 96% 
et hanol. The filters were dried and recounted . Percentage incorporation for 
each strand synthesized , was then calculated as: 
(cpm on post-wash filterlcpm on pre-wash filter) X 100% 
7 .8.2 Cloning of cDNA into .Agt11 Expression Vector 
.Agt11 dephosphorylated arms and other components for cloning, were 
purchased from Promega Biotec, Amersham or Stratagene. 
7 .8.2.1 T4 DNA Polymerase Blunt End Repair of cDNA 
The double stranded (d/s) cDNA synthesis reaction was heat inactivated and 
blunt-ended using T4 DNA polymerase . In some cases, cDNA was extracted 
with phenol:chloroform and precipitated prior to blunt-ending. Under these 
conditions, additional dNTPs (5 mM each) and T4 polymerase buffer (18 mM 
(NH4)2 S04, 6.6 M MgCl2, 10 mM B-mercaptoethanol, 66 mM Tris-HCI pH 
8 .3), or Kienow polymerase buffer (10 mM MgCl2, 50 mM NaCl, 10 mM Tris-
HCI pH 7.5) were added, and the reaction performed in a total volume of 50 µI. 
Two units of T4 DNA polymerase per µg of original mRNA template were used, 
and the mixture was incubated for 15 minutes at 37°C. The reaction was 
· terminated by addition of 1 µI of 0.5 M EDTA pH 8.0. The cDNA was 
extracted with phenol/chloroform, precipitated by addition of ammonium 
acetate and ethanol, and fractionated on a Sephadex G-50 column. cDNA 
derived from the S 1 nuclease method was efficiently blunt-ended using 
mungbean nuclease. 
7 .8.2.2 Methylation of Internal EcoR I Sites 
Up to 1 µg of cDNA was incubated at 37°C with 20 units of EcoR I methylase 
(Promega Biotec or Amersham) in the presence of 1 O mM S-
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adenosylmethionine, 10 mg/ml nuclease-free BSA, methylation buffer (0.1 M 
Tris-HCI pH 8 .0, 10 mM EDTA) and sterile distilled water to a total volume of 
125 µI. After 1 hour, the reaction was stopped by heating at 70°C for 10 
minutes. 
7.8.2.3 Ligation of EcoR I Phosphorylated Linkers to cDNA 
This reaction was done using a vast molar excess ( > 100-fold) of 
phosphorylated linkers to ensure that cDNA ends became ligated to a linker and 
not to each other. 800-1000 ng of linkers (Amersham, Pro mega or New 
England Biolabs) were added to a mixture containing 20 µI (about 100-200 ng) 
of methylated blunt-ended cDNA, 1 mM ATP and 3 µI of ligase buffer (0.05 M 
Tris-HCI p_H 7 .6, 10 mM MgCl2, 10 mM OTT, 50 µg/ml nuclease-free BSA) and 
water to a final volume of 30 µI. After brief mixing, 1 µI ( 100 Weiss units) of 
T4 DNA ligase was added, and the mixture was incubated at 15°C for 16-20 
hours. The ligase was inactivated by heating at 70°C for 10 minutes. (The 
efficacy of the ligation reaction was checked on a 1 % agarose gel). 
7.8.2.4 EcoR I Digestion of linkered cDNA 
The linkered cDNA was digested with 100 units of concentrated EcoR I enzyme 
in a total reaction volume of 100 µI at 37°C for 6 hours. The reaction was 
terminated by heating at 70°C for 10 minutes. 
7.8.2.5 Separation of Excess Linker Molecules 
To remove excess EcoR I linkers and eliminate cDNA molecules smaller than 
500 bp in length, the digested cDNA was fractionated by chromatography 
through a 15 cm Sepharose CL-4B column. The column was equilibrated with 
4 volumes of STE buffer_ ( 100 mM NaCl, 10 mM Tris-HCI pH 8, 1 mM EDTA) 
before applying the cDNA in a 100 µI volume. 100 µI aliquots were collected in 
STE buffer and analysed by Cerenkov counting. The two or three fractions 
with the highest dpm were pooled and precipitated with sodium acetate/ethanol 
at -20°C overnight. Typically fractions 3 and 4 were pooled and, to exclude 
unwanted free linkers, no fractions after No.5 were used. Aliquots of each 
fraction were also checked on thin 1 % agarose gels against end-labelled DNA 
marker fragments. 
cDNA was recovered by centrifuging for 30 minutes at 4°C, and the dried 
pellet dissolved in TE buffer at a final concentration of 25-50 ng/µI. 
7.8.2.6 Ligation of EcoR I-Ended cDNA into Agt11 
Ligation of linkered cDNA into dephosphorylated llgt11 arms included the 
following control reactions: (1) whole llgt11 vector DNA, to monitor the 
efficiency of the packaging reactions and the colour selection; (2) a model 
control EcoR I insert and the llgt11 dephosphorylated arms, to monitor the 
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efficiency of the ligation reaction of DNA into Agt11; (3) control DNA that had 
been subjected to the same reactions as the cDNA (T4 DNA polymerase blunt-
ending; linker addition, etc.), to check the performance of the entire cloning 
procedure. 
To determine the optimal cloning efficiency for each cDNA population (cDNA 
synthesized by RNAse H, random hexanucleotide primers or S1 nuclease 
methods), usually three ligation reactions were performed containing different 
amounts of cDNA in the range 25-100 ng, and a constant amount of Agt11 
dephosphorylated arms. The following table shows a typical set of ligation 
reactions. (Ligation buffer: 50 mM Tris-HCI pH 7 .8, 10 mM MgCl2, 10 mM 
OTT, 50 µg/ml nuclease-free BSA). 
TABLE 7.2.6 : Ligation Reactions of cDNA into .Agt11 
INSERT TUBE 1 TUBE 2 TUBE 3 TUBE 4 TUBE 5 TUBE 6 
DNA 100 ng 50 ng 25 ng 50 ng 100 ng 
EcoR I cut linkered linkered linkered linkered 
ligation blunt ended cDNA cDNA cDNA 
control cloning 
DNA control DNA 
Whole Agt 500 ng 
11 DNA (5µ1) 
Lgt 11 1µg (2µ1) 1µg (2µ1) 1µg (2µ1) 1µg (2µ1) 1µg (2µ1) 
arms 
10 x ligase 1µ1 1µ1 1µ1 1µ1 1µ1 1µ1 
Buffer 
10 m M 1µ1 1µ1 1µ1 1µ1 1µ1 1µ1 
ATP 
T4 DNA 
ligase 0. 1µ1 0 . 1µ1 0. 1µ1 0 . 1µ1 0 . 1µ1 0 .1µ1 
100 units/µ! 
Water to 1 OµI to 10µ1 · to 1 OµI to 1 OµI to 1 OµI to 1 OµI 
Tubes were incubated at 15°C for 15-20 hours and the ligation mix was 
packaged in vitro as described below. 
7 .8.2.7 Packaging of .Agt11 Recombinants 
Packaging extracts purchased from Amersham, Promega or Stratagene were 
used in various reactions. Of the three (tested on the same cDNA population), 
t he Stratagene extract "Gigapack Plus" was found to give the highest 
packaging efficiency. 
Chapter 7 Materials and Methods / 213 
Packaging reactions were performed according to the suppliers' instructions. 
Immediately after thawing, packaging extracts and DNA were mixed and 
incubated at 20°C for 2 hours. 0.5 ml of phage dilution buffer (SM Buffer) and 
10 µI of chloroform were added, the phage stock was gently mixed and stored 
at 4°C. (For libraries that were found to be efficient, half of this phage stock 
was stored in 7% DMSO at -70°C). 
Controls for packaging reactions included, whole ..igt11 and dephosphorylated 
..igt11 arms, as well as the ligated DNA cloning control (see ligation reaction 
table above). 
In trial packaging experiments, the efficiency of the packaging system was 
tested using the supplied lambda c1857 Sam7 DNA together with bacterial 
indicator strains (LE392 for Promega "Packagene" and VCS 257 for Stratagene 
"Gigapack Plus"). 
7.B.2.8 Plating and Titra'tion of Agt11 Libraries 
To calculate the phage titre, an initial 1: 100 dilution of phage in SM buffer 
representing 102 pfu/ml of the original 0.5 ml phage stock, was made by 
adding 30 µI of this stock to 270 µI of SM buffer. This was designated the 102 
dilution. Similar dilutions were made up to dilution 107, in duplicate. 
A single colony of Y1090 cells was inoculated into L-broth containing 0.4% 
maltose and ampicillin (50 µg/ml) and grown at 37°C with good aeration until 
an OD600 between 0. 7 and 0.9 was reached. 100 µI of these cells were then 
dispensed into round-bottom 10 ml Falcon tubes, and 100 µI of each phage 
dilution added to these tubes. Mixtures were incubated at 37°C for 15 
minutes, whereafter they were transferred to a 45°C heating block and 3 ml of 
top agar (kept ready at 45-50°C) was quickly added. Immediately, 20 µI of 
100 mM IPTG and 20 µI of 40 mg/ml of X-gal (BCIG) was added to each tube, 
the contents were mixed and poured onto dry L-agar plates containing 
ampicillin. Plates were left to set for 15 minutes and then incubated at 43°C 
for 3.5 hours followed by overnight incubation at 37°C. 
The number of plaques on plates containing fewer than 1000 pfu were counted 
and average titres were determined from the duplicate titration series. The 
phage titre/ml was calculated by multiplying the total average number of 
plaques by the dilution number (eg 250 plaques on the 1 o5 plate = 2.5 X 107 
pfu/ml). Both the total titre/ml (blue and clear plaques) and the titre of 
recombinants per ml (clear plaques) were calculated. 
7.B.2.9 Evaluation of Libraries 
For each library, the cloning efficiency per µg of cDNA was calculated. In 
addition, the size range of the cDNA inserts of each library was analysed on 1-
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2% agarose gels, by extracting the DNA from 10-12 randomly selected 
recombinant clones (section 7.8.2.10.1) and digesting it with either Miu I, or 
with Kpn I and Sac I. Libraries with the highest number of recombinant clones 
and the largest average cDNA insert range, were selected. 
The libraries screened in this study were not amplified, so as to avert the 
possibility of losing (or reducing the abundance) of poorly growing potentially 
relevant recombinants. However, to guard against loss of libraries through 
contamination (or other circumstances), amplified stocks . were made by pl~ting 
out the entire library at high density on several plates (as for immunoscreening 
but at higher density), adding 5 ml of SM Buffer to each plate and harvesting 
the phage as for making plate lysates (section 7.8.2.10.2). 
7.B.2.10 Lambda DNA Extraction 
For isolation of phage DNA, high titre phage lysates were prepared on a small 
scale using either plate or liquid lysates. The most effective method of DNA 
isolation was however found to be that described by Ausubel et al. ( 1987). 
This method is described below. 
7 .B.2.10.1 DNA Extraction from Liquid Lysates 
7.B.2.10.1.1 Liquid Lysate 
An overnight culture of E.coli Y1090 were grown in L-broth containing 0.4% 
maltose and ampicillin (50 µg/ml). A single plaque from a plated Agt11 cDNA 
library was cored out using a sterile pasteur pipette, and transferred to 0.4 ml 
of SM Buffer for elution of phage at 4°C for 2 hours. 100 µI of eluted phage 
was added to 100 µI of a 10 mM MgCl2/10 mM CaCl2 solution and incubated 
for 15 minutes at 37°C. The mixture was then transferred to 50 ml of NZC 
broth (section 7. C) and shaken vigorously for 6-8 hours until lysis occurred. 
Immediately after lysis, a few drops of chloroform were added and the cell 
debris removed by centrifugation at 10 000 rpm for 10 minutes at 4°C in a 
Beckman JA-20 rotor. The supernatant was immediately transferred to a sterile 
50 ml Falcon tube and stored at 4°C. 
7.B.2.10.1.2 DNA Extraction 
To 40 ml of liquid phage lysate, 8 µI of 5 mg/ml of DNAse and 20 µI of 10 
mg/ml RN Aase was added. The lysate was incubated for 1 hour at 37°C and 
the phage pelleted by centrifugation at 27 000 rpm in an SW-27 rotor for 90 
minutes. The supernatant was decanted and the remaining liquid wiped from 
around the phage pellet. Phage were resuspended in 200 µI of 0.05 M Tris-HCI 
pH 8, transferred to a microfuge tube and vigorously shaken in an equal volume 
of phenol for 20 minutes. After centrifugation for 2 minutes, the aqueous layer 
was re-extracted with phenol for 20 minutes, followed by two chloroform 
extractions. The DNA was precipitated by addition of 1 /1 O volume of 3 M 
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sodium acetate (pH 4.8) and 2 volumes of ethanol, and left at room 
temperature for 1 hour. The DNA was then centrifuged for 10 minutes, 
washed twice in 70% ethanol, dried under vacuum and resuspended in 30 µI 
TE buffer. 
7.8.2. 10.2 Plate Lysates 
Plaques were cored out from the agar plate, using a sterile pasteur pipette, 
deposited in 1 ml of SM buffer containing 20 µI of chloroform and incubated at 
4°C for at least 2 hours. A range of volumes of this stock (50-300 µI) was 
adsorbed to 100 µI of Y1090 cells and the cells were plated out according to 
the standard protocol (section 7.B.3). 5 ml of SM buffer was then added to 
each plat~ and they were shaken gently at 4°C for 3-4 hours. Lysates were 
poured into sterile tubes, a few drops of chloroform added, and centrifuged at 
5000 rpm for 5 minutes at 4°C to remove cellular debris. The supernatant was 
stored in sterile glass vials with 20 µI chloroform at 4°C, or used for DNA 
extraction. 
7.8.3 lmmunoscreening of Jlgt11 Libraries 
7.8.3.1 Antibody Screening Procedure 
A single colony of E.coli Y1090 cells was grown in LB medium containing 0.4% 
maltose and 50 µg/ml ampicillin at 37°C with good aeration until the OD550 
was between 0. 7 and 0.9. 300 µI of these cells were added to 300 µI of 
appropriately diluted phage in SM buffer in a 10 ml Falcon tube . Phage were 
adsorbed to the cells for 20 minutes at 37°C, whereupon 7. 5 ml of top agar 
(kept at 45-50°C) was added to the tube, and the culture poured onto 150 mm 
agar plates. Plates were left to set on a horizontal surface at room temperature 
for 20 minutes, then transferred to 43°C for 3.5 hours. They were then 
overlaid with dry IPTG-saturated ( 10 mM) nitrocellulose filters (Schleicher and 
Schuell), the position of the filters on the plate was marked with a needle, and 
the plates incubated overnight at 37°C. 
The following day, filters were removed, rinsed briefly in TBS (pH 7.9) and 
blocked for 1 hour at room temperature using 2% BSA, 1 % goat serum, 0.05% 
Tween 20 in TBS pH 7.5. The filters were rinsed, test antibody diluted 1 :100 
in 15 ml TBS pH 7 .9, was added, and incubated at 4°C for 6 hours. Filters 
were washed three times for 5 minutes each, and affinity-purified goat anti-
human lgG (H + L) antibody conjugate (Promega) was added at a dilution of 
1: 10000 in TBS, and incubated for 1 hour at 4°C. Filters were washed, and 
transferred to room temperature for the addition of the AP substrate solution. 
This was prepared (per 5 ml of solution) by adding 33 µI of NBT substrate (50 
mg/ml in 70% dimethylformamide) to 5 ml of AP buffer ( 100 mM Tris-HCI, pH 
9.5; 100 mM NaCl, 5 mM MgCl2), mixing and then adding 16.5 µI of (50 mg/ml 
X-gal in 100% dimethylformamide). The solution was used within 1 hour, and 
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added to the filters with gentle shaking for 3-5 hours or longer. The reaction 
was terminated by the addition of AP stop-buffer (20 mM Tris-HCI, pH 8.0; 5 
mM EDTA). 
A positive control consisting of a .Agt11 chicken ovalbumen clone together with 
an affinity purified rabbit anti-chicken ovalbumen antiserum was used (Clontech 
Laboratories). 
7 .B.3.2 Primary Antibody Dilution and Treatment 
The optimal dilution of test antibody for immunoscreening was determined by 
reacting different dilutions of patient sera against non-recombinant .Agt11 phage 
to determine the lowest background against which positive clones might be 
detected. In addition, the .Agt11 chicken ovalbumen clone, diluted 1: 1 o-4 in 
non-recombinant phage, was used together with rabbit anti- chicken ovalbumen 
serum to establish an optimal signal:noise ratio for screening. 
7.B.3.3 Removal of £. coli Cross-reactivity 
Some batches of sera had high levels of anti-£.co/i antibodies. These 
antibodies were removed either by: ( 1) incubating sera with different 
concentrations of E.coli lysate (1 :20, 1 :50, 1 :100, 1 :200) for 30 minutes at 
room temperature with gentle mixing, before using them in immunoscreening; 
or (2) by "pseudoscreening", in which non-recombinant .Agt11 phage were 
plated at 105 phage per 150 mm dish, transferred to filters which were blocked 
for nonspecific binding, and then used as a solid-phase absorbents to remove 
anti-£.co/i antibodies, by adding test sera for 6 hours with gentle shaking at 
4°c. 
7.B.3.4 Affinity Purif_ication of Antibody on Western Blots 
Certain sera were affinity purified against heart antigen before screening the 
libraries. An entire nitrocellulose filter from a Western blot of separated human 
heart extract (sections 7.A.9 and 7.A.11) was used as a solid phase absorbent. 
Sera were incubated with this filter for 2 hours at room temperature. Bound 
antibody was eluted using glycine-HCI pH 2.5 for 2 minutes, and the eluate 
was immediately neutralized in 750 µI (per 5 ml eluate) of 2 M Tris-HCI pH 10. 
7.B.3.5 Purification of Positive Clones 
Positive plaques detected by alkaline phosphatase second antibody screening, 
were easily located against the fainter background of negative plaques (see Fig. 
5.5). (Needle and ink marks were also used for correct alignment). The exact 
positive plaque was cored out using a sterile pasteur pipette and transferred to 
500 µI of SM buffer in a microfuge tube. A few drops of chloroform were 
added and the tube incubated overnight at 4°C. Eluted phage were plated at 
low density (less than 200 pfu), rescreened and the whole process repeated 
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until all the plaques were positive. Stocks of highly-purified phage were stored 
at 4°C (and at -70°C in 7% OMSO). 
7.B.4 Analysis of positive clones 
7.B.4.1 Analysis of Fusion Proteins 
7.B.4.1.1 Isolation of Recombinant Lysogens 
(For establishment of lysogeny by this procedure it was found essential to omit 
yeast extract from all media used). 
A single colony of Y1089 cells was inoculated into 10 ml of L-broth (without 
yeast extract) containing 0.4% maltose and 50 µg/ml ampicillin and shaken 
overnight at 37°C. 1 ml of the overnight culture was then inoculated into 50 
ml of prewarmed L-broth (as above), and incubated with shaking at 37°C for 2-
3 hours until the 00600 reached 0.5 (2. 5 X 10
8 cells/ml). The culture was 
then supplemented with 10 mM MgCl2 and dispensed into 100 µI aliquots and 
kept on ice. Each 100 µI aliquot was infected with 10-50 µI of a phage dilution 
containing about 108 pfu, so as to achieve a multiplicity of infection (m.o.i) of 
5-10. The culture was incubated at 32°C for 20 minutes, and the infected 
cells were diluted for plating at a density of about 200 per 90 mm plate, and 
incubated overnight at 32°C. From each such plate, 25 colonies were picked 
using sterile cocktail sticks, and each colony was spotted onto duplicate L-agar 
plates containing ampicillin. One plate was incubated at 32°C and the other at 
43°C. Lysogens were identified by their ability to grow at 32°C but not at 
43°c. 
7 .B.4.1.2 Fusion Proteins 
50 ml of L-broth pH 7.5 was inoculated with a single colony of a specific 
Y1089 recombinant lysoge·n, and incubated at 32°C with vigorous shaking until 
the culture had grown to an 00600 of 0.6 (about 5 hours). The temperature of 
the culture was then rapidly raised to 45°C, by the addition of 50 ml of L-broth 
prewarmed to 70°C, followed by immediate immersion of the flask in a 45°C 
waterbath with vigorous shaking for 20 minutes. 5 mM IPTG was then rapidly 
added and the flask was incubated for about 45-60 minutes at 38°C. The 
longest incubation time without lysis occurring was determined for each 
recombinant lysogen, and found to be usually less than 1 hour. At this optimal 
time, lysogenized cells were rapidly harvested in a JA-10 rotor at 5000 rpm for 
5 minutes at 30-37°C. Pelleted cells were rapidly resuspended in 1 /20 the 
original culture volume in TEP Buffer (100 mM Tris-HCI pH7.4, 10 mM EOTA, 1 
mM PMSF), and immediately frozen in liquid nitrogen and stored at -70°C. To 
lyse the induced lysogens, they were thawed at 37°C, refrozen in liquid 
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nitrogen, thawed again and sonicated (3 X 10 s) to reduce viscosity. The 
sonicated extract was centrifuged at 10 000 rpm for 10 minutes to remove cell 
debris. The proteins in the supernatant were precipitated with 3 volumes of 
saturated ammonium sulphate at 4°C for at least 60 minutes. It was stored as 
a slurry or else centrifuged at 10 000g for 20 minutes, the supernatant 
discarded and the pellet redissolved in TEP buffer at approximately 10 mg/ml of 
protein. It was then either analysed as a crude extract by immunoblotting 
against sera, or further processed for purification of the fusion protein on anti-
B-galactosidase immunoaffinity columns (see Results). 
7.8.4.2 Analysis of DNA Positive Inserts 
7 .8.4.2.1 Subcloning of jgt11 Inserts into pUC19 
7 .8.4.2.1.1 In-gel Ligation of Insert into pUC1'9 
Subcloning of inserts from Agt11 into pUC19 was done by in-gel ligation 
according to the method Struhl ( 1985). Recombinant Agt11 DNA was digested 
w ith EcoR I, and then subjected to electrophoresis in 0. 7% low melting agarose 
(SeaPlaque) using TAE Buffer. The released insert was excised from the gel in 
t he smallest possible volume (20-40 µI) using a sterile scalpel blade and 
transferred to a sterile microfuge tube. The gel slice was then heated at 70°C 
for 15 minutes. 7 µI of this insert DNA was combined with 2 µI of EcoRl-cut 
pUC19 at an insert:vector concentration ratio of 5: 1, and incubated at 37°C for 
~ 3 minutes before addition of 11 µI of ice-cold ligation mixture containing 2 X 
ligase buffer, ATP and T4 DNA ligase. The reaction was quickly mixed and 
placed on ice . Mixtures were incubated at 15°C overnight (or up to 48 hours). 
For transfection, gel ligation mixtures were remelted at 73°C for 5-10 minutes, 
and 5 µI of ligation mixture was used to transfect 200 µI of competent E.coli 
cells. 
7 .8.4.2.1.2 Plasmid DNA Isolation 
7 .8.4.2. 1.3 Small Scale (Rapid) Preparation 
10 ml of sterile L-broth was inoculated with E.coli and shaken overnight at 
37°C. Before DNA extraction, glycerol stocks were made by mixing equal 
volumes (500 µI) of overnight culture and glycerol stock buffer (65% 
glycerol/0.1 M MgS04/25 mM Tris pH 8). 
Remaining cells were pelleted at 4000 g for 10 minutes, and . resuspended in 
200 µI of 25 mM Tris pH 8.0, 10 mM EDTA, 50 mM glucose for 5 minutes at 
room temperature. To lyse the cells and denature the DNA, 400 µI of 0.2 M 
NaOH, 1 % SOS was added for 5 minutes on ice. Genomic DNA was 
precipitated by addition of 300 µI of 3 M potassium acetate pH 4.8, and 
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removed by centrifugation at room temperature for 5 minutes. Plasmid DNA, 
contained in the supernatant, was precipitated by adding 3/4 volume of 
isopropanol and incubating at -20°C for 30 minutes. The DNA was pelleted, 
washed twice with 70% ethanol, vacuum dried and dissolved in TE buffer. 
7.8.4.2.1.4 Large Scale Preparation 
A 100 ml overnight culture of transfected E.coli was grown in L-broth 
containing 50 µg/ml ampicillin was prepared. To amplify plasmid DNA, 
chloramphenicol was added to a final concentration of 200 µg/ml. After a 
further 5 hours of shaking at 37°C, the bacteria were harvested by 
centrifugation at 4000g for 10 minutes at 4°C. The pelleted cells were 
resuspended in 50 mM Tris-HCI pH 8.0 containing 25% sucrose (Clear Lysate 
Buffer A) and then incubated on ice for 5 minutes before addition of lysozyme 
to a final concentration of 2 mg/ml. After a further 5 minutes on ice, 1. 5 ml of 
250 mM EDTA, pH 8.0, was added. After another 5 minutes, 50 mM Tris-HCI 
pH 8.0, 6.25 mM EDTA, 0.5% Triton X-100 (Clear Lysate Buffer 8) was added, 
and the suspension left on ice for 20 minutes with occasional gentle swirling. 
Bacterial debris was removed by centrifugation at 20 000 rpm in a Beckman 
JA-20 rotor for 40 minutes at 4°C. CsCI was added at 1 g per ml of 
supernatant, and to each 10 ml of this mixture was added, 0.8 ml of 10 mg/ml 
ethidium bromide . The samples were centrifuged in sealed polyallomer tubes 
for 36 hours at 49 000 rpm in a Beckman Ti-60 rotor at 18°C. The band 
containing plasmid DNA was visualised under UV light, and removed. To 
remove ethidium bromide, the DNA was extracted 4 to 5 times with an equal 
volume of water-saturated 1-butanol, until the pink colour disappeared. The 
aqueous phase was extensively dialysed against 0.1 X TE at 4°C, and DNA in 
the dialysate precipitated at -20°C, washed with 70% ethanol, dried and 
dissolved in sterile water or TE buffer. 
7.8.4.2.1.5 Preparation of Competent E.coli Cells 
Competent E.coli DK-1 cells were prepared by inoculating 3 ml of an overnight 
culture into 300 ml of L-broth in a 1-litre flask. The cells were grown at 37°C 
with vigorous shaking for about 1-2 hours until the OD650 was between 0.2-
0.4. The cells were then pelleted at 4000g for 5 min at 4°C, and gently 
resuspended in 40 ml of an ice-cold sterile solution of 60 mM Ca Cl 2, 10 mM 
PIPES, pH 7.2. The suspension was incubated on ice for 30 minutes, and the 
cells again centrifuged at 4000g for 5 minutes at 4°C. The pellet was gently 
resuspended in 4 ml of 60 mM CaCl2, 10 mM PIPES pH 7.2, and 15% glycerol. 
200 µI aliquots were rapidly frozen in a dry ice/ethanol bath and immediately 
stored at -70°C until needed. 
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7.8.4.2.1.6 Plasmid DNA Transfection of E. Coli Cells 
An aliquot of frozen competent cells was thawed on ice for 30 minutes. 
Between 5 and 100 ng of DNA (in TE buffer or ligation mixture) was added to 
100 µI of cells in a round-bottom Falcon tube, and incubated on ice for 30 
minutes. The cells were heat-shocked for 3 minutes in a 43°C waterbath with 
gentle agitation. 1 ml of L-broth was added to the cells which were then 
incubated at 37°C for 1 hour. Transfected cells (50-250 µI) were plated onto 
agar plates containing ampicillin (50 µg/ml), and incubated at 37°C overnight. 
Circularised (uncut) and cut pUC19 were always included as transfection 
controls. 
7 .8.4.2.2 Sequencing of DNA 
Positive DNA inserts subcloned from Agt11 into pUC19 were sequenced using 
t he modified T7 DNA polymerase, Sequenase (United States Biochemical). The 
pUC19 double stranded DNA ( 1-2 µg) was denatured at 37°C for 30 minutes in 
0 .2 N NaOH. This reaction was neutralised by addition of 2 µI of TE and 7 µI 
of 1 N HCI. The primer (0.5 pg in 1 µI) was added and the reaction incubated 
at 37°C for 30 minutes, whereupon the template- primer DNA was precipitated 
in 50 µI of ethanol overnight at -20°C. The DNA was pelleted by 
centrifugation, washed in 70% ethanol, dried and dissolved in 8 µI of water and 
2 µI of 5 X sequenase buffer (200 mM Tris-HCI, 100 mM MgCl2, 250 mM 
NaCl, pH 7.5) . To the annealed DNA mixture, the following were then added in 
a final volume of 15.5 µI and left for 5 minutes at room temperature: 6.25 mM 
fresh OTT, 0.2 µM dNTPs (dATP, dGTP, dTTP), 10 µCi 32P-dCTP and 2 units of 
Sequenase enzyme. The reaction was then terminated by adding 3.5 µI of the 
labelled DNA mixture to each of four termination mixes (section 7 .C) containing 
one of the four dideoxynucleotides. The termination reaction preceded for 5 
minutes at 37°C, and was then inactivated by addition of 4 µI of sequenase 
stop buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% 
xylene cyanol) and heating at 75°C for 2 minutes. Reactions were placed on 
ice, and 3 µI aliquots of each were loaded onto a 1 meter vertical 
polyacrylamide gel and electrophoresed at 2400 V for 6-10 hours. The gels 
were dried and exposed to X-ray film for 24 hours. 
7 .8 .5 General Nucleic Acid Techniques 
7.8.5.1 Formaldehyde Agarose Gel Electrophoresis of RNA 
RNA was fractionated on 1 % agarose gels containing 2.2 M formaldehyde as 
described by Maniatis et al. ( 1982). Ag arose was boiled in RNA Running Buffer 
(40 mM MOPS, 10 mM sodium acetate, 10 mM EDTA, pH 7 .0) and then cooled 
with stirring to 60°C before the addition of formaldehyde . Horizontal gels were 
poured and run at 150 mA for 2-5 hours. 
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7.8.5.2 Agarose Gel Electrophoresis of DNA 
DNA was heated at 65°C for 5 minutes prior to fractionation on horizontal 
agarose gels (0.5-3% depending on size of fragments to be resolved). Large 
gels were run for 4-6 hours at 150 mA constant current in TAE Buffer (4 mM 
Tris, 5 mM sodium acetate, 1 mM EDTA, pH 7.8). Minigels were run for 45 
minutes at 50 mA in TBE Buffer (90 mM Tris-Borate, 90 mM boric acid, 2 mM 
EDTA, pH 8.3). Gels were stained in 0.5 µg/ml ethidium bromide and 
visualised under UV light. 
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7.C BUFFERS AND SOLUTIONS 
The composition of some commonly used buffers and solutions used are 
presented below. More specialised buffers are described in the text of sections 
7.A and 7 .8. 
ABTS/H20 2 ELISA substrate solution 
Dissolve 40 mM ABTS (Sigma) in distilled water 
Add 100µ1 ABTS to 10 ml fresh citric acid pH 4 
Add 100µ1 of 30% H202 immediately before use. 
AEC lmmunocytochemistry substrate solution 
1 mg AEC dissolved in 0.25ml N-N-dimethylformamide. 
Add 3.5 ml of acetate buffer pH 5.2 
Add 38µ1 of 3% H202 
Filter before use. 
Stable for only 2-3 hours. 
Alkaline phosphatase (AP) buffer 
100mM Tris-HCI pH 9.5 
100mM NaCl 
5mM MgCl2 
Alkaline phosphatase (AP) stop buffer 
20mM Tris-HCI pH 8.0 
5mM EDTA 
Alkaline phosphatase (AP) substrate solution 
33µ1 of 50mg/ml NBT in 70% dimethylformamide in 5ml AP buffer 




7 % Acetic acid 
The nitrocellulose filter was stained in this solution for 5 minutes then 
destained in hot 2% acetic acid 
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Ampicillin plates 
Autoclaved solution was allowed to cool to about 55°C before adding 2 .5mls 
of 1 Omg/ml ampicillin (final concentration of 50µg/ml): 
5g Tryptone 
2 .5g Yeast extract 
2.5g NaCl 
7.5g Bacto-agar 
per 500mls water 
40ml of the solution was added per 100mm diameter plate. 





























Dignam buffer A 
1 OmM HEPES, pH 7 .9 
1.5mM MgCl2 
10mM KCI 
0.5mM OTT (add fresh) 
Dignam buffer C 




25% v/v glycerol 
0.5mM OTT (add fresh) 
0.5mM PMSF (add fresh) 
Dignam buffer D 
20mM HEPES, pH 7 .9 
0.1M KCI 
0.2mM EOTA 
20% v/v glycerol 
0.5mM OTT (add fresh) 
0.5mM PMSF (add fresh) 
DNA stop buffer 




ELISA blocking buffer 
1% BSA 
1 % goat serum 
1 OOmM glycine 
in TBS, pH 7.5 





Stored at 4°C, used within 2 weeks 
ELISA PBS-Tween wash buffer 
0.01 % Tween 20 
in PBS pH 7.4 
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GKN buffer for mAb (per liter of distilled water) 
8.0g NaCl 
0.4g KCI 
3 .56g Na2HP0412H20 
2.0g Glucose 
0.01 g Phenol Red 
Autoclave to sterilise 
Glycerol stock buffer for plasmids 
65 % glycerol 
0.1M MgS04 
25mM Tris-HCI, pH 8 .0 
H.A.T medium for mAb Selection (100 x) 
To make 25ml -
3.75ml FCS 
5.00ml SP2 conditioned medium 
0.25ml HAT 
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0.25ml Antibiotics (penicillin 100 U/ml; streptomycin 100 µg/ml) 
16. 5ml RPMI-H-B 












pH to 7.25, then add 5mM CHAPS detergent. 
HT/FCS/SP2 mAb conditioned medium 
15ml FCS (Flow or Gibco Myoclone) 
20ml SP2 24hr conditioned medium 
1 ml HT 100 x 
1 ml Antibiotics 
66ml RPMI-HEPES-bicarbonate 
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12.5 µI 30% H202 
lmmunoblotting transfer buffer 
0.05 M Tris 
0 .3 M Glycine 
20% v/v Methanol 
Kienow polymerase buffer (10 x) 




For 1 liter: 
1 Og tryptone 
5g yeast extract 
5g NaCl 
Set pH 7. 5 using 1 N Na OH 
LB medium (per litre) 
1 Og tryptone 
5g yeast extract 
5g NaCl 
1 ml 1 N NaOH 
Ligase buffer { 10 x) 
500 mM Tris-HCI 
70mM MgCl2 
100mM OTT 
500µ9/ml nuclease-free BSA 
Methylation buffer 
0.1 M Tris-HCI, pH 8.0 
10mM EDTA 
NZC broth 
1 Og NZ Amine A 
5g NaCl 
2g MgCl2.6H20 
Autoclave 30 min 
Made to 0. 1 % in Casamino Acids 
Made to 1 litre 






8.1 mM Na2HP04. 7H20 
pH 7.0 
Plasmid mini-prep solution 1 
25mM Tris-HCI, pH 8 .0 
10mM EDTA 
50mM glucose 
Plasmid mini-prep solution 2 
0.2N NaOH 
1% sos 
Plasmid mini-prep solution 3 
3M potassium acetate, pH 4.8 
Plasmid clear lysate buffer A 
50mM Tris-HCI, pH 8.0 
25% sucrose 
Plasmid clear lysate buffer B 
50mM Tris-HCI, pH 8.0 
6.25mM EDTA 
0.5% Triton X-100 
Reverse transcriptase buffer (for S1 cDNA ) (5 x) 
250mM Tris/HCI pH 8.3 
500mM KCI 
30mM MgCl2 
Reverse transcriptase buffer (for RNAse H cDNA) (5 x) 
1 OOmM Tris-HCI, pH 8.3 
10mM MgCl2 
140mM KCI 
RNA Extraction Solution D 
4 M guanidinium thiocyanate 
25mM sodium citrate, pH 7 .0 
0.5% sarcosyl 
0. 1 M B-mercaptoethanol 
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RNA gel running buffer (5 x) 
0.2M Morpholinopropansulfonic acid (MOPS) 
50mM Na acetate 
50mM EDTA 
pH 7.0 









0.25% bromophenol blue 
5 % B-mercaptoethanol 





Sequenase stop -buffer 
95% Formamide 
20mM EDTA 
0.05% Bromophenol blue 
0.05% Xylene cyanol 
S1 nuclease buffer (10 x) 
0.3M Na acetate, pH 4.5 
3M NaCl 
100mM ZnCl2 
SM lambda diluent buffer 
1 OmM Tris-HCI, pH 7. 5 
10mM MgCl2 
STE buffer 
1 OmM Tris-HCI, pH 8.0 
100mM NaCl 
1mM EDTA 
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T4 DNA polymerase buffer (5 x) 
0.09M (NH4)2S04 
0.33M Tris-HCI, pH 8.3 
0.33M MgCl2 
0 .05M B-mercaptoethanol 
T AE agarose electrophoresis buffer { 10 x) 
40 mM Tris 
50 mM Na acetate 
10 mM EDTA 
pH 7 .8 with glacial acetic acid 
TBE agarose electrophoresis buffer { 10 x) 
0.90M Tris 
0.90M boric acid 
25mM EDTA 
pH 8.3 
TE buffer { 10 x) 
1 OOmM Tris-HCI 
10mM EDTA 
pH 8.0 
TEP fusion protein buffer 
100mM Tris-HCI, pH 7.4 
10mM EDTA 
1mM PMSF 
Tris buffered saline + Tween 20 {TBST) 
1 OmM Tris-HCI pH 8.0 
150mM NaCl 
0.05% Tween 20 
Tris buffered saline {TBS) 
25mM Tris 
0.9% w/v NaCl 
pH 7.5 
Versene Stock Buffer (5 x) (per litre) 
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APPENDIX A 
STATISTICAL TESTS AND UNIVARIATE DESCRIPTIVE STATISTICS 
See next 12 pages for tables of univariate descriptive statistics for each group 
of subjects. 
Diagram of Box Plot 
Y ...... ............... . largest observation in data set 
s 75th % + 1.5 (IOR) 
+ 
... ..... ..... 75th percentile 
... .. ....... . arithmetic mean 
1-------1 ............. median (50th percentile) 
'---~--' ........ ... .. 25th percentile 
X ..................... smallest observation in data set 
;;: 25th % - 1.5 (IOR) 
* > 3 x IOR 
O ............ .. . < 3 x IOR 
The median was used to describe the average value of the variables. Where the median is used, 
the descriptive measure of dispersion used is the interquartile range or the distance between the 
25th (01) and the 75th (03) percentile. The standard deviation is a measure of the spread of 
observations around the arithmetic mean. The skewness of the frequency distribution of the 
variable can be gleaned from the relative position of the mean and the median, together with the 
associated measures of dispersion. 
Statistical Analyses 
Mann-Whitney-U Test: 
This test was used to test the hypothesis that there is no difference in the medians of the two 
groups compared. This test was used instead of the t-test, since the number of observations in 
the groups compared were generally not equal, and the underlying distributional assumptions of 
the t-test were not met. 
Spearman Rank Correlation Coefficient: 
The Spearman Rank Correlation Coefficient gives a measure of linear assoc1at1on between 
variables, without requiring that the data are normally distributed . The significance of the value 
of the correlation coefficient depends on the size of the sample used to calculate it. The results 
from the hypothesis test are greatly influenced by the sample size of each of the two variables, 
and caution must therefore exercised in interpreting results . 
Fisher's Exact Probability Test: 
This test is used when two independent sample variables are small in size and are in two 
mutually exclusive classifications. The test determines whether the two groups differ in the 
proportion in which they fall into the two classifications. The test does not depend on 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ADMISSION CRITERIA FOR PATIENTS 
ACUTE RHEUMATIC FEVER (ARF) 
Admission Criteria for Patients 243 
i) must fulfill the Jones Criteria (as revised by the American Heart Association 1984), 
ii) must have carditis according to usual clinical criteria, 
iii) must have been given no medication except penicillin or antifailure treatment, 
iv) must have informed parental consent, 
v) must have had no heart operations, 
vii can have an initial attack of ARF or have acute on chronic rheumatic fever, 
v) symptoms present for less than 14 days. 
CHRONIC RHEUMATIC HEART DISEASE (CRF-a, CRF-c) 
ii must be regular attenders at the clinic, 
ii) must have had no heart operations, 
iii) must have had no episodes of ARF within the previous 1 2 months, 
iv) must have no signs of ARF at the time of entry, 
v) must be on no drugs other than penicillin or antifailure therapy, 
vi) must have been on no steroids during the previous 12 months, 
vii) must have been documented to have had regular penicillin prophylaxis 
viii) must have clinically and echocardiographically documented rheumatic valvular disease, 
ix) must have informed parental consent (i.e . children), 
x) must be older than 5 years. 
ACUTE GOMERULONEPHRITIS (AGNI 
ii the symptoms must have been present for less than 7 days, and they must have been 
in-patients for less than 48 hours, 
ii) the features must be of classic AGN, i.e. oliguria, dark urine, fluid overload, haematuria, 
and hypertension, 
iii) the haematuria must be on dipstix at least 3 +, 
iv) there must be at most 2 + proteinuria on dipstix, 
v) serum albumin must be greater than 30 g/L, and cholesterol less than 6 mmol/L, 
vi) they must have received no medication other than penicillin, diuretics or anti-
hypertensives, 
vii) there must be no organic heart disease, 
viii) there must be no history of rheumatic fever. 
ISCHAEMIC HEART DISEASE (IHD) 
Subjects in this group were drawn from patients undergoing cardiac catheterization and 
coronary angiography for ischaemic heart disease. None of them had any history or clinical 
evidence of rheumatic heart disease. 
NORMALCONTROLS(CONT~.CONT~) 
i) must have no immunological disease, 
ii) must have no illness which might affect immune syste~, 
iii) must have had no history of acute rheumatic fever, 
iv) must have a clinically normal heart, 
v) must be on no medication, 
vi) must be older than 5 years, 
vii) must have informed parental consent (i.e . children). 
/ 
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